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ABSTRACT  
Micronutrient recommendations are derived using a risk analysis paradigm. This commonly involves 
a process of three, separate yet interconnected, risk activities to assess, communicate and manage risk. 
Research has suggested a lack of transparency in the application of risk analysis activities during the 
process of setting micronutrient recommendations. The aim of this thesis was to identify the practical 
challenges of communicating risk internally - between experts and/or stakeholders - and understand 
the implications of these challenges for achieving a transparent micronutrient risk analysis process. A 
series of three international qualitative studies were conducted which employed narrative literature, 
interview and case study methods. Research was primarily related to the process of setting folate and 
vitamin D dietary reference values (DRV) or regarding the implementation of DRV via food-based 
dietary guidelines (FBDG). Results identified challenges to the communication of risk across all three 
risk activities (risk assessment, risk communication and risk management). These challenges included 
clarifying the terms of reference between risk assessors and risk managers during the DRV problem 
formulation stage; equivocal lay involvement and ambiguous handling of uncertain (unknown, 
indefinite, unreliable) evidence during DRV risk assessment; inconclusive evidence of successful risk 
communication (FBDG); and ubiquitous inconsistency of DRV/FBDG terminology throughout risk 
analysis. Findings suggested specific areas where effective (valid and credible) internal 
communication of risk is required between risk experts and/or stakeholders involved in the risk 
analysis process. This is distinct from, and in addition to, traditional risk communication activities 
conducted with the general public/stakeholders outside the risk analysis process. Overcoming the 
challenge of communicating risk is a prerequisite for achieving a transparent micronutrient risk 
analysis, and can aid future debates on the pre-eminent micronutrient recommendation setting 
process. 
iii 
 
ACKNOWLEDGEMENTS 
Thank you to everyone I collaborated with throughout the course of completing each of these 
published works. I would like to thank my EURRECA colleagues for their belief in me and dedication 
to carrying out the challenging data collection underlying each manuscript. In addition, thank you to 
the wider EURRECA network, with whom I continue to enjoy working and chancing upon on various 
occasions – the world of nutrition is delightfully diverse, yet small! I also acknowledge the good will 
and contributions from individuals and institutions who participated in these studies. I hope you feel 
proud of your involvement if you have the opportunity to read this thesis or any of the enclosed 
publications. 
Thank you to past and present members of the Food Consumer Behaviour and Health Research 
Centre team (particularly Julie Barnett, Bernadette Egan, Monique Raats, Dick Shepherd, Lada 
Timotijevic) for your support, the opportunities awarded to me as a researcher and my autonomy 
during EURRECA to carry out each study and pursue each publication.  
Thank you to various inhabitants of 6/9AC04 (Gerda, Jopes, Kate, Neil, Shumaisa) for your calmness, 
philosophical debate and humour. Similarly, thanks to the much appreciated faculty technical and 
professional support team, including Andrew Barnes, Nigel Woodger, Mark Cole and Clare Sharman, 
who have never failed to be anything but warm, useful and interesting voices of reason. 
Many thanks to the NIHR RDS team and LSHTM for allowing me the time and space to complete 
this work. A special thanks to Julie Barnett and Inge Tetens, whose encouragement was important in 
giving me the confidence to pursue my ideas. Thanks to Alison and Debbie; 44 Rossiter Road 
(garden, kettle, Amanda’s patience) and most importantly Test Match Special for getting me over the 
line. 
Friends and family, thank you for your support, patience and unerring faith in me; apologies for the 
protracted route to PhD! Bonjour Henry! Love to all. 
 
 
 
 
 
 
“The scientific method is based on what I prefer to call the inquiring mind-set” 
Sir Harry Kronto, 2007 
iv 
 
CONTENTS 
1. INTRODUCTION .............................................................................................................................. 1 
1.1 Why set recommendations for micronutrients? ............................................................................ 2 
1.1.1 Micronutrients are necessary for health ................................................................................. 2 
1.1.2 Efficacy of recommendations .............................................................................................. 10 
1.2 What are micronutrient recommendations? ................................................................................ 12 
1.2.1 Inconsistent terminology ...................................................................................................... 12 
1.2.2 Disparity in micronutrient recommendations....................................................................... 13 
Table 1 Disparity in vitamin D and folate DRV for adults ........................................................... 16 
Table 2 Variation in DRV nomenclature ...................................................................................... 17 
Figure 1 Dietary Reference Values as a distribution of individual nutrient requirement ............. 18 
1.3 How are micronutrient recommendations set? ............................................................................ 19 
1.3.1 Risk analysis paradigm ........................................................................................................ 19 
1.3.2 Communication of risk......................................................................................................... 22 
Figure 2 Three activities of risk analysis ...................................................................................... 25 
1.4 Research questions ...................................................................................................................... 26 
1.4.1 Overall research question ..................................................................................................... 26 
1.4.2 Specific research questions .................................................................................................. 26 
1.5 Methods....................................................................................................................................... 27 
1.5.1 Qualitative methodology ...................................................................................................... 27 
1.5.2 Qualitative methods ............................................................................................................. 28 
1.5.3 Thematic analysis ................................................................................................................. 30 
Table 3 Type and nature of the body responsible for setting micronutrient recommendations .... 31 
2. SUMMARY OF PUBLISHED WORKS FORMING THESIS ........................................................ 32 
2.1 Abstracts ..................................................................................................................................... 32 
2.1.1 Publication 1: Micronutrient recommendation stakeholders’ beliefs on dietary guidelines: a 
qualitative study across six European countries/regions ............................................................... 32 
2.1.2 Publication 2: Consumer involvement in dietary guideline development: opinions from 
European stakeholders .................................................................................................................. 33 
2.1.3 Publication 3: A review of consumer awareness, understanding and use of food-based 
dietary guidelines .......................................................................................................................... 34 
v 
 
2.1.4 Publication 4: Communication of scientific uncertainty: international case studies on the 
development of folate and vitamin D Dietary Reference Values.................................................. 35 
2.1.5 Publication 5: EURRECA-Evidence-Based Methodology for Deriving Micronutrient 
Recommendations ......................................................................................................................... 36 
2.2 Table 4 Contribution of thesis author to co-authored published works forming thesis .............. 37 
2.3 Co-author statement .................................................................................................................... 38 
3. CONCLUSION ................................................................................................................................. 42 
3.1 Summary of findings ................................................................................................................... 42 
3.1.1 Terminology ......................................................................................................................... 43 
3.1.2 Lay involvement .................................................................................................................. 43 
3.1.3 Efficacy ................................................................................................................................ 44 
3.1.4 Uncertainty ........................................................................................................................... 45 
3.2 Limitations .................................................................................................................................. 48 
3.2.1 Context ................................................................................................................................. 48 
3.2.2 Approach .............................................................................................................................. 48 
3.2.3 Bias ...................................................................................................................................... 49 
3.3 Future research ............................................................................................................................ 50 
3.4 Closing comments ....................................................................................................................... 52 
Figure 3 Terminology aid for risk communication ....................................................................... 53 
4. REFERENCES ................................................................................................................................. 54 
APPENDICES ..................................................................................................................................... 73 
Appendix 1: Published works context .............................................................................................. 74 
Appendix 2: Published works forming thesis ................................................................................... 75 
Appendix 2.1 Publication 1: Micronutrient recommendation stakeholders' beliefs on dietary 
guidelines: a qualitative study across six European countries/regions ......................................... 75 
Appendix 2.2 Publication 2: Consumer involvement in dietary guideline development: opinions 
from European stakeholders.......................................................................................................... 76 
Appendix 2.3 Publication 3: A review of consumer awareness, understanding and use of food-
based dietary guidelines ................................................................................................................ 77 
Appendix 2.4 Publication 4: Communication of scientific uncertainty: international case studies 
on the development of folate and vitamin D Dietary Reference Values ....................................... 78 
Appendix 2.5 Publication 5: EURRECA-Evidence-Based Methodology for Deriving 
Micronutrient Recommendations .................................................................................................. 79 
Appendix 3: Table 5 relationship between published works 1-5 and thesis ..................................... 80 
vi 
 
Appendix 4: Supporting publications 1-6 ......................................................................................... 81 
Appendix 4.1 Supporting publication 1: From micronutrient recommendations to policy: 
consumer and stakeholder involvement ........................................................................................ 81 
Appendix 4.2 Supporting publication 2: The process of setting micronutrient recommendations: a 
cross-European comparison of nutrition-related scientific advisory bodies ................................. 82 
Appendix 4.3 Supporting publication 3: Changing micronutrient intake through (voluntary) 
behaviour change. The case of folate ............................................................................................ 83 
Appendix 4.4 Supporting publication 4: EURRECA - A framework for considering evidence in 
public health nutrition policy development................................................................................... 84 
Appendix 4.5 Supporting publication 5: Scientific decision-making and stakeholder 
consultations: The case of salt recommendations ......................................................................... 85 
Appendix 4.6 Supporting publication 6: Stakeholders’ views on factors influencing nutrition 
policy: a qualitative study across 10 European countries ............................................................. 86 
Appendix 4.7 Table 6 Contribution of thesis author to co-authored supporting publications ...... 87 
Appendix 5: A note on EURRECA .................................................................................................. 88 
Appendix 6: Curriculum vitae........................................................................................................... 89 
 1 
 
1 INTRODUCTION 
A nutrient is “a substance that nourishes an organism” and inherently good for one’s health, yet both 
under and over exposure of micronutrients (vitamins and minerals) can lead to undesirable health 
effects (Collins, 2016). This makes the risk analysis of micronutrient exposure a complex decision-
making process: where risks for high (toxic) intakes have to be considered, as well as risks for 
inadequate/beneficial (deficient/‘optimal’) intakes (CAC, 2015). Further complexity originates from 
the variability and uncertainty of the evidence on the role of micronutrient intake/status on health, 
which can differ per micronutrient, by health outcome or population requirements (e.g., dependent 
upon gender, age, life-stage, genes or lifestyle; WHO, 2004).  
A risk analysis paradigm is used to set recommendations for micronutrients (Yoe, 2012). This 
involves a structured approach to analyse risk via the application of three activities: risk assessment 
(to estimate risk); risk management (to judge the un/acceptability of risk) and risk communication (to 
coherently exchange risk information; EFSA, 2012). The application of these activities can differ 
dependent upon the risk situation (problem) under study (CAC, 2015; IOM, 2008). Nevertheless, all 
elements of the process are expected to be systematically and transparently documented, with 
uncertainty and variability in scientific data/information/knowledge explicitly acknowledged (IOM, 
2007). This enables the quality of risk analysis results to be interpreted across activities and 
encourages responsible governance structures for managing risky public health situations (Renn, 
2008). 
Research has questioned whether risk analysis is sufficiently transparent across the different European 
countries and international regions responsible for setting recommendations for micronutrients 
(Dhonukshe-Rutten, 2010). Ambiguity has been observed when setting folate and vitamin D dietary 
reference values (DRV), regarding the decisions taken to account for uncertain and variable evidence 
during risk assessment (King, 2007). Furthermore, it has not always been clear why food-based 
dietary guidelines (FBDG) have been the preferred risk management option contrary to risk 
assessment advice to employ alternative strategies, such as mandatory fortification (Jensen, 2012).  
Challenges of communicating risk and uncertainty may, in part, explain the ambiguity and lack of 
transparency during the process of setting micronutrient recommendations. Considerable research has 
been conducted to encourage the transparent communication of risk between those inside and outside 
the risk analysis process. Less attention however, has been paid to the role of communicating risk 
within the risk analysis process (between risk analysis activities, risk experts and/or stakeholders; 
Renn, 2008). It is therefore, the aim of this thesis to identify challenges to communicating risk 
internally - between risk experts and/or stakeholders - and understand the implications of these 
challenges for achieving a transparent micronutrient risk analysis process. The context considered is 
that of setting folate/vitamin D DRV, as well as reflecting upon the connotations for FBDG.  
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1.1 Why set recommendations for micronutrients? 
1.1.1 Micronutrients are necessary for health 
Micronutrients are vitamins and minerals required in small or trace amounts for healthy growth, 
development and bodily/brain function (Geissler, 2011). This is due to the array of metabolic 
processes that are dependent upon micronutrients (Garrow, 2003). For instance, folate facilitates DNA 
replication and cell division (Wagner, 1995); iodine is a component of the hormones responsible for 
growth and physical/mental development (Ristic-Medic, 2013); iron is required to form haemoglobin 
and myoglobin for the transport and storage of oxygen (Harvey, 2013); vitamin A is necessary for 
effective vision (i.e., eye development in utero) and reproduction (Clagett-Dame, 2011); vitamin D 
and calcium are essential for bone health (IOM, 2011); and zinc is part of the enzymes/proteins 
essential for immune system function (Lowe, 2013).  
A deficit of micronutrients can develop into the clinical signs and symptoms associated with 
micronutrient deficiency disease, which if left untreated can be fatal (Groff, 2000; WHO/FAO, 2006). 
Iron deficiency anaemia is the most common micronutrient deficiency disease, affecting 
approximately a sixth of the global population or one billion people and accounting for over half the 
anaemia cases recorded worldwide (Kassebaum, 2016; WHO, 2015). Anaemia is a condition where 
red blood cell production and the oxygen carrying capacity of the blood (haemoglobin) decreases, 
limiting the body’s ability to distribute oxygen to the peripheral tissues (WHO, 2015). In iron 
deficiency anaemia this can lead to numerous health consequences including increased morbidity and 
mortality via reduced physical performance/work capacity; complications before and after birth (e.g., 
pre-term delivery); and increased maternal mortality (Hass, 2001; Lopez, 2016). Iron deficiency 
anaemia may be the most common, yet deficiency in any micronutrient is associated with a range of 
adverse health effects and deficiency diseases (Tulchinsky, 2010). For example, anaemia can also be 
the consequence of a deficiency in folate, vitamin A and vitamin B12 (as well as via non-micronutrient 
causes, such as inherited disorders or parasitic infections; WHO, 2015). In addition, to name but a 
few, a deficiency in calcium is indexed to the disease of osteoporosis (Heaney, 2003); a lack of iodine 
results in iodine deficiency disorders, which include goitre, impaired mental function, hypo-/hyper-
thyroidism and cretinism (Zimmermann, 2015); vitamin C is indexed to scurvy (WHO/FAO, 2004); 
vitamin D deficiency is indexed to rickets or osteomalacia (Horlick, 2007); and zinc deficiency is 
linked to a wide range of conditions including growth rate, dermatitis, diarrhoea and depressed 
immune function (Prasad, 1991).  
Public health interventions, such as improved hygiene, sanitation and nutrition, have reduced the 
global prevalence of micronutrient deficiency and the burden of micronutrient deficiency diseases; 
however, micronutrient deficiency remains a public health issue for populations in both the developed 
and developing countries of the world (Lim, 2012). The populations most vulnerable to micronutrient 
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deficiency include those in a life-stage where micronutrient requirements are higher; those with a 
greater incidence of general under-nutrition, including insufficient energy and protein intakes; and 
those with a greater susceptibility to infectious disease (Bailey, 2015a; Potter, 2006). These 
vulnerable populations are more likely to be found in developing areas with less well established 
public health infrastructure, and include a disproportionately greater number of women, infants and 
children (Andersson, 2012). Nevertheless, a range of micronutrient deficiencies have been observed 
in populations across all life stages and throughout both developing and developed regions (Bailey, 
2015a; Tulchinsky, 2010; WHO, 2006). For example, in 2004 the WHO European region was 
estimated to account for 20% of the global population at risk of iodine deficiency and related iodine 
deficiency disorders (WHO/UNICEF, 2007; Zimmermann, 2008). In addition, comparisons of 
national dietary intake monitoring and surveillance data across Europe have suggested 20% of adults 
have inadequate intakes of calcium, folate, iodine, selenium and vitamin D (European Nutrition 
Health report I and II Elmadfa, 2009; Roman-Vinas, 2011). Micronutrient deficiency thus, persists in 
areas that seemingly have established public health infrastructures and a plentiful supply of 
micronutrients (Kaganov, 2015). 
The reasons for micronutrient deficiency are multi-factorial and complex, involving a combination of 
social, environmental and physiological factors. Social factors, such as personal, cultural, economic or 
political characteristics, can all affect the motivation, opportunity or ability to access food and carry 
out certain dietary practices (e.g., lifestyle attitudes limiting the consumption of fresh fruits and 
vegetables; socio-economic status reducing an ability to purchase particular foods; IOM, 1998a; 
NCM, 2014). Environmental factors (e.g., climate, geography, geology etc.) are influential via their 
impact on the micronutrient content of foods (e.g., reductions in selenium soil content reduce the 
selenium in the food supply; latitude affecting the months of the year exposed to particular 
wavelengths of sunlight to endogenously synthesise vitamin D; WHO, 2004). Similarly, physiological 
factors (e.g., biology, genetics, current and past health/nutritional status), can all affect an individual’s 
homeostatic regulation/utilisation of a micronutrient upon exposure (e.g., congenital differences in 
folate metabolism enzymes); and individual physiological requirements of a micronutrient (e.g., life 
stage, such as female micronutrient adaptations during the peri-conception period, pregnancy and 
lactation; Allen, 2005; EVM, 2003). It is therefore, a challenge - particularly at a public 
health/population level - to understand the causal relationship between what one consumes 
(micronutrient intake), how this is digested, circulated and stored within the body (micronutrient 
status) and the absence/presence of adverse health outcomes (e.g., micronutrient deficiency diseases; 
Ashwell, 2008; Bailey, 2015a; Dhonukshe-Rutten, 2010; Matthys, 2011). 
In 2007-2012 the EURRECA (European micronutrient recommendations aligned) network of 
excellence categorised the evidence surrounding the role of micronutrients on health into the 
aforementioned three areas:  micronutrient intake, micronutrient status and health, as part of a large 
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scale project investigating the possibility of aligning recommendations on micronutrients across 
Europe. One output from this work was the identification of 10 micronutrients that could be 
considered of public health priority, which included calcium, copper, folate, iodine, iron, selenium, 
vitamin B12, vitamin C, vitamin D and zinc (Cavelaars, 2010). The priority of each micronutrient was 
judged first on the volume of new evidence that had amassed to explain the relationship between 
micronutrient intake, status and the absence/presence of adverse health effects (i.e., new knowledge). 
Second, indications of inadequate micronutrient status from monitoring or surveillance data were 
reviewed (i.e., the incidence/prevalence of deficiency/disease). Third, the degree of disparity in 
recommendations for micronutrients between different countries/international regions was considered 
(i.e., an indication of recommendation uncertainty/variability; Cavelaars, 2010). All of the ten priority 
micronutrients identified are necessary for health; therefore, of public health import, and would have 
been suitable subjects for this thesis. It was decided however, to focus upon the two priority 
micronutrients of folate and vitamin D. These micronutrients were considered topical i.e., folate and 
vitamin D recommendations were being reviewed/updated in a number of countries/international 
regions around the time of the thesis research (table 1). In addition, the process of setting 
micronutrient recommendations for folate and vitamin D represents a challenge from both the public 
health policy and scientific investigation point of view, which forms a particularly complex and 
interesting field of inquiry (HCN, 2009; Timotijevic, 2013a; Timotijevic, 2013b). These challenges 
are illustrated below, using the three evidence categories employed by EURRECA of micronutrient 
intake, micronutrient status and health (Matthys, 2011). 
Micronutrient intake 
Micronutrients can be sourced from foods naturally rich in certain vitamins or minerals; foods 
processed with fortified or added micronutrients; as well as those available in dietary supplements 
(either singularly or as a multi-nutrient supplement). In this way, folate is a term which encompasses 
both natural derivatives of folate in foods, as well as the synthetic forms of folic acid used in 
supplements and fortification practices (Garrow, 2003; SACN, 2006). Good sources of natural food 
folate include liver, green leafy vegetables, yeast extract, legumes and some fruits (especially oranges 
and strawberries; Bailey, 2010; EVM, 2003). Common fortified foods which are good sources of 
folate include foods produced with fortified wheat flour, breakfast cereals, fat spreads/margarine and 
fruit juices (Lawrence, 2009; SACN, 2006). Folate intake however, cannot simply be recorded by 
measuring the folate content of individual foods. This is because bioavailability determines how much 
of the folate consumed corresponds to the amount of folate that is biologically active or stored in the 
body (Hoey, 2013). The degree of folate bioavailability, and how to account for this when estimating 
folate intake or folate status, has been a subject of discussion (McNulty, 2004). The bioavailability of 
natural folate foods; folic acid fortified foods; or folic acid supplements can range from 10-98% 
(Bailey, 2010; EVM, 2003). This can be due to the source of folate (e.g., folic acid is more stable 
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during processing/ingestion and raw natural food folates are more bioavailable than cooked folates); 
host genetic variations (e.g., in the enzymes available for folate digestion); or the combinations of 
foods consumed (e.g., a mixed diet can provide folate bioavailability of approximately 50%; 
Berdanier, 2015; IOM, 1998b; WHO, 2004). Dietary folate equivalents (DFE) can be employed to 
create a common reporting unit for folate. In this way, 1 DFE is used to represent 1 µg food folate or 
0.6 µg of folate from fortified food/supplement consumed with food or 0.5 µg of folic acid 
supplement taken on an empty stomach (EFSA, 2014a; IOM, 1998b). DFE has not been universally 
accepted method to express folate intake, due to uncertainty and variability in the ability to measure 
folate status (discussed further in micronutrient status section below; Hoey, 2013). This has resulted 
in different micronutrient recommendation setting bodies choosing different methods to report folate 
intake, either via DFE (e.g., in the United States of America and at the European level; EFSA, 2014a; 
IOM, 1998b), or absolute folate intakes (e.g., in the UK and the Netherlands; HCN, 2003; SACN, 
2006).  
Accurately measuring the micronutrient intake of vitamin D can also be problematic (NCM, 2014). 
Vitamin D is a fat soluble vitamin, which has two main physiological forms: vitamin D2 
(ergocalciferol) and vitamin D3 (cholecaliferol). Vitamin D2 is produced by ultraviolet irradiation of 
ergosterol in plants, fungi and lower life forms; therefore, oily fish, eggs, full fat milk products and 
liver are good natural dietary sources of vitamin D2 as the vitamin D2 has been concentrated along the 
food chain (EVM, 2003). Vitamin D can also be food in foods that have been fortified, such as fat 
spreads/margarine, milk, breakfast cereals, and fruit juices (EVM, 2003). Unique to the micronutrient 
of vitamin D is the ability for the skin to produce vitamin D3 when exposed to certain wavelengths of 
sunlight/ultraviolet light (Geissler, 2011). The season, weather conditions, skin melanin content and 
factors that might block the skin rays (e.g., sunscreen, clothing), can all affect endogenous vitamin D 
synthesis (WHO, 2004). In addition, geographical location is important with regions above 37 degrees 
latitude unlikely to receive the necessary wavelengths of sunlight for endogenous vitamin D synthesis 
during Oct to Mar, due to the position of the earth rotating and revolving around the sun during these 
months (Peterson Fundamentals of Physical Geography, 2010). Following ingestion and skin 
synthesis, both forms of vitamin D can be either stored or reduced to the active steroid hormone 1,25-
dihydroxyvitamin D2 in the liver and kidneys (EFSA, 2016b; SACN, 2016).  
It is difficult to quantify the relative contributions of each source of vitamin D (dietary and 
endogenous synthesis from sunlight; Balvers, 2015). Population vitamin D intake can be 
under/overestimated dependent upon whether a measure of endogenous vitamin D synthesis is 
included as a source of vitamin D; yet, establishing sunlight exposure is a challenge for national 
dietary intake surveys (Jacques, 1993). Measuring sunlight exposure involves recording time spent 
outdoors (e.g., possible via the use of light sensors on wrist work accelerometers more traditionally 
associated with measuring sleep patterns or physical activity), as well as information on the degree 
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skin was exposed to the sun whilst outdoors and whether the light wavelengths were suitable for 
vitamin D synthesis (e.g., information on time of the day/year and latitude; NCM, 2014). 
Furthermore, in relation to public health policy if one takes into account sun exposure when 
considering vitamin D intake then this involves collaboration across national health departments and 
scientific experts to ensure nutrition/toxicology/medical assessments and priorities are consistent and 
aligned i.e., aligning health promotion advice to ensure sun exposure is encouraged for sufficient 
vitamin D production, yet skin cancer risk is reduced by warning of sun over exposure (Cashman, 
2011).  
Dietary intake measures are not without their own challenges (Lennernas, 1998). National dietary 
intake surveys play an important role in helping to inform public health policy; however, it is 
inherently difficult to establish accurate and reliable measures of micronutrient intake via dietary 
assessment methods (Illner, 2012; Satia-Abouta, 2003). Self-reported measures (e.g., food frequency 
questionnaires, food diaries, 24-hour recall interviews) are often critiqued regarding their accuracy, 
primarily due to the potential for incomplete recall and misreporting which can bias data collection 
(Westerterp, 2002). In addition, these measures are reliant on the use of food composition databases to 
convert dietary level data into nutrient level data and such databases can be incomplete, particularly 
regarding processed foods; thus affecting the ability to accurately reflect folate or vitamin D intake 
from fortified foods (FAO/INFOODS, 2003).  
Micronutrient status 
Biological markers (biomarkers) can be used to overcome the difficulties of performing dietary 
assessment with self-reported data; yet these are to be used with caution (Wild, 2001). Biomarkers 
indicate the amount of micronutrient that is biologically active, circulating or stored within the body 
e.g., via measuring the blood concentration of a nutrient or metabolite (IOM, 2007). A review of 
folate biomarkers indicated red blood cell folate and serum/plasma folate can be two robust and 
sensitive biomarkers for long-term dietary folate intake/stores and recent folate intake, respectively 
(Harvey, 2010). Nevertheless, variability is still apparent between assays and laboratories when using 
these biomarkers (Harvey, 2010). Furthermore, there is deliberation as to a) the most appropriate cut-
off values to diagnose folate deficiency, sufficiency and toxicity and b) whether to consider using the 
same cut-off values with different assays (Pfeiffer, 2007). An alternative biomarker to indicate folate 
status is plasma total homocysteine concentration, yet this marker can be influenced by other B 
vitamins and factors such as age, sex, ethnicity and lifestyle (Hoey, 2013). There has therefore, been 
some deliberation as to the validity of using biomarkers and establishing the correct cut-off points to 
denote deficiency or sufficiency for folate (as well as a number of other micronutrients; Bailey, 
2015b).  
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Similarly, heterogeneity has repeatedly been observed in the assays used to measure vitamin D status, 
indicating a lack of precision and accuracy in the assays available (Binkley, 2010; Lamberg-Allardt, 
2013; Rosen, 2011; Sempos, 2012; Snellman, 2010). This has led to calls for an international standard 
to measure vitamin D via total serum or plasma 25-hydroxyvitamin D (25(OH)D; Cashman, 2013; 
Sempos, 2015). The Vitamin D Standardization Program (VDSP) was created in the USA in 2010 and 
has been gaining recognition and international partners to align standard operating procedures for 
measuring vitamin D status (Cashman, 2013). Nevertheless, the validity of markers to measure 
vitamin D status can still be confounded by how much sunlight one might have been exposed to, as 
well as by the cut-off points used to denote deficiency or adequacy (Cashman, 2013; Jaques, 1993). 
Serum 25(OH)D is commonly used to measure vitamin D status because the plasma level of 
biologically active vitamin D (1,25-dihydroxyvitamin D) is subject to homeostatic control; therefore, 
serum 25(OH)D is considered a more valid marker of all source vitamin D (from the diet, via sunlight 
exposure and from converted liver adipose stores; Rosen, 2011). Furthermore, the cut-off points to 
denote vitamin D deficiency using serum 25(OH)D measurement are also subject to debate (Cashman, 
2011; Ross, 2011). A level of 25 nmol/l serum 25(OH)D has been accepted as the marker for 
deficiency; however, more recently there have been questions as to whether this should be raised to 
30 nmol/l or 50 nmol/l (Horlick, 2007; IOM, 2007; Rosen, 2011; Thusen, 2012). In addition, a 
biomarker assay provides but a snap shot of someone’s status for that particular period of time. 
Vitamin D is a fat soluble vitamin; however, vitamin D stores will be depleted upon underexposure to 
dietary or sunlight derived vitamin D sources. Vitamin D status therefore, can vary throughout the 
year from winter to summer seasons. This can have repercussions for interpretation of the correct 
deficiency cut-off point as an observation of 30 nmol/l during the summer months is likely to 
represent a greater deficiency than an observation of 30 nmol/l during the winter (Balvers, 2015).  
An inability to accurately establish folate and vitamin D intake/status is one of the issues to be 
managed when setting micronutrient recommendations (Aggett, 2010; MacFarlane, 2016). This is 
because uncertain, unknown or variable information on folate/vitamin D exposure will affect whether 
the evidence available is considered robust or reliable regarding, for example, the mechanisms of 
action and systematic pathways that might further the understanding of exactly why and how these 
micronutrients are necessary for health (Casgrain, 2010; Gregory, 2001). Further consequences 
include, uncertainty with interpreting evidence regarding the prevalence and incidence of 
deficiency/toxicity (and similarly, the clinical diagnosis/treatment of deficiency/toxicity), as well as a 
limited ability to evaluate the success or failure of public health interventions (MacFarlane, 2016). 
How a recommendation setting body might choose to manage the uncertainty of establishing 
micronutrient exposure can differ between countries and international regions (Doets, 2008). For 
example, the North American and UK vitamin D recommendations have removed the uncertainty 
surrounding the relative contributions of endogenous synthesised vitamin D versus dietary vitamin D 
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by assuming minimal sun exposure and instead judging recommendations based predominantly upon 
the evidence related to dietary vitamin D intake alone (IOM, 2011; SACN, 2016). 
Health 
Folate is involved in cell division and cell maintenance, with requirements highest where rapid cell 
division is necessary, such as during pregnancy or periods of growth (HCN, 2008; SACN, 2006). 
Derivatives of folate (folate co-enzymes) are required for one carbon transfer reactions. These are 
necessary for RNA/DNA synthesis (e.g., purine/pyrimidine synthesis); methylation reactions and 
amino acid metabolism (EVM, 2003; Hoey, 2013; McNulty, 2008). Deficiency of folate therefore, 
can lead to a reduction in DNA biosynthesis and impaired cell replication. This can result in folate 
deficiency megaloblastic anaemia, where fewer red blood cells are released into circulation and these 
are malformed (immature or unusually large; Groff, 2000). Clinical symptoms of megaloblastic 
anaemia include insomnia, fatigue and/or cognitive impairment (EVM, 2003; Geissler, 2011; Hoey, 
2013). In addition, inadequate folate status during the peri-conceptual/early pregnancy period is 
associated with increased congenital malformations of the brain, vertebrae and skull resulting in 
neural tube defects, such as anencephaly, encephalocele and spina bifida (Geissler, 2011; RCOG, 
2003).  
As a water soluble vitamin, folate is not stored within the body and excess folate is excreted by the 
kidneys. This homeostatic self-regulation limits the likelihood of the body being subjected to toxic 
levels of folate (Geissler, 2011). There have however, been concerns regarding excess exposure to 
folate (Bailey, 2015b). These have been particularly in relation to the uncertainty of adverse health 
outcomes with long term exposure to unnecessarily high levels of circulating folate in non-targeted 
sections of the population (e.g., not women who are capable of having a child; Wright, 2007). In 
addition, the risk to older people regarding the ability of abundant folate intake to mask vitamin B12 
(cobalamin) deficiency i.e., complicate the aetiology of megoblastic anaemia (SACN, 2006). 
Diagnosis of folate deficient megaloblastic anaemia is complicated regards identifying whether folate 
deficiency is the primary or secondary cause of the anaemia (Devalia, 2014). Deficiency in both B12 
and folate can lead to megaloblastic anaemia due to interactions between these vitamins (Savage, 
1994). Addressing anaemia with folate can therefore, mask an underlying B12 deficiency. This can 
have severe consequences, as B12 is required for neurological function as well as for red blood cell 
production and DNA synthesis (Garrow, 2003). This means there is a risk that B12 deficiency could 
remain a ‘silent’ deficiency with the potential to cause irreversible damage, particularly for older 
people where there is a higher prevalence of B12 intestine malabsorption (Tulchinsky, 2010). These 
considerations have led to scientific and political debate concerning whether folic acid fortification is 
required as a risk management strategy and how this would be implemented (Jensen, 2012; 
Timotijevic, 2010; WHO/FAO, 2006). Several countries have shown a reluctance to implement wide-
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spread mandatory folate fortification (e.g., of wheat flour), despite repeated advice from scientific 
bodies that this would be beneficial (e.g., in the UK; DH/COMA, 2000; SACN, 2006) and reports 
from North America that have suggested a reduction in neural tube defects since mandatory 
fortification was introduced (Honein, 2001; Liu, 2004). 
The interactions between folate and vitamin B12 and resultant health outcomes of neural tube defects 
and megaloblastic anaemia, illustrates the difficulty of examining micronutrients in isolation. The 
degree to which a micronutrient is considered necessary for health is influenced by the scope of the 
problem to be addressed i.e., which factors are taken into account when looking at the relationship 
between micronutrient intake, status and health (e.g., which micronutrient interactions; characteristics 
of the population vulnerable to adverse health effects; health outcomes/health outcome biomarkers of 
interest have been considered). For example, there has been a growing body of research that has 
begun to investigate the association between folate deficiency and diseases not traditionally indexed 
as micronutrient deficiency diseases, such as non-communicable diseases. This research has 
suggested folate deficiency could be related to cardiovascular disease/stroke (via raised total plasma 
homocysteine levels); cancer (via single carbon transfer reactions and subsequent DNA 
replication/cell division); or depression (via an association between folate and serotonin; EVM, 2003; 
SACN, 2006; Taylor, 2003). The knowledge to-date however, remains inconclusive as to the role of 
folate on the aetiology and pathology of non-communicable diseases (SACN, 2006).  
There have also been suggestions vitamin D could play a role outside the traditionally indexed 
micronutrient deficiency diseases (Horlick, 2007). Vitamin D is important for musculo-skeletal 
health; playing a key role in calcium and phosphorous homeostasis by targeting the kidney, small 
intestine and bone to regulate calcium and phosphorous absorption, re-absorption or formation (EVM, 
2003). Vitamin D deficiency during childhood is associated with skeletal deformities, such as rickets; 
whereas deficiency in adulthood is associated with exacerbating osteoporosis, causing osteomalacia 
(softening of the bones), and muscle weakness or the risk of fracture (Horlick, 2007). The finding that 
the majority of the body’s cells and tissues have vitamin D receptors has led to a plethora of scientific 
investigation to establish whether vitamin D could be associated with a range of health comes, 
including non-communicable chronic diseases (e.g., cancers, auto-immune diseases, or cardiovascular 
disease) and all-cause mortality (Horlick, 2007; SACN, 2016). It has however, been difficult to 
extricate the contribution of vitamin D in the development or treatment of non-communicable chronic 
diseases, particularly as opposed to or in collaboration with other nutrients, dietary patterns and 
lifestyle factors (e.g., smoking, alcohol, physical activity; Heaney, 2003). The current knowledge to 
support the role of vitamin D on health outcomes outside the traditionally indexed micronutrient 
deficiency diseases is therefore, lacking and currently recommendations for vitamin D continue to be 
developed soley in relation to the indexed musculo-skeletal health outcomes (EFSA, 2016; SACN, 
2016). 
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1.1.2 Efficacy of recommendations 
To understand the current evidence base surrounding the role of micronutrients in health it is useful to 
comprehend the history and potential future direction of nutrition. Current nutrition knowledge has 
been built upon pioneering work throughout the centuries. The relationship between food and health 
has been known since early man regarding foods to be avoided (food safety) or sought (nutrition) to 
ensure survival (Covello, 1985). Aristotle, circa 400 years BC, purported the importance of nutrition 
to life and the soul: “…nothing is nourished which does not have a share in life” (Aristotle, De Anima 
ii4, 416b:20-23). It was not until the 18th century that nutrition was explored as a science by the 
systematic and methodological investigation of the links between food and health. A well-known 
example is the case of Sir James Lind who introduced the notion of dietary deficiency diseases. Lind 
was a Surgeon-General in charge of health policy for the British Navy in the 18th century. Lind 
conducted trials with sailors and observed rapid recovery from scurvy in sailors who were provided 
with citrus fruits (due to what we know now was the vitamin C content of the fruit). This finding 
ensured the provision of limes on long sea voyages, with sailors encouraged to drink lime juice daily; 
hence why British sailors have been known as “limeys” (Lind, 1753). Further developments in 
nutrition came with the isolation and synthesis of micronutrients in the 20th century. This enabled the 
formal identification of a range of micronutrient deficiency diseases, such as the association between 
folate and anaemia, as well as that between vitamin D and rickets (Garrow, 2003).  
The 21st century continued to bring advances in technology and measurement or analysis techniques 
(e.g., metabolomics or epidemiology modelling analytics) that have enabled opportunities for 
contemporary nutrition to examine the existing nutrition knowledge base and provide a greater 
understanding of nutrient metabolism (Mozaffarian, 2010). The validity (precision, accuracy, 
reliability) of markers used to estimate micronutrient intake, measure micronutrient status and 
diagnose micronutrient deficiency are being refined as methods become more precise (Bailey, 2015b). 
This is particularly pertinent for folate and vitamin D, in light of the issues discussed above regarding 
disagreement of cut-off values and variability in assay methodology reliability (Harvey, 2010).  
A greater understanding of nutrient metabolism has the potential to enable further studies to 
investigate the health implications of micronutrient deficiency regarding traditionally indexed 
diseases, as well as sub-clinical adverse health effects (de Castro Kroner, 2015; SACN, 2016). For 
example, the effect of seasonal variation of vitamin D intake/status or potential adverse health effects 
with a vitamin D status which is not currently considered clinically deficient; yet, could be 
insufficient to meet physiological demands (Bischoff-Ferrari, 2006; Shenkin, 1997). Furthermore, the 
prospect of being able to study nutrient metabolism in greater detail provides the opportunity to 
examine the complex interactions between multiple micronutrients and a range of adverse health 
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outcomes, rather than the traditional approach of looking at a single nutrient or mechanism and its 
relationship to a specific (micronutrient deficiency) disease (Aggett, 2010; Heaney, 2003).  
Advances in measurement and analysis techniques have been accompanied by shifts in the health 
status of local, regional and global populations (Lim, 2012; Popkin, 2006). This has led to a change in 
public health priorities, which has encouraged the investigation of a potential role of micronutrients in 
the aetiology and pathogenesis of a wide range of diseases, including chronic and long-term 
conditions (e.g., cancers, cardiovascular diseases, cognitive diseases etc.; WHO, 2010). Recent 
reports from the Global Burden of Disease study have shown a shift in disease burden from infectious 
disease to non-communicable chronic diseases, which has threatened to undermine progress made to 
improve global public health via public health interventions and advances in medicine (Lim, 2012). 
Changes in population demography, such as an ageing population have contributed to this shift. This 
is because despite mortality decreases and increases in life expectancy rates, the chronic nature of 
non-communicable disease and related conditions (e.g., hypertension and obesity) has been linked to 
premature death (nearly 30% of non-communicable disease related deaths in low income countries 
occur in those under 60 years old) and a greater proportion of latter years associated with illness and 
disability (including multiple co-morbidities i.e. occurrence of more than one illness or condition at 
the same time; Lim, 2012; Vos, 2012).  
In sum, section 1.1 has illustrated micronutrients are necessary for health; yet there remains 
considerable debate in the scientific, political and general public areas - particularly in relation to 
folate and vitamin D recommendations - regarding the risk of micronutrient deficiency; the efficacy of 
current public health policies to prevent deficiency; and the exact role of micronutrients on health 
(e.g., diseases not traditionally indexed as micronutrient deficiency diseases; Bailey, 2015a; EFSA, 
2016; IOM, 2007; SACN, 2006). The evidence base surrounding micronutrient deficiency diseases is 
substantial and has evolved over a number of years. The constant evolution of nutrition science 
however, warrants a periodic review of recommendations to ensure they remain relevant and effective 
public health tools (e.g., are based upon the most up-to-date knowledge). This is necessary as there 
are gaps in knowledge, particularly regarding populations which are simultaneously hard to study and 
vulnerable to micronutrient deficiency (e.g., pregnant women, babies, infants and young children).  
Furthermore, and to a greater extent, the knowledge base surrounding the role of micronutrients in 
chronic disease aetiology and pathology is incomplete and in its infancy; yet, these investigations 
could significantly aid our understanding of chronic and acute diseases (Bischoff-Ferrari, 2006; de 
Castro Kroner, 2015; Heaney, 2003). These issues present a challenge to those who set micronutrient 
recommendations, regarding whether recommendations should address a complex definition of 
health; one that includes the absence of micronutrient deficiency disease, as well as the promotion of 
healthy ageing and protection from non-communicable diseases/related conditions (i.e. minimise 
premature mortality, disability or morbidity; Murphy, 2016; NCM, 2014; Yetley, 2016).  
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1.2 What are micronutrient recommendations? 
1.2.1 Inconsistent terminology 
In general, micronutrient recommendations can be considered population targets of vitamin and 
mineral intake necessary for growth, development and function throughout the human lifespan 
(Dhonukshe-Rutten 2010; King 2007). These can be in the form of quantitative Dietary Reference 
Values (DRV), which refer to an intake that represents the distribution of requirements to avoid a 
clinical deficiency disease (e.g., the intake of vitamin D to avoid rickets in children; Geissler, 2011).  
Recommendations can also be in the form of qualitative/quantitative Food-Based Dietary Guidelines 
(FBDG) that can be used by individuals (WHO/FAO, 1998). Again, regarding vitamin D, the 
requirements for vitamin D (alongside other nutrients) are implicit in the UK 8 tips for eating well 
“eat more fish – including a portion of oily fish each week” (PHE, 2016).  
Variability, inconsistency and ambiguity has been observed in the technical terminology and concepts 
used to describe both DRV and FBDG. This is especially so for DRV, where different 
countries/international regions have developed their own nomenclature to represent a set of 
recommendations (King, 2007; Pavlovic, 2007; Prentice, 2004; table 2). The diversity of terms used 
to represent DRV can be seen with the concept of ‘adequate’ micronutrient intake i.e., the intake level 
deemed sufficient to meet the micronutrient requirements of the majority of the population (Ashwell, 
2008; King, 2007; Pavlovic, 2007; Prentice, 2004). Adequate intake can refer to the Recommended 
Nutrient Intake (RNI) in the recommendations for the German speaking countries of Germany, 
Austria and Switzerland; the Population Reference Intake (PRI) at the European level; the Reference 
Nutrient Intake in the UK; the Recommended Intake (RI) in the Nordic Nutrition Recommendations 
of Denmark, Finland, Iceland, Norway and Sweden; and Recommended Dietary Allowance (RDA) in 
the Netherlands or the United States of America (Ashwell, 2008).  
International initiatives have attempted to clarify DRV terminology. A United Nations University 
working group convened in 2007 and produced a set of definitions, including two main values based 
on ‘adequate’ intake. These included the Average Nutrient Requirement (ANR) and the Individual 
Nutrient Level (INLx). The ANR represents the level of (micronutrient) intake adequate for half the 
people in a population group, given a normal distribution of requirement (derived from a statistical 
distribution of requirement criterion for age and sex, based on biological endpoints/biochemical 
measures; King, 2007). The INLx represents the level of (micronutrient) intake adequate for virtually 
all of those in a particular age and sex population group. This is most commonly calculated at INL97.5 
and equivalent to protecting approximately 97.5% of the population i.e., mean plus two standard 
deviations. Furthermore, the European Food Safety Authority (EFSA) updated their DRV 
terminology in the scientific guidance for deriving DRV in 2010 (EFSA, 2010a). This document 
sought to clarify DRV terminology across Europe and produced an alternative set of definitions to the 
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UNU, with comparable terms to the ANR and INL97.5 represented by the Average Requirement (AR) 
and Population Reference Intake (PRI), respectively (EFSA, 2010a; figure 1). The IOM and EFSA 
initiatives were designed to standardise terminology across international regions to aid 
communication and facilitate transparency in the approach to micronutrient risk analysis. 
Recommendations since 2010 have however, not aligned their terminology with UNU or EFSA and 
have instead maintained their own nomenclature (e.g., RI in the 2012 Nordic Nutritional 
Recommendations and RNI in the UK vitamin D DRV 2016 report; NCM, 2014; SACN, 2016). 
Ambiguity associated with FBDG terminology is less documented; yet still a potential source of 
confusion. This was illustrated during an international workshop “Dietary Guidelines: Past 
Experiences and New Approaches” held in Canada in 2002 (Anderson, 2003). The workshop 
participants were from the (predominantly) English speaking countries of Australia, Canada and 
USA; however, a diversity of terminology was observed when discussing dietary guidelines. This 
included the interchangeable use of the terms ‘dietary guidance’, ‘dietary guidelines’, ‘guidelines to 
healthful eating’ and ‘food guides’ (Anderson, 2003). Although not explicitly referenced, the EFSA 
scientific opinion on deriving FBDG suggested a requirement for clarity in the definition of the term 
FBDG. FBDG was defined as constituting “science-based policy recommendations in the form of 
guidelines for healthy eating” (EFSA, 2010b). A glossary was appended to this document to 
differentiate FBDG from DRV, as well as FBDG from dietary goals. In this way, DRV and dietary 
goals were considered to be terms associated with internal risk assessment and risk management 
activities, whereas FBDG were considered communications primarily directed to those outside the 
risk analysis process and associated with risk communication activities (EFSA, 2010b).  
The work conducted by EFSA and UNU to standardise terminology surrounding either DRV or 
FBDG has highlighted the potential for confusion and ambiguity surrounding micronutrient 
recommendations. In both the food and non-food area, consistent terminology has been considered 
paramount to a transparent and effective decision-making process, reducing the opportunity for 
arbitrary disagreements (EFSA, 2009; Garza, 2007; Teigen, 1998) and enabling effectual 
collaboration between experts and/or stakeholders from different disciplines or backgrounds 
(Burgman, 2005; Moss, 2000). This thesis sought to characterise the full range of terms (from DRV to 
FBDG) used to represent micronutrient recommendations by experts and stakeholders involved in the 
micronutrient risk analysis for different European countries/regions.   
1.2.2 Disparity in micronutrient recommendations 
Micronutrient recommendations can be aligned between international countries; however, there are 
also a number of disparities between countries/regions (Doets, 2008; Doets, 2010). A degree of 
standardisation in DRV is apparent where countries have collaborated to derive DRV for a particular 
region, such as in North America (Canada and USA); Australasia (Australia and New Zealand); the 
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German speaking countries (Austria, Germany and Switzerland); or the Nordic countries (Denmark, 
Finland, Iceland, Norway and Sweden). DRV can however, still differ between international regions, 
individual countries or international organisations (Doets, 2008). For example, folate and vitamin D 
DRV have been seen to vary from 200-400 mcg/d and 5-20mcg/d, respectively and the presentation of 
these DRV can vary, particularly regarding the population age ranges employed (table 1; Doets, 
2010).  
There is an expectation for FBDG to differ between countries to reflect a county’s dietary practices 
and risk management goals (EFSA, 2010b). In contrast, there has been debate as to whether scientific 
knowledge on genetic or epigenetic similarities/differences is sufficient to justify different DRV for 
different countries (Allen, 2014; Dhonuske-Rutten, 2010; Vickers, 2014). This has led to a suggestion 
that differences in the application of the risk analysis framework could account for the disparity in 
DRV (Doets, 2008). For example, research has suggested contextual factors such as the infrastructure 
or resources available, as well as political public health priorities can influence how and why 
recommendations are set (Timotijevic, 2011). Furthermore, disparity could be accounted for by 
differences in methodological approach, such as the calculation of AI or PRI dependent upon whether 
data were considered in/sufficient to calculate the average requirement. Another example could be the 
choice of health end points or adequacy cut-off points. This might partially account for differences 
seen in folate DRV where no consensus was identified on the criterion for adequate erythrocyte folate, 
serum folate or serum homocysteine biomarker concentrations (Doets, 2010; MacFarlane, 2016). 
These decisions might appear predominantly relevant to conducting risk assessment activities; yet 
they can have consequences throughout risk analysis (Doets, 2010; MacFarlane, 2016). For example, 
differences in vitamin D DRV might originate from the use of different vitamin D cut-off points in the 
marker of vitamin D status (serum 25-(OH)D) to represent in/adequacy. Dependent upon which cut-
off points have been selected this could lead to the over or under estimation of population vitamin D 
deficiency/insufficiency/adequacy, which in turn may lead to an over or under assessment of public 
health concern (Cashman, 2011; Cashman, 2013; Ross, 2011). 
The uncertainty and variability in the evidence used to develop DRV could provide an explanation for 
observed DRV disparity (Doets, 2008). Previous research investigating vitamin D DRV was unable to 
identify the reason for the observed disparity due to a paucity of information on the DRV decision-
making process, with eminence-based decisions suggested as key to derive the final DRV 
(Dhonukshe-Rutten, 2010; Doets, 2008). Expert judgement or eminence-based decisions are required 
to weigh evidence, handle uncertainty and variability in evidence and reach expert consensus to 
produce DRV (EFSA, 2014b). These decisions may vary dependent upon the context of the DRV 
setting process e.g., the time period, the experts involved, the health priorities of a particular country 
etc. Transparently articulating the context to decisions can be challenging and expert judgement often 
involves a collective judgement that is more than the sum of the individual pieces of information cited 
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in a DRV report (Andrews, 2013). Transparency in this process however, could be crucial to 
establishing the validity of DRV, as well as confirming what is known, what is unknown and what 
remains uncertain regarding the role of micronutrients in health (EFSA, 2014b). This can in turn 
safeguard the valid application of DRV, particularly when developing food labelling regulations, 
assessing the adequacy of population intakes or communicating risk effectively to those inside or 
outside the risk analysis process (Cope, 2010). This thesis sought to explore areas of the micronutrient 
risk analysis process where previous research had identified a lack of transparency, particularly 
related to the internal communication of risk or uncertainty between risk experts and/or stakeholders.     
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Table 1 Disparity in vitamin D and folate DRV for adults (male/female, not including life stages e.g., pregnancy or lactation) 
 
European Food 
Safety Authority 
(EFSA) 
UK 
Germany, 
Austria, 
Switzerland 
Denmark, 
Finland, Iceland, 
Norway, Sweden 
USA & Canada 
Australia & New 
Zealand 
WHO/FAO 
Vitamin D mcg/d 
15 
(AI, >18 years, 
EFSA 2016b) 
10 
(PRI, >17 years, 
SACN 2016) 
20 
(AI, >18 years, 
DACH 2015) 
10* 
(PRI, 18-74 years, 
NCM 2014) 
15** 
(PRI, 19-70 years, 
IOM 2011) 
5 
(AI, 19-50 years, 
NHMRC 2006) 
5** 
(PRI, 19-50 years, 
WHO/FAO 2004) 
Folate mcg/d 
330 
(PRI, >15 years, 
EFSA 2014a) 
200 
(PRI, >18 years, 
DH/COMA 1991) 
300ab 
(PRI, >18 years, 
DACH 2013) 
300c 
(PRI, >18 years, 
NCM 2014) 
400d 
(PRI, >19 years, 
IOM 1998a) 
400 
(PRI, 19-70 years, 
NHMRC 2006) 
400 
(PRI, >19 years, 
WHO/FAO 2004) 
*20mcg/d if little or no endogenous synthesis 
**considering minimal sun exposure/no endogenous vitamin D synthesis 
a 1 µg DFE = 1 µg food folate = 0.6 µg folic acid from fortified food/ supplement consumed with food = 0.5 µg folic acid supplement empty stomach 
b Women capable/willing to be pregnant also to take daily supplement of 400 µg folic acid 4 weeks prior and 8 weeks after conception to prevent NTD 
c Women capable/willing to be pregnant recommended to ingest 400 µg/day 
d Women capable/willing to be pregnant recommended to take 400 µg folic acid daily from fortified foods and or supplements to reduce the risk of NTD 
PRI: Population Reference Intake = average daily intake to meet requirements of majority; AI: Adequate intake = average daily intake to meet approximated 
intake assumed to be adequate (calculated when PRI cannot be determined); NTD: Neural tube defects 
Adapted from EFSA NDA (EFSA Panel on Dietetic Products, Nutrition and Allergies; 2014a). Scientific Opinion on Dietary Reference Values for folate. 
EFSA J, 12(11):3893, 59 pp. doi:10.2903/j.efsa.2014.3893; EFSA NDA Panel (2016). Draft scientific opinion on DRV for vitamin D. EFSA J, x(x)x 179 pp. 
doi: 10.2903/j.efsa.2016.xxx 
   
17 
 
Table 2 Variation in DRV nomenclature  
UNU term UNU definition Comparable to 
Nutrient Intake Value Set of recommendations 
Dietary Reference Intakes (USA) 
Reference values for nutrient intake (DACH) 
Dietary Reference Values (UK; EFSA; France) 
Average Nutrient Requirement 
Average requirement estimated from statistical distribution of 
required intake for specific criterion (e.g., biomarker/ health 
indicator) or population group (age/sex) 
Estimated Average Requirement 
Individual Nutrient Level97.5 
Nutrient level for healthy individuals in a specific population 
covering the needs of approximately 97.5 % of the population 
Recommended Nutrient Intake (DACH; UK; WHO) 
Population Reference Intake (France; EFSA) 
Recommended Average (Latvia) 
Recommended Daily Allowance (Netherlands; 
USA) 
Recommended Intake (Nordic countries) 
Adequate Intake 
Observed/experimentally derived intake in defined population 
group to sustain health. Employed when insufficient data to 
establish statistical distribution of individual requirements and 
cannot derive ANR/INLx 
Estimated value for adequate intake (DACH) 
Adequate intake (France; Netherlands; EFSA; USA) 
Safe Intake (UK) 
Acceptable Intake (WHO) 
Acceptable range 
Range of safe intake values used when insufficient information 
available 
Acceptable range (EFSA) 
Estimated value for adequate intake (DACH) 
Adequate area of intake (Netherlands) 
Safe Intake (UK) 
Adapted from Dhonukshe-Rutten et al. (2010). European micronutrient recommendations aligned: a general framework developed by EURRECA. EJCN, 
64:S2-S10 
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Figure 1 Dietary Reference Values as a distribution of individual nutrient requirement (SD: standard deviation, adapted from EFSA, 2010a)
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1.3 How are micronutrient recommendations set? 
1.3.1 Risk analysis paradigm 
Risk analysis provides a process for making decisions in risky or uncertain situations by analysing the 
probability of an adverse health effect, as well as the severity of that effect when exposed to an 
identified hazard (CAC, 2015). This approach to risk analysis originated from the work of Pascal in 
the 17th century; led by theories of probability (e.g., the ability to quantify likelihood) and the 
identification of causal links between hazardous activities and adverse health effects (Covello, 1985). 
Contemporary risk analysis is carried out using a framework of three separate, yet inter-connected 
activities to estimate risk (risk assessment); to coherently exchange risk information (risk 
communication); and to judge the un/acceptability of risk (risk management; EFSA, 2012; figure 2).  
The use of a formal risk analysis framework in nutrition is relatively recent (Bier, 2016). A series of 
food related health scares during the 1980-1990’s (Salmonellas, E-Coli, Bovine Spongiform 
Encephalopathy (BSE) via new variant Creutzfeldt-Jakob Disease, nvCJD) led to a loss of confidence 
(consumer, expert, media) in the traditional controls for food safety (e.g., toxicology and 
microbiological safety; Garrow, 2003). These events called in to question the integrity of the 
institutions deemed responsible for managing societal risk (Frewer, 2003; Smith, 1999). In addition, 
expertise was questioned with the general public seemingly as informed as the experts to make 
sensible decisions for minimising risk (Jasanoff, 1997). This led to wide scale discussions on how 
risks to public health should be assessed, communicated and managed (Renn, 1998).  
In 1995 WHO/FAO advocated the risk analysis paradigm to manage risk in the food area 
(WHO/FAO, 1995). The precept for risk analysis had been practiced in various other fields, such as 
toxicology, engineering, environmental or medical sciences. This involved formalising the risk 
decision making process into the three activities of assessment, communication and management 
(Yoe, 2012). The influence of uncertainty on the decision making process was to be explicitly 
recognised throughout all activities. This was to enable a balanced and educated assessment of a 
situation i.e., surrounding particular un/desirable outcomes; thus, providing the opportunity to make 
informed decisions to manage risk (Aven, 2009). Adoption of risk analysis in the food area involved 
both a fundamental change in attitude, as well as infrastructure (Houghton, 2008). Risk assessment 
was to be conceptually and in some cases structurally separated from risk management (e.g., in the 
UK with the creation of the Scientific Advisory Committee on Nutrition, SACN and at the European 
level in the European Commission (EC) with the creation of the European Food Safety Authority, 
EFSA) to ensure a degree of risk assessment independence and discourage a pre-determined risk 
management option from overly influencing an assessment of risk (Mackerras, 2012).  
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Interpretations of uncertainty and risk 
Nutrition risk analysis is complex, not least due to the multiple interpretations of the concepts of risk 
and uncertainty. There is no universal definition of risk (Aven, 2012; Renn, 1998). In mathematics, 
risk can be considered a calculable phenomenon, in science and medicine risk is an objective reality 
and in sociology risk is a societal phenomenon (Althaus, 2005). The very concept of risk analysis is 
therefore, open to interpretation and can pertain to calculations (mathematics), principles (science and 
medicine) or wisdom (philosophy; Althaus, 2005). Nevertheless, underlying all these concepts is the 
notion of uncertainty and acceptance that risk is a distinction between reality and possibility (Aven, 
2012). Uncertainty is inherent in risk analysis; nothing is 100% certain and risk can be considered 
primarily, yet not restricted to, the calculation of probability to identify and express uncertainty 
(Aven, 2012). It is the explicit recognition and communication of where information is uncertain or 
variable that enables a decision to be made in difficult situations and completes a risk analysis. 
The evidence base surrounding food and health is abundant with uncertainty, as illustrated in the 
previous micronutrient intake, status and health sections. It is therefore, difficult to establish the exact 
role of diet in cancer risk (Key, 2004); the interactions between nutrients; genetic predispositions; and 
the most effective interventions to improve population diets (e.g., fortification policies or food-based 
dietary guidelines; Jensen, 2012; Key, 2004). The principles of risk analysis, particularly during risk 
communication activities, encourage the disclosure of what and how uncertainty is handled i.e., 
explicit recognition of any uncertainty either in the current state of knowledge or in the adequacy of 
the available data (e.g., accuracy/quality or degree of incomplete/quantity of data; Bailer, 1999; IOM. 
2007; WHO/FAO, 2004). Where evidence is considered lacking, unreliable or indefinite then clear 
documentation is expected to detail the scientific knowledge used to develop plausible assumptions 
and reach scientific consensus (EFSA, 2014b). Uncertainty could be considered a flaw, an obstacle to 
conducting risk analysis and something that should be reduced. The use of models (e.g., Bayesian, 
Montecarlo etc.) can seek to reduce uncertainty by concentrating on elements of a risk situation which 
can be calculated and predicted, such as errors in sampling, measurement techniques, systematic bias 
etc. (Nilsen, 2003). These models instead of creating a false aim of certainty can be used to describe 
uncertainty to aid decision making (CPD/PBL/Rand Europe, 2008). To date, risk analysis remains a 
practical endeavour, where uncertainty is considered ever-present and the objective is to deal with 
uncertainty in an explicit, systematic and transparent manner (Buchanan, 2004).  
The skill of risk analysis is in being able to acknowledge, interpret and handle uncertainty (Aven, 
2009). This requires both scientific and non-scientific judgement as “…what society is supposed to 
tolerate or accept can never be derived from looking at evidence alone. Likewise, evidence is essential 
if we are to know whether a value has been violated or not or to what degree” (Renn, 2006). It is 
therefore, a skill to be able to interpret the scientific probability estimates related to risk and 
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measurements of uncertainty (recognising existing knowledge, areas of scientific consensus and areas 
of ignorance), together with the non-scientific social values which give meaning to why a risk 
analysis is being performed and what assumptions or values have been used to provide context to the 
decision making process (Renn, 2006). 
Principles for nutrition risk analysis 
The Codex Alimentarius Commission Procedural Manual sets out the general principles for nutrition 
risk analysis (CAC, 2015). Codex was established by the WHO and FAO in 1963 to promote fair 
practices in food trade and produce guidelines for both food safety and nutrition risk analysis. These 
guidelines were produced or borrowed from alternative areas of risk analysis, most notably toxicology 
(CAC, 2015; EFSA, 2010a; King, 2007). There are however, questions as to the appropriateness of 
this approach to the field of nutrition (NCM, 2014). The concept of food safety and nutrition risk 
analysis are similar; however, exposure to nutrients is recognised as a biological necessity, carrying 
favourable health effects as opposed to the food safety risks of exposure to chemical or 
microbiological pathogens (Tijhuis, 2012). Nutrients are not inherent hazards, such as toxins; 
therefore, both undesirable and desirable outcomes have to be weighed regarding micronutrient 
exposure (Tijhuis, 2012). This has led to a particular emphasis in nutrition risk analysis on problem 
formulation as a preliminary risk management activity to clarify the problem and risk under study 
prior to risk assessment (e.g., whether upper limits or toxicology assessments are to be incorporated; 
which health outcomes are to be assessed), as an appropriate solution can only be sought if the correct 
problem has been defined (CAC, 2015). 
Four stages of nutrition risk analysis are outlined in the Codex manual: problem formulation, risk 
assessment, risk communication and risk management (figure 2; CAC, 2015). Problem formulation is 
classified as a preliminary risk management activity, whereby risk assessors and risk managers 
interact to identify the purpose of a nutritional risk assessment. The risk assessment stage is a 
scientific process comprised of four steps: (i) Hazard identification e.g., adverse health effects from 
inadequate and excessive nutrient intake; (ii) Hazard characterisation i.e., nature of adverse health 
effects taking into account homeostatic mechanisms and adaptation; bioavailability factors and 
methodological differences in assessment of nutritional risk of inadequate or excessive intakes 
(qualitative/quantitative evaluation); (iii) Exposure assessment e.g., likely intake of nutrients 
(qualitative/quantitative evaluation); (iv) Risk characterisation i.e., probability of occurrence and 
severity of potential adverse health effects based on i-iii (qualitative and/or quantitative estimation).  
The development of folate or vitamin D dietary reference values would typically involve steps one 
and two. In these steps systematic literature reviews can be undertaken to source data and evidence to 
answer the problem under study. This evidence is then evaluated (with full disclosure of any 
uncertainty) and expert consensus is used to provide provisional advice to risk managers or assist with 
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step three. In a full risk assessment, reference values (steps one and two) are combined with a nutrient 
intake/exposure assessment (step three) to assess exposure in relation to the reference values (step 
four).  
The risk management stage is where advice from the risk assessment is used (together with evidence 
from any requested additional sources (e.g., economic, environmental, toxicological risk assessment; 
research on the potential impact of risk management decisions on dietary patterns or lifestyle 
behaviours) to judge the acceptability of risk and inform the development of recommendations in risk 
management. The risk communication stage is an activity designed to disseminate information, as 
well as to ensure all information required for effective risk management is incorporated into the 
decision making process. The involvement of all interested parties is encouraged by the transparent 
and coherent communication of the risk analysis procedure, including any constraints, uncertainties 
assumptions and their impact on the risk analysis.  
The implementation of risk analysis activities can vary by the organisation responsible for national or 
international micronutrient recommendations (Yoe, 2012). Those who practice nutrition risk analysis 
might share the same underlying principles; however, the application of these principles and the 
content of the activities outlined above are not standardised across nations or international regions 
(IOM, 2007; Jardine, 2003). For example, risk analysis activities may be carried out using different 
technical details (e.g., the population age bands used for setting recommendations; Doets, 2008), 
concepts (e.g., the definition and use of adequate intake; Dhonuskhe-Rutten, 2010) or infrastructure 
(e.g., whether the recommendations are set by an ad-hoc or standing committee; Timotijevic, 2011).  
1.3.2 Communication of risk 
The communication of risk underlies the whole risk analysis process and is of particular import 
regarding the problem formulation stage and risk evaluation following risk assessment (IOM, 2007; 
Renn, 2008). Effective risk communication provides a means to document the process of risk 
analysis; to convey the context necessary to correctly interpret representations of uncertainty or risk; 
both of which serves to increase the credibility of the risk analysis process (Aven, 2009; EFSA, 
2016a; Schreider, 2010).  
Definitions of risk communication activities relate to both the internal and external communication of 
risk: to all parties both within and outside the risk analysis process (CAC, 2015). This is illustrated by 
the most recent Codex procedural manual, which defines risk communication activities as those that: 
(i) promote awareness and understanding of the specific issues under consideration during the risk 
analysis; (ii) promote consistency and transparency in formulating risk management 
options/recommendations; (iii) provide a sound basis for understanding the risk management 
decisions proposed; (iv) improve the overall effectiveness and efficiency of the risk analysis; (v) 
strengthen the working relationships among participants; (vi) foster public understanding of the 
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process, so as to enhance trust and confidence in the safety of the food supply; (vii) promote the 
appropriate involvement of all interested parties; and (viii) exchange information in relation to the 
concerns of interested parties about the risks associated with food (CAC, 2015). A similar definition 
can be seen in European Commission documents, with risk communication written into the legal 
constitution of EFSA as an “interactive exchange of information and opinions throughout the risk 
analysis process as regards hazards and risks, risk-related factors and risk perceptions, among risk 
assessors, risk managers, consumers, feed and food businesses, the academic community and other 
interested parties, including the explanation of risk assessment findings and the basis of risk 
management decisions” (EC, 2002).  
The majority of risk communication activities focus upon the external communication of risk to those 
outside the risk analysis process, at the end of the risk analysis process. This encourages the 
involvement of stakeholders (i.e., individuals/organisations willing to invest resources and accept 
some responsibility for the development of micronutrient recommendations) and the general public. 
This is in line with a post-1990 emphasis of responsible risk governance, which requires risk analysis 
outputs to be open and transparent to increase credibility of the process and perceived trust in 
scientific expertise/risk governance (Cini, 2008; EC, 2006; EFSA, 2009; EFSA, 2006; NICE, 2012). 
A commitment to risk governance initiatives to encourage greater transparency and stakeholder 
involvement may seem the correct thing to do (Schreider, 2010); nevertheless, the implementation of 
transparency initiatives can be limited or represent certain challenges (Turilli, 2009). For example, 
detailing and providing access to all elements of the risk analysis process can present challenges in 
terms of the resources required, technical ability or confidentiality and wider trust issues (e.g., 
articulating the nature of risk assessment or inherent uncertainty of scientific endeavour, detailing 
contradictory views during commonplace expert discussions whilst maintaining unanimity in the final 
scientific advice; Bal, 2004; Lofstedt, 2011; Palmer, 2011). 
A considerable body of work has been conducted by the research fields of risk communication and 
risk perception to support effective communication of risk between those involved in risk analysis and 
stakeholders or lay members of the general public that are external to the process (McGloin, 2009; 
Yoe, 2012). The initial focus of this research was on how the general public perceived risk and 
uncertainty, so that the risk communications could be effectively designed and understood (Renn, 
2008). These fields have expanded to recognise that experts and the general public can interpret risk 
differently e.g., the mortality benefits weighed heavily by experts might be outweighed by a 
potentially wider range of factors considered by the general public (ethical, social, economic, 
morbidity/disability factors; Cope 2010). Subsequently, there has been a greater awareness of the 
value of two-way communication of risk between those internal and external to the risk analysis 
process (Yoe, 2012). The purpose of this is to recognise insights and intelligence that can be gained 
from both experts and the general public to ensure a breadth of values and knowledge is considered 
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during the risk analysis process. This can inform the feasibility and acceptability of risk management 
options and improve the quality of a risk analysis outcome (Entwhistle, 1998; EFSA, 2006; EFSA, 
2010a; Saunders, 2010; Schreider, 2010; Slovic, 1987).  
Less attention has been paid to communication of risk between risk experts and/or stakeholders 
internal to the risk analysis process, with this recognised as an undervalued and under researched area 
(Renn, 2008). The internal communication of risk has the potential to be of comparable importance as 
external risk communication by providing the dialogue and means for all experts/stakeholders 
involved in risk analysis to share a common understanding of the risk situation (problem) under study; 
the process of risk analysis (e.g., how they are to be involved and what their responsibilities might be; 
Renn, 2008; Yoe, 2012) and ensure knowledge (including any uncertainty) underlying any numerical 
or verbal statements of risk are effectively communicated between risk analysis activities to reduce 
the likelihood of misunderstandings (Fischoff, 2013).  
The diversity of scientific disciplines involved in the field of nutrition can make it particularly 
problematic to communicate risk between nutrition experts. Nutrition is predominantly set in the 
biological sciences; however genetic, social and environmental sciences are also key to understanding 
the effects of food on metabolism and health, as well as understanding the behaviour that might 
determine a nutrient intake or status (Cannon, 2005). Each discipline will bring their own dictionary, 
ontology and interpretation of scientific concepts, such as the source and definition of uncertainty 
(Andretta, 2014; Carey, 2008). Furthermore, the stakeholders of recommendations for micronutrients 
are also diverse: representing a variety of interests along the food chain, including different 
governmental departments (e.g., Ministries of Health, Agriculture, Education or Environment); 
scientific advisory committees (e.g., UK Scientific Advisory Committee on Nutrition, SACN); health 
professionals (clinical/ public health); academics (from nutrition to microbiology); food industry 
(‘from farm to fork’); non-governmental organisations (such as, charities, consumer and special 
interest groups); and lay members of the general public (Walls, 2011). These issues are magnified in 
the creation of international recommendations when the nuance of language provides an additional 
level of complexity for effectively communicating risk (Carey, 2008).  
The effective communication of risk internal to the risk analysis process could be central to achieving 
a transparent micronutrient risk analysis process (Frewer, 2011). An ability to understand differences 
or similarities in terminology and concepts used throughout risk analysis (between different risk 
experts, stakeholders or nationalities) can ensure uncertainty is correctly articulated to convey what is 
known, what is not known and how this non/information has influenced the decisions that led to the 
micronutrient recommendations (Yeo, 2012). This provides an opportunity for the risk analysis 
process to be clear, coherent and accessible; thus a possibility to share best practice and effectively 
involve stakeholders and the general public throughout all three risk analysis activities (Cope, 2010). 
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Figure 2 Three activities of risk analysis and the noteworthy fourth activity of problem 
formulation in nutrition risk analysis (adapted from WHO/FAO, 1997 & Yoe, 2012) 
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1.4 Research questions 
Preparatory work was conducted by the thesis author (supporting publications 1-6, Appendix 4), 
together with literature reviews (white and grey) of transparency initiatives, risk communication 
research and (micro)nutrition risk analysis. This resulted in an observation that certain areas of the 
micronutrient recommendation setting process were not sufficiently transparent and that this could be, 
in part, due to difficulties in communicating risk, internally, within the risk analysis process i.e., 
between risk analysis activities and risk experts (risk assessors, risk managers, risk communicators) or 
stakeholders. The internal communication of risk during risk analysis was considered an under-valued 
and under-researched form of risk communication, separate from formal risk communication 
activities more commonly associated with disseminating risk assessment and risk management 
outputs to the ‘wider world’. This observation formed the basis of the current thesis. As such, the 
below overall research question (aim) and specific research questions (objectives to explore) were 
generated. 
1.4.1 Overall research question 
The aim of this thesis was to identify the practical challenges of communicating risk internally - 
between experts and/or stakeholders -  and understand the implications of these challenges for 
achieving a transparent micronutrient risk analysis process.  
1.4.2 Specific research questions 
Research question 1 (terminology) 
What is the nature of the variety in terminology used to describe micronutrient recommendations 
across a range of multi-national stakeholders?  
Research question 2 (lay involvement) 
How do a range of multi-national stakeholders view lay stakeholder involvement in the process of 
setting micronutrient recommendations? 
Research question 3(efficacy) 
What is the evidence that risk management outputs (e.g., FBDG) are monitored for their efficacy? 
Research question 4 (uncertainty) 
What are the challenges to transparently handling uncertain evidence during the development of 
micronutrient recommendations (problem formulation, evidence evaluation, derivation of quantified 
DRV)? 
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1.5 Methods  
This thesis has used qualitative methodology, with the three studies underlying the five published 
works all employing qualitative study designs (semi-structured interviews, case studies and narrative 
literature review) and thematic analysis (method of analysis to report patterns within data; Merriam, 
2002). The below describes the procedures employed and justification for their selection. 
1.5.1 Qualitative methodology 
A distinction is often made between qualitative and quantitative methodology. Qualitative 
methodology is largely born out of social sciences (e.g., anthropology, sociology and clinical 
psychology; Merriam, 2002) and associated with an interpretive/constructionist approach that accepts 
the subjective acquisition of knowledge. In contrast, quantitative methodology is largely practiced in 
the natural sciences and associated with a scientific/positivist approach that seeks to acquire objective 
knowledge. There has however, been an increasing value placed upon employing qualitative methods 
to study phenomena in the natural sciences (particularly in the medical and health care setting; 
Greenhalgh 1997; Maleterud 2001a). In addition, that less emphasis should be placed on performing 
scientific investigation from one or either paradigm; instead to accept that science, in practice, can 
draw on multiple paradigms as illustrated by the below quote: 
“…[a scientist] must appear to the systematic epistemologist as a type of unscrupulous 
opportunist: he appears as realist insofar as he seeks to describe a world independent of the 
acts of perception; as idealist insofar as he looks upon the concepts and theories as free 
inventions of the human spirit (not logically derivable from what is empirically given); as 
positivist insofar as he considers his concepts and theories justified only to the extent to 
which they furnish a logical representation of relations among sensory experiences. He may 
even appear a Platonist or Pythagorean insofar as he considers the viewpoint of logical 
simplicity as an indispensable and effective tool of his research.”  
Einstein, 1949.  
A qualitative approach was considered appropriate in this thesis due to the complexity of the 
phenomenon under study (micronutrient recommendation setting process) i.e., the number of 
stakeholders, activities and contextual factors involved that were outside the control of the researcher 
(Yin, 2003). Qualitative methods have been criticised for a lack of objectivity and reliability; 
however, all of the available research methods to conduct qualitative or quantitative research have 
limitations and if done correctly qualitative research is no less rigorous than correctly conducted 
quantitative research (Black, 1994; Malterud, 2001a; Malterud, 2001b). Taking this into account, the 
qualitative methodology and methods used in this thesis were considered appropriate to answer the 
research questions in this thesis; the recognised strengths and weaknesses of this decision (including 
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disclosure of how bias has been minimised or might influence the validity of findings) are discussed 
in section 3.2 (Black, 1994; Breakwell, 1995; Mays, 1995).  
1.5.2 Qualitative methods 
The process of setting micronutrient recommendations has been a relatively inaccessible and under 
researched area of study (Aggett, 2010). Consequently, qualitative case study, interview and narrative 
review methods were utilised to study the multiple perceptions of the micronutrient risk analysis 
process and understand the meaning of those perceptions that could help to answer the thesis research 
questions. Bias in the form of subjectivity - from both the researchers and the participants of study - 
was accepted as intrinsic to the research process, apparent throughout sampling, data collection and 
analyses. This bias was minimised by acknowledgement that the thesis author’s perspective (personal 
characteristics, ability to reflect on assumptions and view findings from alternative perspectives) 
would be a component of the research; by detailed provision of the study method (context, sampling 
strategies, ethical concerns, data collection/ processing/ analysis/ interpretation/synthesis); and by the 
credible use of interview/text quotes when presenting results (Greenhalgh, 1997; O’Brien, 2014; 
Tong, 2007). These principles were consistently applied via the use of thesis author designed 
protocols to ensure the research was as robust as possible. This was particularly important due to the 
collaborative nature of the data collected during study 1 and study 3 of this thesis. A number of 
international partners, with varying degrees of qualitative or nutrition research experience, were 
involved in collecting data relevant to their respective country/region’s micronutrient 
recommendations. The above principles were enforced by regular communication to clarify research 
questions and objectives (via a minimum of twice yearly face-to-face meetings; a face-to-face 
qualitative training session; monthly phone meetings; and weekly e-mail contact, all organised, run 
and led by the thesis author). Furthermore, sample selection for the interviews conducted in studies 1 
and 3 was led by the thesis author. Information on the risk experts and stakeholders 
responsible/involved in the micronutrient recommendation setting process across Europe was 
gathered from previous research (de Wit, 2008; Dhonukshe-Rutten, 2013; Doets, 2008; Timotijevic, 
2011; table 3) and collated to provide, for each country/ region, both a starting point and a suggested 
boundary for sampling/interview recruitment. Any changes from the initial sampling strategy, such as 
institutional changes in those responsible for setting recommendations were discussed and captured in 
reporting. Stakeholders were originally classified into groups; however, the meaning of these different 
stakeholder groups and their responsibility/involvement in micronutrient risk analysis varied across 
countries (e.g., health professionals represented academics in countries which had less food/nutrition 
academic representation). It was therefore, decided unsuitable to conduct analysis by stakeholder 
group. Protocols also detailed the methods to be employed for data collection and analysis. Semi-
structure interviews were used in study 1 and 3 and these schedules were created by the thesis author 
based upon preparatory research (Timotijevic, 2010; Timotijevic, 2011); literature reviews (both grey 
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and white) and the specific research questions under study, in line with guidelines for establishing 
interview schedules (Breakwell, 1996; Mays, 1995). The pre-set interview questions were developed 
to encourage an in-depth exploration in areas of micronutrient risk analysis considered non-
transparent (e.g., ambiguity surrounding stakeholder involvement or how uncertain evidence is 
considered).  
Study 2 employed a narrative review method to explore the impact of recommendations regarding the 
efficacy of FBDG. A systematic, meta-analysis literature review was not deemed appropriate for the 
various quantitative, qualitative and mixed methodology research expected to be reviewed; due to the 
variety of methods, study designs and potential few common variables to align analyses (Baumeister, 
1997). Instead a narrative review was conducted using a theoretical framework of awareness, 
understanding and use to capture and categorise findings (Grunert, 2007). In addition, the 
methodological quality of the papers (and studies) reviewed were based on guidelines from 
Greenhalgh et al. on assessing methodological quality of published papers, including judgement of 
the study aim, purpose, method, design, theoretical framework, analysis, findings, discussion, 
presentation and references (Greenhalgh, 1997).    
Study 3 employed a case study method: collating a range of data from multiple sources, including 
semi-structure interviews, desk research and direct observation (the latter, most relevant to the UK). 
Case study research is often employed when conducting “empirical enquiry that investigates a 
contemporary phenomenon within its real-life context” (Yin, 2003). This was therefore a suitable 
method to study the challenge of transparently handling uncertain evidence during the development of 
micronutrient recommendations. Three a priori areas were the focus of the case studies: i) the request 
to develop DRV, e.g., the source of the request, scope the request and reasons for the request; ii) the 
process of DRV evidence evaluation e.g., selection and evaluation of evidence; and iii) the integration 
of evidence to develop final DRV e.g., formation of quantitative numbers and advisory committee 
report. These areas were selected as relevant to the specific research question and were based upon 
previous and preparatory research (Doets, 2008; Timotijevic, 2010; Timotijevic, 2011). The 
advantage of using this case study method was the ability to use multiple sources to dispute or 
corroborate findings and increase the validity of final interpretations (Yin, 2003). Interview 
participants were selected using the recruitment strategy of study 1; however, only the risk experts 
and stakeholders who had direct involvement in the micronutrient recommendation setting process 
were targeted (as opposed to stakeholders involved to a lesser degree). Desk research was led by the 
thesis author with suggested key word searches produced in English and amended by researchers in 
each country/region. These case studies were used to describe and explore this area of nutrition 
recommendation setting in different countries/regions where previously it had been demonstrated that 
knowledge was limited (Aggett, 2010; Darke, 1998; Doets, 2008).  
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1.5.3 Thematic analysis 
The aim of thematic analysis is to categorise data and identify patterns/themes from which a 
description can be derived to understand a situation (Joffe, 2004). This method of analysis was 
selected as the most appropriate for the team of researchers who collected the data in each individual 
country/region, whom had varying degrees of qualitative research experience. Thematic analysis is 
not necessarily attached to any particular theory and this allowed the diverse research team an 
accessible and flexible research tool that could “provide a rich and detailed, yet complex account of 
data” (Boyatzis, 1998; Braun, 2006; Braun, 2012; Joffe, 2004). Alternative analysis approaches were 
not deemed appropriate for this thesis, such as Interpretative Phenomenological Analysis (IPA), 
which represents an individual perception of a situation (Smith, 2009) or discourse analysis, which 
looks at a dialectic relationship between a producer and reader of text i.e., reconciling the difference 
between these different perceptions (Wodak, 2008). IPA and discourse analysis would have required a 
greater level of researcher qualitative experience, and potentially more time, than was available. 
Furthermore, the idiosyncratic nature of IPA and the detailed attention to language required in 
discourse analysis would have limited the ability to collate data and consider themes across the 
multiple languages in the countries/regions and cases sampled.  
The thematic analysis conducted in study 1 and 2 followed protocols developed by the thesis author. 
This protocol, included a step by step approach to data analysis, emphasising the principles of 
qualitative thematic research e.g., becoming familiar with the data; iteratively generating codes and 
searching for themes; reflecting upon and challenging interpretations of the data (Boyatzis, 1998; 
Braun, 2006; Braun, 2012; Joffe, 2004). The thesis author led the analysis strategy for both study 1 
and 2, producing initial skeleton coding templates based upon the research questions under study 
(similarly reflecting semi-structure interview schedules and desk-research literature searches) and 
initial reviews of the data from the UK, Netherlands or Denmark/Nordic countries. Templates were 
later modified by researchers in each country. Initial coding and theme development was conducted 
by the researchers who collected the data, in their native language, to maintain the authenticity of data 
interpretation. These, largely descriptive reports with initial themes and illustrative quotes in English 
were then collated by the thesis author, who endeavoured to answer the research questions and 
interpret, as well as, synthesise the data across interviews/cases from different countries/regions.  
Ethical procedures were followed for all of the research underlying this thesis. The sample 
participants were not considered to be from vulnerable populations; however, research was still 
conducted in compliance with country specific data protection and ethical requirements. This included 
the use of anonymous quotes and at times the removable of identifiable data, such as in study 3 
(Brown, 2015) where stakeholder groups have not been disclosed to protect the anonymity of the 
participants involved.
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Table 3 Type and nature of the body responsible for setting micronutrient recommendations 
Country Body responsible Type of body  Inception 
Australia & New 
Zealand 
Australian National Health and Medical Research Council (NHMRC); Australian 
Department of Health and Aging (DOHA); New Zealand Ministry of Health (NZ 
MOH)  
Expert advisory committee and 
governmental 
* 
Czech Republic Ministry of Health, Department of Public Health; Scientific Committee for Food Governmental and working group * 
DA-CH countries German Nutrition Society (DGE); Austrian Nutrition Society (OGE); Swiss 
Society for Nutrition Research (SGE) and Swiss Nutrition Association (SVE) 
Nutrition society 1992 
Italy Italian Society of Human Nutrition (SINU); National Research Institute on Food 
& Nutrition (INRAN) 
Nutrition society (scientific with 
links to governmental bodies) 
1977 
Netherlands Ministry of Health; Health Council of the Netherlands (HCN) Governmental and independent 
scientific advisory body 
1992 
Nordic countries Nordic Committee of Senior Officials on Food Issues, EK-Livs.; Working Group 
on Diet & Nutrition (NKE) 
Project group nominated by NKE 2000 
Poland Ministry of Health; National Food & Nutrition Institute, Warsaw Governmental 1963 
Serbia Ministry of Labour and Social Policy Governmental and expert group * 
Spain Madrid University; Spanish Society of Community Nutrition (SENC) Expert group and nutrition society * 
UK (Department of 
Health devolved to each 
region) 
Department of Health; Scientific Advisory Committee on Nutrition (SACN) 
(previously Committee on Medical Aspects of Food & Nutrition Policy, COMA) 
Governmental and advisory 
committee of independent experts 
1991 
*: information was not provided; DA-CH countries: Germany, Austria, Switzerland; Nordic countries: Denmark, Finland, Iceland, Norway, Sweden 
Adapted from de Wit et al. Inventory of currently used methods for defining and applying micronutrient recommendations in Europe. A EURRECA report for 
RA1.3-2, 2008 
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2 SUMMARY OF PUBLISHED WORKS FORMING THESIS 
2.1 Abstracts 
This thesis is formed of five published works, presented below in summary as five abstracts; each 
manuscript can be found in full in appendix 2.  
 
2.1.1 Publication 1 Micronutrient recommendation stakeholders’ beliefs on dietary guidelines: a 
qualitative study across six European countries/regions 
 
Brown KA; Timotijevic L; Barnett J; Ruprich J; Řehůřková I; Hermoso M; Andersen L-F; Lillegaard 
ITL; Fernández-Celemín L; Larrañaga A; Lončarević-Srnić A; Raats MM (2011a). Micronutrient 
recommendation stakeholders' beliefs on dietary guidelines: a qualitative study across six European 
countries/regions. European J of Clinical Nutrition, 65(7):872-4, doi: 10.1038/ejcn.2011.38 
http://www.nature.com/ejcn/journal/v65/n7/abs/ejcn201138a.html       
 
A range of stakeholders have been involved in the development and implementation of dietary 
guidelines (DG) across Europe. Seventy-seven semi-structured qualitative interviews explored 
stakeholders’ beliefs of DG in six European countries/regions. A main theme, variation in the 
interpretation of the term dietary guideline, was identified using thematic analysis. Descriptions of 
DG varied across stakeholder groups and countries. Reference was made to both food-based and 
nutrient-based guidelines, including the terms food-based DG and food guides (for example, 
pyramids), nutrient recommendations, dietary recommendations, dietary reference values and 
guideline daily amounts. The terminology surrounding DG requires greater clarity. Until that time, 
stakeholders would benefit from increased awareness of potential misinterpretations and the 
implications of this on multi-stakeholder, multi-national policy development and implementation. 
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2.1.2 Publication 2 Consumer involvement in dietary guideline development: opinions from 
European stakeholders 
 
Brown KA; Hermoso M; Timotijevic L; Barnett J; Lillegaard ITL; Rehurkova I; Larranaga A; 
Loncarevic-Srmic A; Frost Andersen L; Ruprich J; Fernandez-Celemın L; Raats MM (2013). 
Consumer involvement in dietary guideline development: opinions from European stakeholders. 
Public Health Nutrition, 16(5):769-776, doi: 10.1017/S1368980012005125 
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8884146&fileId=S13689
80012005125     
 
The involvement of consumers in the development of dietary guidelines has been promoted by 
national and international bodies. Yet, few best practice guidelines have been established to assist 
with such involvement. Qualitative semi-structured interviews explored stakeholders' beliefs about 
consumer involvement in dietary guideline development. Interviews were conducted in six European 
countries: the Czech Republic, Germany, Norway, Serbia, Spain and the UK. 
Seventy-seven stakeholders were interviewed. Stakeholders were grouped as government, scientific 
advisory body, professional and academic, industry or non-government organisations. Response rate 
ranged from 45 % to 95 %. Thematic analysis was conducted with the assistance of NVivo qualitative 
software. Analysis identified two main themes: (i) type of consumer involvement and (ii) pros and 
cons of consumer involvement. Direct consumer involvement (e.g. consumer organisations) in the 
decision-making process was discussed as a facilitator to guideline communication towards the end of 
the process. Indirect consumer involvement (e.g. consumer research data) was considered at both the 
beginning and the end of the process. Cons to consumer involvement included the effect of vested 
interests on objectivity; consumer disinterest; and complications in terms of time, finance and 
technical understanding. Pros related to increased credibility and trust in the process. Stakeholders 
acknowledged benefits to consumer involvement during the development of dietary guidelines, but 
remained unclear on the advantage of direct contributions to the scientific content of guidelines. In the 
absence of established best practice, clarity on the type and reasons for consumer involvement would 
benefit all actors. 
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2.1.3 Publication 3 A review of consumer awareness, understanding and use of food-based 
dietary guidelines 
 
Brown KA; Timotijevic L; Barnett J; Shepherd R; Lahteenmaki L; Raats MM (2011b). A review of 
consumer awareness, understanding and use of food-based dietary guidelines. British J of Nutrition, 
106:15-26, doi: 10.1017/S0007114511000250A 
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8297188&fileId=S00071
14511000250 
 
Food-based dietary guidelines have primarily been designed for the consumer to encourage healthy, 
habitual food choices, decrease chronic disease risk and improve public health. However, minimal 
research has been conducted to evaluate whether food-based dietary guidelines are utilised by the 
public. The present review used a framework of three concepts, awareness, understanding and use, to 
summarise consumer evidence related to national food-based dietary guidelines and food guides. 
Searches of nine electronic databases, reference lists and Internet grey literature elicited 939 articles. 
Predetermined exclusion criteria selected twenty-eight studies for review. These consisted of 
qualitative, quantitative and mixed study designs, non-clinical participants, related to official food-
based dietary guidelines for the general public, and involved measures of consumer awareness, 
understanding or use of food-based dietary guidelines. The three concepts of awareness, 
understanding and use were often discussed interchangeably. Nevertheless, a greater amount of 
evidence for consumer awareness and understanding was reported than consumer use of food-based 
dietary guidelines. The twenty-eight studies varied in terms of aim, design and method. Study quality 
also varied with raw qualitative data, and quantitative method details were often omitted. Thus, the 
reliability and validity of these review findings may be limited. Further research is required to 
evaluate the efficacy of food-based dietary guidelines as a public health promotion tool. If the purpose 
of food-based dietary guidelines is to evoke consumer behaviour change, then the framework of 
consumer awareness, understanding and use of food-based dietary guidelines may be useful to 
categorise consumer behaviour studies and complement the dietary survey and health outcome data in 
the process of food-based dietary guideline evaluation and revision. 
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2.1.4 Publication 4 Communication of scientific uncertainty: international case studies on the 
development of folate and vitamin D Dietary Reference Values 
 
Brown KA; de Wit L; Timotijevic L; Sonne A-M; Lähteenmäki L; Brito Garcia N; Jeruszka-Bielak 
M; Sicińska E; Moore AN; Lawrence M; Raats MM (2015). Communication of scientific uncertainty: 
international case studies on the development of folate and vitamin D Dietary Reference Values. 
Public Health Nutrition, 18(8):1378-1388, doi: 10.1017/S1368980014002006 
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=9671940&fileId=S13689
80014002006    
 
Transparent evidence-based decision making has been promoted worldwide to engender trust in 
science and policy making. Yet, little attention has been given to transparency implementation. The 
degree of transparency (focused on how uncertain evidence was handled) during the development of 
folate and vitamin D Dietary Reference Values was explored in three a priori defined areas: (i) value 
request; (ii) evidence evaluation; and (iii) final values. Twenty-one interviews were conducted across 
six qualitative case studies (semi-structured interviews and desk research) in Australia and New 
Zealand, Netherlands, Nordic countries, Poland, Spain and the UK. A common protocol was used for 
data collection, interview thematic analysis and reporting. Results were coordinated via cross-case 
synthesis.  
Transparency of process was not universally observed across countries or areas of the 
recommendation setting process. Transparency practices were most commonly seen surrounding the 
request to develop reference values (e.g. access to risk manager/assessor problem formulation 
discussions) and evidence evaluation (e.g. disclosure of risk assessor data sourcing/evaluation 
protocols). Fewer transparency practices were observed to assist with handling uncertainty in the 
evidence base during the development of quantitative reference values. Implementation of 
transparency policies may be limited by a lack of dedicated resources and best practice procedures, 
particularly to assist with the latter stages of reference value development. Challenges remain 
regarding the best practice for transparently communicating the influence of uncertain evidence on the 
final reference values. Resolving this issue may assist the evolution of nutrition risk assessment and 
better inform the recommendation setting process. 
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2.1.5 Publication 5 EURRECA-Evidence-Based Methodology for Deriving Micronutrient 
Recommendations 
 
Dhonukshe-Rutten RAM; Bouwman J; Brown KA [sections 2, 8 & 9]; Cavelaars AEJM; Collings R; 
Grammatikaki E; de Groot LCPGM; Gurinovic M; Harvey LJ; Hermoso M; Hurst R; Kremer B; Ngo 
J; Novakovic R; Raats MM; Rollin F; Serra-Majem L; Souverein OW; Timotijevic L; van' t Veer P 
(2013). EURRECA-Evidence-Based Methodology for Deriving Micronutrient Recommendations. 
Critical Reviews in Food Science and Nutrition, 53(10):999-1040, doi: 
10.1080/10408398.2012.749209 
http://www.tandfonline.com/doi/abs/10.1080/10408398.2012.749209  
 
The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence 
explored the process of setting micronutrient recommendations to address the variance in 
recommendations across Europe. Work centred upon the transparent assessment of nutritional 
requirements via a series of systematic literature reviews and meta-analyses. In addition, the necessity 
of assessing nutritional requirements and the policy context of setting micronutrient recommendations 
was investigated. Findings have been presented in a framework that covers nine activities clustered 
into four stages: stage one “Defining the problem” describes Activities 1 and 2: “Identifying the 
nutrition-related health problem” and “Defining the process”; stage two “Monitoring and evaluating” 
describes Activities 3 and 7: “Establishing appropriate methods,” and “Nutrient intake and status of 
population groups”; stage three “Deriving dietary reference values” describes Activities 4, 5, and 6: 
“Collating sources of evidence,” “Appraisal of the evidence,” and “Integrating the evidence”; stage 
four “Using dietary reference values in policy making” describes Activities 8 and 9: “Identifying 
policy options,” and “Evaluating policy implementation”. These activities provide guidance on 
how to resolve various issues when deriving micronutrient requirements and address the 
methodological and policy decisions, which may explain the current variation in recommendations 
across Europe.
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2.2 Table 4 Contribution of thesis author to co-authored published works forming thesis 
Publication 
KAB contribution 
Citation 
number  
 
RQ 
formation/ 
design 
Lit. 
review 
Data 
collection 
Study co-
ordination/ 
management 
Data 
analysis 
1st 
draft 
author 
Draft/ revise 
intellectual 
content 
Published 
version 
approval 
1. Brown KA, Timotijevic L, Barnett J, Ruprich J, 
Řehůřková I et al. (2011a). Micronutrient 
recommendation stakeholders' beliefs on dietary 
guidelines: a qualitative study across six European 
countries/regions. EJCN, 65(7):872-874 
   UK 
 UK & 
cross-country 
analysis 
 KAB 
 UK & 
cross-country 
analysis 
 2 
2. Brown KA, Hermoso M, Timotijevic L, Barnett J, 
Lillegaard ITL et al. (2013). Consumer involvement 
in dietary guideline development: opinions from 
European stakeholders. PHN, 16(5):769-76 
   UK 
 UK & 
cross-country 
analysis 
 KAB 
 UK & 
cross-country 
analysis 
 1 
3. Brown KA, Timotijevic L, Barnett J, Shepherd R, 
Lähteenmäki L et al. (2011b). A review of consumer 
awareness, understanding and use of food-based 
dietary guidelines. BJN, 106(1):15-26 
     KAB   20 
4. Brown KA, de Wit L, Timotijevic L, Sonne A-M, 
Lähteenmäki L et al. (2015). Communication of 
scientific uncertainty: international case studies on the 
development of folate and vitamin D DRV PHN 
18(8):1378-1388 
  
 UK      
 cross 
country 
  UK & 
cross-country 
analysis 
 KAB 
 UK & 
cross-country 
analysis 
 0 
5. Dhonukshe-Rutten R; Bouwman J; Brown KA; 
Cavelaars AE; Collings R et al. (2013). EURRECA - 
Evidence-based methodology for deriving 
micronutrient recommendations. CRFSN, 53(10): 
999-1040 
  
activities 
2, 8 & 9 
 
activities 
2, 8 & 9 
 
activities 2, 
8 & 9 
 activities 
2, 8 & 9 
 
activities 
2, 8 & 9 
RDR 
 activities 
2, 8 & 9 
 
activities 
2, 8 & 9 
12 
RQ: research question; KAB: Kerry Ann Brown; : small; : medium; : large 
 38 
 
2.3 Co-author statement 
 39 
 
 40 
 
 
 41 
 
 42 
 
3 CONCLUSION 
3.1 Summary of findings 
This thesis started from the position that communication of risk and transparency during risk analysis 
was valuable, with openness and honesty key principles of scientific endeavour and regulatory 
processes, lying at the cornerstone of why and for whom risk analysis is performed (Abbasi, 2004; 
Breakwell, 2007; Schreider, 2010). Previous research had indicated that international transparency 
initiatives were difficult to implement, particularly, regarding stakeholder involvement or the 
handling of uncertain evidence during micronutrient risk analysis (Aggett, 2010; Dhonukshe-Rutten, 
2010; Doets, 2008; Florini, 1999; King, 2007; Lofstedt, 2013; Timotijevic, 2010; Timotijevic, 2011). 
This thesis sought to identify the practical challenges of communicating risk during micronutrient risk 
analysis activities and understand whether this could be a limitation to achieving a transparent 
process. The published works enclosed have presented evidence of a number of challenges: the 
challenge of inconsistent terminology (Brown, 2011a; Dhonukshe-Rutten, 2013, section 2); the 
challenge of facilitating lay involvement (Brown, 2013; Dhonukshe-Rutten, 2013, section 8); the 
challenge of evaluating recommendation efficacy (Brown, 2011b; Dhonukshe-Rutten, 2013, section 
9); and the challenge of handling uncertain evidence (Brown, 2015; Dhonukshe-Rutten, 2013, section 
2). These challenges have been characterised as relevant to the internal communication of risk and 
uncertainty during risk analysis i.e., the communication of risk between experts and/or stakeholders 
involved within/across any of the risk assessment, risk communication or risk management activities. 
This is distinct from, and in addition to, the traditional external risk communication activities that are 
commonly associated with the general public/stakeholders outside the risk analysis process.  
This thesis supports the suggestion that the internal communication of risk between 
experts/stakeholders/risk analysis activities has to-date been undervalued and under-researched (IOM, 
2007; Renn, 2006; Renn, 2008). Increasing awareness of the importance of effectively 
communicating risk, both internally and externally during risk analysis, has the potential to facilitate 
the implementation of inter/national initiatives for transparent scientific and regulatory risk analysis 
processes. In addition, discussion of these challenges (particularly regarding how to handle 
uncertainty in the evidence base and stakeholder involvement) can enable debate on the pre-eminent 
micronutrient recommendation setting process; to ensure recommendations portray both accurate and 
meaningful representations of the risk (un/certainty of un/desirable outcomes) from identified 
micronutrient intakes or dietary patterns. The thesis findings relevant to specific research questions of 
section 1.4 are detailed below. 
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3.1.1 Terminology 
Brown et al. 2011a confirmed variety in the terminology employed when discussing micronutrient 
recommendations and the nature of this variety was explored. Findings were in line with previous 
research, which had identified different nomenclature used by different countries to describe their 
respective DRV (Ashwell, 2008; Dhonukshe-Rutten, 2010; Doets, 2008; Hornig, 2004; King, 2007) 
or FBDG (Anderson, 2003). A range of risk experts and stakeholders were sampled from several 
different countries/regions in this research and variety in terminology was expected. The magnitude of 
the variety and breadth of terminologies used was however, surprising; particularly the overlap and 
ambiguity between the concepts of DRV and FBDG. This finding carries significance for 
international organisations who attempt to harmonise procedures across countries, such as EFSA or 
WHO (WHO, 2010). In addition, this represents an added level of complexity for countries who adopt 
recommendations developed in other regions and may use similar/alternative terms for the 
same/different concepts.  
The findings from Brown et al. 2011a relate to the overall thesis aim, as inconsistency in nutrition 
terminology has been described as a primary barrier to transparency of process and stakeholder 
involvement during risk analysis (Aggett, 2010). It is therefore, possible that one step to achieve 
transparency in the development of micronutrient recommendations might be to clarify the 
terminology used across risk analysis activities in different countries/regions. For example, figure 3 
depicts how different terminologies may be related to each risk analysis activity. This figure was 
based upon the EFSA scientific opinions on DRV and FBDG (EFSA, 2010a; EFSA, 2010b) and 
created for the protocol of study 3 (Brown, 2015). The requirement to create such a tool for the 
purpose of this research further supports the need to be aware of terminology differences that might 
restrict meaningful communication within and between risk analysis activities, stakeholders, 
countries/regions and wider to those who implement or utilise micronutrient recommendations in 
research, policy or practice (DRV or FBDG; Brown, 2011a; Dhonukshe-Rutten, 2013, section 2).  
3.1.2 Lay involvement 
Brown et al. 2013 characterised stakeholder views on the type and value of lay involvement when 
setting micronutrient recommendations. Advantages were seen in lay involvement regarding 
traditional risk communication activities, such as communicating risk assessment and risk 
management outputs and considering how an audience might receive a communication. Concerns 
were however, raised as to the value of lay involvement during risk assessment/management activities 
(Brown, 2013; Dhonukshe-Rutten, 2013, section 8). This highlighted another practical challenge for 
the implementation of a transparent risk analysis process. The inclusion of lay perspectives at an early 
stage of risk analysis has been considered a means to increase transparency of decision-making, as 
well as improve the quality of the final decisions. The latter relates to ensuring risk analysis outcomes 
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are relevant and meaningful, reflecting the different levels of risk acceptability or perceptions of risk 
held across the general public; to whom recommendations are ultimately designed to protect (Aven, 
2009; EFSA, 2015). Clarity and consistency in terminology, as above, would assist with overcoming 
any perceived challenges in lay involvement from lack of understanding. Another step would be 
learning from different disciplines, which have greater experience of utilising lay involvement. For 
example, the use of patient and public involvement or shared decision making has been actively 
encouraged in medicine where lay perspectives are respected (alongside those of other stakeholders) 
as valid and credible input to inform healthcare decisions/research agendas (Stewart, 2005; 
Williamson, 1998). This involvement has been considered central to a) making healthcare services 
more accessible/acceptable to the general public and b) to improve patient health and quality of life 
outcomes (Charles, 1997; Crawford, 2002; Elwyn, 2004; Schipper, 2016). The UK DRV process was 
one of the few explored in this thesis where there was a mandatory requirement to ensure lay 
representation on the advisory committee responsible for setting DRV (SACN) and a practice of open 
meetings to allow lay (or any stakeholder) access to the DRV setting process. These moves are to be 
applauded in terms of fulfilling transparency initiatives and providing opportunities for expert led 
assumptions to be challenged; however, it would be interesting to fully explore the positive/negative 
impact of these policies, such as whether open meetings resulted in the non-discussion of certain 
issues due to un/necessary fear of scrutiny or misinterpretation.  
3.1.3 Efficacy 
Brown et al. 2011b reviewed the evidence available on the efficacy of FBDG and found minimal 
evidence of FBDG being used by the general public; however, it was not clear whether this lack of 
evidence represented a lack of FBDG efficacy or was more related to a lack of definitive purpose or 
evaluation measures from which to draw a conclusion on FBDG efficacy. The evidence was 
inconclusive as to whether FBDG have been effective in promoting healthy dietary practices or if they 
achieve the purpose for which they were designed (e.g., ensure adequate dietary intake to meet 
recommendations for micronutrients; Brown, 2011b; Dhonukshe-Rutten, 2013, section 9). Recent 
research has substantiated these findings, suggesting the purpose of FBDG is not universally clear and 
indicating the design of FBDG could be more appropriate to assist health professionals rather than act 
as direct communications to the general public (FAO/FCRN, 2016).  
FBDG are informed by micronutrient DRV (risk assessment) and can often be interpretations of 
nutrient/dietary goals (risk management); yet, FBDG are primarily considered a risk communication 
activity. A lack of demonstrable FBDG success could be due to the undefined purpose of FBDG 
during risk management activities or insufficient utilisation of risk communication research in 
nutrition risk communication activities. Traditional risk perception and risk communication research 
lies outside the scope of this thesis; nevertheless, it is related. These research fields have made a 
distinction between science education and the communication of science. The latter is related to a 
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two-way communication, where audience perception and information needs are considered. The 
former refers to one-way information provision, whereby science determines the facts that should be 
conveyed (Fischhoff, 2013). This research recognises value can be gained from two-way information 
provision i.e., at the minimum, feedback on how information has been interpreted and received by the 
target audience (Frewer, 2011). For example, we all have alternative perceptions of healthy dietary 
practices; different motivations for choosing to eat certain foods; often discrepant prioritisation of 
food-/health-related risks; and degrees of trust in the validity or credibility of a message dependent 
upon the medium or author (Bouder, 2015; Trew, 2008). All of these factors (and many more) 
represent potential barriers that might explain why one would choose to employ or ignore (in part or 
entirely) an outcome of the (micronutrient) recommendation setting process, such as FBDG (Atkins, 
2015; Kearney, 2007). In other words, no matter how logical the data, statistical or theoretical models 
that represent risk (i.e., uncertainty or magnitude of un/desirable outcomes), if these representations 
do not seem plausible (correspond with a recipient’s mental models) they are unlikely to be accepted 
by an individual or group of individuals (Aven, 2009; Bostrum, 1994; Skarlatidou, 2012). This has 
repercussions for the current thesis, as risk experts and stakeholders in each of the risk activities will 
have their own beliefs, knowledge and experiences which shape how they construe the risks and 
inherent uncertainties related to a recommendation (Aven, 2009; Schunemann, 2006). Expertise 
associated with traditional risk communication could be utilised throughout risk analysis, to assist 
with the challenge of communicating risk and uncertainty coherently and transparently within and 
between all activities, as well as ensuring traditional risk communication activities, such as FBDG, do 
not become divorced from either the knowledge gained throughout the risk analysis process or the 
audiences to whom they are directed (Goldberg, 2004). 
3.1.4 Uncertainty  
The case studies presented in Brown et al. 2015 provided valuable insights into the challenge of 
transparently handling uncertain evidence throughout the process of setting folate and vitamin D 
DRV. In line with previous research (Timotijevic, 2011), Brown et al. 2015 demonstrated that those 
countries with formal/permanent infrastructures to conduct risk analysis appeared more transparent 
(accessible and understandable documentation on the DRV process) than countries who performed 
risk analysis on an ad-hoc basis e.g., the UK Scientific Advisory Committee on Nutrition (SACN) as 
opposed to Spain where co-ordinated action at a national level was in its infancy and DRV had been 
developed by dedicated individuals. Nevertheless, challenges were identified across all countries 
regarding the transparent handling of uncertainty in all three areas investigated: problem formulation, 
evidence evaluation and derivation of quantified DRV (Brown, 2015; Dhonukshe-Rutten, 2013, 
section 2). The problem formulation stage (e.g., clarification of the terms of reference/scope of the 
risk assessment task) is one of the few stages of risk analysis where there was an expectation for 
explicit collaboration between risk assessment and risk management activities. Previous work has 
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highlighted this stage, where science (assessment) and policy (management) interact, as being 
particularly complex and important to nutrition risk analysis (CAC, 2015; Taylor, 2008; Timotijevic, 
2013a; Timotijevic, 2013b). This has led to debate over whether the risk analysis framework is 
sufficiently flexible to provide the opportunity for necessary risk management and risk assessment 
discussions (Hornig, 2004; Taylor, 2008; van Sluijs, 2010). For example, whether the current 
framework provides the fora to clarify risk management expectations (e.g., risk management 
repercussions following risk assessor conclusions), as well as risk assessment feasibility (e.g., risk 
assessment concerns over risk manager demands of “no decision is not an option” despite uncertainty 
in the available evidence base), whilst also upholding a requirement for activity separation to maintain 
the independence of risk assessment. Maintaining the independence of risk assessment is valued to 
minimise conflicts of interest, such as a pre-determined risk management strategy overly influencing a 
risk assessment conclusion or unelected risk assessment scientists overly influencing risk 
management policy selection (IOM, 2007). This independence can however, be difficult to establish, 
as demonstrated by the recent controversies with EFSA risk assessment panel members, who were 
affiliated with an organisation funded by the food industry and considered to be conflicted by their 
interests (Corporate European Observatory, 2012). In addition, independence is not without its 
disadvantages. For example, the recent release of the Dietary Guidelines for Americans (HSS/USDA, 
2015) has been contentious, with those responsible for the scientific advice underpinning the DGA 
dissatisfied by how this advice was rejected or altered when forming the official DGA e.g., omissions 
related to sustainable diets, increasing the variety of diets; and reducing the reliance on animal-based 
foods (Katz, 2016). There has been an increasing practice of outsourcing specific tasks during risk 
assessment to ensure the independence of risk assessment activities, such as the systematic literature 
reviews during evidence evaluation (e.g., in the Nordic countries; NCM, 2014). This has led to a 
greater importance placed on procedures such as GRADE (GRADE, 2004) to encourage the 
systematic detailing of evidence evaluation, regarding how uncertainty is handled and the decisions 
taken to ‘weigh’ the strength/quality/balance of evidence. These procedures remain imperfect, as there 
are difficulties practically implementing the GRADE system and articulating the (implicit/explicit) 
values and assumptions underlying the complex expert judgements taken during risk analysis 
(Andrews, 2013; WHO, 2010). They do however, help to systematically highlight where there are 
uncertainties in the evidence and force risk assessors and risk managers to explicitly consider 
uncertainty and ambiguity in their decision-making (Yoe, 2012). 
The Brown et al. 2015 findings are comparable to those seen in other fields of risk analysis (food and 
non-food), where practical difficulties have been observed collating uncertain evidence and detailing 
the arguments of how uncertainty has been systematically considered and played a part in any final 
decisions/recommendations (Lofstedt, 2013; van der Sluijs, 2010; Walls, 2011). The findings of 
Brown et al. 2015 have implications for the overall thesis, because if the necessary tools and skills to 
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overcome the challenges identified in this thesis do not exist then inter-/national transparency 
initiatives may be purporting unrealistic expectations for transparency (Bailar, 1999; Coglianese, 
2009). This could be a reason why international agencies mandated to fulfil transparency initiatives 
have begun to give considerable attention to the practical difficulties of implementing these 
initiatives, as well as the positive and negative consequences to their implementation (EFSA, 2016a; 
IOM, 2011). For example, EFSA who are mandated to perform transparent risk assessment and risk 
communication activities (risk management being the responsibility of the EC) have been considering 
the dilemma of transparently identifying and describing uncertainty. As a consequence, EFSA are in 
the process of developing a toolbox of guidance to systematically weigh evidence and communicate 
(quantitative or qualitative) uncertainty in the food area. This guidance supports the findings in this 
thesis, explicitly referring to the requirement for greater awareness of communicating risk and 
uncertainty between risk analysis activities as an ‘enabling mechanism’ to conduct transparent risk 
analysis (EFSA, 2016a). A draft toolbox will undergo internal EFSA testing in 2016. It will be 
interesting to observe the progress of this pilot testing and how it might advance the practice of 
communicating risk within and between risk analysis activities, as well as to those outside the risk 
analysis process. This thesis supports this initiative, further arguing some such toolbox could help to 
ensure there is transparent, consistent and coherent communication of risk throughout risk analysis 
(both internal and external to the risk analysis process). 
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3.2 Limitations 
This thesis provided a unique opportunity to identify the practical challenges of communicating risk 
during the micronutrient risk analysis process across a number of international countries/regions. To 
adequately interpret the findings herein it is necessary to present the context within which this 
research was conducted, as well as acknowledge the limitations of the methodology and methods 
used. This has been provided below.   
3.2.1 Context 
The process of setting micronutrient recommendations has been continually evolving (IOM, 2007); 
thus, the findings represented in this thesis are time bound, related to the contemporary processes, 
procedures and approaches observed from 2008-2012, in the five years the thesis author was part of 
the EURRECA network of excellence. Since this work, new micronutrient recommendations have 
been released or are eminently due for release (e.g., UK draft vitamin D DRV, SACN, 2016; EC draft 
vitamin D DRV, EFSA, 2016b; UK ‘Eatwell guide’ FBDG, PHE, 2016). In addition, research 
continues to move on a-pace within the nutritional sciences to address the gaps in knowledge and 
uncertainties that constrain the process of setting micronutrient recommendations. For example, to 
combat the non-standardised measurement of serum 25(OH)D (Schleicher, 2016); understanding the 
interactions between different micronutrients and different health outcomes (Bolland, 2014); or the 
effect of folic acid fortification in populations where vitamin B12 deficiency is prevalent (Allen, 
2016). The micronutrient recommendation processes observed in this thesis might therefore, have 
adapted; observed uncertainty issues may have been surpassed by those related to advances in 
metabolomics, epidemiology dose-response techniques or even paradigm shifts (e.g., the growing 
pressure to consider planetary health as intrinsic to human health; FAO/FCRN, 2016). Furthermore, 
since 2012 risk governance has gained greater attention, with transparency becoming an increasing 
political priority (Rothstein, 2006); thus the application of the risk analysis framework in certain 
countries/regions is likely to be different going forward than when the studies underlying this thesis 
were conducted. Nevertheless, the developments of new initiatives, such as the EFSA risk assessment 
procedures for expert elicitation and the communication of risk and uncertainty (EFSA, 2014b; EFSA, 
2016a), highlight the relevance of this thesis. Effective communication of risk is therefore, becoming 
fundamental to achieving a transparent risk analysis process: to ensure all risk experts, stakeholders 
and the general public are engaged with the limitations of new evidence and how this might contribute 
to or change knowledge considered to be state-of-the-art (Delogu, 2016). 
3.2.2 Approach 
A pragmatic approach was taken during the research underlying this thesis to fulfil a policy need. The 
scope of the overall research question was generated by preparatory work, which in turn had been led 
by a European Commission research agenda to harmonise micronutrient recommendations in Europe. 
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This thesis did not set out to endorse or oppose a requirement for recommendations to be harmonised. 
Nevertheless, it was this European Commission research call that provided the context within which 
the research questions were generated, rather than these being generated by a specific theory. This 
limited the scope of the overall research question, for example the communication of risk was 
restricted to the micronutrient risk analysis process, as opposed to nutrition risk analysis as a whole 
(macro- and micronutrients). Furthermore, research was predominantly limited to the study of 
European countries. An opportunity was taken to include data from Australia and New Zealand in the 
final case study and results have been reflected upon the research conducted outside Europe (in 
particular, North America); yet the majority of the research was conducted in the European context 
and this limits the ability to transfer these results to situations outside of Europe. Conversely, the 
overall and specific research questions were flexible to enable the pragmatic selection of qualitative 
research methodology and a range of research methods (narrative review, interview and case study); 
chosen to be appropriate to answer the research question under study within the resources (time, skill, 
finance) available. Resources did however place one further limitation on the scope of the thesis. 
Micronutrient recommendations are often set in isolation, one or two micronutrients at a time. It was 
thus, not considered plausible to explore the process used to set all micronutrients. Instead the case 
studies focused upon folate and vitamin D DRV, both of which had been subjects of topical debate 
and controversy regarding the emergence of new evidence of non-/selection of relevant policy options 
(e.g., fortification; HCN, 2008; Mensink, 2013; SACN, 2007). In addition, these DRV had 
recently/were currently being reviewed in a number of the countries sampled. Furthermore, these 
micronutrients were considered of public health relevance, being two of the ten priority 
micronutrients identified by previous EURRECA work (Cavelaars, 2010). This thesis might well have 
explored a number of other micronutrients in detail, particularly iron which is considered a global 
micronutrient of interest or iodine where there has been contention on the non-/advocacy of 
mandatory iodisation programmes in different European countries (Lazarus, 2008). The 
micronutrients of iron and iodine would have been associated with different stakeholders and 
uncertainties. It is therefore, unclear whether the findings of this thesis might have been different if 
alternative micronutrients had been selected. 
3.2.3 Bias    
As with all research there are inherent strengths and weaknesses in the research methodology and 
methods employed. A particular challenge with this research was the collaborative nature of the 
interview and case study work (study 1 and study 3). The thesis author led the overall and specific 
research questions for these pieces of work: taking responsibility for the design and project 
management of the research. This was in addition to completing the UK arm of each research study, 
as well as compiling and completing the overall analysis and interpretation of the research across all 
countries. A team of international colleagues however, were involved in the collection and analysis of 
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individual country/region data. As such the research team varied in their qualitative and nutrition 
experience. This complicated the ability to standardise recruitment, data collection and analysis. For 
example, interview data represented risk expert and stakeholder perceptions of the micronutrient 
recommendation setting process and as such were not ‘objective’ measurements of this process; thus 
researcher skill was required to acknowledge and disclose subjectivity in both the interviewees and 
the researcher’s interpretation of the interview data. 
To counter such factors, detailed protocols were established by the thesis author. These were designed 
to ensure the research was both accessible to the multi-disciplinary teams, as well as complying with 
the basic principles of qualitative research outlined in the British Medical Journal (Greenhalgh, 1997) 
and via COREQ (the consolidated criteria for reporting qualitative research; Tong, 2007) e.g., 
regarding sufficient awareness and detail of the research team; study design; analysis and findings. 
For example, protocols included the requirement to wherever possible challenge (corroborate or 
affirm) interview data (particularly retrospective data with long time lags e.g., the UK and COMA 
1991 DRV) via desk research (also triangulation in the UK via direct observation of SACN meetings). 
In addition, the research team had routine contact throughout the research to provide support and the 
opportunity for clarification, the updating of protocols and consistency in protocol application. These 
measures were designed to minimise bias and maximise rigour throughout this research, clarifying 
research goals, ensuring common sampling recruitment strategies and the systematic documentation 
and reflection of researcher subjectivity throughout data collection and analysis across researchers and 
countries. Bias towards the thesis author perspective and over representation of UK data during cross-
country analysis (interviews and case studies) was minimised by maintaining specific research 
questions throughout to lead the design of the interview schedules and skeleton analysis templates; as 
well as the analysis, interpretation and presentation of results (e.g., all identified themes were 
considered irrespective of the proportion of the total sample they represented). In addition, cross-
country analyses were frequently reflected back to the research team to conserve the authenticity of 
data and understanding of the context from individual countries/regions (e.g., the alternative roles 
different stakeholder groups might play in each country). In sum, despite these methodological 
limitations, as a whole, this research has provided valuable perspectives on the challenges 
(particularly relevant to vitamin D and folate DRV developed in Europe) to achieving a transparent 
micronutrient risk analysis process and invaluable contributions to the suggestion effective 
communication of risk between risk experts and stakeholders is a prerequisite to transparency of the 
risk analysis process.  
3.3 Future research 
This thesis concluded that communication of risk within the risk analysis process (between risk 
experts as well as risk experts and stakeholders) had the potential to facilitate transparency during the 
micronutrient recommendation setting process. These results could be utilised by a) investigating the 
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most effective means to improve communication within the risk analysis process: between the risk 
experts of different activities, as well as between risk experts and stakeholders; b) investigate the 
effect of improved communication of risk within the risk analysis process on (measures of/impacts of) 
transparency.  
In relation to a) and following on from 3.1.1 and figure 3 it could be valuable to further clarify the 
terminology used regarding micronutrient recommendations by categorising and linking the terms 
used between international risk experts and stakeholders to create a micronutrient recommendation 
setting typology. This could be used to facilitate communication of risk, particularly to ensure 
consistency of language and more importantly meaning during international organisation 
communique. EFSA commissioned a mixed methods review of terms for describing risk and or 
uncertainty in EFSA publications from 2008 to early 2010 and has proposed to create a series of 
glossaries to facilitate transparency (EFSA, 2012; Flari, 2011). This research design could be repeated 
for the terms used to relate to micronutrient recommendations. A skeleton typology could then 
become an organic framework, subject to verification from risk experts and stakeholders where words 
and their meaning (in English or different languages) could be added and linked to produce a live map 
of terms. Furthermore, it could be worthwhile to conduct another series of qualitative studies 
(interviews, focus groups) to fully explore the definition of ‘health’ from risk expert, stakeholder (and 
potentially also general public), perspectives. For example, this thesis observed the challenge of 
communicating the risk of adverse health effects. It could therefore, be valuable to establish how one 
might conceptualise health to inform how un/desirable outcomes are both considered and 
communicated throughout the risk analysis process e.g., how to conceptually deal with the notion that 
healthy ageing might include the recognition that chronic disease is inevitable; thus we might have a 
chronic disease in waiting and health would be delaying the advent of that disease for as long as 
possible. Lastly, in reference to b) the development of the EFSA uncertainty toolbox provides an 
excellent opportunity to test the effect of improved communication of risk (between risk assessors and 
risk managers) on transparency. It would be interesting to know if this toolbox will be rolled out 
across all of the EFSA risk assessment activities (e.g., nutrition and non-nutrition related) or if an 
experimental design would be able to see the impact of a guidance tool intervention versus a ‘practice 
as normal’ on the transparency of the risk analysis process, as measured fulfilment of risk governance 
obligations (transparency initiatives); efficiency savings during risk analysis (time); improved co-
ordination between risk assessment and risk management activities or efficacy of recommendations 
(compliance with recommendations/reduction of micronutrient-related negative health outcomes).  
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3.4 Closing comments 
This thesis suggested effective communication of risk between risk experts, as well as risk experts and 
stakeholders, is a prerequisite for achieving a transparent (valid and credible) micronutrient risk 
analysis process. This relates to the communication of risk throughout risk analysis, to ensure 
consistency of terminology; facilitate stakeholder involvement and the handling of uncertain evidence 
within and between risk analysis activities, from DRV problem formulation to evaluating the impact 
of risk management outputs (e.g., FBDG). The importance of this will only increase as micronutrient 
risk analysis becomes more complex: incorporating evidence from new technologies and techniques 
in risk assessment (e.g., metabolomics or epidemiology) and demanding ever more difficult decisions 
during risk management (e.g., prioritising long term planetary health over short term human health). 
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Figure 3 Terminology aid for risk communication throughout the process of setting 
micronutrient recommendations. Adapted from Brown, 2011a; CAC, 2015; EFSA, 2010a; 
WHO, 1997; Yoe, 2012.  
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Appendix 1 Published works context 
The University of Surrey degree committee accepted an application for the thesis author to pursue a 
PhD via published works in Sep 2014. The current thesis was subsequently submitted for a degree of 
Doctor of Philosophy on the bases of published works in Sep 2015. The research underlying each 
publication was completed whilst I was a full time Research Fellow at the University of Surrey 
working for the European micronutrient recommendation aligned network of excellence (European 
Commission, Framework Programme 6, EURRECA NoE), between 2008 and 2012. The thesis author 
led three of the EURRECA studies under the Surrey led Consumer and Stakeholder Integrating 
Activity work package. The original grant description of work was adapted by the thesis author to 
focus on communication of risk between experts and/or stakeholders (lay or other), rather than 
restricting the work to consumers and stakeholders alone. The thesis author took responsibility for 
amending research design elements of the original grant description of work, including the use of 
thematic analysis for Brown et al. 2011a and Brown et al. 2013a rather than Interpretative 
Phenomenological Analysis; the use of a narrative review in Brown et al. 2011b rather than a 
systematic review; and the use of a case study design in Brown et al. 2013.  
Five publications form the core of this thesis. The publications were completed 2011-2015, whilst the 
thesis author continued to work as a full time Research Fellow at Surrey on two European 
Commission, Framework Programme 7 projects (The role of health-related claims and symbols in 
consumer behaviour, CLYMBOL and Studying the need for food and health research infrastructures 
in Europe, EuroDISH). The thesis author is the main author on four of these publications (Brown, 
2011a; Brown, 2011b; Brown, 2013; Brown, 2015). These publications were based upon three studies 
the thesis author designed, project-managed, conducted and analysed in collaboration with European 
colleagues. The thesis author was also part of the core writing team for the fifth publication 
(Dhonukshe-Rutten, 2013). This fifth publication drew on the findings of the four main author 
publications, together with those from the six supporting publications (Appendix 4), to inform the 
development of the overall framework. The thesis author’s specific contribution to the fifth 
publication was writing sections 2, 8 and 9 (in collaboration with Lada Timotijevic), which involved 
the collation, analysis and interpretation of the work performed by the Consumer and Stakeholder 
Integrating Activity throughout the duration of the EURRECA project.  
The published works in this thesis contributed to and therefore aligned with the conclusions of 
EURRECA; however, the objectives and conclusions of this thesis differ from EURRECA. 
EURRECA sought to align the micronutrient recommendation setting process for Europe. As such, 
transparency was considered a necessary goal of an aligned and standardised process. This thesis 
sought to identify challenges of communicating risk and conducting a transparent micronutrient risk 
analysis process; irrespective of whether micronutrient recommendations were/were not aligned. 
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A range of stakeholders have been involved in the development and implementation of dietary guidelines (DG) across Europe.
Seventy-seven semi-structured qualitative interviews explored stakeholders’ beliefs of DG in six European countries/regions.
A main theme, variation in the interpretation of the term dietary guideline, was identified using thematic analysis. Descriptions
of DG varied across stakeholder groups and countries. Reference was made to both food-based and nutrient-based guidelines,
including the terms food-based DG and food guides (for example, pyramids), nutrient recommendations, dietary recommenda-
tions, dietary reference values and guideline daily amounts. The terminology surrounding DG requires greater clarity. Until that
time, stakeholders would benefit from increased awareness of potential misinterpretations and the implications of this on
multi-stakeholder, multi-national policy development and implementation.
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Introduction
The European Commission has encouraged the involvement
of multi-sector stakeholders in the development, implemen-
tation and use of public health-related policies, such as
dietary guidelines (DG), to establish consistent and coherent
health promotion approaches both within and between
European Union member states (EC, 2007). Individual
country/regional factors (for example, socio-cultural), have
limited the feasibility of DG content alignment at a
European level. Nonetheless, there has remained an oppor-
tunity to share best-practice methods and align the aims,
uses and processes for DG development.
A common understanding of both the technical terminol-
ogy as well as the aims and uses of DG has been required to
ensure effective stakeholder involvement in DG develop-
ment within countries and the alignment of the DG
development process between countries. In 1996, an FAO/
WHO consultation report (FAO/WHO, 1996) produced a set
of definitions that distinguished between DG, food-based
dietary guidelines (FBDG) and Dietary Reference Values.
Statements that promoted nutritional well-being in the
general public and could be expressed in both nutrient and
food-based terms were considered to be DG. These guidelines
take into account the complicated interacting factors of
habitual dietary eating patterns to provide guidelines, which
can be used as the basis for policy development and
consumer communications. FBDGs were described as nutri-
tion education in the form of foods for use by individuals
and Dietary Reference Values as quantitative population
level reference estimates for individual nutrients. These
definitions have been cited in the literature surrounding DGs.
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However, perhaps due to the diverse array of participants
involved in DG development and implementation, there has
remained an inconsistency in the terminology used in both
grey and academic literature (Anderson et al., 2003; Prentice
et al., 2004; Ashwell et al., 2008). This has been highlighted
by an editorial for the proceedings of a workshop and
symposium supplement, where the authors acknowledged
variety in both meaning and use of DG terminology within
and between the workshop participants from North America
and Australia and the resultant proceedings publications
(Anderson et al., 2003).
Aim
This study explored the use of DG terminology by a range of
stakeholders across different European countries. The term
DGs was selected to allow for comparisons with previous
observations on terminology (Anderson et al., 2003) and
because it was believed to be the most understandable and
translatable term across stakeholders and countries.
Method
A qualitative semi-structured interview design was used to
explore the beliefs of micronutrient recommendation stake-
holders across six European countries/regions. In total, 77
interviews were conducted. Stakeholders were defined as
‘individuals or organisations willing to invest resources and
accept some responsibility for the development of micro-
nutrient recommendations-may also be consumers’ and
grouped as government (GOV), scientific advisory body
(SAB), professional and academic (PRO), industry (IND) or
non-government organisations (NGOs, included charities,
consumer and special interest groups, Table 1). Data were
collected in six European countries/regions: Czech Republic
(CR), DACH countries (DACH, predominantly Germany),
Norway (and one Nordic Nutrition Recommendations
member from Denmark), Spain, Serbia and the United
Kingdom (UK). Stakeholders were interviewed either face-
to-face or via the telephone, recorded with prior obtained
consent and transcribed verbatim. The 21 CR participants
were recruited within the context of a workshop. Response
rates ranged from 45% (DACH) to 95% (CR). The data were
analysed using thematic analysis (Boyatzis 1998; Joffe and
Yardley, 2004). Each country completed template analysis in
their own language using a skeleton coding structure created
and modified by partners during preliminary analyses.
Thematic analysis was then carried out by each country
and an English-translated summary of identified themes and
illustrative quotes was provided. This paper has reported on
one commonly identified theme from the collated country
summaries.
Results and discussion
A common main theme, variation in the interpretation of
the term dietary guideline, was identified across the inter-
views using thematic analysis.
A variety of terminologies and definitions were used to
describe DG across the interviews. These were similar to
those previously commented on by Anderson et al. (2003)
and included FBDG and food guides (for example, pyramids
and plates), nutrient recommendations, dietary recommen-
dations, dietary reference values and guideline daily
amounts.
‘yofficial recommendation about what people should
be eating in order to stay healthy.’ [NGO UK 5]
‘Recommendations for intake of specific nutrients’
[GOV DACH 4]
‘The food pyramid is the most important translation of
nutrient declarations’ [SAB DACH 2]
‘They are specific recommended values of particular
nutrients, mainly macronutrients.’ [IND CR 14]
The majority of stakeholders, particularly in the CR, DACH,
Norway and UK, described DG as having both nutrient- and
food-based aspects.
‘Today it is nutrient based but also something on food
[.] it is a bit of a combination of both.’ [GOV NOR 7]
‘yI think it would be quite wide ranging. I would say
it would be a nutrient level, micronutrients or macro-
nutrients, but it could also be food based.’ [IND UK 6]
A few stakeholders also mentioned a more general level of
DG that related to overall energy balance and non-diet-
related guidelines, such as physical activity or sustainability,
‘yand then you have a separate group of advices that
are linked to the total diet and energy intake. And
where one has to adjust dietary guidelines against
lifestyle and type of physical activity’ [PRO NOR 1].
Table 1 Stakeholder sample
Country Stakeholder group
PRO GOV. SAB NGO IND Other Total
CR 6 4 2 4 4 1 21
DACH 2 2 2 2 2 0 10
NO 1 2 3 1 2 0 9
SER 5 3 0 4 3 0 15
SPA 4 3 2 2 1 0 12
UK 1 1 2 2 4 0 10
Total 19 15 12 15 15 1 77
Abbreviations: CR, Czech Republic; DACH, Germany, Austria and Switzerland;
GOV, government; IND, industry; NGO, non-government organisation; NO,
Norway; PRO, professional and academic; SAB, scientific advisory body; SER,
Serbia; SPA, Spain.
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Stakeholders, particularly in the CR, Serbia and UK, expli-
citly referred to ambiguity in the term ‘dietary guideline’
and requested clarification. In Serbia this was a translation
issue, where the majority of interviews were eventually
carried out using the term dietary recommendations and a
Serbian word ‘preporuke’ rather than the term dietary
guidelines and a Croatian word ‘smernice’,
‘yif you say guidelines though [.] depends how you
divide the, define the guideline.’ [SAB UK 2]
‘It is necessary to distinguish what DG we are talking
about.’ [PRO CR 7]
‘I would say dietary recommendations.’ [PRO SER 7]
Language translation issues may in part have accounted for
variation in the way that DG were described, as interpreta-
tion was also required for the Norwegian use of the terms
‘kostra˚d’ for guidelines and ‘anbefalinger’ for recommenda-
tions. In addition, variation may have emanated from the
range of stakeholders interviewed and the different perceived
purposes of dietary guidelines. It was not possible to conduct
data analysis by stakeholder group due to the incompatible
nature of the stakeholder groups who appeared to vary in
their involvement of DG development across countries. This
has been shown in previous research where stakeholder
involvement may differ due to the socio-political context
and degree of stakeholder influence in respective countries
(Timotijevic et al., 2010). However, there was a range of DG
purposes suggested across the interviews and interpretations
of the term DG, which may explain the variety of
interpretations for the term DG. The uses of DG mentioned
included health promotion advice for consumers (for
example, food-based DGs and food labelling); school
children education; advice to special groups of consumers
(for example, athletes or diabetics); communication and
monitoring tools for government or health professionals and
compliance tools for members of the food industry.
‘yguideline is something that should lead to the
execution of recommendations.’ [GOV SER 5] ‘Dietary
guidelines are documents that are aimed at health
professionals. They allow us to tell to the population
what the recommendations are.’ [IND SPA 60]
‘Of crucial importance is the specification of DG for
school canteens.’ [NGO CR 12]
Conclusion
The exploratory nature of this study justified the use of a
qualitative design. However, caution must be taken with
interpretation of these qualitative results in terms of their
reliability and generalisability outside of the sample studied.
Nevertheless, this study has provided useful insights into
stakeholders’ beliefs on DG. Previous observations of DG
terminology ambiguity both within and between countries
appeared to have been supported (Anderson et al., 2003).
Furthermore, it has been highlighted that this ambiguity
may be due to the variety of audiences and uses of DG. To
conclude, the terminology surrounding DG requires greater
clarity. Until that time, those who are in the process of
developing DG or are attempting to align DG-related health
policies would benefit from greater awareness of the
potential ambiguity surrounding DG terminology and the
implications of this on multi-stakeholder, multi-national
health policy development and implementation.
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Abstract
Objective: The involvement of consumers in the development of dietary guide-
lines has been promoted by national and international bodies. Yet, few best
practice guidelines have been established to assist with such involvement.
Design: Qualitative semi-structured interviews explored stakeholders’ beliefs
about consumer involvement in dietary guideline development.
Setting: Interviews were conducted in six European countries: the Czech
Republic, Germany, Norway, Serbia, Spain and the UK.
Subjects: Seventy-seven stakeholders were interviewed. Stakeholders were grouped
as government, scientific advisory body, professional and academic, industry or
non-government organisations. Response rate ranged from 45 % to 95 %.
Results: Thematic analysis was conducted with the assistance of NVivo qualitative
software. Analysis identified two main themes: (i) type of consumer involvement
and (ii) pros and cons of consumer involvement. Direct consumer involvement
(e.g. consumer organisations) in the decision-making process was discussed as a
facilitator to guideline communication towards the end of the process. Indirect
consumer involvement (e.g. consumer research data) was considered at both the
beginning and the end of the process. Cons to consumer involvement included
the effect of vested interests on objectivity; consumer disinterest; and compli-
cations in terms of time, finance and technical understanding. Pros related to
increased credibility and trust in the process.
Conclusions: Stakeholders acknowledged benefits to consumer involvement
during the development of dietary guidelines, but remained unclear on the
advantage of direct contributions to the scientific content of guidelines. In the
absence of established best practice, clarity on the type and reasons for consumer
involvement would benefit all actors.
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A variety of national and international bodies have pro-
moted the involvement of consumers as stakeholders in
health research, policy and practice(1–3). This has included
the development of dietary guidelines(4), a set of statements
that could be expressed in both nutrient- and food-based
terms for the promotion of nutritional well-being in the
general public(5). Suggested benefits of consumer involve-
ment have related to the process of scientific decision
making, such as fostering trust in the process via transpar-
ency, as well as improving the quality of final decisions(4,6,7).
In terms of process, consumer involvement has been
led by a move for greater accessibility to science(6,8,9),
where ‘people have the right and duty to participate
individually and collectively in the planning and imple-
mentation of their health care’(10). Regarding content,
consumer involvement is premised upon incorporation of
consumer values and perspectives to broaden the range
of knowledge considered and allow the opportunity for
assumptions to be challenged(4,6,11–13).
y Current address: Norwegian Scientific Committee for Food Safety, PO
Box 4044 Nydalen, N-0404 Oslo, Norway.
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Consumer involvement can take a variety of forms in
terms of who would be involved, in what way and to
what degree(13). The general public is the intended end-
user of dietary guidelines. Thus, all members of the public
have the potential to be involved, from individual lay
consumers to those representing vulnerable consumers or
consumers in general, such as consumer groups or con-
sumer advocates(14). Participation may be via the use of
qualitative or quantitative consumer research data (e.g.
focus groups testing draft guidelines or food choice and
dietary intake data) or at invitational/open consultations
and decision-making meetings(6).
There has been limited research in Europe on the
current practice of consumer involvement in the devel-
opment of dietary guidelines(15). Timotijevic et al.(9)
explored stakeholder (including consumer groups)
involvement in the decision-making process for micro-
nutrient recommendations and suggested involvement
differed across European countries, influenced by a
country’s political and historical context. For example, in
the Czech Republic, where new democratic nutrition
policies were in their infancy, stakeholder involvement
was encouraged but not consistently employed. In the
UK, stakeholder involvement was more formalised.
This has likely been in response to the visible health
scares that occurred in the UK (e.g. variant/non-variant
CJD, the human prion disease caused by BSE), as well as
the positioning of public health nutrition in key policy
decisions(9).
Inconsistency in the employment of consumer involve-
ment across Europe may also be due, in part, to the lack of
evidence-based best practice for consumer involvement in
scientific decision-making processes(16). Minimal data have
been available to evaluate the impact of consumer invol-
vement or highlight the potential advantages of involvement
in the development of dietary guidelines(9).
A greater degree of research has been conducted in
relation to consumer involvement in the clinical health-
care field (‘clinical’ referring to the treatment of disease,
predominantly at an individual level, as opposed to
dietary guidelines which refer to public health promotion
at a population level). Various models to describe consumer
involvement have been developed, such as Arnstein’s
ladder of participation(17), which contained three main
categories of involvement: non-participation, degrees of
tokenism and degrees of citizen power. However, this has
since been criticised for its lack of applicability in today’s
health-care context(18). More recent research has sug-
gested three general classifications of involvement: public
communication (e.g. recipients of information campaigns),
public consultation (e.g. responders to draft consultation
documents) and public participation (e.g. members of
advisory committees). Yet, research in the health-care field
has also been limited by a paucity of data evaluating the
impact of various types of consumer involvement(6,13,19–21).
This was illustrated by an updated Cochrane review which
emphasised the lack of data from randomised controlled
trials on the effects of consumer involvement in health-care
decisions, such as the development of clinical practice
guidelines(22). Alternative study designs have attempted to
evaluate the impact of consumer involvement, particularly
regarding public engagement in health policy develop-
ment(23,24). However, evaluation has been hampered by the
methodological difficulties of identifying and measuring
positive/negative impacts of consumer involvement on
either the decision-making process (e.g. decision-maker
experience, engagement, financial or time costs) or the
content and effectiveness of final decisions and their
implementation (e.g. content quality, improvements in
public health, use of guidelines)(6,25).
The international and European political will for con-
sumer involvement in scientific decision-making pro-
cesses does not appear to have been transferred into the
practice of consumer involvement across Europe. This
may be explained by country-specific social, historical
or political contexts. However, implementation may have
been further complicated by the lack of established best
practice guidelines or evidence on the most effective form
of consumer involvement. The current study used a quali-
tative interview design and sought to explore any com-
monalities in the beliefs of a variety of stakeholders from
different European countries on consumer involvement in
the development of dietary guidelines. The aim was to bring
a multi-national and multi-stakeholder perspective to dis-
cussions on potential avenues for pan-European consumer
involvement best practice guidelines.
Method
Design
Qualitative semi-structured interviews explored stake-
holders’ beliefs about consumer involvement in dietary
guideline development (both nutrient- and food-based
recommendations). A common protocol was used by the
researchers responsible for data collection in each country.
Interviews were held face-to-face or over the telephone.
Consent was obtained for participation and all interview
recordings, which were later transcribed verbatim. All
quotes have been made anonymous.
Setting
Interviews were conducted during 2008–2009 in six
European countries: the Czech Republic (CZ), Germany
(GE; predominantly Germany, but also D-A-CH countries’
recommendation representatives), Norway (NO; pre-
dominantly Norway, but also one Nordic nutrition
recommendation representative from Denmark), Serbia
(SE), Spain (ES) and the United Kingdom (UK). The
countries sampled represented diversity in geographical
location, socio-cultural and institutional infrastructure as
well as history of dietary guideline development.
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Participants
Participants were recruited based upon a template of
stakeholders involved in the development of (micro)
nutrient recommendations in each country. Stakeholders
were defined as ‘individuals or organisations willing to
invest resources and accept some responsibility for the
development of (micro) nutrient recommendations – may
also be consumers’. They were grouped as government,
scientific advisory body (SAB), professional and aca-
demic, industry or non-government organisations (NGO;
included charities, consumer and special interest groups,
Table 1). The twenty-one CZ participants were recruited
within the context of a workshop. Remaining participants
were recruited by email or telephone. The response rates
ranged from 45 % (GE) to 95 % (CZ).
Interview schedule
The semi-structured interview schedule consisted of three
sections:
1. Stakeholder general beliefs about dietary guidelines.
2. Stakeholder beliefs on consumer awareness, under-
standing and use of dietary guidelines.
3. Stakeholder beliefs on consumer involvement in
developing dietary guidelines.
The current study presents results from the research
question related to section 3: stakeholder beliefs on
consumer involvement in developing dietary guidelines.
Nevertheless, data from all three sections of the interview
were explored regarding this research question.
The term ‘dietary guideline’ was believed to be the
most understandable and translatable term across stake-
holders and countries and was initially used in section 1
of the interview schedule. Previously published results
from this data set reported variation in the interviewee-led
interpretation of the term ‘dietary guideline’(26). Thus, the
reader should be aware that ‘dietary guideline’ has referred
to both nutrient- and food-based recommendations
throughout the present paper.
Prompts were used where necessary to encourage
elaboration on relevant points. All interview schedules
were translated by the researchers responsible for data
collection, with care taken to maintain the meaning of
each question.
Data analysis
The data were analysed using thematic analysis(27). The
aim of thematic analysis is to ‘describe how thematic
contents are elaborated by groups of participants and to
identify meanings that are valid across many partici-
pants’(28). A skeleton coding structure was created and
modified by researchers in each country during pre-
liminary analyses. The final template used by all six
countries allowed the addition and omission of codes
where necessary. All countries completed coding in their
own language and then created a summary of identified
themes and illustrative quotes in English. Qualitative data
analysis software NVivo 8, 2008 assisted the collation and
thematic analysis of multiple-country data.
Results
The two main themes, (i) type of consumer involvement
and (ii) pros and cons of consumer involvement, together
with their related sub-themes, are reported below with
illustrative quotes presented in Tables 2 and 3.
1. Type of consumer involvement
1a. Direct or indirect involvement
Stakeholders appeared to discuss several ways that
consumers could be involved in dietary guideline devel-
opment, which have been categorised as either indirect
or direct involvement. Indirect consumer involvement
utilised information on consumers to aid the decision
making during dietary guideline development (e.g. first-
hand anecdotal practice experience or consumer research
data on consumer health indicators, dietary intake/
nutrient status, lifestyle attitudes/behaviours or opinions
on dietary guideline communication materials). Direct
involvement referred to lay consumers, consumer group
representatives or consumer advocates actively partici-
pating in the decision-making process (e.g. presence on
committee meeting panels or via plenary/workshop/
written consultation practices).
1b. Which consumers to involve?
Stakeholders were not always clear who they believed
would be the most suitable consumers to involve. In
relation to direct consumer involvement, the majority of
interviewees often referred to ‘consumer organisations’,
‘consumer associations’ and ‘consumer groups’, with only
a few interviewees considering direct lay consumer
involvement. The difficulty in identifying the appropriate
consumer organisations to involve was highlighted by a
few of the stakeholders in terms of the large number of
organisations that could potentially represent consumers.
Table 1 Stakeholder interview sample
Stakeholder group
Country IND GOV NGO PRO SAB Other Total
CZ 4 4 4 6 2 1 21
GE 2 2 2 2 2 0 10
NO 2 2 1 1 3 0 9
SE 3 3 4 5 0 0 15
ES 1 3 2 4 2 0 12
UK 4 1 2 1 2 0 10
Total 15 15 15 19 12 1 77
IND, food industry; GOV, government; NGO, non-governmental organisa-
tion; PRO, professional/academic; SAB, scientific advisory body; CZ, Czech
Republic; GE, Germany1D-A-CH countries’ recommendation representatives;
NO, Norway1one Danish Nordic nutrition recommendation representative;
SE, Serbia; ES, Spain; UK, United Kingdom.
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Regarding indirect consumer involvement, consumers
were described at both a broad population level and a
subgroup level. Dietary guidelines were considered
applicable to the ‘general population’ with terms such as
‘citizens’ or the ‘general public’ frequently used whilst
discussing the data required for guideline development,
as well as ensuring effective communication and use of
the guidelines. Yet, stakeholders rarely identified them-
selves as consumers (aside from one stakeholder – UK
SAB). Consumer data specific to various target subgroup
populations were also mentioned. Subgroups appeared
to represent those vulnerable to nutrition inadequacy
or overexposure defined by both physiological and
social descriptors (e.g. life stage, sex, age as well as
education level, socio-economic status, rural/urban,
health motivation).
1c. Timing of consumer involvement
The majority of stakeholders appeared to believe that
consumer involvement, either direct or indirect, was
necessary at the end of the dietary guideline development
process mainly in regard to guideline communication.
A number of interviewees also advocated some benefit in
consumer involvement at the initial stages of dietary
guideline development. There was a sense that consumer
information or opinion would not be required during
what was regarded as the scientific content stage of
development in between the initial scoping of the pro-
blem and later communication stages.
2. Pros and cons of consumer involvement
2a. Interests
Several interviewees commented that direct consumer
involvement in the decision-making processes may
detract from the – scientific or other – objectivity of the
decision-making process. There was some concern that
consumer representatives may act as lobbyists or that
ideological or political motives could influence what was
regarded as a scientific and independently objective
decision-making process. In contrast, a small number of
interviewees believed that food safety might be a higher
Table 2 Main theme 1: type of consumer involvement
Sub-theme Quote (identification reference, country, stakeholder group)
1a. Direct or indirect
involvement
‘It would have to be a multidisciplinary body and within that body should be one of the consumer
representatives’ (41, SE, GOV)
‘I think consumers already participate through the surveys done with them, as the FFQ or the diet histories’
(56, ES, NGO)
1b. Which consumers
to involve?
‘They’ve just got a list of consumer organisations, and actually it’s a much broader sector than that. So say for
example they tend not to think of environmental organisations as being consumer organisations’ (68, UK, NGO)
‘Predominantly the relatively educated consumer [will be more aware of dietary guidelines] because he will
also understand them right away’ (22, GE, GOV)
1c. Timing of
involvement
‘y [the consumers] can of course not be a part of what the dietary guidelines should be, but how one should
give such advice and guidelines’ (32, NO, NGO)
‘Perhaps at the first stages, someone representing the consumers, i.e. a Consumer Association, should
participate to guide and give their opinion. At a final stage, when the draft is done, then we could test it with
the consumers’ (57, ES, IND)
SE, Serbia; GOV, government; ES, Spain; NGO, non-governmental organisation; UK, United Kingdom; GE, Germany1D-A-CH countries’ recommendation
representatives; NO, Norway1 one Danish Nordic nutrition recommendation representative; IND, food industry.
Table 3 Main theme 2: pros and cons of consumer involvement
Sub-theme Quote (identification reference, country, stakeholder group)
2a. Interests ‘What do not belong to the process, in my opinion, are for example interest associations [y] it could
compromise the objectivity’ (23, GE, PRO)
‘We sometimes deal with consumers’ questions about foods in our consumers’ association. But they are more
connected to food safety and quality. So DG aren’t very important for us. Consumers don’t approach us with
these questions’ (1, CZ, NGO)
2b. Credibility and trust ‘But I do not see that the consumers have a large role in the development of the DG. That is scientific based,
but it is extremely important that the consumers have trust in the process of making the DG’ (33, NO, SAB)
‘[y] part of their [consumer representatives] responsibility is to ensure that we are operating in a way that is
accessible. All of the processes that we engage in are open for public scrutiny, and there are explicit
invitations at the start of many of the process for people to provide information’ (69, UK, GOV)
‘We can still learn from consumers, their wishes and their habits, good and bad’ (42, SE, PRO)
2c. Process
complications
‘I don’t think there are any disadvantages other than, it might take longer, because obviously a bigger group,
you’re going to have more discussion. You’re going to have, you know, more views to take into account’
(70, UK, PRO)
‘The disadvantage is that consumers complicate scientists’ work [y]’ (2, CZ, SAB)
GE, Germany1D-A-CH countries’ recommendation representatives; PRO, professional/academic; DG, dietary guidelines; CZ, Czech Republic; NGO,
non-governmental organisation; NO, Norway1one Danish Nordic nutrition recommendation representative; SAB, scientific advisory body; UK, United Kingdom;
GOV, government; SE, Serbia.
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priority for consumers rather than nutrition issues such
as dietary guideline development. For example, one stake-
holder (CZ NGO) commented on the resources of
the consumer organisations. They stated that the often
limited resources (manpower and finance) of small con-
sumer organisations would be likely to prioritise food
safety above nutrition matters such as dietary guidelines,
whereas other stakeholders such as the food retail
industry might have the capacity to fund involvement in
both areas.
2b. Credibility and trust
The majority of stakeholders recognised that consumer
trust in the process of dietary guideline development was
an advantage to ensure that the guidelines were per-
ceived as credible. However, only a minority identified
direct consumer involvement as a route to establish trust
and legitimise the process through adequate representa-
tion and transparency. The majority advocated the use of
consumer indirect involvement via consumer research,
particularly in relation to testing communication mes-
sages. The identification of consumers’ health and dietary
status, lifestyle habits, values and motivations were con-
sidered important during the development of guidelines
and ‘testing’ the dietary guidelines. Such consumer research
was expected to improve guideline implementation and
effectiveness. Only one stakeholder suggested that direct
consumer representation during the decision-making
process might improve the content of the guidelines
by bringing a degree of practicality to the discussions
(UK NGO).
2c. Complications
Several interviewees mentioned that direct consumer
involvement would be a disadvantage to the process due
to increasing the time and financial cost of guideline
development. It was perceived that consumers who did
not have any prior knowledge in the dietary guideline
area would find it difficult to follow discussions in terms
of the technical language used and interpretation of the
data, which would limit the degree of their involvement
and lengthen discussions.
Discussion
Research findings provided an insight into the beliefs of
multiple stakeholders across a variety of European
countries on the implementation of consumer involvement
in the development of dietary guidelines. Stakeholders
appeared aware of several different types and potential
pros and cons of consumer involvement. Benefits were
primarily in relation to indirect involvement via the use of
consumer research data to inform guideline development
and communication strategies. In addition, direct invol-
vement was believed to help foster trust and credibility in
the guideline process to assist with effective guideline
implementation. Regarding guideline content, stake-
holders either minimally or negatively referred to direct
consumer involvement, citing the development of con-
tent to be a predominantly scientific stage of the process.
The role of consumer involvement as described above
may be explained by the stakeholders’ perception of who
a ‘consumer’ was. In the identified theme ‘type of con-
sumer involvement’, there was a grouping of consumers
by education level and a disassociation with consumers
by all but one stakeholder. Stakeholders may have per-
ceived an ‘imagined consumer’(29), wherein consumers
were viewed as passive beneficiaries of expert advice
rather than active contributors to advice formation (e.g.
public communication involvement(21)). Thus, consumer
involvement was considered more appropriate in the
non-scientific aspects of guideline development. Simi-
larly, in the identified theme ‘pros and cons of consumer
involvement’ there was a perception that consumers
would lack the expertise necessary to follow the technical
content during scientific discussions. Stakeholders iden-
tified this as a limiting factor for consumer involvement
which may also prolong and increase the financial costs
of the guideline development process.
Lack of expertise and resultant additional financial and
time burdens has been cited in previous research as a
disadvantage to consumer involvement during scientific
decision making and guideline development(9,20). Con-
sumer involvement, particularly during technical discus-
sions, may present a number of difficulties(30). In contrast,
consumers may not lack expertise and it may take no
longer or be more expensive to involve consumers.
Regardless, if difficulties are present they can be over-
come to allow consumer views to either complement the
technical knowledge of non-consumer experts or chal-
lenge any previously held assumptions, both of which
may improve the quality of guideline content and ulti-
mate success of any guideline implementation(14,31).
The potential effect of consumer involvement on sci-
entific objectivity was also mentioned as a further barrier
to consumer involvement during the guideline content
discussions. Stakeholders referred to the possible effect of
consumer ideological or political vested interests which
might bias the scientific decision-making process during
guideline development. Previous research has recognised
the difficulties of establishing a truly objective scientific
process and that bias has the potential to influence a
process such as the development of guidelines(32).
Nevertheless, this is relevant to all parties involved in the
process, as there is a possibility of inherent bias via per-
sonal, professional, academic or commercial inter-
ests(14,32). Many scientific bodies have routinely requested
members to disclose potential conflicts of interest(33,34).
Difficulties remain with the responsibility on the indivi-
dual to identify what might constitute a potential conflict
of interest. Yet, the transparent declaration of interest
from all stakeholders, including consumers, as well as the
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explicit detailing of evidence and values underpinning
decisions, may help to negate some of the apprehension
shown towards consumer involvement in the present
study. Indeed, increased transparency and greater invol-
vement of consumers has been suggested as a means to
limit conflict of interest issues and prevent bias from
individual or group private interests which may not be in
line with public health(35).
Stakeholders did acknowledge the benefits of con-
sumer involvement in terms of providing an increased
sense of legitimacy, credibility and trust in the process of
developing guidelines. The need for legitimacy, cred-
ibility and trust was particularly discussed in relation to
countries which had multiple guidelines or a high degree
of media influence that was seen to confuse or dilute
a consistent dietary guideline public health message.
This has often been proposed as a primary purpose for
consumer involvement or public engagement with
science(12,36–38). In addition, arguably, in the Western world
at least, trust in the food system and those who oversee its
delivery and advice has become ever more important in
relation to nutrition where a number of consumers have
become far removed from the origin of their food(39).
There may be limits to the degree these findings can be
transferred outside the sample studied. The exploratory
nature of the present study justified the use of a qualita-
tive design and steps were taken to limit any biased
interpretation of these perceptions. A common protocol
was employed to maximise study rigour via clarity of
the research goal and the consistent method of data col-
lection, analysis and reporting. This also enabled the
combination of data across countries. To maintain the
cultural context and authenticity of the data the majority
of qualitative interpretation was conducted in the native
language. It was not possible to conduct data analysis by
country or stakeholder group due to the incompatible
nature of the stakeholder groups, who appeared to vary
in their involvement of dietary guideline development
across countries. Instead data were analysed with a focus
on commonalities across the whole data set and any
observed individual differences were highlighted.
The stakeholder views depicted were not intended to
represent the totality of views from the six countries or
those involved in setting either (micro) nutrient-based
or food-based dietary guidelines. Interviewees varied in
their previous experiences as either the consumers or
working alongside consumers, involved during the devel-
opment of dietary guidelines. It is unclear the degree
these past negative or positive experiences of consumer
involvement may have influenced any assumptions about
consumers and consumer involvement reported in the study.
In addition, the confusion surrounding the terminology in
this area(26,40) has led to the present study interviewing those
responsible for and collecting results referring to a variety of
nutrient- and food-based guidelines (Dietary Reference
Values, nutrient goals, Food-Based Dietary Guidelines).
Nevertheless, the views presented have provided a
glimpse of how consumer involvement may be perceived
in relation to the development of ‘dietary guidelines’ from
a wide range of stakeholders across multiple countries.
Results have suggested that political advocacy for con-
sumer involvement in scientific decision-making needs to
be accompanied by clarification on the role of any con-
sumer involvement from the outset of any collaboration.
Identifying the purpose, advantages and/or disadvantages
of this involvement may assist with identifying the type of
involvement required (e.g. public communication, public
consultation or public participation(21,23)) and ensuring that
expectations are clear, the significance of any input is con-
sidered(13,22,41) and the possibility of token consumer
involvement(17) or the misuse of often limited (guideline
development or consumer) resources is avoided.
Future research may yet establish evidence-based
best practice for the most effective type of consumer
involvement to support the successful development of
dietary guidelines. Alternatively, it may not be possible to
establish harmonised best practice. Different degrees or
types of consumer involvement may be warranted due
to the variance in experience, influence and visibility
of consumers across different countries or situations. Until
such time that further data become available on the
impact of different forms of consumer involvement, it
may be prudent to support a flexible approach based
upon the practical experience of others and a general set
of agreed principles, such as the agreement of clear and
specific aims, objectives and outcomes(3,22,31,42,43)
Conclusions
Organisations will continue to call for greater consumer
involvement, primarily as part of a wider request for
improved public engagement with science and a multi-
stakeholder approach to preventing dietary-related ill-health.
There is currently limited data on the impact of, or to justify
best practice for, consumer involvement in the development
of dietary guidelines. Until this can be established it may be
wise to adopt a flexible approach to involving consumers.
The main conclusion from the present study has been that
whatever type of consumer involvement is undertaken it
would be advisable to make transparent the role of
consumers to all parties prior to any involvement, as well
as in the final report writings, to aid the evaluation of
consumer impact.
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Abstract
Food-based dietary guidelines (FBDG) have primarily been designed for the consumer to encourage healthy, habitual food choices,
decrease chronic disease risk and improve public health. However, minimal research has been conducted to evaluate whether FBDG
are utilised by the public. The present review used a framework of three concepts, awareness, understanding and use, to summarise con-
sumer evidence related to national FBDG and food guides. Searches of nine electronic databases, reference lists and Internet grey literature
elicited 939 articles. Predetermined exclusion criteria selected twenty-eight studies for review. These consisted of qualitative, quantitative
and mixed study designs, non-clinical participants, related to official FBDG for the general public, and involved measures of consumer
awareness, understanding or use of FBDG. The three concepts of awareness, understanding and use were often discussed interchangeably.
Nevertheless, a greater amount of evidence for consumer awareness and understanding was reported than consumer use of FBDG. The
twenty-eight studies varied in terms of aim, design and method. Study quality also varied with raw qualitative data, and quantitative
method details were often omitted. Thus, the reliability and validity of these review findings may be limited. Further research is
required to evaluate the efficacy of FBDG as a public health promotion tool. If the purpose of FBDG is to evoke consumer behaviour
change, then the framework of consumer awareness, understanding and use of FBDG may be useful to categorise consumer behaviour
studies and complement the dietary survey and health outcome data in the process of FBDG evaluation and revision.
Key words: Food-based dietary guidelines: Consumers: Awareness of dietary guidelines: Understanding of dietary guidelines:
Use of dietary guidelines
Food-based dietary guidelines (FBDG) have been described as
‘consistent and easily understandable translations of popu-
lation nutrient goals to encourage healthy habitual food
choices and improve public health’(1). They consist of written
messages (e.g. UK 8 tips for eating well(2)), which are com-
monly depicted in the form of visual food guides (e.g.
German 3-D food pyramid(3)). The purpose of these messages
and food guides appears to be various in terms of the audi-
ence, application and aim. FBDG have been used to provide
information to the consumer, monitor population dietary
patterns, check compliance of food industry as well as to
align health policies and nutrition programmes (e.g. food
stamps, school meal composition and food labelling)(4–6).
The development and implementation of national/regional
FBDG has the potential to bring substantial health and econ-
omic benefits. FBDG were originally developed to combat
nutrient-deficiency disease, but they may play an important
role in discouraging/encouraging the adoption of certain diet-
ary patterns, which have been associated with preventing
chronic non-communicable diseases (CNCD; e.g. CVD, certain
cancers). Modifiable risk factors such as diet and physical
activity have been suggested to account for up to 30 % of
*Corresponding author: Dr M. M. Raats, fax þ44 1483 682913, email m.raats@surrey.ac.uk
Abbreviations: CNCD, chronic non-communicable diseases; DGA, Dietary Guidelines for Americans; FBDG, food-based dietary guidelines; FGP, Food
Guide Pyramid.
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morbidity and mortality in the USA(4), and ill health from poor
diet has been estimated to cost the UK National Health Service
billions of Great British Pounds each year(7).
The FAO and the WHO have actively promoted FBDG with
the International Conference on Nutrition(8), the expert con-
sultation meeting(9) and the Countrywide Integrated Noncom-
municable Diseases Intervention programme(10), all pivotal in
encouraging the development of FBDG in countries across the
world(4). Despite the promotion of FBDG, there has been little
evaluation of their effectiveness or monitoring of their impact
on population health(11). Attention has arguably been directed
away from evaluation and focused on the development of
FBDG, such as translating nutrient reference values into
FBDG or investigating the mechanisms behind dietary pattern/
nutrient compound effects on certain health outcomes(11).
For example, the USA have a long history and commitment
to government-led consumer dietary guidance, where the
Dietary Guidelines for Americans (DGA) have been released
every 5 years since 1980, with a legal obligation for their
release written into the congressional mandate since
1990(11,12). Yet, there remains no obligation to evaluate the
DGA(6).
Limited evaluation of FBDG has led to an uncertainty in the
efficacy of FBDG and the role that they may play in (1) chan-
ging consumer health behaviours, (2) improving population
nutrient/dietary intake/status or (3) decreasing negative
health outcomes such as CNCD(4,13). The design of public
health initiatives such as FBDG may ultimately contribute
towards the achievement of (3) decrease in CNCD. However,
measuring CNCD incidence (or intermediary health markers of
CNCD) before and after FBDG implementation is insufficient
to evaluate the impact of FBDG on CNCD. Chronic diseases
by their nature involve small changes over time. Therefore,
a plethora of multidimensional factors may have influenced
a particular CNCD aetiology and pathogenesis. Repeated
national dietary surveys provide data a step between FBDG
implementation and CNCD incidence, which yields valuable
information on FBDG compliance and monitoring of dietary
patterns. However, aside from the practical problems inherent
in collecting dietary intake data (e.g. energy levels(14)), these
sets of data can be similarly influenced by many factors.
Thus, a certain dietary intake pattern may have changed
irrespective of FBDG implementation(15).
An additional dataset, which can provide evaluative infor-
mation a step closer to the implementation of FBDG, can
come from consumer dietary behaviour studies. These may
provide additional information by either directly asking consu-
mers about the influence of FBDG on their dietary beha-
viours/dietary choices and their subjective understanding
and use of FBDG or using tasks to test consumer objective
understanding and use of FBDG. The majority of this research
is likely to be conducted during FBDG development or
following short-term interventions of FBDG implementation.
These studies consist of qualitative study designs such as
interviews and focus groups or quantitative designs such as
questionnaire surveys. Furthermore, they may take the form
of mixed designs, e.g. a questionnaire survey with a number
of open-ended questions. There are inherent advantages and
disadvantages to the choice of different study methods (e.g.
qualitative interviews susceptible to interviewer and interpret-
ation bias, but allow depth to answers and idiosyncratic data v.
questionnaire forced choices but population-level findings),
with each employed depending on the study rationale.
The variety of study rationales and designs of consumer
studies to evaluate or revise FBDG limits the possibility of con-
ducting a meta-analysis review. The present study sought to
provide a narrative review of this research by categorising
studies using the three concepts of awareness (conscious
perception), understanding (subjective and objective) and
use (single use, extended, indirect and direct) in an adapted
theoretical framework developed by Grunert & Wills(16). The
framework is based upon classic consumer decision-making
research on how information provision (e.g. FBDG) deter-
mines choice when there are multiple options available, as
well as upon attitude and change research on whether consu-
mers process information, conduct cost–benefit analysis and
find meaning, which is a prerequisite for information to
affect behaviour (for further details, see Grunert & Wills(16)).
The categorisation and interpretation of consumer behaviour
studies may provide valuable information on how, if at all,
FBDG influence consumer dietary choices and the employ-
ment of FBDG, and thus complement the dietary survey and
health outcome data in the process of FBDG revision and
the evaluation of FBDG efficacy.
Methods
A total of nine electronic databases were searched (PubMed,
Web of Science, EconLit, IPSA (International Political Science
Abstracts), PsychInfo, EMBASE (Excerpta Medica Database),
Cochrane, IBSS (International Bibliography of the Social
Sciences) and CINAHL (Cumulative Index to Nursing and
Allied Health Literature)), together with manual searches of
reference lists and Internet searches of grey literature.
Search terms
The search strategy consisted of an unlimited date range until
August 2009, any language and the following search terms
(used in PubMed and modified slightly in other databases):
(food based dietary guidelines) or (food-based dietary guide-
lines).
All references were entered into an endnote library. The
initial search in PubMed was entered first, and all additional
searches were added to the library only after comparison
for duplicates with the PubMed search. The final library
contained 939 articles before exclusion (Table 1).
Exclusion–inclusion criteria
References were excluded using predefined exclusion criteria
devised by the research team (Table 1). The majority of studies
were excluded, because they were conducted in a clinical set-
ting and involved dietary guidelines for the maintenance of
participants who had underlying health problems or diseases
(e.g. CVD, alcoholism and HIV). These participants were
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excluded from the review, because they may have different
motivations and health needs to the general public(6,13). In
addition, a large number of quantitative studies were
excluded, which analysed food-frequency data and retrospec-
tive compliance with FBDG or used FBDG as a benchmark to
measure ‘healthiness’ of diet.
Initially, papers were excluded or included on the basis of
their abstracts. Where clarification was needed, full-text
papers were obtained and excluded using a data coding
form (Table 2 is a condensed version of this form). Strenuous
efforts were made to find the original sources of studies by
searching online, emailing authors and translating papers
into English. When it was not possible to find the original
sources of data, primarily due to unpublished, inaccessible
or untranslatable data, citations were included in the review.
This has limited the available details, thus judgement of quality
for certain studies.
Framework
The three concepts of awareness (conscious perception),
understanding (subjective and objective) and use (one time,
extended, direct and indirect) taken from the theoretical
framework developed by Grunert & Wills(16) were used to
categorise study findings. Categorisation was decided using
the study-reported terminology (i.e. what was described as
awareness, understanding or use) as well as interpretation
by one research member. The validity of grouping was re-
viewed and confirmed by the study authors. Only the study
details relevant to consumer awareness, understanding or use
of FBDG were reviewed and reported in the present review.
Quality and risk of bias
No studies were excluded on the basis of quality or research
design, but the quality of the studies (qualitative, quantitative
and mixed designs) and risk of bias were judged using the
guidelines for assessing methodological quality of published
papers by Greenhalgh(17). This involved judging the details
available on the study aim, purpose, method, design, theoreti-
cal framework, analysis, findings, discussion, presentation
and references.
Results and discussion
A total of twenty-eight studies were reviewed, which
employed both qualitative methods such as interview and
focus groups and quantitative methods such as questionnaire
surveys. Of the twenty-eight studies, sixteen referred exclu-
sively to the US DGA, Food Guide Pyramid (FGP(18)) or
MyPyramid(19). The quality of the twenty-eight studies varied
with definition of terms (awareness, knowledge, preference,
understanding and use), often unclear and used interchange-
ably, as well as with study design or method details at times
incompletely reported (especially as expected in the cited
findings). Analysing and comparing the results from the
twenty-eight studies was difficult due to the different ratio-
nales and study designs employed. However, we sought to
provide an overview of the findings from the studies
reviewed. Findings have been reported in relation to the
three concepts of awareness, understanding and use, and
organised by study design (qualitative, quantitative and
mixed).
Awareness
The FGP has been used throughout the US education system,
and focus groups with American elementary schoolchildren
reported that the majority had seen the FGP and they were
aware of the key elements of the DGA (1990)(20). Similarly,
in Chile, more recent focus group data indicated that Chilean
schoolchildren were aware of the Chilean food guide (Chile
FGP; S Olivares, unpublished results, cited in Albert(21)).
In contrast, focus groups with US adults in the 1990s reported
that some had awareness of a few DGA, but that the majority
were unfamiliar with the DGA (1995)(22). Likewise, in New
Zealand, focus groups and key informant interviews in 1998
indicated that older people, parents and children–adolescents
had limited awareness of the FBDG, and few participants
appeared to have seen the official FBDG-related education
booklets(22–24). More recent focus groups with US adults indi-
cated that many consumers were aware of the DGA (2000)(25).
This was also observed with focus groups of women in Baja
California who showed some awareness of two food guides,
the Pyramid of Health and the Apple of Health, with the
Pyramid believed to be more familiar than the Apple(26–28).
Reported quantitative data indicated that awareness in the
USA may have increased over time. American surveys in
1994 (n 1945) and 1995 (n 1001) reported that one-third of
those sampled were aware of the DGA (1990). With respect
to the FGP, awareness was also one-third (33 %) in 1994 but
significantly increased to 43 % in 1995(29). In a different
survey, two-thirds of the Americans appeared to recognise
or be aware of the FGP by 1997(30,31). More recent surveys
with grocery shoppers in 2000 showed that 75 % were
Table 1. Literature review excluded and included papers
Reason for exclusion/inclusion References
Excluded
Duplicate missed; non-European
language; unpublished data
or unavailable paper
16
Clinical/dental participants or
animal studies (animal nutrition
or related to animal nutrition)
348
Unofficial FBDG or non-general
public FBDG (children, elderly and sports)
192
Supplements/fortification; CAM;
labelling/health claims or toxicology/food safety
105
Food-frequency data or nutrition
intake/status measures to check
compliance with FBDG
250
Included
Search terms: (food based dietary guidelines)
or (food-based dietary guidelines)
28
Total 939
FBDG, food-based dietary guidelines; CAM, complementary and alternative
medicine.
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Table 2. Papers and studies reviewed
First author and year Country – FBDG Aim Design and measures Sample Analysis Results
van Dillen (2003)(15) The Netherlands – FBDG Nutrition awareness
and food conversation
topics
Mixed study. Qualitative
focus groups FBDG
relevant Focus
groups – card sort task
to pick five food topics
and ranked importance
n 30 Three mixed
sex groups:
(1) 18–30 years;
(2) 31–50 years;
(3) 51–80 years
Coding framework
and themes
categorised using
NUD*IST (QSR
Melbourne, Australia)
software
Consumers believed that
they ate healthily –
possibly lacked nutrition
awareness (defined as
realisation of one’s
personal risk behaviour
regarding nutrition)
Lytle (1997)(20) USA – FGP (1992)
and DGA (1990)
Child understanding and
interpretation of DGA
(1990) and FGP (1992)
Qualitative. Focus groups
and interviews with a
food identification task
(name three foods with
high/low fat, high sugar/low
sugar, fruit, vegetables
or grains). Questions based
on Piaget’s stages of
cognitive development/social
cognitive theory. Pilot feedback
resulted in DGA ‘moderate’
phrasing to ‘a little’
Convenient sample
recruited from after
school daycare. n 141,
54 % girls, two school
districts near Minneapolis
and St Paul Minnesota.
K–4th and 5–6th grade.
Primarily white, middle SES
Video data transcribed
verbatim. Coding
templates identified
concepts, which
were sorted, summarised –
independently reviewed.
FIT – two reviewers
evaluated and scored
response (inter-rater
reliability 98 %) No
test of prior nutrition
knowledge
Differences observed across
age groups with a
younger/pre-operational/
concrete stage of
cognitive development.
Difficulties interpreting
abstract ideas of
variety/healthy weight
and identifying foods high
in salt/sugar/grains.
Difficulties observed in
interpreting serving size
from the FGP. Vast
majority had seen the
FGP but unable to
articulate learning
Olivares (unpublished
results, cited
in Albert(21))
Chile – FBDG and
pyramid
Evaluation of FBDG and
food guide
(1) Qualitative study in schools and
(2) quantitative Internet
quasi-experimental survey
Asked about FBDG and
pyramid, then received
information and awareness
and willingness to change
diet were measured
(1) Schoolchildren had
seen pyramid but did
not understand portions.
30 % knew FBDG and
60 % knew the pyramid.
(2) Information provision
increased awareness
and willingness to
change diet to 80 %
Geiger (2001)(22) USA – DGA 1995 Revision of DGA Qualitative. Market research
company. Focus groups have
shown different DGA formats:
(1) seven DGA; (2) seven
DGA in two tiers;
(3) four top tier DGA
n 40 Six single sex (three men
and three women) groups with
eight persons per group.
Recruited by telephone and
paid for participation
25–45 years
Somewhat familiar with
FGP. Most unfamiliar
with DGA but had heard
some messages.
Confused by ‘maintain
or improve your weight’,
‘balance the food you eat
with physical activity’
and ‘balance’. Preferred
version (3)
Cameron (1998)(23) New Zealand – FBDG Evaluation of written health
education materials
Qualitative focus groups.
Key informant interviews
Children, adolescents,
parents and older persons
Few older people, parents,
children or adolescents
had seen the booklets.
Materials were found
unappealing/outdated
by adolescents,
complicated by
parents and informative
by older people
Trustin (1998)(24) New Zealand – FBDG
IFIC (2005)(25) USA – DGA (2000) Perspectives of DGA Qualitative. Market research
company. Focus groups
Four groups, seven to ten people
each, two US cities. BMI
22–30 kg/m2, age 25–55 years.
One session to split into four
groups: (1) nutrition savvy
women; (2) common sense
women; (3) dieters/restricting
food/food groups;
(4) diet opposed
Consumers know what to do
but do not always do it.
Many were aware of
DGA. Many were
confused, can name
nutrients but do not
understand them.
Distinguish between
eating for health and
eating for weight loss.
Quotes provided
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Table 2. Continued
First author and year Country – FBDG Aim Design and measures Sample Analysis Results
Barcadi-Gascon
(2002)(26)
Baja California – Apple
of Health
(1996) and Mexico
Pyramid of Health (1998)
Compare and evaluate the
two guides for message
understanding and ability
to apply messages
Qualitative focus groups with
a diet plan task to measure
objective understanding
Women of 7 or 15 years
of schooling
Diet mean plan scores
insignificantly different
(Apple 76·7 %, Pyramid
64·1 %). Preference
for Apple as more
attractive, colourful,
clearer to identify food
groups and servings
Levy (1995)(29) USA – FGP (1992)
and DGA (1990)
Paper prepared for Dietary
Guideline Advisory Committee
Quantitative. Survey Significant increase in
FGP awareness
(1994–5) 33–43 %.
In FGP (1995)
recognised .DGA
or 5/d. In FGP (1994)
and (1995), one-third
were aware of DGA
ADA (1997)(30) USA – FGP (1992) Quantitative. Survey 67 % Americans were aware
Kennedy (1998)(31) USA – FGP (1992) Quantitative. Survey More than two-thirds of
Americans sampled
recognised FGP
Wheat Foods
Council (2001)(32)
USA – FGP (1992) Quantitative. Gallup survey (1994),
(1996) and (2000)
Primary grocery shoppers In the 2000 survey, 75 %
were somewhat or very
familiar with FGP (60 %
in the 1994 and 1996
surveys)
Olivares (2004)(33) Chile – FBDG and
pyramid
INTA formal evaluation of FBDG
dissemination
Quantitative. Survey Nutritionists of provisional
health services
Educational sessions
(n 36 120). 500 000
leaflets, posters and
flyers distributed
Keenan (2002)(34) USA – DGA (1995) Knowledge and understanding
of DGA, sources of health
information
Mixed. Telephone open-ended
survey questions. Number
of DGA recalled (maximum
possible thirteen versions
of seven guidelines)
Next-birthday method of
random respondent
selection from 1000
telephone numbers
in three zip codes
(1 £ high- and 2 £
low-median income).
Response rate: 400/976
contacted. 56 % women
of 18–49 years. 4·3 %
did not graduate from
high school. Twin cities
area, Minnesota
Tallied number of DGA
recalled. Stepwise
multiple regression to
explain variance in
knowledge scores
Qualitative: fat guideline
knowledge poor. Quantitative:
.50 % unaware of nutrition
federal policy/DGA document.
Few named FGP (n 38) or
DGA (n 1). Average DGA
recalled 2·5/13. Diet high in
vegetables, fruit and low in fat
were the most commonly
recalled (n 208, 191 and 188,
respectively). Higher number
of media sources predicted
higher recall (r 2 0.08, P,0·001)
Hunt (1995)(37) UK – BOGH (1994) Testing ten versions of the food
guide for effectiveness in conveying
nutrition concepts to consumers;
consumer preferences for guide
format; preference effects on
understanding and recall of food
guide messages (also carried out a
questionnaire survey asking health
professionals’ views on the guide,
but those results have
not been included)
Qualitative interviews and tasks.
Awareness measure ‘In your
opinion what are the main
things you need to do to
eat healthily?’. Task – random
allocation to three groups:
(1) control, no guide (n 298);
(2) one out of ten guides seen
briefly (n 883); (3) one out
of ten guides seen throughout
(n 893). Four tasks: SUB;
COM; SOR; DISH. Asked
preference for guide name,
most- and least-appealing guide
n 2074 SES groups C
(59 %) and D (41 %)
Recruited from town
centres using a quota
system to ensure
representative in
sex and age of the
general public. 53 %
female. 14 %, 11–18 years;
30 %, 19–30 years; 32 %,
31–45 years; 24 %, 46 þ years
Nutritional awareness
scored using a
predefined list of five
statements (e.g. eat
more fruit/vegetables).
The scores are as follows:
3/5, high awareness (9 %);
1 or 2/5, medium (71 %);
none, low awareness (20 %).
One-way ANOVA, t tests
and x 2 test. Only significant
results have been reported
here – see paper for statistics
Sex, age and SES effects
seen on the performance
of different tasks. Nutrition
knowledge effect on all
four tasks – higher level
of nutritional awareness
performed better than
lower. COM and SOR
task performance better
with a guide seen
throughout than the
control group.
Prior exposure affected
most- and least-preferred
choices with those who
had previously seen a
guide more likely to say
they preferred it v.
control group
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Table 2. Continued
First author and year Country – FBDG Aim Design and measures Sample Analysis Results
Achterberg (1989)(38) USA – DGA (1985) Four studies which evaluated DGA
(1985) brochures and bulletins
Qualitative. Design common
to four studies: (1) pre-interview;
(2) intervention of reading
brochures/bulletins;
(3) post-interview. Random
allocation to the
treatment/control group
Women (n 72), 30–40 years,
high school diploma or
higher, median income
All four studies had difficulties
in interpreting DGA,
especially the abstract ideas
‘desirable weight’, ‘healthy
weight’ and ‘too much’.
Misunderstood brochures
and DGA. Most groups
learned a significant amount
but relatively small amounts
compared with what they
could have learnt.
Those who learned the
most consistently had
fewer misconceptions.
No sex difference once
prior knowledge/
misconceptions controlled
Achterberg (1990)(39) USA – DGA (1985) Women (n 60), 30–45 years
and 60 þ years, high school
diploma or higher,
median income
Achterberg (1991)(40) USA – DGA (1985) Men (n 45), 30–45 years,
high school diploma or
higher, median income
Auld (1991)(41) USA – DGA (1985) Men (n 40), 30–50 years,
high school diploma or
higher, median income
Holm (1991)(42) Denmark – FBDG Interviews at the end of a
different 8-month study
that served Danish
recommendation diets
Men and women in their 20’s Surprised diet consisted of
familiar foods, large
volumes of vegetables,
potatoes and bread, and
was palatable
Duenas (unpublished
results, cited
in Albert(21))
Pre-Thailand – FBDG and
Nutrition Flag (1998)
Tested the food guide
and messages
Qualitative. Interviews
about understanding
of portion size and
quantities using the flag
Public from department
stores, food markets,
factories, universities
and bus stations
Developed rice serving
spoon the as household
unit for measuring foods
Britten (2006)(43) USA – FGP (1992) Consumer understanding
and use of FGP messages
and possible revisions in terms
of understandable terminology,
educational messages and
actionable messages
Qualitative. Market
research company.
Twenty-six focus groups,
three US cities in two
phases: (1) 2002, eighteen
groups (eight to twelve
people). Individual task
for objective understanding/
knowledge and discussed by
the group. Place food groups
and on blank FGP and place
composite meals on FGP.
(2) 2004, eight groups
(eight to eleven people)
(1) Weighted by marital
status, age, education,
race/ethnicity, employment
status and household. Equal
number of male and female
single sex groups (n 178).
Eighteen groups: 6 £
general adults, 4 £ 60 þ years,
4 £ food stamp recipients,
4 £ overweight (2) n 75.
Eight groups (4 £ 25–49 years,
4 £ 50—79 years)
Transcribed and verified.
Systematic content
analysis. Systematic
content analysis, organised
by group type and location.
Themes identified, common
recurring themes
selected and draft
report produced.
Draft reviewed by
staff who had observed
focus groups to validate
analysis
(1) FGP familiar. Recognised
some messages but
misinterpreted food
group placement and
quantities. Task .80 %
put one food group in the
wrong tier. No problems
with composite task.
Understood select more
foods from the bottom,
but not the ‘sprinkled’
graphic. (2) Lifestyle
obstacles to FGP use.
Limited understanding
of whole grains, fat,
vegetable subgroups
and physical activity
Albert (2007)(44) Grenada, Dominica,
St Lucia and
St Vincent, and the
Grenadines – FBDG
Process of developing FBDG
in four countries
Qualitative. Field tests:
(1) pre-interview;
(2) follow a DG 1 week;
(3) post-interview. Diet variety
knowledge ¼ grouping of food
items. Focus groups shown:
(1) FBDG;
(2) food guide;
(3) both together
Field tests: heads of households
from various parts of the country.
Focus groups: women and
men from rural and urban
parts of the country
Field tests: many barriers
to FBDG. Focus groups:
corrections and
adjustments made
to messages and
graphics based on results
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Table 2. Continued
First author and year Country – FBDG Aim Design and measures Sample Analysis Results
Campbell (1996)(46) USA – FGP (1992) Quantitative. Survey 58 % Americans heard of FGP
and 13 % say they understand
Zhao (2001)(47) China – FBDG and Food
Guide Pagoda (1997)
Trial of effectiveness of the
guidelines as a mass
education tool
Quantitative. Soon after
the publication of FBDG.
Understanding and nutrition
knowledge pre- and post-repeated
promotions of FBDG and pagoda
n 5145 from five cities with
different geographic and
economic conditions
FBDG meaning increased
12–93 % in 1 year, more
so with children and elderly.
Nutrition knowledge
increased from 48–59 to
68–91 %. Schoolchildren
balanced breakfast increased
26–52·5 %
Kennedy (1996)(48) USA – DGA (1995) Consumer perceptions of DGA
concepts and perceived
barriers to following DGA
Qualitative. Market research
company. Focus groups
Twelve focus groups in three
US cities; all single sex.
Four groups, cross section;
eight groups, target groups
of African-Americans, elderly,
overweight, food stamp recipients
Four themes: (1) difference
between recommendations
and what is already known
as well as what needs to
be known to use; (2)
most consumers were
not motivated by health
consequences underpinning
DGA; (3) perception of DGA
do not explain ‘how to do it’;
(4) would like DGA in
straightforward language –
no time, energy or
inclination to learn
nutritional science
Love (2001)(49) South Africa – FBDG Assess comprehension, interpretation
and implementation of preliminary
South African FBDG as a nutrition
education tool for women in
KZN and the WC
Qualitative. Focus groups.
Aided with colour photos
of different foods (non-branded,
uncooked) discussed previous
exposure to FBDG, interpretation
of FBDG, constraints to
implementation and ability to
plan a day’s meals using the
FBDG
Five magistrate districts in KZN
and the WC. Random selection
dependent on settlement type
(non-urban, urban in/formal),
ethnicity (black, mixed, Indian
and white). Only women who
made purchased food and food
preparation decisions.
137 women, 19–63 years
Transcribed and coded,
analysed to identify
common themes
Fruit/vegetables and fat
guidelines familiar to all
groups. FBDG well
understood. Confused
with the terms ‘legumes’,
‘animal foods’ and
‘healthier snacks’.
Barriers to FBDG
implementation cost
availability, taste
preferences, purchase
habits, traditional food
preparation/cooking,
time, accessibility and
attitudes to health. Many
felt already implemented
several FBDG, and all
were able to construct a
day’s meals using FBDG
FMI (1997)(50) USA – FGP (1992) Quantitative. Survey Shoppers 27 % changed purchases
FBDG, food-based dietary guidelines; FGP, food guide pyramid; DGA, Dietary Guidelines for Americans; SES, socio-economic status; FIT, food identification task; IFIC, International Food Information Council; ADA, American Dietetic Associ-
ation; INTA, International Institute on Food Technology and Nutrition; BOGH, Balance of Good Health; SUB, substitution; COM, comparison; SOR, sorting; DISH, composite dish; DG, dietary guideline; KZN, KwaZulu-Natal; WC, Western
Cape; FMI, Food Marketing Institute.
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‘somewhat/very familiar’ with the FGP(32). All of the aforemen-
tioned studies refer to evaluating the outcome of FBDG
implementation. During the review of FBDG in Chile, they
evaluated the output of FBDG implementation. A survey by
the International Institute on Food Technology and Nutrition
reported that .36 000 people had participated in FBDG nutri-
tion education programmes and .50 000 leaflets, posters and
flyers had been distributed. This provides information on the
dissemination of FBDG-related material reported in terms of
FBDG evaluation, but it does not provide a measure of out-
come in terms of awareness(33).
The definition of awareness differs slightly throughout the
studies reviewed but predominantly relates to familiarity or
knowledge of a FBDG or food guide. A mixed methods
study in The Netherlands defined awareness slightly differ-
ently. A high amount of ‘knowledge’ was reported in response
to the question ‘what dietary guidelines do you know?’.
However, the researchers suggested that participants may
have lacked nutrition awareness in terms of ‘realisation of
one’s own personal risk behaviour regarding nutrition’, because
the focus group participants may have mistakenly believed
that they ate healthily or followed the FBDG/food guide(15).
An American telephone interview study supported the
1990s US focus group data indicating that there was some
but not widespread awareness of the DGA. Participants
reported an average recall of less than 2·5 DGA (1995) out
of a possible 13, and only one out of 400 responders correctly
identified the DGA as the US nutrition policy document(34).
It is difficult to assess the effect of awareness from the
studies reviewed. Awareness has been suggested as a prere-
quisite to behaviour change(35), and this was indicated by
the reporting of a Chilean Internet study intervention, which
implied that the provision of information improved awareness
both of the 1997 Chile FBDG/food guide and willingness to
change diet (S Olivares, unpublished results, cited in
Albert(21)). However, the reality of the relationship between
awareness and behaviour change is complicated by many
other factors such as liking and preference, which can be dif-
ferentially affected by awareness. For example, the previously
mentioned Baja Californian focus group study reported that
participants consciously stated that they were more familiar
with the Pyramid food guide, yet they preferred the Apple
food guide, stating that it was more attractive, colourful and
clearer to identify foods and food group servings(28). In con-
trast, a UK study compared ten food guide versions during
the development of the UK Balance of Good Health plate
(1994)(36) and found that those who had previously seen a
guide (higher awareness, unconscious/conscious) were more
likely to display a preference for the shape they were exposed
to compared with the control group who had not seen any
guides. It was hypothesised that preference, or familiarity,
for a guide may affect an individual’s ability to extract the
guide’s key information either by being more likely to notice
and recall information or by familiarity, leading to loss of
attention to the information(37). The aforementioned studies
indicated that there was a degree of awareness of FBDG
and food guides, an apparent greater awareness of food
guides compared with FBDG and a possible trend of increased
awareness over time. However, the measurement and defi-
nition of the concept awareness was not always clear, and
the terms of familiarity, awareness and knowledge were
used both interchangeably and differentially across studies.
Clarifying what is meant by awareness and how this is
measured would be crucial when comparing data across
studies to evaluate FBDG and when trying to study the com-
plicated relationship between awareness, understanding and
use of FBDG.
Understanding
Awareness of FBDG or food guides does not appear to auto-
matically translate into understanding of FBDG. Focus groups
and interviews with US schoolchildren suggested that they
were comfortable using the terms ‘low fat’ and ‘low sugar’,
but they had difficulties when asked to display objective
understanding of these terms by naming three foods in
either of these categories, particularly with the younger chil-
dren(20). Similarly in Chile, schoolchildren, although aware
of the FGP, did not understand the portion information por-
trayed within the pyramid (S Olivares, unpublished results,
cited in Albert(21)).
Studies that have looked at subjective understanding in
terms of asking participants what they understood indicated
that misunderstandings were common with abstract ideas.
This was observed particularly in relation to weight, physical
activity, health, variety or balance, where focus group partici-
pants stated confusion with guidelines that included ‘desirable
weight’, ‘healthy weight’, ‘maintain or improve your weight’,
‘balance the food you eat with physical activity’ and ‘healthy
snacks’(20,22,38–41).
Consumer understanding of food quantities such as portion
and serving sizes was often confused. In Denmark, partici-
pants were surprised that a Danish nutrient recommen-
dation-compliant diet that they had followed could consist
of such large volumes of food, especially vegetables, bread
and potatoes(42). Researchers in Thailand and America found
that specific examples rather than volumes and weights
were useful to explain quantities to consumers. The ‘rice ser-
ving spoon’ was developed as a household measure after con-
sumer testing of the Thai Nutrition Flag (G Duenas,
unpublished results, cited in Albert(21)). American focus
groups reported a preference for quantity size guidance to
be depicted in cups for food and minutes for physical activity,
rather than ounces or terms such as sedentary. However, con-
fusion remained with fruits and vegetables, where quantities
or portion sizes were still considered confusing and difficult
to measure even with household units such as cups(43).
A number of studies selected in the present review reported
consumer understanding of guidelines but omitted raw data or
referred to unpublished results(44). This has been observed in
previous FBDG reviews(45). For example, an interesting paper
depicted FBDG development in four Eastern Caribbean
countries, which involved focus groups, interviews and field
tests, where participants were asked to employ one FBDG
for a week. However, within the space constraints of the
K. A. Brown et al.22
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article, no specific understanding measurement methods or
results were reported.
The quantitative results suggested an inconsistent relation-
ship between increased awareness and increased understand-
ing. In an American survey, 58 % of those sampled said they
had heard of the FGP, but only 13 % said they understood
it(46). In contrast, a review paper reported a study with a
sample of more than 5000 participants, where understanding
of the Chinese 1997 FBDG grew on average from 12 to 93 %
within a year following repeated promotions of the guidelines
and Food Guide Pagoda. The largest effect was observed with
schoolchildren and the elderly(47). The UK Balance of Good
Health study demonstrated that food guides may improve
objective understanding of a healthy diet and food groups,
yet also highlighted the complicated nature of the relationship
between awareness (or exposure) and understanding. Those
who had been shown one of the ten Balance of Good
Health food guide versions performed significantly better
than the control group on comparison and sorting tasks.
However, understanding was dependent on sex, age, socio-
economic status and nutrition awareness(37).
A mixed design study with US focus groups suggested that
equal awareness of FBDG may not lead to equal understand-
ing, and results demonstrated consumer misinterpretation of
guidelines. The ‘eat a diet low in sugar’ guideline was con-
sidered to be ambiguous and difficult to quantify, whereas
the dietary fat guideline produced the most confusion with a
particular lack of understanding relating to the saturated fat
recommendation and those that involved percentages. For
example, when participants were told about the DGA of
,30 % total fat and then asked to quantify the amount of satu-
rated fat that was recommended, answers ranged from 0 to
50 %. This study suggested that the new DGA (2000) that
incorporated behavioural messages would be better under-
stood than the DGA (1995)(34).
The studies reviewed in this section appeared to show
mixed results for consumer understanding. Some studies
showed a general understanding of the key concrete concepts
of FBDG and food guides, but some difficulties were observed
with understanding abstract concepts and specific ideas such
as portion sizes and quantities. There is a need for further pro-
spective studies to investigate the long-term effect of FBDG
information provision on different aspects of FBDG under-
standing (subjective and objective) and how this might affect
dietary behaviour change or the use of FBDG.
Use
Few studies explicitly measured consumer-intended or actual
use of FBDG/food guides or indicated that use of FBDG
could be a measure of FBDG effectiveness. Focus group dis-
cussions referred to the barriers of FBDG use, considering
time constraints, disinterest in shopping and preparation of
food as potential barriers to one’s daily food choices(43).
A number of studies, which predominantly measured consu-
mer understanding of FBDG and food guides, commented
on the need for concrete behavioural examples and messages
to enable consumers to use the guidelines. Suggestions
included the consumer behaviours such as remove chicken
skin rather than eat less fat(48) and visual examples (solid fat
v. oils) rather than technical terminology (saturated v. unsatu-
rated fat)(43). It was stressed that these should be from the
consumer’s point of view rather than the scientific standpoint
and must not require consumers to become nutritional
scientists(20,38–41,43,48,49).
A quantitative Food Marketing Institute trends data survey
reported that 27 % of US shoppers said they used FGP
information to make changes in their food purchases(50),
and another survey reported that only 13 % of those sampled
said they used the DGA(46). One quantitative study in China
did include behavioural measures following the promotion
of the 1997 ‘Guidelines for Chinese residents’ and Food
Guide Pagoda. They indicated that the percentage of school-
children who had a healthy breakfast increased from 26 to
52 % following the intervention(47). It is not clear whether
the children (or parents) consciously employed the promoted
guideline, if these effects were sustained or if these changes
may be explained by other factors, but it is a rare example
of a concrete behavioural outcome measured as an indicator
of FBDG success. From the limited information available in
the papers reviewed in this section, it appears that FBDG
and food guides are minimally used by consumers.
Conclusion
The present review has presented a wide variety of study
approaches and applied methods and the possible limitations
of these needs to be addressed. External validity may have
been limited by unrepresentative samples due to the small
sample sizes and the qualitative nature of the focus groups/
interviews, as well as the convenient samples used in a
number of the quantitative surveys. In addition, there was a
possibility of bias during qualitative data analysis interpret-
ation and a lack of controlled confounding variables
or over-interpretation during quantitative data analysis.
Furthermore, the present review may not have sourced all of
the studies relating to FBDG evaluation. For example, studies
that used alternative terminology for FBDG, investigated
unofficial FBDG, focused on one guideline rather than
FBDG in their entirety, or measured concepts other than
consumer awareness, understanding or use of FBDG. Never-
theless, we believe that the present review is replicable and
exhaustive in terms of the research question, and it has
highlighted several issues to consider in future public health
initiatives and research surrounding FBDG.
First, a degree of consumer awareness and understanding of
FBDG was identified by the literature reviewed. Evidence of
FBDG use was limited, but the researchers acknowledged
the possibility that consumers may not believe that it is necess-
ary to follow FBDG to eat healthily or they might use FBDG
without consciously realising that they are doing so, and that
this would not have been apparent from the literature
reviewed.
Second, the review indicated that the promotion of FBDG
may not have always been accompanied by evaluation of
effectiveness, or that research conducted on FBDG successes
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and failures has not always been widely published or made
available(4). This evaluation is necessary to ensure that the
efficacy of FBDG can be judged and that FBDG achieve the
purpose for which they are designed. For example, there is
a growing trend to move away from nutrient-based targets pri-
marily designed to prevent nutrient-deficiency diseases and to
derive FBDG from healthy food-based dietary targets, which
may be more appropriate to change lifestyle behaviours
associated with lowering chronic disease risk(51,52). Evaluation
is required to identify whether these alternatively devised
FBDG and the use of dietary pattern goals are more effica-
cious at changing consumer behaviour or lowering CNCD risk.
Third, to be of most use, future studies that aim to evaluate
FBDG would benefit from stating the objectives of the FBDG
that are being evaluated, with explicit clarification as to how
FBDG effectiveness will be measured and the definition of
any concepts such as awareness or understanding. In particu-
lar, we would like to highlight the dependence of study find-
ings on the questions asked in relation to both qualitative and
quantitative research designs and the need for clarity to allow
the replication of studies and the reliable interpretation of
results. In addition, the study aim, design, methods and results
should be fully reported to allow study comparisons and
judgement on the external/interval validity and reliability of
the study findings.
Lastly, FBDG have been in existence for a number of years,
yet they do not appear to have been as effective as hoped at
changing consumer behaviour or helping to reduce the inci-
dence of CNCD. Proposed reasons for this have related to a
lack of political support, non-participation of stakeholders
and conflict with market forces during FBDG development
and implementation. There is also arguably an acknowledged
uncertainty in both the nutritional science and social sciences
in terms of the complicated relationship between diet and
disease, the difficulties of applying theoretical models to diet-
ary pattern behaviour change as well as the recognition that
food is only one of the several preventable chronic disease
risk factors(4,11,53).
Evaluation of FBDG effectiveness is necessary to measure
the contribution of FBDG in safeguarding population health
and disentangling the contribution of FBDG from those of
the many coexisting public and private health initiatives, as
well as to aid FBDG revision and monitor any unanticipated
consequences of FBDG implementation(6,11,54). The frame-
work of consumer awareness, understanding and use of
FBDG may be a useful way to evaluate FBDG in addition to
monitoring health outcome and nutritional intake/status.
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Abstract
Objective: Transparent evidence-based decision making has been promoted
worldwide to engender trust in science and policy making. Yet, little attention has
been given to transparency implementation. The degree of transparency (focused
on how uncertain evidence was handled) during the development of folate and
vitamin D Dietary Reference Values was explored in three a priori deﬁned areas:
(i) value request; (ii) evidence evaluation; and (iii) ﬁnal values.
Design: Qualitative case studies (semi-structured interviews and desk research).
A common protocol was used for data collection, interview thematic analysis and
reporting. Results were coordinated via cross-case synthesis.
Setting: Australia and New Zealand, Netherlands, Nordic countries, Poland, Spain
and UK.
Subjects: Twenty-one interviews were conducted in six case studies.
Results: Transparency of process was not universally observed across countries or
areas of the recommendation setting process. Transparency practices were most
commonly seen surrounding the request to develop reference values (e.g. access
to risk manager/assessor problem formulation discussions) and evidence
evaluation (e.g. disclosure of risk assessor data sourcing/evaluation protocols).
Fewer transparency practices were observed to assist with handling uncertainty in
the evidence base during the development of quantitative reference values.
Conclusions: Implementation of transparency policies may be limited by a lack of
dedicated resources and best practice procedures, particularly to assist with the
latter stages of reference value development. Challenges remain regarding the best
practice for transparently communicating the inﬂuence of uncertain evidence on
the ﬁnal reference values. Resolving this issue may assist the evolution of nutrition
risk assessment and better inform the recommendation setting process.
Keywords
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Micronutrient Dietary Reference Values
Advisory committee
Historic public health scares (e.g. in the UK following the
Phillips inquiry into variant CJD/new variant CJD, the
human prion disease caused by the BSE crisis in 1996)
contributed to a general commitment for transparency,
openness and evidence-based (information indicating
whether a belief or proposition is true or valid) decision
making in food-related science and policy(1). This resulted
in the formal separation of science and policy activities
and adoption of the risk analysis framework(2).
The risk analysis framework was ﬁrst adapted for use
in the food area following a joint FAO/WHO expert
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Sciences, University of Groningen, Groningen, The Netherlands.
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consultation in 1995(3). The framework has been comprised
of three interconnected activities: (i) risk assessment
(scientiﬁc evaluation of health effects); (ii) risk manage-
ment (policy decisions to minimise risk); and (iii) risk
communication (exchange of risk information in/outside
the framework). A principle has been to maintain the
separation of activities while recognising the interaction
between activities (e.g. separation can vary from different
organisations to different groups/tasks within the same
organisation responsible for different activities)(3).
Central to implementation of the risk analysis frame-
work has been the encouragement of transparency and
disclosure of uncertainty in the evidence underlying
scientiﬁc advice (risk assessment) or political decision
making (risk management)(2,4). The transparent handling
of uncertainty may refer to ‘explicit recognition of any
uncertainty either in the current state of knowledge or in
the adequacy of the available data’ (e.g. accuracy/quality
or degree of incomplete/quantity of data)(5). Transparency
and openness have been promoted to achieve greater
accountability and credibility during risk analysis, improved
communication between stakeholders (e.g. science, policy,
industry, health practice) and safeguard the abuse of public
organisation power or resources(2,6–8).
Policies of transparency can be found across various
public health disciplines responsible for risk analysis
activities, such as the European Food Safety Authority
(EFSA), the National Institute for Health and Care Excellence
(NICE) and FAO/WHO(2,4,9). Implementation of these
policies requires the process and outcome of a risk ana-
lysis activity to be evident and obvious, i.e. documented
and understandable (transparent), as well as accessible
(open)(7,8,10,11). This may be related to the organisation
responsible for a risk analysis activity (e.g. disclosure of
organisation role and responsibility, membership, con-
ﬁdentiality signed agreements, declaration of interest) or
the technical content of the activity (e.g. disclosure of non-
published requests, methods, ﬁndings and conclusions via
websites, reports and manuscripts, meeting minutes and
agendas, open consultations and open meetings, release
of data and study results, etc.).
A commitment to transparency and openness may
seem the correct thing to do in view of due diligence
towards scientiﬁc practice(8). Nevertheless, the imple-
mentation of transparency per se may be limited
or represent certain challenges(11). Detailing and providing
access to all elements of the risk analysis process may be
challenging in terms of resource, technical, conﬁdentiality
or wider trust issues (e.g. articulating the nature of risk
assessment or inherent uncertainty of scientiﬁc endeavour;
detailing contradictory views during commonplace expert
discussions while maintaining unanimity in the ﬁnal scientiﬁc
advice)(12,13).
Nutrition risk assessment to derive micronutrient
Dietary Reference Values (DRV) is an area where greater
transparency and openness has been encouraged(14). DRV
are developed in the ﬁrst two steps of the risk assessment
process. The identiﬁcation of a nutrient-related hazard
in a food/food group is established in step one (nutrient-
related hazard identiﬁcation). The qualitative/quantitative
evaluation of adverse health effects associated with a
nutrient is established in step two (nutrient-related hazard
characterisation). This constitutes the development of
DRV. In a full risk assessment, DRV (steps one and two)
would be combined with a nutrient intake/exposure
assessment (step three) to assess exposure in relation to
the DRV (step four)(15). Once completed, the scientiﬁc
advice from the risk assessment is used to inform develop-
ment of recommendations in risk management. Thus,
the development of DRV can be considered a precursor to
the development of micronutrient recommendations.
Recommendations are deﬁned as population targets of
micronutrient intake necessary for adequate growth,
function and health throughout the human lifespan. These
are widely used in monitoring and evaluating population
intakes as well as in developing public health policies,
interventions and dietary risk communications (e.g. food-
based dietary guidelines to help the population meet
recommended intakes)(14,16).
The widespread use of DRV (directly or indirectly via
recommendations) belies the complexity and uncertainty
with which they are developed. The ﬁrst stage of DRV
development has been referred to as the ‘nutrition
problem formulation stage’. During problem formulation
risk managers and assessors are required to establish a
shared understanding of the problem and the purpose of
the risk assessment(10). Previously, the primary focus of
DRV development was to devise intakes related to nutrient
deﬁciency or overconsumption. More recently the remit of
DRV has expanded to also encompass intakes for health
beneﬁts (including intakes to delay the onset of disease).
Yet, the evidence base surrounding the role of nutrition
on health has been far from certain. Hence, prevailing
scientiﬁc knowledge is used to handle limitations and
uncertainty in the evidence (unknown, unreliable or
indeﬁnite evidence), develop plausible assumptions and
complete the DRV development process(14,17).
Guidelines have been produced to assist with the
development of DRV (e.g. the Institute of Medicine’s
Dietary Reference Intakes (DRI) for the USA and Canada;
the EFSA Panel on Dietetic Products, Nutrition and Allergies’
Scientiﬁc Opinion on principles for deriving and applying
DRV)(16,18). Yet, no standardised approach or agreed
best practice has been used to set DRV. Furthermore,
disparity has been observed in DRV developed by different
national or international bodies (e.g. vitamin D DRV).
The lack of agreed best practice and disparity in DRV has
led to confusion among inter/national policy decision
makers, health professionals, the food industry and
consumers(19).
An open and transparent DRV process has the potential
to assist with understanding why values differ between
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countries by clearly detailing what, why and how deci-
sions were made, particularly regarding the degree of
uncertainty in the evidence and how this was handled
or inﬂuenced the strength of the ﬁnal risk assessment
conclusions/resultant reference values(19,20). This would
inform the debate on DRV development best practice.
Furthermore, increased documentation, understanding
and accessibility to the DRV process could contribute to
the responsible use of DRV throughout risk management
and risk communication activities(2,14).
The European Commission-supported Network of
Excellence EURRECA (EURopean micronutrient RECom-
mendations Aligned, FOOD-CT-20006-36196, 2007–2012)
was tasked with reviewing the methodologies used to
derive DRV, assessing the reasons for value disparity and
the potential for methodological alignment across national
and international DRV development. Early EURRECA
ﬁndings highlighted the importance of the nutrition pro-
blem formulation stage to ensure risk assessment activities
remained achievable while also fulﬁlling the requirements
of risk managers(20). Further research suggested DRV
disparity was unlikely to be explained by differences in
concepts, deﬁnitions or deﬁned population groups.
Instead it was considered likely to be due to different
interpretations or assumptions taken while accounting for
uncertainty and limitations during evidence evaluation(19).
Finally, research identiﬁed variation in the transparency of
different types of bodies in relation to how risk managers
integrated DRV with other types of advice to develop
recommendations(20). The current study built upon these
previous ﬁndings. Transparency and openness during the
DRV risk assessment process was explored, with a parti-
cular focus on how uncertainty in the evidence base was
handled. Three areas of interest, likely to demonstrate
handling of uncertainty in the evidence base, were iden-
tiﬁed during DRV development: (i) the request to develop
DRV; (ii) the process of DRV evidence evaluation; and
(iii) the integration of evidence to develop ﬁnal DRV.
Method
Design
Qualitative in-depth case studies explored the handling
of uncertain evidence and the transparency of vitamin D
and folate DRV development in six countries/regions:
(i) Australia and New Zealand (ANZ); (ii) the Netherlands
(NL); (iii) the Nordic countries (Denmark, Finland, Iceland,
Norway and Sweden; NOC); (iv) Poland (PL); (v) Spain
(ES)(21); and (vi) the United Kingdom (England, Northern
Ireland, Scotland and Wales; UK).
Each country/region produced a descriptive report
based upon semi-structured interviews with at least two
advisory committee members together with desk research
(Table 1). A common protocol was followed throughout.
The interview schedule, desk research and ﬁnal case study
report all centred upon the transparency and handling of
uncertain evidence in three predeﬁned areas: (i) the
request to develop DRV, e.g. source of request, scope of
request, reasons for the request; (ii) the process of DRV
evidence evaluation, e.g. selection and evaluation of
evidence; and (iii) integration of evidence to develop ﬁnal
DRV, e.g. formation of quantitative numbers and advisory
committee report.
Transparency and openness was qualitatively judged via
the availability of accessible, understandable documenta-
tion on the DRV process (e.g. downloadable/upon request
meeting agendas, minutes and key discussion documents;
ability to attend open meetings and consultations and
documentation surrounding DRV; documented risk analysis
policy, organisation role and responsibility, membership,
declaration of interest; stakeholder involvement; etc.).
Vitamin D and folate were selected due to their
prioritisation as micronutrients of interest in Europe(22).
Countries/regions were originally selected from Europe
with a subsequent opportunity taken to also collect data
in Australia and New Zealand. The countries/regions
sampled represented diversity in the age and method of
Table 1 Country/region, number of interview samples, response rate, and references and associated updates for the folate and
vitamin D DRV
Country No.
% response
rate Folate Vitamin D
ANZ 4 57 NHMRC 2006(38) NHMRC 2006(38)
NL 4 67 HCN 2003(27), HCN update 2008(39) HCN 2000(40), HCN update 2008(41)
NOC 4 80 NNR 2004(42) NNR 2004(42), *NNR 2012 published subsequent
to data collection(26)
PL 4 100 Jarosz and Bułhak-Jachymczyk 2008(43) Jarosz & Bułhak-Jachymczyk 2008(43)
ES 3 100 Moreiras 2011(44), Ortega 2011(45), Serra Majem
2001 (SENC)(46), Martínez 2010 (FESNAD)(47)
Moreiras 2011(44), Ortega 2011(45), Martínez 2010
(FESNAD)(47)
UK 2 33 COMA 1991(48), SACN folate 2006(49) COMA 1991(48), SACN vitamin D update 2007(50);
*new vitamin D DRV expected 2014
DRV, Dietary Reference Values; ANZ, Australia and New Zealand; NL, Netherlands; NOC, Nordic countries (Denmark, Finland, Iceland, Norway and Sweden);
PL, Poland; ES, Spain; UK, United Kingdom; NHMRC, Australian National Health and Medical Research Council; HCN, Health Council of the Netherlands
(Gezondheldsraad); NNR, Nordic Council of Ministers’ Nordic Nutrition Recommendations; SENC, Spanish Society of Community Nutrition; FESNAD,
Federación Española de Sociedades de Nutrición, Alimentación y Dietética; COMA, Committee on Medical Aspects of Food Policy; SACN, Scientific Advisory
Committee on Nutrition.
*Recommendations under development at time of study data collection.
1380 KA Brown et al.
developing DRV as well as in geographical location, socio-
cultural factors and institutional infrastructure. Data sets
were collected from December 2010 to June 2011.
Interviews
Interviewees were recruited due to their involvement in
the advisory committee and/or development of vitamin D
or folate reference values. This included members of the
advisory committee and/or members of relevant advisory
committee working subgroups. The response rate ranged
from 33 % (UK) to 100 % (ES and PL; Table 1). Consent
was obtained from each participant, with interviews
recorded and later transcribed verbatim. All data were
made anonymous and held in accordance with the local
data privacy laws (e.g. UK Data Protection Act)(23). The
semi-structured interview schedule was piloted and
devised by the research team with questions focused upon
the transparency and handling of uncertainty in the
aforementioned three areas of DRV development.
Desk research
Sourced documents related to the development of vitamin
D or folate DRV in each country/region. Keyword searches
were conducted of advisory committee websites, publica-
tion websites (e.g. PubMed Central) and search engines
(e.g. Google). Documents referred to during the interviews
and manual searches of references elicited several addi-
tional documents. Further information was obtained in the
UK case study via observation at two open advisory
committee meetings (14 February 2011 and 7 June 2011).
Desk research key search terms included variants of the
nutrient name (e.g. folate and folic acid), variants of the
word DRV (e.g. micronutrient recommendations, nutrient
intake values, nutritional objectives) and/or the advisory
committee name (e.g. Health Council for the Netherlands).
Excluded documents were not relevant to vitamin D or
folate DRV, the speciﬁc country/region, human nutrition
or healthy populations or were duplications from previous
searches. Desk research was led and organised by ques-
tioning the transparency and handling of uncertainty in the
aforementioned three areas of DRV development.
Analysis
Initial interview and desk research analysis was conducted
in the native language using template analysis and a
skeleton coding structure created and modiﬁed by partners
during preliminary analyses(24). Case studies consisted of
an English-translated summary of interview- and/or desk
research-identiﬁed themes with illustrative quotes orga-
nised by the three areas (value request, evidence evalua-
tion and ﬁnal values). Construct validity was upheld by
limiting the subjective collection of data and performing
traceable literature searches. Internal validity was upheld
by encouraging several interpretations of the data to be
considered. Multiple sources of information (triangulation
between interview, desk research and DRV reports where
possible) were used to cross-reference (corroborate/
dispute ﬁndings). The uniform framework of case study
reporting allowed further analysis where cross-case
synthesis was used to describe and identify any differ-
ences or similarities across countries/regions in the trans-
parency and handling of uncertainty(25). One research
team member conducted the cross-case synthesis. The
qualitative software NVivo version 9 (2010) was used to
organise case study data. A subsection of the data was
cross-coded by another research team member. One
fewer theme was identiﬁed by the second coder. This was
subsequently dropped from further analysis. Agreement
on remaining themes and sub-themes was 91%. Inter-
pretation of cross-case analysis results was reﬂected back
to case study authors and amended where necessary.
Data presentation
Interview quotes have been displayed in the tables using
double quotation marks and italics. Verbatim quotes have
been modiﬁed in publication for improved readability.
Case study/desk research text has been displayed in the
tables using single quotation marks. The term ‘micro-
nutrient recommendation’ was used in the interview
schedule and throughout the present study. This term
could be translated and understood across the cases
sampled as pertaining to either micronutrient DRV or the
use of values to make recommendations.
Note that quotes have been unaltered in this respect and
differences in the terminology can be seen as cases refer to
their respective micronutrient recommendations, e.g. ‘The
term “Nordic Nutrition Recommendations” refers to a set
of dietary reference values (DRVs) for essential nutrients
that includes the average requirement (AR), recommended
intake (RI), upper intake level (UL), lower intake level (LI),
and reference values for energy’(26).
Results
Transparency and openness of the DRV process (i.e.
documentation, understanding and accessibility) varied
across the countries/regions (cases) and different areas of
the DRV development process studied. Results have been
presented below in the three areas studied: (i) the request to
develop DRV; (ii) the process of DRV evidence evaluation;
and (iii) the integration of evidence to develop ﬁnal DRV.
Request to develop DRV
In ES, where multiple sets of DRV were developed by
different individuals, teams and organisations (Spanish
Society of Community Nutrition (SENC), Federación
Española de Sociedades de Nutrición, Alimentación y
Dietética (FESNAD), Universidad Complutense de Madrid),
minimal documentation could be found to clarify details on
the source, scope or reason for the request to develop DRV
(meeting agendas/minutes, discussion documents, press
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releases, website pages, ﬁnal report details, journal
publications). However, the Spanish interview data were
more informative and interviewees openly discussed
details surrounding the request for previous DRV. In
contrast, greater information (via desk research and
interview data) on the request to develop DRV was
available in countries/regions with an ofﬁcial set of DRV
and a clear body tasked with their development, such as in
ANZ (National Health and Medical Research Council
(NHMRC)/Ministry of Health (MOH)), NL (Health Council
of the Netherlands (HCN)), NOC (Nordic Council of
Ministers (NCM)), PL (National Food and Nutrition Institute
(Instytutu Żywności i Żywienia; IŻŻ)) and UK (Committee
on Medical Aspects of Food Policy (COMA)/Scientiﬁc
Advisory Committee on Nutrition (SACN); Tables 1 and 2).
Regarding the source of the request to develop DRV,
Spanish interviewees cited the majority of activity was
undertaken by independent and academic institutions. On
the other hand, in the ﬁve cases of ANZ, NL, NOC, PL and
UK the requests were predominantly sourced from the
government or within the advisory committee as a set
programme of work.
Across all six cases the reasons provided for the request to
develop DRV ranged from acknowledged discrepancy
between local DRV and those of other countries, DRV age,
the emergence of new data, a set time cycle for the
programme of work, information provision to assist policy
option selection and triggers from monitoring practices, such
as clinical health outcomes or markers of chronic disease
risk (e.g. neural tube defects, LDL). However, details on the
ﬁnal trigger to initiate a request for particular nutrient DRV to
be reviewed or developed were not always transparent, i.e.
the inﬂuence of lobbying (professional, academic, com-
mercial or special interest group) on initiating or suppressing
any development of DRV. Similarly, the criteria for judging
when DRV were ‘too old’, when there was ‘sufﬁcient’ new
evidence to initiate renewing DRV or at what point disease
incidence constituted a public health issue to address were
not always transparently documented.
The scope of request differed between cases. In the
ANZ, PL and ES cases the scope of the request centred
upon the utilisation and adaptation of international DRV to
each respective country/region (predominantly the US/
Canadian DRV in ANZ and PL; various international DRV
in ES). This was clearly detailed in ANZ. The NHMRC was
asked to assess the body of evidence used to establish the
US/Canadian DRV (and any relevant literature that had
subsequently been released) and provide an opinion on
one of four courses of action: whether they should adopt,
adopt with minor changes, adopt with substantial changes
or reject the US/Canadian DRV in ANZ.
The remaining three cases (NL, NOC and UK) all
referred to the importance of clarifying the scope of the
request and iterative interactions between government
representatives and advisory committee members during
the nutrition problem formulation (e.g. to demarcate risk
assessment/risk management activities or develop values
for deﬁciency/adequacy/optimal/toxicity). Problem for-
mulation was deemed necessary to ensure the request
would be both appropriate and achievable (e.g. scientiﬁc
limits of knowledge and resource constraints such as
expertise, ﬁnance, time). Transparency appeared to be
the greatest regarding the current UK vitamin D DRV
development process. Here, the public was allowed to
attend an open meeting where the scope of the request
was discussed (also known as ‘terms of reference’ in the
UK) and online access was made available for downloading
detailed meeting minutes and discussion documents
surrounding request clariﬁcation.
Process of DRV evidence evaluation
Several discussions were undertaken on how to evaluate
and interpret evidence that contained methodological and
theoretical uncertainties (e.g. folate assay method, folate
Table 2 Request to develop DRV
Value request Quotes: case study text or interview [case study/participant reference]
Source of request “No, it has not been the Government as in other countries... there have been private initiatives but nothing coming
from the Government.” [ES]
“…items of work can come to the SACN in three ways: they can come from Government, requests from Government;
from the Committee itself; and from… anybody just writing to the Committee. The reality is the Committee’s
workload means it’s mainly driven by Government.” [UK]
Reason for request “All nutrients are reviewed one way or the other every eight year and then they put special focus on some of them
every time. And vitamin D has been discussed very much in the last years, also in America, so that is why vitamin D
is one of the chosen nutrients.” [NOC]
“Concerning the folate, firstly quite huge discrepancies between Polish recommendations and those in other
countries. Secondly, elevated blood homocysteine level and quite big percentage of neural tube defects in Polish
population. Also the health policy, how to improve the situation (…).” [PL]
Scope of request “What we did is making the question more precise and operationalised it, like it is called, in cooperation with the
MHWS. Let’s say, the original questioning is a bit adapted in such a way that we could better provide answers.” [NL]
‘The Chair emphasised the need for a broad risk assessment, which would inform government whether the newly
available data on vitamin D has implications for UK public health policy.’ [UK]
DRV, Dietary Reference Values; ES, Spain; SACN, Scientific Advisory Committee on Nutrition; UK, United Kingdom; PL, Poland; MHWS, Ministry of Health,
Welfare and Sport; NL, Netherlands.
“Italics and double quotation marks denote interview quotes”; ‘single quotation marks denote case study/desk research text’.
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equivalents, uncertainty factors, bioavailability factors,
vulnerable population groups, mechanisms of action,
multiple nutrient interactions). These discussions were
present in the cases which adopted/adapted existing
international DRV as well as those which developed their
own DRV (Table 3). For example, the ANZ, PL and ES
cases made reference to the evidence evaluation pre-
viously conducted in the original DRV as well as the
additional evidence evaluation required to ensure adapted
DRV were up-to-date and relevant to their respective
country/region.
To increase the transparency and scientiﬁc rigour of the
evidence evaluation process, four cases (ANZ, NL, NOC,
UK; Table 4) used protocols to guide evidence evaluation,
address uncertainty in the data and limit interpretation
bias. These evidence evaluation protocols differed slightly.
Yet, all four cases provided guidance on the systematic
reviewing of literature (including meta-analyses), the
assessment of individual study quality/risk of bias and
accounting for uncertainty when weighting or deciding the
strength of the evidence base.
ANZ, NL and NOC used a series of checklists to assess
study quality and a number of categories to differentiate
between results from different study designs. The UK also
utilised a series of checklists but discouraged the use of
numerical grading. It was clearly acknowledged that a
degree of subjective judgement was still required with the
application of these protocols, especially when moving
from the quality assessment of each study to collating the
strength of the total evidence. Nevertheless, the following
of a protocol for evidence evaluation and reporting
of results was seen by these four cases as important
steps towards a standardised approach to the evidence
evaluation decision-making process.
Integration of evidence to develop ﬁnal DRV
Interviewees across all cases acknowledged that evidence
evaluation did not constitute the end of the DRV develop-
ment process. Evidence evaluation ﬁndings needed to be
appraised in the context of the original request to form the
ﬁnal DRV. Expert judgement was required to take account
of the underlying certainty of the evidence, decide the
strength of evidence and conclude with speciﬁc reference
values. This stage of the process appeared to be less stan-
dardised with few transparent protocols available to aid the
expert deliberation and consensus seeking decision-making
process (Table 5).
The four cases which employed evidence evaluation
protocols (ANZ, NL, NOC, UK) appended these protocols
to reports and used them to guide descriptions of the
strength and degree of certainty in the evidence under-
lying each DRV. In addition, prior to the publication
of DRV reports, the standard practices of peer review
(NL, NOC, PL) and invited or open consultation (ANZ,
NL, NOC, PL, UK) provided an element of transparency
and credibility to the process. Nevertheless, from the
interviews it was clear that considerable discussions
occurred between the evidence evaluation stage and
the creation of the ﬁnal DRV, even in relation to the
wording or terminology used to describe DRV concepts
(particularly PL) or the strength of evidence/degree of
uncertainty (particularly UK). However, the details from
many of these discussions were rarely communicated in
the ﬁnal report.
Two interviewees (ES, NL) speciﬁcally mentioned that
the exact discussions undertaken by those developing
DRV were not commonly reported. Reasons cited for this
included a concern for the conﬁdentiality of those who
developed the recommendations as well as a belief that it
Table 3 Process of DRV evidence evaluation
Evidence evaluation Quotes: case study text or interview [case study/participant reference]
Protocols for evidence
evaluation
‘The NHMRC explains the reviewers were directed to take the body of evidence and key papers used to
establish the USA/Canadian dietary reference intakes and provide an analysis of any vital missing documents
and/or documents which were published after the Canadian dietary reference intakes were established, using
the NHMRC’s six levels of evidence.’ [ANZ]
“Historically we have had recommended intakes in Spain, as well as food composition tables, but it was not clear
how they were made (...).” [ES]
‘In the 2006 reconsiderations the committee applied a rating system for weighing quality of scientific evidence
based on CBO’s “evidence based guideline development” and SIGN grading system, in which the highest
level of evidence include only systematic reviews of good quality [2 & 6, appendix C & D resp.]. Despite, there
were various uncertainties related to scientific evidence.’ [NL]
‘Systematic literature reviews will be performed to minimise potential reporting bias through comprehensive and
reproducible searches using clearly defined search strategies together with clearly defined and described
selections and reporting protocols. This means that the reviewing of literature will be more systematic in
connection with NNR5 than it has been in earlier rounds.’ [NOC]
‘The consultation document [Code of Practice for Scientific Advisory Committees, published by the Government
Office for Science 17th Sep 2010] was circulated to members, along with a short paper “How SACN operates”
to describe SACN practices relevant to the specific areas covered by the consultation questions. This was
appended with a copy of the Committee’s framework for evaluation of evidence.’ [UK]
DRV, Dietary Reference Values; NHMRC, Australian National Health and Medical Research Council; ANZ, Australia and New Zealand; ES, Spain; CBO, Dutch
Institute for Healthcare Improvement; SIGN, Scottish Intercollegiate Guidelines Network; NL, Netherlands; NNR5, Nordic Council of Ministers’ Nordic Nutrition
Recommendations, 5th edition; NOC, Nordic countries (Denmark, Finland, Iceland, Norway and Sweden); SACN, Scientific Advisory Committee on Nutrition;
UK, United Kingdom.
“Italics and double quotation marks denote interview quotes”; ‘single quotation marks denote case study/desk research text’.
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Table 4 Protocols used to assess study quality/risk of bias across cases (PL/ES unknown)
ANZ (NHMRC 2000)(51) NL (CBO 2007(52) and SIGN 50 2007(53)) NOC (NNR5 Working Group 2011)(54) UK (SACN 2008)(55)
Assessment of study
quality/risk of bias
Quality checklist Quality checklist Quality checklist (total quality score) Quality checklist
Six evidence categories; Six evidence categories; Three evidence categories;
I: RCT systematic review A1: Systematic reviews (2 grade A2
studies + )
A: Low level of bias. Considered valid.
High quality. Valid estimation of nutrient
exposure. Control for confounders in
design and analyses.
II: ≥1 RCT
A2: Randomised, double-blind
comparative intervention study (good
quality/size) B: Bias not sufficient to invalidate results.
Do not meet all A category criteria.
May be missing information, thus
difficult to assess limitations
III-1: Pseudo-RCT
B1: Systematic reviews of good quality
(2 grade B2 studies + )
C: Significant bias that may invalidate the
results
III-2: Comparative studies with concurrent
controls, cohort, case–control or
interrupted time series
B2: Comparative (not A2), good quality
cohort or patient case studies
III-3: Comparative studies with historical
control, ≥ 2 single arm/interrupted time
series without parallel control group
C: Non-comparative studiesIV: Case series, post/pre test
D: Opinion of the committee
Strength of evidence
summary
Narrative summary Four categories; Four categories; Narrative summary
Convincing: 1 grade A1 or ≥2 grade A1 Convincing (high): Causal/absence of
relationshipProbable: 1 grade B1 or ≥2 grade B2
Probable (moderate): Causal relationshipInsufficient: 1 grade A2 or B2 or grade C
Limited–suggestive (low): Suggestive of
effect direction
Insufficient: Based upon the committee’s
opinion (grade D)
Limited–no conclusion (insufficient):
Limited quantity, inconsistent effect
direction
PL, Poland; ES, Spain; ANZ, Australia and New Zealand; NHMRC, Australian National Health and Medical Research Council; NL, Netherlands; CBO, Dutch Institute for Healthcare Improvement; SIGN, Scottish
Intercollegiate Guidelines Network; NOC, Nordic countries (Denmark, Finland, Iceland, Norway and Sweden); NNR5, Nordic Council of Ministers’ Nordic Nutrition Recommendations, 5th edition; UK, United Kingdom;
SACN, Scientific Advisory Committee on Nutrition; RCT, randomised controlled trial.
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was unnecessary to report every aspect of discussions that
occurred during the deliberations before a consensus
was reached. An exception was observed in NL when a
disagreement of an advisory committee member could not
be resolved during the formation of the folate DRV(27).
Consequently, a footnote was added to the Dutch report
detailing a minority position of disagreement regarding the
expression of folate v. folic acid as well as folate equiva-
lent selection.
Discussion
Transparency and openness of the DRV process was not
universally adopted across countries or areas of the DRV
development process studied. Implementation of transpar-
ency policies may be limited by a lack of dedicated
resources and best practice procedures, particularly to assist
with the latter stages of reference value development.
Findings aligned with previous research regarding
transparency in risk management activities(20). The countries
with dedicated advisory committees for risk assessment
activities (ANZ, NL, NOC, PL and UK) demonstrated
greater transparency of the DRV process than ES, where
coordinated action at a national level was in its infancy
and DRV had been developed by dedicated individuals.
Arguably, NL, NOC and UK appeared to display the
most transparency (also potentially ANZ, although the
underpinning US/Canadian DRV setting process was not
studied). Similarly to the above, this could be explained
by a greater legal and clariﬁed role of the relevant advisory
committees and their responsibilities (demarcation between
risk assessors, risk managers and risk communicators),
a higher political priority or greater dedication of resources
for nutrition and a longer tradition of DRV development.
Furthermore, both NOC and UK were currently updating
DRV at the time of study. Thus, the nature of transparency
observed may have reﬂected the current increased calls for
transparency and been associated with the most recent
micronutrient DRV setting processes.
All cases demonstrated differences in transparency (in
general and speciﬁc to the handling of uncertain evidence)
across the three a priori areas studied (value request,
evidence evaluation and ﬁnal values). Based upon these
ﬁndings, the status quo for current best practice regarding
transparent and open handling of uncertainty in nutrition
risk assessment has been discussed below.
Regarding the request to develop DRV, transparency
was increased via documentation and accessibility to the
iterative discussions between risk assessors, risk managers
and others in problem formulation. These discussions
acknowledged the uncertainty and limitations of the
evidence base available to ensure the feasibility of the risk
assessment task. This transparent detailing of the source,
scope and reasons for any DRV request corresponded
with guidance seen in a number of international risk
assessment procedural documents (e.g. the nutrition pro-
blem formation stage before nutrition risk assessment
activity in CODEX Alimentarius; deﬁning the problem
in the EURRECA framework for setting micronutrient
recommendations)(10,14).
Transparency in risk assessment evidence evaluation is
designed to minimise the probability of bias(28). Best prac-
tice for transparent handling of uncertainty in the cases
studied referred to the documented protocols designed to
guide and standardise the process of sourcing and inter-
preting evidence. Bias was reduced by employing an
independent body to conduct the review and reproduci-
bility was increased by employing standardised systematic
literature review processes. Difﬁculties were still seen
regarding the handling of uncertainty during evidence
evaluation and communicating how this inﬂuenced the
quantiﬁcation/qualiﬁcation of risk (e.g. the merits of
grading different types of evidence). In addition, whether
Table 5 Integration of evidence to develop final DRV
Final values Quotes: case study text or interview [case study/participant reference]
Reporting of strength and
uncertainty in evidence
‘Published throughout the 2006 NRV document are justifications which state how each nutritional
recommendation was established. The NHMRC states that a decision should be made about what
is feasible and appropriate in a given situation and the extent to which reasonable standards have
been met by the available body of evidence’. [ANZ]
‘Although the NRV are evidence-based wherever possible, the data to establish recommendations is
generally very limited (…) Therefore, the Working Party had to rely on subjective professional
judgements to estimate recommendations from alternative age, gender or life stage categories.’
[ANZ]
‘NNR 2004 where there is a chapter for each micronutrient where recommendation are stated followed
by discussion of the evidence and uncertainty.’ [NOC]
“Well, maybe not all uncertainties are published. In other words, it is clear that there have been
discussions, comments, questions that have not been published (…).” [ES]
“(…) the exact discussion that takes place and the names of the committee members who said what,
this is confidential.” [NL]
DRV, Dietary Reference Values; NRV, Nutrient Reference Values; NHMRC, Australian National Health and Medical Research Council; ANZ, Australia and New
Zealand; NNR, Nordic Council of Ministers’ Nordic Nutrition Recommendations; NOC, Nordic countries (Denmark, Finland, Iceland, Norway and Sweden);
ES, Spain; NL, Netherlands.
“Italics and double quotation marks denote interview quotes”; ‘single quotation marks denote case study/desk research text’.
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restricting a review to evidence from randomised
controlled trials or meta-analyses limited the scope of the
review or the utility of the ﬁnal advice/reference values.
However, the constant updating and disclosure of
evidence evaluation procedures in the most recent cases
reﬂected an ability to detail the overall strength of
evidence reviewed.
Few protocols were available to assist with the articula-
tion of, or guide the transition from, evidence evaluation to
the integration of evidence and development of quantitative
values/ﬁnal DRV. This has been highlighted previously in
the health-care area, where difﬁculties have been observed
translating evidence evaluation into scientiﬁc advice for use
in recommendation/guideline development(29,30). These
ﬁndings support the requirement for further initiatives such
as the EFSA consultation exercise in 2013 on how to con-
duct consistent procedures for expert elicitation during risk
assessment(31).
Cases demonstrated that consensus seeking was an
essential stage of the DRV development process, designed
to increase validity and reliability of decisions rather than
relying upon an individual’s judgement. However, it was
difﬁcult to identify the best practice for transparently
developing quantitative DRV; values that require a certainty
not always apparent in the underlying data. The production
of a transparent DRV report documenting the complexity
of evidence-based expert decision making, the strength of
advice and the areas of uncertainty remained a challenge.
This had the potential to pose subsequent problems for
the interpretation of DRV by those outside the advisory
committee (e.g. responsible for setting micronutrient
recommendations/relevant toxicology risk assessment
activities)(32–34).
The present study was based upon qualitative case
studies. Therefore, the selection of micronutrients, coun-
tries and the three a priori deﬁned areas of study may
have limited external validity and the degree to which
these ﬁndings can be transferred outside the sample
studied. The authors recognise the study would have
beneﬁted from including analysis of other countries that
develop micronutrient DRV, e.g. the USA/Canada. The
exploratory nature of the present study justiﬁed the use of
a qualitative design and steps were taken to limit biased
interpretation. A common protocol and the three a priori
deﬁned areas of study were employed to maximise study
rigour via clarity of the research goal and the consistent
method of data collection, analysis and reporting. This
also enabled the combination of data across countries.
Construct validity was upheld by limiting the subjective
collection of data, regular monthly research team meetings
and performing traceable literature searches. Internal
validity was upheld by encouraging several interpretations
of the data to be considered. To maintain the cultural
context and authenticity of the data, the majority of
qualitative interpretation was conducted in the native
language and information from interviews, observation or
desk research provided the ability to cross-reference
ﬁndings. The case studies (data collection, analysis and
reporting) were led by the three a priori deﬁned areas and
did not represent the totality of the DRV development
process. Nevertheless, they have provided an insight into
the nature of transparency, in particular regarding the
handling of uncertain data, available in an evidence-based
decision-making process across multiple countries/regions.
Debate shall continue regarding the best practice for
nutrition risk assessment, particularly handling uncertainty
in the evidence surrounding nutrition, diet, lifestyle and
health and rating the overall evidence underpinning
DRV(35). Future discussions may focus on adaptations to the
risk analysis framework to facilitate increasing requirements
for nutrition risk–beneﬁt assessment in the development
of DRV(26,36). Furthermore, how to meet the challenge of
incorporating developing evidence bases into risk assess-
ment, such as those related to individual differences (e.g.
metabolomics), non-randomised controlled trial study
designs or whole-diet approaches (e.g. epidemiology)(15).
It may not be possible or necessary for all countries/
regions to follow an aligned DRV risk assessment proce-
dure nor for all reference values to be identical. However,
transparency, as well as increasing the accountability and
credibility of DRV development, can facilitate the sharing
of best practice to inform the evolution of nutrition risk
assessment. Therefore, the recent transparency initiatives
from the EFSA, such as proposals to promote public access
to risk assessment technical data, are to be welcomed(37).
Conclusion
Implementation of transparency policies may be limited
by a lack of dedicated resources and best practice pro-
cedures, particularly to assist with the latter stages of
reference value development. Challenges remain regard-
ing the best practice for transparently communicating the
inﬂuence of uncertain evidence on the ﬁnal reference
values. Resolving this issue may assist the evolution of
nutrition risk assessment and better inform the recom-
mendation setting process.
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The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence explored the process of
setting micronutrient recommendations to address the variance in recommendations across Europe. Work centered upon
the transparent assessment of nutritional requirements via a series of systematic literature reviews and meta-analyses. In
addition, the necessity of assessing nutritional requirements and the policy context of setting micronutrient recommendations
was investigated.
Findings have been presented in a framework that covers nine activities clustered into four stages: stage one “Defining the
problem” describes Activities 1 and 2: “Identifying the nutrition-related health problem” and “Defining the process”; stage
two “Monitoring and evaluating” describes Activities 3 and 7: “Establishing appropriate methods,” and “Nutrient intake
and status of population groups”; stage three “Deriving dietary reference values” describes Activities 4, 5, and 6: “Collating
sources of evidence,” “Appraisal of the evidence,” and “Integrating the evidence”; stage four “Using dietary reference values
in policy making” describes Activities 8 and 9: “Identifying policy options,” and “Evaluating policy implementation.” These
activities provide guidance on how to resolve various issues when deriving micronutrient requirements and address the
methodological and policy decisions, which may explain the current variation in recommendations across Europe.
[Supplementary materials are available for this article. Go to the publisher’s online edition of Critical Reviews in Food
Science and Nutrition for the following free supplemental files: Additional text, tables, and figures.]
Keywords EURRECA, framework, dietary reference values, systematic review
INTRODUCTION
In Europe, micronutrient recommendations established by
national and international committees of experts are used by
Address correspondence to Rosalie Dhonukske-Rutten, Division of Human
Nutrition, Wageningen University, P.O. Box 8129, 6700 EV Wageningen, The
Netherlands. E-mail: rosalie.dhonukshe-rutten@wur.nl
public health policy decision makers to monitor and assess the
adequacy of the diets of population groups (Dhonukshe-Rutten
et al., 2010a). There is no standardized approach for deriving
recommended intake levels of micronutrients in Europe (Pren-
tice et al., 2004; King et al., 2007; Blanquer et al., 2009; Berti
et al., 2010). In 2007, the EC-funded Network of Excellence,
European Recommendations Aligned (EURRECA) was estab-
lished as a direct result of the socio-political climate in Europe
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Figure 1 Final EURRECA framework describing the process for setting micronutrient requirements. The framework includes nine activities that have been
clustered in four different stages.
and tasked with identifying the means by which to align mi-
cronutrient recommendations. Alignment includes the scientific
content (objectivity, transparency, common basis), the processes
to collate and summarize evidence, and the application of results
by regional, national, and international stakeholders who evalu-
ate their policy options and implement the chosen applications
(Dhonukshe-Rutten et al., 2010a).
EURRECA has outlined what it considers to be the different
stages that are core to the process of deriving and applying
micronutrient recommendations:
• Defining the problem
• Monitoring and evaluating
• Deriving dietary reference values (DRVs)
• Using DRVs in policy making
Each stage consists of two or three activities (Fig. 1) that those
involved in deriving and applying nutrient recommendations
need to be considered.
The first stage “Defining the problem” (Activities 1 and 2)
sets out the process by which DRVs will be set and includes
defining the underlying problem to be addressed.
The purpose of the second stage “Monitoring and evaluating”
is to define appropriate methods to be used to estimate popula-
tion nutritional health and identify groups at risk of malnutrition.
It is needed throughout the process of both establishing mi-
cronutrient recommendations and their subsequent application
in policy and practice. In this stage involving Activity 3 and 7,
the intake and status of the micronutrient in question is moni-
tored and evaluated.
The stage “Deriving dietary reference values” consists of
three sequential activities (4, 5, and 6). It describes how a va-
riety of sources of evidence can be collected, interpreted, and
integrated into average requirements (ARs) in a harmonized
and standardized way. From these, reference values for mi-
cronutrient intake for specified proportions of the population
(resembling the definition of AR and population reference in-
takes (PRI)) can be derived.
The stage “Using dietary reference values in policy making”
includes two activities (8 and 9) where policy makers identify
appropriate policy goals and options and evaluate policy imple-
mentation. This stage then also feeds back into the “Defining
the problem” stage.
THE EURRECA FRAMEWORK FOR DERIVING
AND USING MICRONUTRIENT REQUIREMENTS
Defining the Problem: Identifying the Nutrition-Related
Health Problem (Activity 1)
At the beginning of the 20th century, reference values ad-
dressed the nutrient needs for the prevention of deficiencies and
related health problems. Currently, these health problems are
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not highly prevalent in the Western societies. There has been
a shift in the way that DRVs are set, which is more focused
on the increasing prevalence of chronic disease. Increasingly,
nutrient recommendations setting bodies now include optimal
health and the prevention of chronic diseases when setting new
reference values.
Currently in Europe, however, only 10 countries included
“prevention of chronic diseases” in addition to “prevention of
deficiency diseases” in their definition of adequacy (unpub-
lished work of EURRECA). The derivation of new or updated
nutrient reference values should ideally be based on specific
health outcomes related to functional capacities or the avoid-
ance of disease. However, as convincing scientific evidence on
the dose–response relationships between intake and health is
often not available, other criteria of adequacy are used, such
as subclinical nutritional health conditions identified by spe-
cific biochemical or functional measures, or requirements to
maintain physiological balance. These markers are useful to the
extent that they can be considered as intermediates in the path-
way between nutrient intake and the ultimate health or disease
endpoint. As a separate approach, the nutrient balance in appar-
ently healthy subjects can be used as a starting point for setting
recommendations; this refers to maintenance of stores, losses,
and tissue growth. Although this is a widely used approach in
nutritional science, it is strictly speaking based on apparently
healthy people, and will thus lead to estimates of adequate intake
(AI) rather than AR and PRI.
Although similar concepts and definitions are used around
the world for the different reference values, the exact terminol-
ogy differs. Because of its European scope, EURRECA used
the European Food Safety Authority (EFSA) terminology (AR,
PRI) for practical purposes of (dietary) reference values (DRVs),
and the neutral United Nations University (UNU) terminology
where this was required from the scientific point of view (Me-
dian INL or INL50 corresponding to average nutrient require-
ment (ANR) or AR when the requirement follows a standard
normal distribution; individual nutrient level or INL97.5 for
PRI) (King et al., 2007). The EURRECA network focused on
the process of deriving the AR and its distribution. The average
intake requirement (AR) is based on the median of the intake-
requirement distribution of individuals and defined as the intake
sufficient to meet the requirements of 50% of a specific pop-
ulation group, and recommended that the intake values are in
practice defined as the PRI, which denotes the intake sufficient
to meet the requirements of the majority (∼97.5%) of a specific
population group.
The ultimate choice of the health criteria will depend not
only on the available scientific evidence but also on the actual
public health situation and health goals of each specific country
(Taylor, 2008). Scientists should provide policy makers with
tools such as health criteria and their implications in order to
make choices and set priorities. As a consequence of prioritizing
different health outcomes or the criteria for acceptable health
outcomes, it is possible to have multiple ANRs for different
functional outcomes. Nutrition and public health policy makers
should then determine which level of adequacy is preferred or
achievable.
Health Outcomes Considered in EURRECA
EURRECA considered and reviewed the following health
criteria in order to choose the health outcome:
1. The occurrence of diet-related chronic disease or precursors
of disease; these health criteria can be considered as “health
outcome.”
2. Clinical biomarkers of key biochemical micronutrient func-
tions relevant to nutritional health status; these health criteria
are briefly labeled as “status markers.”
3. Nutrient balance; maintenance of body stores by adequate
compensating obligatory losses and providing needs for re-
production and growth during the life cycle.
EURRECA identified the most relevant health outcomes by
determining the number of hits that emerged in preliminary
searches of the literature combined with the opinion of scientific
nutritional experts (see also Activity 6, Expert consultation).
Supplementary Table 1 shows the health outcomes studied for
the micronutrients, which were reviewed within the framework
of EURRECA for different life-stage groups.
Principally, EURRECA covered two different concepts
that are effective in order to derive reference values (King
et al., 2007). They include the factorial approach and the
dose–response approach, which are illustrated in Fig. 2 and
which will be described in more detail in Activities 4, 5, and 6.
The final component, i.e., the formulation of recommended mi-
cronutrient intake for specific population groups is the outcome
of both approaches together with a number of policy issues that
are further detailed in Activities 2 and 8.
Population Groups
Definition of apparently healthy. Reference values are
designed for the planning and evaluation of a diet to keep
Table 1 Key characteristics of the case studies to examine the processes of
establishing micronutrient DRVs
Three micronutrients known for a
recent or past history of policy
debates
Folic acid, Iodine, Vitamin D1
Countries representing different
institutional contexts and a
north–south gradient in Europe
Czech Republic, Italy, Netherlands,
Nordic countries (Denmark,
Finland, Iceland, Norway,
Sweden), Poland, Spain
Quantitative and qualitative
methods allowing triangulation
Quantitative and qualitative online
questionnaire (de Wit et al., 2008)
Qualitative interviews (de Wit, in
preparation, Jeruszka-Bielak, in
preparation)
In-depth desk research
Note: 1Part of the case study for vitamin D was based on Denmark as a
representative of the Nordic countries.
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Figure 2 Two concepts that both provide scientific evidence for setting nu-
tritional reference values: factorial approach (left) and dose–response approach
(right). The factorial approach estimates losses and needs for maintenance and
growth by actually measuring the various (exchanges between) body pools,
which usually requires advanced methods in selected study groups. The results
lead to adequate intake levels, unless a critical pool size has been established.
The dose–response approach addresses depletion–repletion studies, RCTs, and
observational studies covering a wide dose range. When a health criterion can
be specified and the data allow extrapolation of the dose–response curve to the
lower end of the intake range, an AR can be estimated as well (see activity 6).
(Color figure available online.)
populations healthy. This involves studying the association
between intake, status, and health outcomes. The question
of what constitutes a healthy population has become more
complex during the past 50 years as a result of better under-
standing of health and chronic disease etiology and because
there is no overall definition or consensus (Sheffer and Taylor,
2008; Taylor, 2008). In the EURRECA network, apparently
healthy was defined as the absence of diseases based on clinical
signs and symptoms of micronutrient deficiency or excess and
normal function as assessed by laboratory methods and physical
evaluation (World Health Organization (WHO) and Food and
Agriculture Organization of the United Nations (FAO), 2004).
However, depending on the specific research question, the
exact definition of apparently healthy varied slightly, i.e., was
tailored, in EURRECA’s research activities.
Defining life-stage population groups. As nutrition-related
health problems may differ between population groups, it is im-
portant to identify and clearly define the population groups of
concern. Within Europe, operational categories of age groups
vary, especially for children, adolescents, and elderly peo-
ple (Doets et al., 2008). The age of transition from “adult”
into the “elderly” category varied between the age of 50 and
76 years. Moreover, some countries defined an additional cate-
gory of “late” elderly thus acknowledging the specific needs of
a growing population group in Europe. Pregnant and lactating
women are defined in almost all countries and some countries
distinguished various stages of pregnancy (usually according
to trimesters, sometimes weeks) and pre-pregnancy. For some
micronutrients, specific population groups are mentioned, i.e.,
post-menopausal and menstruating women (iron), sunlight ex-
posed people (vitamin D), smokers (vitamin C), and formula fed
infants (calcium and zinc). The EFSA panel on Dietetic Prod-
ucts, Nutrition and Allergies (NDA) (EFSA, 2010) recently pro-
posed to use nutrient-specific age ranges depending on the nu-
trient and the available scientific data to derive reference values.
To define age groups, three options were considered: (1)
chronological age, (2) physiological age; use of functional char-
acteristics (e.g., growth and puberty), or (3) social age. These
were all potential purposes for which the reference values might
be used (e.g., complementary feeding programs). To avoid con-
fusion, EURRECA decided to use the same life-stage groups for
all nutrients as proposed by the UNU (Atkinson and Koletzko,
2007). Special attention must be paid to the needs of infants
and the elderly (above 65 years) as they have a relatively high
requirement of certain micronutrients per unit body weight and
energy intake.
Population groups considered in EURRECA. Before the re-
search activities commenced, EURRECA defined the following
life-stage groups when reviewing best practices and evidence
for setting requirements:
• Infants (0–12 months: ∼5% of the EU27 populations),
• Children and adolescents (1–18 years: ∼15–20% of the EU
27 populations),
• Adults (19–64 years: ∼60% of the EU 27 populations),
• Elderly (65+ years: 15–20% of the EU 27 populations),
• Pregnant women
• Lactating women
These categories are in line with the population groups de-
fined by the EFSA panel (2010).
In addition to age and life cycle, other population grouping
criteria used were related to physiological, biological, and cul-
tural factors. This included factors related to body size (such as
height and weight, obesity, and physical activity); and biological
variation in needs further addressed in Activity 6.
Finally, factors such as ethnicity and socio-economic status
may be relevant to increased vulnerability to inadequacies re-
sulting from limited access to nutritious foods. Health policy
makers may decide to include socio-economic and political as-
pects in the context of surveillance of the actual micronutrient
intake and status, and nutritional health problems in specific
population groups. Therefore, in addition to the different age
groups studied (from infants to elderly), EURRECA also ad-
dressed low income and immigrant status as potential determi-
nants of inadequate micronutrient intake (Activity 7).
Micronutrients
The prioritization of micronutrients. Reasons for updating
reference values vary from statutory obligations, discrepancies
with other countries’ recommendations, health status or disease
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Figure 3 Prioritizing micronutrients for the purpose of reviewing their requirements: a protocol developed by EURRECA (Cavelaars et al., 2010).
incidence through to the emergence of new science or lobbying
from those within or outside the scientific advisory boards of
the nutrient recommendation setting bodies (Dhonukshe-Rutten
et al., 2010a). Reviewing and evidence-based updating of mi-
cronutrient recommendations is, however, costly both in time
and money. EURRECA developed a simple systematic prioriti-
zation process to decide which micronutrients to focus on first.
This fits within the adoption of evidence-based decision-making
in public health recommendations and helps move the process
away from sole reliance on expert opinion and toward thought-
ful consideration of the total body of evidence. In this process,
it is important to question whether there is enough evidence
to warrant re-assessment of the current requirements. The pro-
cess (schematically outlined in Fig. 3) was guided by three main,
content-related criteria for reviewing and revising micronutrient
recommendations:
(a) Amount of relevant and functional, new scientific evidence
available for a particular micronutrient for different life-
stage population groups.
(b) Public health relevance of the micronutrient through mea-
sures of dietary inadequacy and disease burden for the dif-
ferent population groups, including vulnerable groups such
as low income and immigrant population.
(c) Heterogeneity defined as between-country differences in
current micronutrient recommendations in Europe.
Although the three criteria were easily measurable and repro-
ducible in a short time frame, eminence-based expert opinion
was required to compensate for the lack of a comprehensive
overview of micronutrient inadequacy in different population
groups in Europe. Alternatively, a more thorough and time-
consuming process involving the same basic principles could
evaluate more thoroughly the amount of new evidence, to iden-
tify new outcomes, and to provide additional information on
dose–response relation such as described by Yetley et al. (2009).
Micronutrients considered by EURRECA. The above
process was applied to a long list of 28 micronutrients provided
to EURRECA by the EFSA Panel. Based on this process the
micronutrients vitamin D, iron, folate, vitamin B12, zinc, cal-
cium, vitamin C, selenium, iodine, and copper were prioritized
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(Cavelaars et al., 2010). This priority list of micronutrients was
further refined by factors such as (i) avoidance of duplication of
work already started by other organizations, e.g., vitamin D and
calcium, (ii) micronutrient expertise available in the network,
and (iii) available resources within the EURRECA network.
Therefore, EURRECA eventually focused on the following
micronutrients: iron, zinc, folate, vitamin B12, selenium, and
iodine. In summary, the selection process included evidence
derived by a scientific protocol, whereas the other three criteria
refer to driving factors in the socio-political context, such as
the efficient use of available expertise and financial resources.
These process-related issues are further detailed in Activity 2.
Defining the Problem: Defining the Process (Activity 2)
Deriving DRVs and setting recommendations provide a tool
for policy makers to set public health nutrition policy; thus, al-
though the use of DRV ranges widely (e.g., in medical care, to
aid development of policy options such as food labeling, toward
food composition data), they are developed with policy purpose
in mind. Public health nutrition policy has been variably concep-
tualized in terms of values and intentions with a public health
nutrition outcome in mind (Lawrence, 2007), as a process of
influence and power relevant to public health nutrition (Walt,
1994) and as a decision relevant to food and nutrition (Margetts
et al., 2004). Common to all these conceptualizations is recog-
nition that public health nutrition policy includes a consistent
approach to a nutrition problem that can change over time; that
it includes a statement of values and intentions; and that it is
legitimized by authority of individuals, offices, or organizations.
Following the definition of the problem and the recognition
of the public health nutrition dimension, any discussion about
which policy option to adopt requires the establishment of the
breadth and strength of scientific evidence on the relationship
between micronutrient intake and health status (e.g., increased
sodium intake links with increases in blood pressure); health
status and health outcome (e.g., blood pressure links with coro-
nary heart diseases); and micronutrient intake and health out-
come (e.g., sodium intake and coronary and heart diseases).
A summary of such evidence and the resulting micronutrient
DRVs should ideally be conducted by an independent scientific
advisory body (SAB) brought together for its (inter)national
credibility and expertise relevant to the problem to be addressed.
The EURRECA Network of Excellence examined the pro-
cesses of establishing micronutrient DRVs and the present activ-
ity represents a summary of research to define this process, with
a particular emphasis upon normative aspects of the workings of
SABs. This has been done by bringing together the key findings
from the following data collection activities (see Table 1).
The focus on three micronutrients across six European coun-
tries ensured development of contrasting case studies (N =
18) in terms of historical context as well as current micronu-
trient recommendations-setting processes and nutrition policy
decision-making.
Scientific Advisory Bodies (SABs)
SABs are groups through which expert advice enters the po-
litical process. They can be established institutions, short-term
commissions, ad hoc and standing committees and informal
networks of experts. Their key role is to feed technical recom-
mendations into the policy development process (Morestin et al.,
2010; Timotijevic et al., 2011a). The type of SAB varies by its
statutory and legal role. EURRECA work has identified a diverse
institutional architecture of SABs for nutrition operating across
Europe including Scientific Advisory Committees (SACs, often
called “advisory councils”); public health institutes and research
centers; nutrition societies and individual experts (Timotijevic
et al., 2011a). Evidence suggests that SABs play a crucial role
in advising government on development and implementation
of nutrition policies in Europe: WHO have noted the possible
link between the existence of SABs and the degree to which
nutrition policies are developed and implemented (Tru¨bswasser
and Branca, 2009). Extending this work, EURRECA case stud-
ies examined the extent to which the type of SAB influences
policy options recommended and showed that the likelihood
of adopting regulatory micronutrient policies (e.g., mandatory
fortification) does not vary by the type of SAB. Nevertheless, it
upholds the findings (Tru¨bswasser and Branca, 2009) that the ex-
istence of a dedicated SAC is linked with a greater public health
nutrition orientation of policy champions and a more evolved
nutrition policy landscape—both institutionally and politically
(Timotijevic et al., 2011a, 2011b). Thus, although costly, es-
tablishing such a committee (if it is not present already) is an
important step toward transparent micronutrient DRVs.
EURRECA work suggests that, before setting up such a com-
mittee, a careful deliberation about the terms of reference is re-
quired. This will determine substantial aspects of the workings
of the SAB: the composition and purpose of the committee; the
scientific and normative aspects of decision-making both within
the committee (e.g., the criteria for assessing scientific evidence
and making conclusions) and beyond it (e.g., how to deal with
stakeholder comments). The terms of reference must be specific
enough to enable identification of appropriate expertise. Nev-
ertheless, a degree of autonomy should be granted to the SAB
to define the problem in a way that enables it to work within
the realm of the existing knowledge. This definition should be
explicit about how uncertainties and assumptions will be dealt
with (Timotijevic et al., 2013a).
SAB composition. There are many ways to identify suitable
expertise for an SAB relevant to micronutrient recommenda-
tions. Individual expertise, institutional authority, representation
of a sector, and representation of different types of knowledge
are common and often overlapping criteria for selection. In
some cases, the decision about who will be invited is made by
the standing SAC (e.g., the UK; Timotijevic et al., 2011a), while
in others, the policy maker engages in recruitment of suitable
expertise (Timotijevic et al., 2011a). Identifying the right
skills/expertise mix and the appropriate experts is a complex
process often criticized for a lack of transparency and bias (Bi-
jker et al., 2009). The selection of SAB experts should ideally
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Table 2 Composition of Scientific Advisory Bodies in Europe: fields of expertise
Fields of Expertise
Public health/ Bio/ Risk Food
Country No. of members Selection criteria Nutrition Epidemiology Medicine chemistry assessment technology
Czech Republic 8 (self-selected) Individual expertise • • •
Specific sector
Italy 4 working groups
(8–10 members each)
Individual expertise • • • • •
Institutional authority
Specific sector
Netherlands 38 Individual expertise (independent
experts)
• • • •
Nordic countries∗ 30 (selected by
governments)
Individual expertise (scientific) • • • •
Institutional authority
Poland 5 Individual expertise (experience) • • •
Institutional authority (long-term
employment)
Specific sector
Spain 3 Individual expertise •
Institutional authority
Bullets indicate the fields of expertise of the members of scientific Advisory Bodies in different European countries.
Note: ∗Denmark, Finland, Iceland, Norway, Sweden.
follow a protocol, both in terms of disciplines represented but
also in terms of what counts as “expertise” (Timotijevic et al.,
2011b). In addition, key to recruiting experts into SABs is to
ensure that conflicts of interests are dealt with appropriately.
Requirement for the expression of conflict of interest is not
only a route to transparency but also to ensuring legitimacy of
an SAB’s decision by removing the questions of decision bias.
In reality, however, expertise relevant to specific micronutrients
may be scarce and access to it may be further limited due to the
increased pressures (through research funding policies) upon
scientists to engage in “impactful” research by collaborating,
for example, with industry (Rockey and Collins, 2010).
The type of expertise (in terms of the disciplines represented
at the SAB) involved in setting micronutrient DRVs for a sin-
gle micronutrient and the type of body involved (based on its
statutory role) varies widely across Europe (Timotijevic et al.,
2011a). Based on the Europe-wide survey of the process of
setting of micronutrient recommendations conducted by EUR-
RECA partners, we can conclude that most countries mention at
least three of the following fields of expertise: nutrition, (public)
health, medicine, biochemistry, food technology, epidemiology,
food hygiene, and toxicology (Table 2). In several countries
(e.g., UK) as well as at the European level, lay or consumer
representatives are included in the SAC or the working groups.
The way in which expertise is defined and SAB are structured
determines how a problem is framed, which in turn influences
the decisions around the inclusion or exclusion of particular
perspectives and the way in which facts are selected and in-
terpreted and conclusions are drawn. The nature and source of
expertise may also be significant factors in whether scientific
advice is taken up in the policy making process. Such diversity
appears to reflect (a) the diverse “terms of reference” presented
to the SAB; (b) the extent of the public health nutrition orien-
tation within the country including the way it is institutionally
embedded (e.g., see Table 2 or 3)—that is, how central and ex-
plicit the public health nutrition agenda is to the national health
policy (Jeruszka-Bielak et al., in preparation); (c) the scientific
resources, i.e., the development of science, the range of tech-
nical expertise available; (d) the broader societal engagement
(e.g., institutions other than government and the public at large)
with the generic problem of public health nutrition; and (e) the
financial resources (Timotijevic et al., 2011a).
Table 3 Bodies responsible for public health nutrition policy in Europe
Country Body Responsible Type of Body
Czech Republic Ministry of Health, Department of Public Health, supported by the Scientific
Committee for Food - iodine
Governmental, working group for iodine
Italy Italian Society of Human Nutrition (SINU), supported by the National Research
Institute on Food and Nutrition
Nutrition society (scientific with links to
governmental bodies)
Netherlands Ministry of Health, supported by The National Health Council (TNHC) Governmental, TNHC is an independent scientific
advisory body
Nordic countries Nordic Committee of Senior Officials on Food Issues, EK-Livs., supported by the
Working Group on Diet and Nutrition (NKE)
Project group nominated by NKE
Poland Ministry of Health, supported by the National Food and Nutrition Institute, Warsaw Governmental
Spain Madrid University and Spanish Society of Community Nutrition (SENC) Nutrition society, expert group
∗Denmark, Finland, Iceland, Norway, Sweden
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Stakeholder involvement and normative decision-making.
While there are many frameworks for collating and interpret-
ing scientific evidence, the protocols for how to deal with the
normative aspects of decision-making that include issues of dis-
agreement between scientists (on matters of nature of evidence,
interpretation of evidence, and implications of the evidence for
public health and/or policy), consultations with stakeholders
on matters under discussion within SAB, and how to respond
and take on board stakeholder submissions to consultations are
scarce yet critical, as EURRECA work has shown (Timotijevic
et al., 2010b; Timotijevic et al., 2013a). Wider involvement in
decision-making of SAB is called upon by a range of EU pol-
icy documents, e.g., Science in Society Action Plan (European
Commission, 2001a, 2001b); Communication on Collection and
Use of Expertise (European Commission, 2002), as it is thought
to increase transparency and accountability, improve the qual-
ity of decisions and contribute to the democratic capital of the
decision-making body and science governance. For instance,
EFSA specifies the following steps for consultations: the draft
report is put up for public consultation for at least 60 days dur-
ing which opinions are collected (mostly in written format) and
considered. EFSA typically produces response to consultation
where it justifies the way the comments have been incorpo-
rated into the report, usually within 3 weeks from receiving the
comments.
However, we know little about how this evolves in prac-
tice even when consultations are conducted publicly and posted
online. The role of stakeholder consultations within the work-
ings of SAB is of particular relevance in the context of recent
questions about the utility and ethics of such an endeavor. For
instance, in the UK, there have been increased calls for scientific
independence from vested interests (which stakeholder consul-
tation can act to obscure; Government Office for Science, 2009).
Similarly, recent academic literature has shown that stakeholder
consultations are particularly problematic in the domain of sci-
ence where vested interests seek to influence decisions (Bijker
et al., 2009), such as the case of sodium.
EURRECA has conducted research in this domain and tried
to describe the processes of stakeholder consultations where
they are actively endorsed. Where stakeholder consultation is
explicitly permitted, it is with an aim of (a) identifying relevant
evidence to take into consideration and/or (b) as a way of get-
ting feedback on draft reports in preparation for a final report.
These consultations are usually written communique´s that invite
comments from relevant stakeholder groups. It is at the SABs
discretion as to whether to engage with these comments, thus
upholding the principle of scientific autonomy. Nevertheless,
the EURRECA examination of the two cases of stakeholder
involvement (UK SACN and EFSA) shows that it is not al-
ways made explicit how different stakeholders’ contributions
are weighed for their relevance and what mechanisms are in
place to ensure that stakeholder comments are reflected in the
decisions. There is limited information about the procedures in
place to simultaneously manage the potentially contradictory
rationale for scientific independence and stakeholder involve-
ment (Timotijevic et al., 2010b, 2011b), which places an added
pressure upon the SABs to engage in a complex maneuver-
ing of the often irreconcilable objectives of independence and
engagement.
Risk Assessment and Risk Management
The EURRECA case studies (please see Timotijevic et al.,
2013b for information about the methodology employed in the
case studies) have demonstrated that the purpose of an SAB for
Nutrition will be partly premised upon definition of the problem,
but also partly upon the regulatory context and the existing nutri-
tion policy objectives (Timotijevic et al., 2013a). Thus, much of
the activity of dietary modeling and nutrient recommendations
setting within the framework of risk analysis (or RAF; MacK-
erras, 2012). The key feature of RAF is an explicit separation
between risk assessment and risk management (as is the case
with EFSA and the UK SACN, whereby the SAB activity is of-
ten delimited as a risk assessment exercise) deemed necessary in
order to demarcate accountabilities and modes of operation be-
tween scientific and political actors. But this may not always be
possible due to, for instance, institutional characteristics of the
public health nutrition policy (the institutional contexts within
which policy is developed differ across countries, see Table 2
or 3 and Figure 20 for examples of the types of organizations
involved in the process), nor ideal as a way of achieving opti-
mal public health nutrition policy. At the institutional level, re-
searchers have shown that risk assessment is inextricably bound
with social and political context, power relations, and practices
(Bieirle, 1990; Wynne, 2003), which makes demarcation of risk
assessment and management difficult to uphold. There are calls
for greater transparency about the processes of risk assessment
(and about the instances when risk assessment is partly premised
upon political realities), however this may also have a possi-
bly unintended consequence of selective transparency, whereby
SAB members make explicit only those aspects of risk assess-
ment that are characterized by scientific consensus (Walls et al.,
2010).
Communicating Findings to Policy Decision-Makers
SABs review evidence of associations between micronutri-
ent intake, health status, and health outcome to derive micronu-
trient DRVs, and in some cases also provide recommendations
about selection and suitability of a policy option (e.g., mandating
for food fortification with a micronutrient (Dhonukshe-Rutten
et al., 2010b; Timotijevic et al., 2010b). For a policy option
based on micronutrient DRVs, evidence needs to be established
of the risks as well as benefits, e.g., risk of overconsumption.
Clear protocols for selecting, weighing, and interpreting evi-
dence are a norm across the EU and are in line with the princi-
ples of conducting scientific research (Brown et al., 2012). Such
protocols (for instance the “SACN Framework for the Evalua-
tion of Evidence” (Scientific Advisory Committee on Nutrition,
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2011) or “A Guide for Conducting Systematic Literature Re-
views for the 5th edition of the Nordic Nutrition Recommen-
dations” Nordic Council of Ministers, 2011 (NNR5 working
group, 2011)) structure the decision-making, act as guidance and
ensure transparency about the final recommendations. However,
even with the existence of such protocols, the evidence base is
complicated by several factors, including great variation in the
terminology used for micronutrient requirements and hetero-
geneity of recommended micronutrient values; variations in def-
inition of population groups and the various approaches to estab-
lishing micronutrient requirements (for more information please
see Activities 1, 3, and 4). This is certainly a challenge to both the
SAB and the policy makers and it is critical that these assump-
tions are made explicit in communicating conclusions to policy
makers. Nevertheless, there is also an intrinsic problem in com-
municating uncertainties and assumptions to policy makers par-
ticularly in the context of policy areas that often lack explicit po-
litical support and prioritization, such as public health nutrition.
The way in which the SAB conclusions are communicated
to policy makers is sometimes a significant hindrance to the
way science informs and ultimately influences policy. Scien-
tific activity is characterized not by pursuit of the ultimate truth
(or the final proof) but to the contrary, by the efforts to dis-
prove the hypotheses as falsifiability (the potential to disprove
the hypothesis) is an essential criterion of scientific method. As
such, scientific endeavor is based upon the implicit acceptance
of uncertainty. Policy, however, is often communicated through
statements of certainty and hence policy makers seek assur-
ances of certainty from scientists that would give credibility and
ensure effectiveness of the policies they mandate. There is a
general agreement that scientific and technical knowledge can
improve policy as it is understood to be committed to addressing
and communicating best available evidence to decision-makers
(Timotijevic et al., 2011b). How this evidence is to be relayed to
the policy maker, however, is a moot point. The key is to identify
a way of communicating the nature and the degree of uncertainty
that paints an appropriate picture of the state of knowledge in
the scientific community and the extent to which such knowl-
edge can be relied upon to derive optimal solutions. It is widely
accepted that communicating uncertainties is beneficial not only
from the normative point of view (since openness about the na-
ture of knowledge is a key value in our society and increases
trust), but also has an instrumental value (as it can help derive the
best policy). However, communicating uncertainty can also be a
deterrent to a policy maker who seeks assurances from science
in contexts characterized by controversies and vested interests.
SABs must therefore be aware of this conflict and reflectively
deal with those in the process of communicating DRVs and the
associated assumptions/uncertainties.
Monitoring and Evaluating: Establishing Appropriate
Methods (Activity 3)
Understanding the function, physiology, and biochemistry of
a micronutrient is essential for the accurate derivation of dietary
requirements. In the case of micronutrients with no sensitive or
specific biomarker of status, understanding the physiology and
biochemistry may provide insight with the use of -omics tech-
nologies to identify potentially novel indicators of status. The
EURRECA network has summarized the function, physiology,
and biochemistry of a set of 20 micronutrients in the Best Prac-
tice Guidelines (BPGs): Biomarkers of status/exposure (Harvey
et al., 2011). While the principal functions of the majority of mi-
cronutrients are well characterized, it should be acknowledged
that it is vital to explore the most recent data for newly identified
physiological roles as compared with previous estimations these
may seriously impact on the derivation of dietary requirements
in some or all population groups.
In practice the above translates into the identification of ro-
bust data for both dietary intake and status. These data, and their
inter-relationships, in conjunction with those for relevant health
outcomes, facilitate the determination of dietary requirements
for specific population groups (Matthys et al., 2011). Select-
ing the most robust methodology available to assess dietary
intake and status maximizes data reliability; however the choice
of technique may be influenced by the analytical environment,
e.g., studies in the field may impose practical limitations com-
pared with laboratory-based research. As a result EURRECA
has endeavored to identify current best practice for assessing
micronutrient intake and status (Fairweather-Tait and Harvey,
2008; Fairweather-Tait et al., 2009; Serra-Majem, 2009a; Serra-
Majem et al., 2009b) and has collated relevant information use-
ful for deriving individual micronutrient requirements. Ideal
methods for assessing both dietary intake and status are not al-
ways available; therefore, best practices have been developed
for identifying robust dietary assessment instruments relevant
to harmonizing the science of estimating micronutrient intake
and nutritional adequacy in Europe (Serra-Majem et al., 2009b).
In addition, computer-assisted training tools for the validation
and calibration of such dietary assessment instruments have also
been developed by the network (Busstra et al., 2010; Noroozi
et al., 2012) and demonstration material is available on the
EURRECA website (www.eurreca.org/everyone/8321/7/0/32
and www.eurreca.org/Courses/demo/index.html). Regarding
biomarkers, the EURRECA network provided a platform on
which the use of -omics techniques to identify novel data related
to inter-individual variability could facilitate the future identi-
fication and development of new biomarkers of micronutrient
status (van Ommen et al., 2008).
Assessment of Dietary Micronutrient Intake
Establishing accurate dietary micronutrient intakes to al-
low valid comparison between population groups and evaluate
changes in nutrient intake over time requires the use of rigorous
methodology, which may be micronutrient specific. A summary
of the main problems and issues associated with dietary as-
sessment is reported in Matthys et al. (2011). EURRECA has
established best practice for dietary assessment of the European
population through undertaking a series of systematic reviews
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(Serra-Majem, 2009b; Serra-Majem et al., 2009b). The reviews
covered a range of topics related to micronutrient intake focus-
ing on specific population groups outlined in Activity 1, where
intake assessment is acknowledged to be particularly challeng-
ing, and highlighted the potential use of new methodologies
to increase accuracy. Reviews were undertaken to establish the
best and most commonly used methods for assessing nutrient
adequacy, including the consideration of dietary patterns in the
context of European populations. Evaluation of the strength of
various methodologies was undertaken by appraising the mag-
nitude and origin of measurement errors. Specific aspects of
research undertaken by the EURRECA network are considered
in more detail in the following sections.
Diversity in dietary assessment methods. The choice of di-
etary assessment methodology will depend on various factors
including study design and the associated practicalities of con-
ducting the research, along with the explicit aims of the study
being undertaken. No method is free from random or systematic
errors, or prevents subjects changing their food habits. Specific
factors that need to be considered when choosing a method are
the characteristics of the subjects within the study population,
e.g., life-stage, or immigrants and low income groups, the re-
spondent burden of the method, and the available resources.
Some methods may be unsuitable for elderly subjects with poor
memory, busy adults with young children, or those individu-
als with poor reading skills. Other methods require specialized
equipment and computer facilities or highly trained personnel.
The most accurate methods are generally the most costly with
greatest respondent burden and ultimately lower response rates
(Gibson, 2005). For nutrition surveillance studies, for example,
the standard is to use replicates of 24-hour recalls whereas for
proof of principle studies on the relation between dietary intake
and health outcomes food frequency questionnaires (FFQ)-like
methods are the standard. The latter have, though, very different
measurement characteristics that prohibit direct comparability
and necessitate validation and calibration approaches when ap-
propriate.
In a study undertaken by the EURRECA network, the risk
of dietary inadequacy was found to be dependent on a com-
bination of the dietary assessment methodology employed and
the micronutrient being assessed (Ribas-Barba et al., 2009).
More specifically, it was evaluated how applying different di-
etary methods affects risk assessment of inadequate intakes at
the population level and it was revealed that the prevalence of
inadequate intake decreased in conjunction with the method
utilized in the following order: single 24-hour, mean of two
24-hour recalls, FFQ and usual intake based on 24-hour recall
duplicates adjusted for within subject variation. For example,
the effect of utilizing two nonconsecutive 24-hour recalls when
compared with a single 24-hour recall showed a slight decrease
in the prevalence of inadequate intakes for the majority of nutri-
ents. In the majority of cases, but not all, methods that measured
usual intakes, i.e., retrospective food pattern methods such as
FFQs or diet histories, identified lower values of inadequacy
than those obtained by quantitative daily consumption methods
including 24-hour recalls. The study also assessed the impact of
underreporting on the levels of dietary inadequacy (Ribas-Barba
et al., 2009). As expected, the exclusion of underreporters led
to a decrease in the prevalence of dietary inadequacy; however
this has again been shown to be micronutrient and methodology
dependent.
Assessment of food intake is challenging and prone to re-
porting error, especially among infants, children, and adoles-
cents. A review conducted by the EURRECA network attempted
to assess whether FFQs are suitable for the evaluation of mi-
cronutrient intake adequacy in infants, children, and adolescents
(Roman-Vinas et al., 2010). For several micronutrients, the re-
sults of the review highlighted a lack of sufficient data to assess
the usefulness of FFQs to provide robust estimates of intake.
In addition, it was noteworthy that very few potentially rele-
vant validation studies in children incorporated the use of status
biomarkers, which for some micronutrients may provide a surro-
gate measure of intake. Consequently, the review identified the
requirement to undertake further research to address specific
concerns related to FFQ validation in infants, pre-schoolers,
children, and adolescents, particularly with regard to irregular
patterns of intake (small portions, snacking) that is prevalent in
these population groups.
While dietary assessment of populations frequently attempts
to obtain reliable information on supplement use, establishing
accurate intakes is generally difficult. A true picture of intake can
only be ascertained if regard is paid to supplement consumption
patterns, the numbers of nonconsumers, those with sporadic
consumption in times of illness and those who take supplements
on a regular basis (Ribas-Barba et al., 2009).
Quality scoring of dietary intake data. Evaluating the qual-
ity of dietary micronutrient intake assessment is vital to en-
sure the validity of data that may be used in the process of
establishing DRVs. Following EURRECA’s in depth review of
all available dietary assessment validation studies, which ana-
lyzed the utility of a range of dietary micronutrient intake ques-
tionnaires (Henriquez-Sanchez et al., 2009; Ortiz-Andrellucchi
et al., 2009a, 2009b, 2009c; Øverby et al., 2009; Serra-Majem
et al., 2009c), it was concluded that a scoring system was re-
quired to facilitate straightforward evaluation of the reliability
of FFQ data (Serra-Majem et al., 2009a).
A scoring system was developed as a three step process;
step 1 considered variables such as sample population and size,
statistics (group level, correlations, agreement), type of data col-
lection, seasonality, and supplements. Scores ranged from 0 to
7, and validation studies were classified as very good (≥5), good
(5–3.5), acceptable/reasonable (3.5–2.5), and poor (<2.5). The
second and third steps included an adjustment/weighting of the
correlation coefficient according to the quality score in addition
to a rating of the adjusted/weighted correlation. The 124 vali-
dation studies assessed, which reported data from at least one
vitamin were also categorized into three groups dependent on
the reference method or gold standard applied in each case. The
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overall results highlighted that only 5.6% of the studies were
rated as very good quality whereas 16.9% had a poor rating. De-
spite the fact that the model weighs for several methodological
variables, the reference methods can also contain some bias and
therefore the authors cannot rule out remnant bias in the final
model. However, this evaluation tool could be used as guidance
for studies validating dietary intake questionnaires or to assist
researchers select and weigh the results of existing epidemio-
logical studies; in both cases, its use can ultimately contribute to
increasing the quality of evidence in nutrition research (Serra-
Majem et al., 2009a).
Use of a whole-diet approach (using dietary patterns). It
is increasingly recognized that as foods and nutrients are not
consumed in isolation, the combination of possible antago-
nistic and synergistic effects between dietary components is
likely to have a significant impact on health. The likelihood
that overall dietary patterns potentially have a greater effect on
health than any single food or nutrient (Jacques and Tucker,
2001) probably explains the pathogenesis of many chronic,
nutrition-related diseases and in addition the health benefits
derived from diet. Consequently, there has been a gradual shift
away from assessment of single nutrients and foods toward the
evaluation of whole diets and dietary patterns, particularly in
relation to nutrition and health (Hu, 2002; Kant, 2004). As-
sessment of dietary patterns can provide valuable data on dis-
ease prediction and may facilitate investigations on interactions
between intake and other health behaviors, or diet and other
confounders of exposure-disease relationships. Dietary pattern
analysis is also useful in the monitoring and surveillance of pop-
ulations with regard to dietary trends and compliance with food-
based dietary recommendations, and consequently is highly
relevant to policy aspects of DRV setting discussed further in
Activity 8.
The various methods used to characterize dietary patterns
within a population generally fall into two categories. The first
category involves a priori evaluation (hypothesis-oriented) using
score-based approaches, while the second relies on a posteriori
analysis using data-driven dimension reduction techniques, such
as principal components analysis (empirically driven) (Dixon
et al., 2001; Hu, 2002; Kant, 2004; Newby and Tucker, 2004;
Michels and Schulze, 2005; Sa´nchez-Villegas and Serra-Majem,
2005; Roman-Vinas et al., 2009). While rare, some studies have
combined both types of approach (Wright et al., 2004). However,
there is generally little consensus on which approach to employ
in various circumstances. Consequently, the EURRECA net-
work addressed this issue in relation to pregnancy and maternal
and infant health outcomes. A systematic review was under-
taken in this population group to review the literature exploring
associations between dietary patterns obtained from FFQs and
relevant health outcomes (Sa´nchez-Villegas et al., 2010). Of
the seven relevant studies identified, only four employed ques-
tionnaires specifically validated for use in pregnant women and
the use of differing analytical techniques made data compari-
son difficult. However, the review concluded that while using
appropriately validated FFQs was essential, specific considera-
tion should also be given to mineral and vitamin supplements
and the timing of data collection in this population group. In
addition, results should be adjusted for lifestyle and educational
characteristics, and any a priori evaluation requires appropriate
selection of scoring components.
Data selection. As a result of the culmination of a series of
reviews and activities undertaken by the EURRECA network
(described above) with respect to the assessment of dietary mi-
cronutrient intake in the European population, consensus was
reached and BPGs (Claessens et al., 2013) were developed to
enable identification of the most robust intake data that would be
relevant for the derivation of DRVs (Garcia-Alvarez et al., 2009).
Specifically, a decision tree was developed, which facilitated the
screening and selection of appropriate studies for inclusion in the
meta-analysis of intake–status–health relationships for a series
of priority micronutrients. The aforementioned EURRECA sys-
tematic reviews were comprehensive in nature and only included
studies of the utmost quality. While development of the tool was
originally for a specific requirement, it may also be used generi-
cally in the evaluation of intake data from a range of studies and
for a variety of purposes. The original tool that was developed
consisted of a 20 question scoring system, and while rigorous
and robust, it proved unwieldy to utilize in the evaluation of sig-
nificant numbers of studies. As a consequence, a honed version
of the scoring tool was developed in the form of an abbreviated
decision tree (version 1), which was subsequently further refined
into a less restrictive tool (version 2; Fig. 4). In the final ver-
sion, each study is taken through a series of seven questions that
allow the user to evaluate the robustness of dietary intake data
enabling the identification of data of the required standard (data
to “include”), which may ultimately be used in the derivation of
DRVs.
In addition, one of the key achievements of EURRECA
in relation to dietary intake assessment was the development
of a best practice guide for the identification of quality sur-
veys for nutrient intake adequacy assessment in populations on
a country-by-country basis. A step-by-step set of guidelines,
which summarized the process developed to select the “best”
or the “highest quality” dietary survey/study in each country is
shown in Fig. 5 (Garcia-Alvarez et al., 2009). These guidelines
were developed to increase comparability of the dietary data
obtained. The methodology is a two-step process, with the first
phase consisting of the identification of the most appropriate
survey in each country. It was determined that ideally, selected
surveys should focus on nutrition, however in their absence the
second choice should be health surveys including nutritional
data, or lastly household budget surveys with nutritional data.
Briefly, the best practice criteria for identifying surveys in this
initial phase were as follows:
• Data should be collected through the use of a standardized
instrument.
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Diet record or 24h recall 
based on at least 3d (not 
necessarily consecuve)?
INCLUDE
Was an FFQ used?
Was intake of 
supplements recorded? 
(unless intenonally 
excluded in study design)
Was the FFQ validated?
EXCLUDE
NO
NO
NO
NO
NO
YES
YES
YES
YES
EXCLUDE
Was intake of 
supplements recorded? 
(unless intenonally 
excluded in study design)
NO
YES
Figure 4 Abbreviated EURRECA decision tree for evaluation of robust dietary intake data suitable for epidemiological studies to assess associations between
dietary intake and health outcomes.
• Only one survey/study per country can be considered.
• Surveys/studies of cross-sectional nature.
• The most representative survey/study of the country’s popu-
lation (to maximize external validity)—ideally at the national
level (otherwise regional or, lastly, local levels).
• The most recent surveys/studies (only include those con-
ducted after 1990).
• Surveys/studies with the best methodology in accordance with
their objectives (to maximize internal validity).
Following identification of appropriate surveys, it was estab-
lished that a quality scoring system should be applied in the sec-
ond stage of the evaluation process. The six variables considered
in the quality analysis stage, in priority order, are dietary assess-
ment methods, validation, food composition databases, underre-
porting, other factors including anthropometric measurements,
physical activity, etc., and finally the year the survey was con-
ducted.
In order to test the validity of the BPGs on Nutrient Intake
Assessment, following requests from the EURRECA network,
29 out of 32 countries (28 European and 4 European Free Trade
Association countries) responded to questionnaires requesting
information on national surveys, which ultimately resulted in
suitable data being identified from a total of 24 studies/surveys
of the adult population (Blanquer et al., 2009). The resulting
analysis of the data established that the BPGs form an appro-
priate strategy, which can be adopted for the identification of
the best cross-sectional dietary intake data available (Garcia-
Alvarez et al., 2009).
Assessment of Micronutrient Status
Examples of types of status biomarkers include plasma con-
centration, size of body pools, enzyme levels and activities,
urinary excretion, and a range of other biochemical and/or func-
tional indicators, which have varying degrees of specificity and
sensitivity. However, a more integrated approach to the assess-
ment of micronutrient status would ultimately involve measure-
ment of multiple biomarkers that are key components central
to the maintenance of health, metabolic, oxidative, inflamma-
tion, and psychological processes. These intermediary markers
of metabolism could therefore be considered as surrogate mark-
ers of nutritional status. Novel analytical methods, including
nutrigenomics, metabolomics, and proteomics, have been ap-
plied by the EURRECA network to assess these markers (van
Ommen et al., 2009; Bouwman et al., 2012). An example of a
metabolomics approach to assess micronutrient related health
status is described in the micronutrient-specific sections on se-
lenium (Hurst et al., 2013). There is a well-established need
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&
&
               Select only one survey/study per country with the following characteristics: 
“Ideally” select surveys/studies that are: 
                                                If not available, select                              If not available, select 
              By population group
&
 Cross-sectional design 
 Most representative of the country’s population (external validity) 
 Most recent (of those conducted after 1990) 
 With the best methodology (internal validity) 
From the pool of dietary surveys/studies obtained through country experts (questionnaire only): 
First. Regional 
Second. Local 
First. Health with nutritional data 
Second. HBS with nutritional data 
Nutritional National 
Toddlers Infants Children Adolescents Adults (18-65 years) Elderly
Exclude other 
combinations 
Variables considered in the quality analysis (in priority order) 
• Diet assessment methods: Instruments (methods combinations), data collection techniques (three to four options), adequacy assessment (yes/no, methods 
combinations). 
• Validation (yes/no) 
• FCDB including functional & fortified (yes/no). 
• Under-reporting excluded/considered (yes/no). 
• Others: - supplements included (yes/no), functional & fortified included (yes/no), physical activity assessment (yes/no, three assessment methods), 
anthropometric measurements (yes/no, weight/height, measured/self-reported). 
• Year: 1990 – 1999, 2000 – 2004, 2005 & over. 
Figure 5 Summary Best Practice Guidelines on Nutrient Intake Assessment for selecting the best available nutritional intake survey/study per country. More
details on the methods and tools can be found under section “Assessment of dietary micronutrient intake” in the current manuscript. Abbreviations: Household
budget Survey (HBS), Food composition database (FCDB); figure adapted from Garcı´a-Alvarez et al., 2009.
to develop improved biomarkers of status for many micronu-
trients, and the EURRECA network embraced network biology
and nutrigenomic technologies in an attempt to progress the de-
velopment of novel approaches that will ultimately facilitate the
derivation of more accurate and specific dietary requirements
and recommendations.
The EURRECA network undertook a rigorous process with
the aim of identifying and evaluating biomarkers of micronutri-
ent status, which culminated in the production of a set of BPGs
of micronutrient status (Harvey et al., 2011). The BPGs were
initially conceived by the Biomarkers of Status Working Party,
which comprised a group of international micronutrient experts
and EURRECA partners who met in Norwich, UK in early 2008.
Publication of the workshop proceedings (Fairweather-Tait and
Harvey, 2008) included articles on several micronutrients where
the authors critically reviewed traditional biomarkers employed
in surveys, and the development of a network biology model
of micronutrient related health, which may be utilized in future
dietary guidelines. In addition the working party also produced
a table of Biomarkers of Status and Exposure: minerals and vita-
mins, which consisted of a nonexhaustive list of micronutrients
for which DRVs have been produced. The table included a brief
description of biomarkers of status and/or exposure for each
micronutrient, accompanied by a rating of the methodological
limitations and its application in research (suitable for research
only and/or for fieldwork). A star rating (3∗ = excellent) was
used to classify the biomarkers, and a summary of available 3∗
indicators for selected micronutrients is available (Matthys et al.,
2011). As the original remit was to assess biomarkers relevant
for use in epidemiological studies, the EURRECA network has
generally focused on the use of biochemical markers that can be
obtained from blood or urine, rather than functional (e.g., im-
mune function, cognitive function) and nonspecific tests (e.g.,
grip strength). The table was subsequently updated to include
data obtained from a series of systematic reviews undertaken by
the EURRECA network, which focused on a selection of mi-
cronutrients with either public health significance, or a strong
scientific requirement to establish the validity of status biomark-
ers (Biomarkers of Status Working Party, 2011; see evidence-
based assessment of potential biomarkers).
Finally, at the end of the review process, the BPGs were
produced for a nonexhaustive list of micronutrients for which
DRVs had been produced, and included data from the EUR-
RECA systematic reviews along with the expert opinions of the
working party (Harvey et al., 2011). The BPGs provide a basic
introduction to various aspects of intake, function, metabolism,
etc., along with details of relevant biomarkers of status or/and
exposure for each micronutrient.
Evidence-based assessment of potential biomarkers of mi-
cronutrient status. Understanding the relationship between mi-
cronutrient status and health can only be achieved by using
robust biomarkers of status. In order to establish the validity of
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status biomarkers and identify the circumstances in which they
may be relied on in terms of population groups, deficient, or
replete states, etc., the EURRECA Network undertook a series
of systematic reviews, focusing on a selection of micronutrients
with either public health significance, or a strong scientific re-
quirement. Systematic reviews of biomarkers of status were con-
ducted for vitamin B12, zinc, iodine, copper, riboflavin, magne-
sium, vitamin D, polyphenols, n-3 long chain polyunsaturated
fatty acids, and selenium (Fairweather-Tait et al., 2009; Pe´rez-
Jime´nez et al., 2010; Witkowski et al., 2011). A common review
methodology was developed on the basis of identifying studies
that altered micronutrient status, with a subsequent pooling of
the data for each specific biomarker (Hooper et al., 2009). In-
clusion criteria were tailored for each micronutrient depending
on the quantity and quality of available data. If sufficient data
were available included studies were restricted to randomized
controlled trials (RCTs), but where there was a paucity of data
both before–after and nonrandomized controlled trials were also
included. Inclusion criteria also took into account the form of
supplement used in the study and the minimum duration of in-
tervention (supplementation or depletion) required to elicit a
response in the biomarker following a change in status. The
highest dose and longest duration intervention data were se-
lected to statistically analyze biomarker validity. Studies were
subgrouped by population, dose, duration, sex, supplement type,
and analytic method as appropriate in order to assess the con-
sistency of response for each biomarker.
Use of this methodology highlighted specific micronutri-
ents where a plethora of data allowed evaluation using data al-
most solely obtained from RCTs, e.g., vitamin D (Seamans and
Cashman, 2009), and others where there was a lack of suitable
RCT studies, and consequently evaluation had to be undertaken
using lower quality data, e.g., copper (Harvey et al., 2009). In
addition to demonstrating the usefulness of systematic review
methodology to validate the use of biomarkers of status for a
range of micronutrients, it has also highlighted the need for
further research to identify and evaluate novel biomarkers of
micronutrient status.
Biomarkers for micronutrient related physiological pro-
cesses. To date, significant emphasis has been placed on re-
searching the biological activity of single micronutrients, or
interactions between limited combinations of micronutrients.
However, with the development of a systems biology approach,
the potential to study the multiple processes that collectively
underpin molecular, cellular and whole body physiology may
enable an integrated perspective to be taken with regard to
the impact of metabolic effects on health (van Ommen et al.,
2008). The EURRECA network undertook research to establish
novel approaches that may be applied to the assessment of mi-
cronutrient status in relation to health. Apart from established
biomarkers micronutrient status may also be assessed by mea-
suring health status biomarkers reflecting processes that require
sufficient micronutrient availability. Therefore, information on
the effects of micronutrient intake and/or status on selected
biomarkers related to the overarching metabolic, inflammation
and oxidative processes, was extracted from studies that were
included based on the criteria described above (see evidence-
based assessment of potential biomarkers). This information
was captured by the EURRECA network in collaboration with
the European Nutrigenomics Organisation (ENO) on the respec-
tive micronutrient pages of the ‘NuGOwiki’ (European Nu-
trigenomics Organisation, 2012, www.nugowiki.org), an open
source ENO database where anyone can edit/add information
in a typical wiki manner (mediawiki) (Claessens et al., 2013).
To fully appraise the impact of micronutrients on health, a more
holistic view of the biological effects of multiple micronutrients
is needed, including building micronutrient-centered biological
networks (van Ommen et al., 2009) and developing suitable sta-
tistical methods for assessing individual micronutrient-health
effects (Activity 6: “health space” model) (Bouwman et al.,
2012).
Evidence of the direct or indirect effects of individual
micronutrients on selected biomarkers for key physiologi-
cal processes (immune, oxidative, and metabolic processes)
is captured on the micronutrient pages of the NuGOwiki
(www.nugowiki.org/). Micronutrient-centered biological net-
works prepared from extensive literature mining for sele-
nium, vitamin B12, and folate, are also publicly available
(www.wikipathways.org). For the purpose of deriving micronu-
trient requirements, where there are known interactions, it may
be useful to investigate and define the complex micronutrient
biology network based on micronutrient markers, markers of
target function and biological response, micronutrient-related
health status metabolites, and micronutrient-related disease pa-
rameters.
As an example of this EURRECA approach, informa-
tion collated from human studies that met the above-
mentioned selection criteria (NuGOwiki micronutrient portal,
http://www.nugowiki.org/) was used to construct micronutri-
ent biology network models. As an example, the mathematical
model for the multiple micronutrient dependency of the inflam-
matory process can be found in supplemental Figure 1.
Deriving Dietary Reference Values: Collating Sources of
Evidence (Activity 4)
There is significant disparity in the evidence base for
micronutrient recommendations between population groups
(Dhonukshe-Rutten et al., 2010a). Figure 6 conceptualizes ARs
for micronutrients as a function of age (population group and
age across the life cycle), and highlights the widely different
types of evidence and research approaches that underlie these
data. RCTs and epidemiological studies provide evidence for
the adult population group on optimal nutrition in relation
to specific health outcomes and endpoints; while factorial
approaches, combined with estimates of bioavailability, are
generally used during periods of growth and development.
In order to derive reliable recommendations, the most robust
data need to be identified and integrated, while accounting for
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Factorial 
approach
Dose response based on 
RCTs and epidemiological studies or 
factorial approach
Factorial approach
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Pregnancy & lactation
Birth
Infants Children and adolescents Adults, postmenopausal women
Older people
Fetal growth
Shape of curve : 
scaling issue 
(“extrapolation”)
Factorial 
approach
Figure 6 Conceptual representation of average requirements (ARs) for micronutrients as a function of age (population groups and across the life cycle). The
figure highlights the widely different research approaches and scaling methods that underlie the derivation of ARs. This illustrates the need of standardization of
methods and weighing the different types of evidence.
exercise and body composition and size (scaling). As illustrated
by this figure, identifying and collating relevant data for the
derivation of dietary recommendations should ideally be under-
taken using a clearly defined systematic approach that accounts
for the micronutrient, the population group, and the health
outcome/endpoint under assessment (Matthys et al., 2011).
As outlined above (and in Activity 2), nutrient recommen-
dation setting bodies are compelled to use a variety of sources
of evidence to derive dietary micronutrient requirements. The
availability of data from different types of study with various
methodological principles and designs will influence whether
the “factorial” or “dose–response” approach is adopted in the
derivation process (Table 4). The factorial approach principally
depends on physiological data related to micronutrient losses
in balance with absorption. This approach relies on measure-
ments of a variety of factors including requirements for growth,
Table 4 Approaches and study types used to derive micronutrient requirements (adapted from Matthys et al., 2011)
Approach∗ Outcome Measures Study type Principle of method Study design
Applicable population
group
FACTORIAL Physical or metabolic
outcome
Metabolic balance
studies at various
intake levels
Long-term intake = Long-term losses
Requirement: intake level at which
balance (stable body pool, rate of
absorption and excretion) cannot be
maintained.
Cross-sectional
and prospective
All age groups
Growth studies,
biochemical studies
Rate of accumulation of nutrients in the
body (fetus, placenta, etc.), breast
milk composition and volume
Cross-sectional
and prospective
Fetus, infants, pregnant,
and lactating women
DOSE-RESPONSE Health outcome Depletion/repletion
studies
Symptoms occur in response to dietary
insufficiency and alleviate with
sufficiency
RCT Young adults
Biochemical/biological
studies
Identification of subclinical deficiencies
or reduction/lack of function in
relation to specific micronutrient
RCT and
cross-sectional
All age groups
Epidemiological studies Identification of (chronic) diseases
(functional outcomes)
Observational,
interventional
Adults, elderly
Note: ∗The factorial approach relies on measurements of a variety of factors including requirements for growth, pregnancy and lactation, and faecal and urinary
losses that determine requirements to maintain plasma levels or body stores resulting in normal tissue and body function and prevention of adverse health effects
(reference values derived by this approach also rely on the application of a bioavailability factor) to convert the physiological requirement into a dietary intake
value.
The dose–response approach is based on the prediction of a physiologically relevant outcome that could be the measurement of an accepted micronutrient status
biomarker in response to dietary intake, or the assessment of clinical disease endpoints in relation to intake or status.
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pregnancy and lactation, and faecal and urinary losses that de-
termine requirements to maintain plasma levels or body stores
resulting in normal tissue and body function and prevention
of adverse health effects. Reference values derived by this ap-
proach also rely on the application of a bioavailability factor
(Fairweather-Tait and Collings, 2010) to convert the physiolog-
ical requirement into a dietary intake value. The dose–response
approach is based on the prediction of a physiologically rele-
vant outcome, which could be the measurement of an accepted
micronutrient status biomarker in response to dietary intake, or
the assessment of clinical disease endpoints in relation to in-
take or status. Therefore, there is a range of study designs that
may generate pertinent data including intervention trials on mi-
cronutrient exposure up to cohort (nested case control) studies
on micronutrient intake or status as related to intermediate or
late health endpoints. The selection of relevant combinations
of micronutrients, population groups, and health endpoints was
discussed previously (see Activity 3).
Systematic Data Selection
As illustrated by Fig. 6, identifying and collating relevant
data for the derivation of dietary recommendations should ide-
ally be undertaken using a clearly defined systematic approach
that accounts for the micronutrient, population group, and health
outcome/endpoint under assessment (Matthys et al., 2011). Fol-
lowing adoption of best practice for intake, status and health
outcome measures (see Activity 3). EURRECA undertook a
series of systematic reviews with the primary aim of identi-
fying robust data for all age and life-stage population groups,
useful for the derivation of dietary recommendations for the
prioritized micronutrients (vitamin B12, iron, zinc, folate, io-
dine; Cavelaars et al., 2010). Standardized systematic review
protocols and search strategies were developed within EUR-
RECA to facilitate collation of data in three key areas, namely,
intake–status–health (association) relationships, micronutrient
absorption (bioavailability), and factorial estimates. While the
rigorous systematic review process ensured comprehensive data
retrieval, each protocol and search strategy was specifically tai-
lored to explicit research questions and issues associated with
individual micronutrients. Meta-analyses of collated data were
conducted to summarize the relevant estimates (Activity 6).
The standardized systematic review process designed and
adopted by the EURRECA network is summarized in Fig. 7
with further details reported elsewhere (Matthys et al., 2011).
Briefly, the process initially involved conducting multi-database
searches (Medline, Embase (both on OvidSP), and the Cochrane
Library CENTRAL database), each including micronutrient-
specific terms and limited to “humans.” Potentially relevant
studies were identified by searching from database inception,
and resulting reference lists were screened and sorted on
the basis of titles and abstracts. References evidently not
meeting the purposes of the review, e.g., animal studies, were
excluded at this stage. In order to ensure consistency between
reviewers, and to ensure adherence to the inclusion/exclusion
criteria, duplicate screening of a minimum of 10% of titles and
abstracts was conducted independently by two researchers and
differences of opinion resolved through discussion. Full texts
of potentially relevant articles were collected and assessed ac-
cording to the predefined inclusion/exclusion criteria. Abstracts
for which the full article was unavailable were not included,
and articles were considered in a range of languages spoken by
network partners including English, Dutch, French, German,
Hungarian, Italian, Norwegian, Polish, Spanish, Greek, and
Serbian. Again, a minimum of 10% of full texts was indepen-
dently assessed by two reviewers. Reference lists of retrieved
articles and specifically reviews on the same topic were also
checked for relevant studies not identified in the initial search. If
appropriate, experts were also contacted to obtain suggestions
for additional articles that may have provided pertinent data for
the review. Data were extracted into a standardized database,
including bibliographic and methodological information, pop-
ulation characteristics, study group details, and outcome data.
Internal validity indicators specific to the study methodology
were identified, and relevant information collected during data
extraction in order to facilitate subsequent assessment of the
quality of included studies and the risk of bias. Specific details
of the search methodologies and data selection used for various
EURRECA systematic reviews (dose–response and factorial
approach) are described in the following sections.
Building Blocks for Deriving DRVs
Factorial approach and bioavailability. In order to identify
data that may be pertinent for deriving recommendations using
the factorial approach, the EURRECA network undertook a se-
ries of systematic searches with associated data extraction based
on common methodology described above (refer to Systematic
data collection). The overall aim of this activity was to iden-
tify and collate relevant studies and associated data relating to
micronutrient homeostasis, i.e., the balance between losses and
maintenance of body pools. Collation included identifying and
summarizing the evidence for the micronutrient concentration
of breast milk, isotope turnover studies used to assess changes
in body pools, and measurements of menstrual blood loss. A
tailored search strategy was developed for each micronutrient
which, to enable identification of relevant studies across all age
ranges, was not limited to specific population groups. However,
specific search terms relevant to age and physiological stages
in relation to micronutrient requirements were included to al-
low for consideration to be given to issues such as growth and
development, including the formation of new tissues in preg-
nancy and fetal development. Full details of the methodology
can be found elsewhere (Hermoso and Vollhardt, 2010). Data
were identified for five prioritized micronutrients, namely, iron,
zinc, folate, vitamin B12, and iodine, and databases containing
all extracted data can be accessed on the EURRECA website
(Hermoso, 2010a) along with Endnote libraries of the results of
the searches (Collings, 2010; Hermoso, 2010b; Claessens et al.,
2013). Micronutrient-specific results of the systematic reviews
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MASTER library 
(all search results)
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duplicate 
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Conduct database searches 
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Screen search
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Collection of papers and
assessment on the basis of 
full-text,  
Data extraction of final
included papers 
Meta-analysis and modeling
of data 
Full-text in/out assessment Min. 10%
duplication 
Final library of included papers
Data extraction
Meta-analysis & modeling 
Min. 10%
duplication 
Figure 7 Generalized systematic review process for identification of data relevant to the derivation of dietary recommendations.
can be found elsewhere in this issue (Cashman and Kiely, 2013;
Harvey et al., 2013; Hoey et al., 2013; Hurst et al., 2013; Lowe
et al., 2013; Ristic-Medic et al., 2013). The quantitative method-
ology underlying these reviews is explained and illustrated in
Activities 5, 6, and 7.
In many cases the factorial approach cannot be used to ac-
curately derive micronutrient reference values without the ap-
plication of a bioavailability factor to convert the physiolog-
ical requirement into a dietary intake value (Fairweather-Tait
and Collings, 2010). Figure 8 shows the basic equation that
can be employed for the calculation of dietary requirements
based on the sum of losses and requirements for growth and
development adjusted by the appropriate bioavailability factor.
Bioavailability is a function of both food (luminal events relat-
ing to the composition of foods consumed at any one time) and
the individual (host) (systemic factors relating to physiological
need and homeostatic factors) and therefore there is no single
bioavailability figure that can be assigned to a single food source
of a micronutrient. Consequently, host-diet interactions play a
significant role in determining the amount of dietary micronu-
trient available to enter body pools. In order to assess the state-
of-the-art with respect to micronutrient bioavailability issues,
EURRECA held an expert workshop jointly hosted with the
ILSI Europe Additions of Nutrients to Food Task Force to dis-
cuss the priorities and challenges of setting DRVs (Fairweather-
Tait et al., 2010). In addition to a program of presentations
focusing on micronutrient-specific aspects of bioavailability, a
series of breakout sessions challenged the attendees to consider
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Sum of losses (faeces, urine, skin, menses etc) +
Growth & development requirements  
(foetus, pregnancy, lactation etc.)
Dietary Requirements =     
Bioavailability factor 
Figure 8 Basic equation for the calculation of dietary requirements based on the sum of losses and requirements for growth and development adjusted by a
bioavailability factor.
a range of topical bioavailability issues and how they may be ad-
dressed. An overarching workshop conclusion highlighted the
current lack of micronutrient bioavailability data and the asso-
ciated need for further research.
Subsequently, in order to attempt to identify robust data that
may be used in the calculation of bioavailability factors, EUR-
RECA undertook a series of systematic reviews to quantify and
assess the efficiency of micronutrient absorption from whole
diets/meals. The specific aim was to analyze and quantify the
impact of various dietary enhancers, inhibitors, and host-related
factors (e.g., genotype) on micronutrient absorption. The ulti-
mate goal was to provide an evidence base from which bioavail-
ability figures can be derived for setting DRVs/intakes. Using a
similar systematic review methodology to that described above,
specifically designed search strategies were tailored for each
micronutrient followed by screening and data extraction. De-
tails on the results of the systematic reviews and meta-analysis
can be found elsewhere in this issue (Cashman and Kiely, 2013;
Harvey et al., 2013; Hoey et al., 2013; Hurst et al., 2013; Lowe
et al., 2013; Ristic-Medic et al., 2013). Further details on the
methodological approach to summarizing and interpreting the
data, and integrating the evidence can be found in Activities 5
and 6, respectively.
Dose–response approach. Deriving dietary recommenda-
tions using the dose–response approach involves assessing the
dose–response relationships between at least two of the follow-
ing three components: dietary micronutrient intake (I), micronu-
trient body status (S), and health (H) outcomes. The three rela-
tionships of specific relevance are represented in the schematic
diagram in Fig. 9 and include:
• The effect of intake on functional or clinical outcomes (I–H).
• The effect of intake on indicators of exposure or body stores
(biomarkers) (I–S).
• The effect of exposure or body stores (biomarkers) on indica-
tors of functional or clinical outcomes (S–H).
Potential confounders and effect modifiers for the relation-
ships between intake–status, status–health, and intake–health
may include age, sex, country of study, ethnicity, social
class/living conditions/income, smoking, physical activity, body
mass index, total energy intake, intake of other macro and mi-
cronutrients, acute illness and inflammation, life-stage (preg-
nancy, lactation, menopausal stage), exposure and outcome
at baseline and genotype. Consequently, careful consideration
needs to be given to the inclusion/exclusion criteria to ensure
that data from each included study are appropriate for analysis.
EURRECA adopted the standardized systematic review ap-
proach outlined earlier (Hooper et al., 2009; Activity 3) to
identify and collate data that were potentially useful for the
dose–response approach. The review for each micronutrient was
guided by a protocol that was specifically prepared for each
micronutrient. The protocol outlined the eligibility criteria for
studies and data that were suitable for inclusion in the review
process. Briefly, these criteria included:
• Population groups: infants, children and adolescents, adults,
pregnant and lactating women, and elderly.
• Only intervention and observational studies (except for intake-
status studies where cross-sectional data were also consid-
ered).
• Dietary intake data (if assessed using the standards approved
in the BPGs for intake (Activity 3)).
• Status data (if the biomarkers of status used for the assessment
were identified in the BPGs for status (Activity 3)).
The study selection was a stepwise process. Following the
search, the initial step was the screening and sorting on ba-
sis of title and abstract (minimum 10% duplicate screening by
Figure 9 Schematic representation of the relationships of interest for the
derivation of dietary reference values using the “dose–response approach.”
Study types that may provide data to characterize potential I–S–H associ-
ations are suggested for each possible relationship. (Color figure available
online.)
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independent reviewer), followed by sorting by relationship
(intake– status, status–health, intake–health, and intake–status–
health) and population groups (adults and elderly and infants,
children, adolescent, pregnant and lactating women). Following
full text assessment of all potentially relevant papers (mini-
mum 10% duplicate review by independent assessor), key data
were extracted and entered into an Access (Microsoft) database
(Claessens et al., 2013). Variables of interest included intake,
status, and health outcomes and measures of the relationship;
other relevant extracted data included information on study de-
sign, confounders, population size, study duration, and methods
of intake and status measurement. In addition, a set of indica-
tors of internal validity specific to the type of study, e.g., RCT
was collected in order to assess the quality of the study and the
risk of bias. This included method of sequence generation and
allocation, blinding, potential funding bias, number of partici-
pants at start, dropouts, dose check, outcome comparability and
reproducibility, and similarity of most and least exposed groups
at baseline. Based on these indicators, two reviewers decided on
the overall risk of bias. Disagreements were resolved by discus-
sion. The criteria for judging these indicators were adapted from
the Cochrane Handbook (Higgins and Green, 2008). Databases
and search libraries for each of the EURRECA priority mi-
cronutrients can be accessed on the EURRECA website (Berti
et al., 2010; Claessens et al., 2013). Details on the results of the
systematic reviews and meta-analysis on specific micronutrients
can be found elsewhere in this issue (Cashman and Kiely, 2013;
Harvey et al., 2013; Hoey et al., 2013; Hurst et al., 2013; Lowe
et al., 2013; Ristic-Medic et al., 2013). Further details on the
methodological approach to summarizing and interpreting the
data, and integrating the evidence can be found in Activities 5
and 6, respectively.
Inter-individual Variability
The variation in requirements between individuals within
different population groups is generally assumed to be normally
distributed, but definitive data are limited to only a few nutrients.
Where data are available, the PRI is set at the AR plus two
standard deviations, thus meeting the requirements of 97.5% of
the population. In cases where requirements are not normally
distributed, appropriate transformation of the data is undertaken
to achieve normality. In the majority of cases where data on
the inter-individual variation in requirements are unavailable,
a coefficient of variation (CV) between 10 and 20% is used
assuming a normal distribution. The selection of CV is made on
a case-by-case basis and is set at 1.2, 1.3, or 1.4 times the AR
for CVs of 10, 15, and 20%, respectively.
Variability is due in part to influences of gene polymorphisms
on nutrient function within the body. Therefore, the EURRECA
network identified data pertinent to understanding or explain-
ing inter-individual variability in micronutrient requirements for
different population groups.
Regarding biological variation in requirements, EURRECA
explored effects of single nucleotide polymorphisms (SNPs) on
micronutrient metabolism, metabolomics data from a multiple
micronutrient intervention, and examined biological networks
to better understand the interplay between micronutrients and
health at the individual level. To this end, extensive description
of the subjects being studied and foods or diets consumed is cen-
tral to characterize the so-called nutritional phenotype. For this
purpose a “Nutritional Phenotype database” (dbNP) was devel-
oped in collaboration with Nutrigenomics Organisation (NuGO)
and the Netherlands Metabolomics Centre (www.dbnp.org) (van
Ommen et al., 2010). The primary aim of this activity was to
generate a module for this database containing relevant infor-
mation on the relation between functional gene polymorphisms
on micronutrient metabolism and intake. Specifically, this in-
volved identifying data assessing the impact of functional poly-
morphisms (e.g., SNPs) on micronutrient status biomarkers and
associated health outcomes. Five micronutrients were evaluated,
namely, iron, zinc, vitamin B12, selenium, and folate.
Inclusion in the polymorphism database required studies to
report a statistically significant association between a genotype
of relevance to the micronutrient and a EURRECA status
biomarker (Activity 3). Searches were conducted using the
CENTRAL Cochrane Library, Medline and Embase (both on
OvidSP) databases and were based on specific micronutrient,
status biomarker, and polymorphism terms and limited to
humans. Potentially relevant articles were screened and
identified in accordance with the process described above. Data
from relevant papers were extracted into a tailored database
(Claessens et al., 2013) designed to ensure capture of all relevant
data. Statistical data on significant relationships pertaining to
relevant genotype-status associations were recorded along with
specific information on the polymorphisms and demographic
details of the population group under evaluation. The resultant
database is available as a web resource at http://web-php06.
tno.nl/eurreca/index.php and further details on key polymor-
phisms associated with micronutrient status are included in
each of the micronutrient summary papers for iron (Harvey
et al., 2013), zinc (Lowe et al., 2013), selenium (Hurst et al.,
2013), and folate (Hoey et al., 2013). To date, due to the lack
of relevant data, no information related to SNPs have been
used in the derivation of DRVs. The collation of polymorphism
data into a single database by the EURRECA network is an
initial step toward recognizing future developments and the
likelihood of such data being incorporated into the derivation
of micronutrient requirements.
Deriving Dietary Reference Values: Appraisal of the
Evidence (Activity 5)
Once the relevant papers are identified and the data extracted,
it is critical to transparently summarize and interpret the avail-
able evidence. Systematic literature searches provide the basis
for narrative reviews that summarize the studies one by one and
qualitatively compare and interpret their results qualitatively.
If the health outcomes and exposures are sufficiently compa-
rable, systematic literature searches also provide a basis for
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quantitative reviews or meta-analyses to go beyond this qualita-
tive review process by systematic extraction and presentation of
the quantitative pieces of information, to analyze their variation,
and—if possible—pool them to obtain a summary estimate.
Because of unavoidable shortcomings in study design, re-
cruitment, measurement of dietary exposure, health outcomes,
etc., the scientific data are subject to random and systematic
error, and scientific expert opinion is required to decide on in-
or excluding studies for further quantitative summary. There-
fore, the available studies need to be evaluated according to
the quality of their information. To improve transparency of
this expert-based qualitative step, the quality indicators of the
reviewed papers should be clearly and consistently described.
Study Design: Observational Studies and RCTs
Historically, a framework based on “hierarchy of evidence”
has been applied for basing to judge the strength of evidence
according to study design. This is because different study de-
signs have different strengths and weaknesses and, thus, differ-
ent value in informing decisions. Typically, more weight is given
to good quality RCTs and less weight to observational (nonin-
tervention) studies. The rationale is that observational studies
are potentially subject to bias and additionally cross-sectional
and case-control studies may be subject to reverse causality. In
spite of this, observational data can also provide useful infor-
mation if studies meet rigorous quality criteria as set by differ-
ent authorities (SACN, IOM, EFSA, NORDICS). To examine
intake–status–health (I–S–H) associations, systematic reviews
were conducted within the framework of EURRECA. RCTs and
observational (cohort and cross-sectional) studies were consid-
ered, while case-control studies were excluded (nested case-
control studies were included). Cross-sectional studies were
considered only to evaluate associations that describe steady
state relations, e.g., between usual nutrient intake and concentra-
tion markers, or between socio-economic indicators, micronutri-
ent intake, and concentration markers. Depending on the sources
of evidence, there are different ways to assess data quality
through the application of criteria to assess internal validity (see
below). In the framework of the EURRECA systematic reviews,
indicators of internal validity were collected during data extrac-
tion in order to assess the risk of bias. The indicators are based
on Cochrane guidelines and others (Higgins and Green, 2008).
Observational studies. For cohort studies, the following in-
dicators of internal validity were considered: similarity of most
and least exposed groups at baseline (in terms of stated con-
founders), adequate adjustment of potential confounders in the
analysis, adequate exposure assessment, completion of dropouts
and outcome data, potential funding bias, and other threats to
validity.
For cross-sectional studies, the following indicators of in-
ternal validity were considered: similarity of most and least
exposed groups at baseline (in terms of stated confounders),
adequate adjustment of potential confounders in the analysis,
adequate exposure assessment, and potential funding bias and
other threats to validity (see supplementary document 3 for more
details).
Randomized controlled trials. For studies employing an
RCT design, the following indicators of internal validity were
considered: method of sequence generation and allocation con-
cealment, blinding, dropouts and dropout reasons, potential
funding bias, number of participants at start, dose check (amount
of micronutrient provided), dietary intake data reported, out-
come comparability and reproducibility, and baseline compara-
bility for determinants of the outcome in the intervention and
control groups. Specific criteria are defined in order to assess if
the judgment for each item is yes, no, or unclear. For instance,
the allocation sequence of an RCT will be adequately gener-
ated if the investigators describe a random component in the se-
quence generation process such as referring to a random number
table, using a computer random number generator, coin tossing,
shuffling cards or envelopes, throwing dice, drawing of lots, or
minimization (see supplementary document 3 for more details).
For all study designs, based on their respective indicators,
two independent reviewers decided on the overall risk of bias
(low, moderate, high). For example, in the case of RCTs, low
risk of bias was established if internal validity criteria 1–6 were
met. Disagreements were resolved by discussion. The criteria for
judging these indicators were adapted from the Cochrane Hand-
book (Higgins and Green, 2008). Further tests can be applied
to assess the methodological quality of interventional studies.
For instance, the Jadad score is a tool where studies are scored
according to the presence of three key methodological features
of randomization, blinding, and accountability of all patients,
including withdrawals. The methodological quality of the study
is then classified into low, medium, or high quality (Houthuizen
et al., 2012).
Evaluation of Heterogeneity
The overall grading of the evidence is based on the totality of
evidence and contains elements of judgment in addition to the
assessment of the internal validity as such. The first step is to
evaluate whether heterogeneity of results can be attributed to dif-
ferences in internal validity. Therefore, in the meta-analysis for
each of the study types (RCT, prospective and cross-sectional),
sensitivity analyses were conducted by stratification for “low
risk” and “> low risk”: the overall evidence was graded as low
risk if there were “low risk” studies present and if the results
were stable upon exclusion of the studies with “> low risk of
bias.” In addition, study results were compared between the de-
sign types using the RCT (if available) as the reference design;
the highest graded study types and study quality was used for
arriving at conclusions.
Secondly, once the usable evidence has been identified,
in-depth knowledge about specific characteristics of the study
populations (e.g., physiology, clinical aspects) is necessary
for adequate judgment of the generalizability of results.
This judgment will permit deriving appropriate conclusions,
which will have important implications for practice and further
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research. Therefore, based on the number of studies and number
of participants, the numerical result and its 95% CI, the het-
erogeneity of the results is evaluated (which includes statistical
tests of heterogeneity). In this process, also characteristics of
the micronutrient exposure (dietary or pharmacological doses,
chemical species, food matrix) and population characteristics
are accounted for (serious nutritional deficiency, or generally
adequately fed; in children, adults, and the elderly, men
and women). Thus, the judgment is therefore based on the
consistency, strength, and quality of the studies, and takes into
account all the available evidence obtained with the various
methods, including the knowledge on the mechanism linking
nutrient intake and the occurrence of chronic disease (Sheffer
and Taylor, 2008; EFSA, 2010).
In EURRECA, the heterogeneity in status or health outcomes
was mainly related to dose, and to some extent to life cycle and
sex, but not clearly to other covariates. As long as individual
patient data are not available to better account for covariates,
this implies that the heterogeneity is a real phenomenon that de-
scribes the extent to which different populations behave differ-
ently. Because the results of DRVs are being applied to different
populations in different contexts this variation has to be part of
the pooled estimate and has been incorporated in the derivation
of DRVs.
Overall Quality of the Evidence
The assessment of the quality of the data, the inclusion of
elements of judgment, and the remaining heterogeneity will re-
sult in quantitative estimates that do need a number of qualifiers
to inform both scientists and decision-makers about the appro-
priate use of these data for deriving DRVs.
An example of the judgmental issues can be seen in the
EURRECA analysis for vitamin B12. Estimates on micronutri-
ent losses and of bioavailability were derived from different pop-
ulations but were integrated to arrive at an estimate of the AR.
Regarding the dose–response approach, there was a sufficient
number of adequate RCTs and observational studies to evalu-
ate the intake–status (I–S) association in order to derive ARs
in adults and elderly, but extrapolation to younger age groups
would be required. On the other hand, there was insufficient
sound epidemiological evidence for deriving ARs based on the
I–H or S–H relationship when considering cognitive function as
the health endpoint.
Scientific decisions concerning the micronutrient needs of
populations should be informed by the best available research
evidence. Decision-makers are encouraged to make use of the
latest research and information, and to ensure that decisions
are demonstrably rooted in this knowledge. However, this can
be difficult given the large amounts of information generated
by individual studies. Carrying out and clearly documenting the
meticulous task of summarizing data and their well-informed in-
terpretation will lead to a more transparent and reliable decision-
making process.
Deriving Dietary Reference Values: Integrating the Evidence
(Activity 6)
Deriving DRVs originated in the era of deficiencies. Their
ability to meet the present health challenges must be evalu-
ated and new approaches need to be developed to incorporate
epidemiological evidence on chronic diseases, be in line with
concepts in risk assessment, build on etiological models of dis-
ease causation, and be consistent with current approaches to
evaluate and recommend on population nutrient intake (Sheffer
and Taylor, 2008). As explained in Activity 1, there is a grad-
ual shift from setting DRVs based on preventing deficiencies
and on amounts needed to maintain body stores (Activity 4)
to optimize health, prevent chronic disease, and avoid consum-
ing too much of a nutrient. The interest in using risk reduction
of chronic disease as the basis for establishing micronutrient
recommendations requires insight in the causal relationship be-
tween micronutrients and the disease or health outcome (Ac-
tivity 4). This places greater emphasis on which nutritional in-
termediates or health outcomes are being considered and where
the resulting distribution of requirements is positioned for the
apparently healthy population rather than using a distribution,
which suffices to repair a single micronutrient deficiency un-
til normal function is achieved (see Fig. 6). Additionally, the
relationship between the intake of a nutrient (I) and the risk
of disease (D) based on scientific evidence needs to be quanti-
fied. Consequently, a dose–response relationship between intake
(I) and status/functional markers (S) must be determined. The
integration of the evidence has to accommodate systematic vari-
ations between studies originating from (1) differences in study
quality (assessed by internal validity), (2) study population (age,
gender, body composition, and energy needs), (3) micronutri-
ent dose (level, range, duration, mode of administration), and
(4) other population characteristics (growth, pregnancy, lacta-
tion, etc.).
Quantification of the Evidence
The principles of meta-analysis to quantitatively summarize
research data have been sufficiently described (refs). In this,
activity specific issues relevant to the meta-analyses conducted
in EURRECA are briefly outlined. As described in Activity
4, standardized systematic review protocols and search strate-
gies were developed within EURRECA. Following appraisal of
the evidence, study results were visualized by forest plots (see
supplementary document 4). Of course, this approach requires
assumptions on the shape of the dose–response relationship. To
quantify the strength of the dose–response relationship, the rig-
orous but flexible transformation to a double loge scale was cho-
sen. This transformation is suitable to describe dose–response
as a nonlinear but monotonic concave function of dose, i.e., the
same additional dose is less effective at higher levels of intake,
which is considered a common phenomenon shape in biology
(see Fig. 10). This transformation can be applied to both RCT
data and observational data and also allows one to compare and
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Figure 10 Serum/plasma micronutrient concentration (pmol/L) as a function of dietary micronutrient intake (mcg/day), estimated by random-effects meta-
analyses of observational studies (n = 19) and RCTs (n = 37), on double loge transformed scale (upper panel) and backtransformed scale (lower panel). In the
upper panel, the line for observational studies is less steep, probably because of measurement errors in intake data and a smaller dose range as in RCTs. The overall
pooled regression line (solid) of the loge transformed vitamin B12 intake and loge transformed serum/plasma vitamin B12 status, has a slope of 0.15 (95%CI:
0.13–0.17; upper panel). This means that for every doubling in vitamin B12 intake, the vitamin B12 serum or plasma concentration increases by a factor 2β, i.e.,
11% ( = 20.15 = 1.11). See Dullemeijer et al. (2013).
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integrate RCT and observational studies on intake and biomark-
ers of status (Bar et al., 1991). Clearly, the use of this double
loge scale is specific for continuous responses and not appli-
cable for dichotomous outcomes (although risk is usually also
modeled on the loge scale). In principle, when the health crite-
rion for the specified health outcome or status has been defined,
an appropriate AR can be derived. In addition to measures of
dose–response, it is also possible to meta-analyze data on the
correlation between the intake and response. This can be used to
arrive at a stochastic model to derive ARs and PRI. The regres-
sion slopes of this model are based on results from intervention
studies using high doses of micronutrients, whereas the inter-
cept for the regression lines is determined by the means of the
usual dietary intake and the mean value of the concentration
marker. As the range in intake in intervention studies is large
as compared to usual dietary intake, it is at present assumed
that the well-known errors in assessing the mean baseline pop-
ulation intake are not likely to cause large systematic errors in
our approach. For the transformation of extracted estimates, the
derivation of study-specific regression slopes, and the pooling
of these slopes, we refer to supplementary document 4.
Expert Consultation
Expert knowledge and critical evaluation will always be
needed for the appraisal of the collected data, interpretation
of the results and potential refinement of the analysis. Trans-
parency and alignment of (the process of setting) micronutrient
recommendations is necessary to improve the objectivity and
transparency of values that are derived by national, regional, and
international groups; provide a common basis or background for
groups of experts to consider throughout processes that lead to
micronutrient recommendations; supply a common basis for
objectives and national policies such as fortification programs
and for addressing regulatory and trade issues (King and Garza,
2007). Following this procedure, the expert consultation is piv-
otal at several moments in order to keep track of content-related
issues, nevertheless the expert’s opinion should aim for trans-
parency (European Commission, 2000, 2001a; EFSA, 2009).
As introduced in Activity 1, experts should be consulted to
check the prioritization process. Scientists who already are fa-
miliar with the topics (either micronutrients or health outcomes)
should ideally perform the systematic reviews. For the integra-
tion of the available data, the experts should be re-consulted
in order to address remaining issues to be solved, check for
completion, and for correct representation of the data.
Factorial and Bioavailability Approach
Activities 4 and 5 described the data collection of factorial
and bioavailability studies. The resulting pooled estimates of
needs (numerator) and bioavailability (denominator) are used
to derive the AR, which represents the intake at which an in-
dividual has a 50% chance of meeting his or her requirements.
In case the requirements apply to specific population groups,
such as infants, children, pregnant women, or lactating moth-
ers, the requirements depend on basic physiological needs plus
an additional amount to account for growth or additional needs
(lactation), which requires a combination of factorial and other
methods to derive ARs.
To allow for between-subject variation in requirements, a
distribution of INLs is postulated, with its SD usually set at a CV
of 10–20% of the AR. Moreover, deriving an AR is associated
with many uncertainties. For instance, most factorial estimates
and bioavailability studies included relatively small selected
population groups did not address all factors in the factorial
model, did not always address whole meals or food patterns
(essential to calculate a universal bioavailability factor), etc.
Therefore, the estimated AR also contains scientific uncertainty.
If there is much uncertainty in the estimation of the AR and
little is known on the distribution of individual requirements,
then usually the higher CV is selected. In principle, high quality
studies or variables that can explain biological variability in
nutrient needs could lead to the choice of a smaller CV for
subgroup-specific ARs.
When using the factorial approach to derive reference values,
information on dose–response studies and other health outcomes
must be considered as well. In principle, the factorial estimates
and dose–response estimates on intake–status–health relation-
ships are based on methodologically independent data and for
setting the reference values, the combined quantitative informa-
tion of the factorial estimates and dose–response data should be
both considered (see Fig. 2 and Activity 1).
Dose–Response Model
The dose–response approach ideally combines I–S, I–H, and
S–H data. Within the scope of the EURRECA network, a bivari-
ate stochastic model was initially used to describe the relation
between micronutrient intake and status (I–S) by incorporating
the variability between individuals for both intake and status
measures (Bar et al., 1991). Although most nutritionists are
not familiar with this type of bivariate models, this approach is
commonly used in food safety. Although Carriquiry (1999) has
used a stochastic model to underpin the AR cut-point method
for evaluation of population intakes, our stochastic model is
different as it uses biomarkers and intake data to derive the
AR. Apart from a meta-analysis of associations (Activity 5),
the model additionally requires information on the correlation
between the two variables (the stochastic component) as well as
average intake and average status (e.g., from monitoring data)
to allow for the predictive component of the model. Dullemeijer
et al. (2013) based the associations of their stochastic model on
the RCTs and the intercepts on observational studies identified
for vitamin B12 intake and status: the joint distribution of loge
intake and loge plasma or serum vitamin B12 concentrations
is assumed to be bivariate normal with means (μX, μY), stan-
dard deviations (σX, σY), and correlation ρ, implying a linear
dose–response relation on these scales.
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Figure 11 Conceptual model to derive nutrient reference values using a bivariate model for the intake–status relationship. Downward extrapolation results in
AR- and PRI-like estimates. Upward extrapolation can predict the average intake of a population to serve the needs of 97.5% of its members. It should be noted
that the method applies to populations rather than individuals. (Color figure available online.)
Using the assumption that the AR represents an intake that is
sufficient for 50% of the population (Activity 1), the PRI may be
derived under the assumption of parallel individual lines as the
intake at which the probability of reaching vitamin B12 status is
equal or less than the cutoff of 2.5%. Finally, for the derivation
of reference values, the bivariate marginal distribution I–S is
of interest once thresholds on the health or status variable are
set; the trivariate model could simultaneously account for the
I–H and S–H associations as well. Scenarios regarding desir-
able changes in nutrient intake are considered as shifts of the
bi/trivariate distribution along the regression line for predicting
the status or health outcome. The model can be used to derive
intake levels, which would be required to attain desirable values
of I or S for specified proportions of the population (resem-
bling though not analogous to the definition of AR and PRI;
Fig. 11). It should be noted that the bivariate I–S model is based
on physiological health criteria, similar to most applications of
the factorial approach.
A major advantage of the stochastic method is that it largely
extends the evidence base for deriving DRVs because it allows
the use of widely available dose–response data on I–S and I–H
associations from different types of studies (RCT’s and obser-
vational). However, the practicability of this stochastic method
for deriving the AR and recommended intake depends on the
justification of the assumptions made. Further work needs to
be done to evaluate the sensitivity to these assumptions and to
allow for these limitations.
So far, EURRECA explored a bivariate stochastic model, but
it can be extended to a trivariate model, which also includes
health outcomes in addition to intake and status. The trivari-
ate intake–status–health (I–S–H) model could incorporate all
published information from RCTs and observational studies on
the I–S, I–H, and S–H dose–response association, as the basis
for deriving micronutrient reference values. In short, the trivari-
ate model combines the evidence of the three I–S, S–H, and
I–H dose–response associations in separate meta-analyses, the
results of which are combined using the assumption of condi-
tional independence, i.e., the effect of I on H is fully mediated
by S. This integrated evidence is then combined with the results
of the meta-analyses of the data on the marginal distribution of
I, S, and H to obtain the final trivariate stochastic model. Fu-
ture extension of the model could incorporate covariates and/or
individual patient data (rather than meta-analyzed data).
Scaling of ARs to Other Population Groups
When no original research data are available for cer-
tain population groups—most often this concerns infants and
children—other methods need to be applied to define and align
reference values or ARs. The derivation of DRVs for infants and
children in current dietary reference standards is often based on
methods of extrapolation or interpolation (or in other words
scaling) from adult data or breast milk, owing to the paucity
of relevant research data available, but these are not consistent
across reports (Atkinson and Koletzko, 2007).
Currently, the different methods used for the derivation of
DRVs for infants and children in Europe and worldwide have
led to considerable differences and inconsistencies in DRVs and
age groups between countries for the same age group of infants
or children (Prentice et al., 2004; Atkinson and Koletzko, 2007).
This diversity of values may be attributed to one or more of the
following points: (a) no universally accepted growth or (consid-
erable differences in) reference data, (b) source documents often
do not provide detailed information on the derivation of the ref-
erence values, (c) lack of nutrient-specific growth factors that
take into account specific metabolic properties and the turnover
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Figure 12 Scaling of reference values based on measures of body size, as selected by EURRECA.
of each micronutrient, (d) varying content of nutrients in breast
milk among different studies, (e) use of different extrapolation
methods to obtain DRVs and recommendations in each country,
and (f) inconsistent application of scaling methods within one
age group.
There are several methods for extrapolation, which are based
on different assumptions. Within EURRECA, we selected two
methods that are used most often and that are considered ade-
quate to estimate requirements (see Fig. 12).
Biological Modeling for Multiple Micronutrients
For personalized multi-micronutrient recommendations, in-
formation at biological process level should be integrated and
visualized. To this end, the “health space” model was devel-
oped (Fig. 13). This model is a statistical visualization method
that addresses the effects of treatment in individual subjects.
The visualization is based on predefined biological processes as
determined by systems-biological datasets (metabolomics, pro-
teomics, and transcriptomics). This allows one to evaluate bio-
logical effects depending on shifts of either groups or subjects
in the space predefined by the axes, which illustrate specific bi-
ological processes. We built a conceptual multivariate model for
each axis to represent several biological processes. In this space
each subject has his or her own score on each axis/process, indi-
cating to which extent the treatment affects the related process
(Bouwman et al., 2012). For instance the oxidation status can
be represented by an axis, which is quantified by a combina-
tion of markers (van Ommen et al., 2008; Bouwman et al.,
2012). Assessment of the individual’s health status by mea-
suring these markers combined with the collated evidence
for micronutrient (e.g., vitamin C and E) effects on these
markers (Activity 3) allows for individualized micronutrient
recommendations based on the nutritional health space. Apply-
ing the health space method on data of a human intervention
with an antiinflammatory dietary mix has shown that the model
Figure 13 The health space model visualizes personal micronutrient rec-
ommendations. In the health space each person’s individual response to mi-
cronutrient interventions is visualized for specific biological processes (e.g.,
inflammation). For each biological process, a multivariate statistical model is
built, which is scaled between 0 (the average of all healthy subjects) and 1 (the
average of the unhealthy subjects). All subjects are visualized in the resulting
space. Intervention-induced changes of the position of subjects in this space
may support involvement of micronutrients in health-related biological pro-
cesses relevant to long-term health and disease outcomes. A “real life” example
on data is published (Bouwman et al., 2012a). (Color figure available online.)
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allows visualization of an individual’s health status based on the
assembly of omics data in biologically relevant processes (ap-
plication of the health space is extensively described in Bouw-
man et al., 2012). The health space in the published exam-
ple was built on treated (with a dietary antiinflammatory mix)
and untreated subjects. The model presents treatment group ef-
fects, subgroups and individual responses, since all subjects are
represented individually in the health space visualization. In
this example, it was assumed that treated subjects were more
healthy than untreated. As health does not have an absolute
definition, it is hard to define the precise location of the ori-
gin, which reflects by definition the most healthy status in the
health space visualization. However, the model may help to
define a healthy area and may show that the health area may
be different for certain subgroups. With the underlying models
linking micronutrients to specific processes, different dietary
recommendations may be derived for these different subgroups.
This concept is currently applied and further extended at IABC
(www.iabc.ch). Regarding micronutrient function, within EUR-
RECA, the relationship between micronutrient intake and/or
status and a range of biomarkers (e.g., metabolomics), rep-
resenting inflammatory, oxidative stress, and metabolic stress
processes, was reviewed (www.micronutrientgenomics.org or
http://wiki.nugo.org/index.php/Category:Micronutrients). The
selected biomarkers are metabolites that are known to respond
to dietary interventions and are associated with (or are predic-
tive of) certain chronic metabolic diseases. For selenium, fo-
late and vitamin B12 biological networks have been developed
on the basis of metabolic connections between micronutrient
markers of exposure to food components, markers of target
function and biological response, micronutrient-related status
metabolites, and micronutrient-related disease parameters (see
http://www.wikipathways.org/index.php). This concept is an in-
teresting option to be further explored for mechanistic underpin-
ning and incorporation of the individual’s genetic information
(van Ommen et al., 2010). The health space model could eventu-
ally provide a mechanistic underpinning for other models such
as the intake–status bivariate model and the I–S–H trivariate
model.
Monitoring and Evaluating: Nutrient Intake and Status
of Population Groups (Activity 7)
DRVs are the main instrument in diet planning and nutri-
tional assessment. In addition to evaluation and monitoring of
nutritional situation, they also supply the information necessary
for the development of food labels, nutrition programs, and for
regulations related to fortification.
In Europe, data collected by surveillance are used to evaluate
population nutritional health and give early warning informa-
tion on malnutrition and nutrition health related problems. That
implies that surveillances are considered as a first “screening
test” to identify potential nutritional problems.
Within EURRECA, nutrient intake values were used for
evaluating the dietary adequacy of population groups and for
identification of those that are at risk of low intake. Upper levels
of micronutrient intake that could induce a risk of excessive
intake both from the diet and supplements were not addressed
by EURRECA.
Assessing Dietary Intake and Nutritional Status
Assessment of dietary intake and nutritional status is used
to estimate the proportion of the population that is at risk of
inadequacy, that is, whose nutrient intake and status levels are
below the reference cutoff values (Jensen et al., 1991). Within
the EURRECA Network, the dietary assessment instruments
and population surveillance data and the methods to evaluate
inadequacy of micronutrient intake in Europe were reviewed
(Activity 3). Two methods are preferable to evaluate adequacy
of intake at the population level: the probability approach and
the cut-point method (Carriquiry, 1999), with the latter used
most widely (Tabacchi et al., 2009).
For application of either method, a reliable estimate of pop-
ulation usual intake is needed. Usual intake reflects only the
variation in usual intake among members of the population and
should exclude day-to-day variability in daily intakes (Jensen
et al., 1991). It implies shrinking the distribution of observed
intake to accommodate for random measurement errors, i.e.,
assuming no systematic error. In addition, estimated usual in-
takes of individuals should be independent of each individual’s
requirement. To use the probability approach, the joint distribu-
tion of usual daily intakes and of requirements should be known.
Figure 14 presents an example of how risk of inadequate intake
can be estimated if the distribution of requirement or a given
micronutrient is known.
However, although data on usual nutrient intakes are avail-
able, information on requirement distribution is seldom explic-
itly known and thus for many micronutrients a rough estimate
of the AR and its SD is often used for the life-stage groups
considered.
Figure 14 Risk curve combined with a usual intake distribution where the
mean intake is less than the AR. The mean of the usual intake distribution is 50
units and the majority of the intake values are less than 90 units. At 90 units, the
risk of inadequacy is about 75%. Therefore, in this population, the probability
of inadequacy is high.
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Figure 15 (adapted from Institute of Medicine: Dietary Reference intakes:
Applications in Dietary Assessment; (EAR: estimated average requirement)
corresponds to AR). Joint distribution of intakes and requirements from a hypo-
thetical population of 3000 individuals with the mean intake of 1600 units and
the AR of 1200 units. The triangle labeled A is bounded by the intake = AR line
and the 45◦ line where intake = requirement. Points above the 45◦ line (shaded
area) represent those individuals whose intakes are above the AR, but below
their own individual requirement. Individuals in triangle B have intakes below
the AR, yet above their own requirement. The number of people in triangle A
is approximately equal to the number in triangle B.
The cut-point method does not require such extensive data
on the distribution of requirements, but some other assump-
tions must be fulfilled: (i) when intakes and requirements must
be independent or have low correlation, (ii) the requirement
distribution must be symmetric (e.g., the iron requirements dis-
tribution in menstruating women is known to be highly skewed
due to iron losses), and (iii) variability in intakes among indi-
viduals in the group must be large compared to the variability
in requirements of the individuals (Institute of Medicine, 2000).
The cut-point method estimates the prevalence of inadequacy
as the proportion of individuals whose usual intake is below the
AR (AR: amount of nutrient that covers 50% of the population’s
requirements). Figure 15 shows an example of the application
of the AR cut-point method for joint intake and requirement
data.
To identify vulnerable groups with inadequate micronutrient
intake and/or status, a search was conducted in open access and
gray literature sources. The aim was to collect the best-quality
data that report on micronutrient intake and/or status, and that
fulfill a priori quality criteria for study characteristics (Activity
3). Studies that were included in the analysis had focused on
the EURRECA prioritized micronutrients and had used the EU-
RRECA recommended best practice dietary intake assessment
methods and biomarkers of nutritional status (Activities 1 and
3). Data were collected for all life-stage groups including low
income and immigrants. Despite limitations on the intake data
gathered this way, primarily lack of data for some age groups
and nonharmonized study methodologies, the cut-point method
was applied to evaluate the proportion of the population at risk
of nutritional deficiency. There were used ARs derived for the
Figure 16 Countries with data for seven vitamins and minerals (six for fe-
males) classified according to the number of nutrients with inadequate intakes
above 20% of the population. (DE = Germany; DK = Denmark; ES = Spain;
FI = Finland; IR = Ireland; SE = Sweden; UK = United Kingdom).
Nordic countries (Nordic Council of Ministers, 2004) as these
are the most recent references values set for a series of European
countries. If ARs for micronutrients in Nordic countries were
not reported (calcium and vitamin D in adults, all micronutrients
in children), ARs published for the USA/Canada by the Insti-
tute of Medicine of the National Academies, Food and Nutrition
Board were used (Institute of Medicine, 1998).
Data on intake of vitamin C, vitamin D, vitamin B 12, folic
acid, calcium, zinc, and iron (males only) from seven European
countries were used for the assessment of inadequacy by ap-
plying the cut-point method. Figure 16 shows the proportion
of micronutrients, for which there are inadequate intakes above
20%. Among males, the highest ratios of inadequate intakes
were found in Finland and Sweden: out of seven micronutrients
analyzed, there was observed inadequate intake of three and four
micronutrients, respectively. Among females, for which inade-
quacy was estimated for six micronutrients, the highest ratios of
inadequate intakes were found in Ireland and the UK: six and
five micronutrients, respectively.
For the populations where the study data did not meet the
best practice criteria for intake methods (Activity 3), the AR cut-
point method could not be applied: for example, methodologies
to assess micronutrient intake differed widely between nutri-
tional surveys from Central and Eastern Europe (CEE). More
specifically, for estimating micronutrient intake, the remaining
random error was large for FFQs, whereas for the 24-hour-based
surveys, it was dependent on the number of replicates and the
use of shrinkage methods. Therefore, the width of the distribu-
tion of intakes lacked comparability between the surveys, which
prohibited estimation of the prevalence of micronutrient inade-
quacy. However, their ability to (roughly) estimate mean popu-
lation intake was considered sufficient, so reported mean intake
levels were compared with the ARs proposed by Nordic Nu-
trient Recommendations (Nordic Council of Ministers, 2004).
Figure 17 shows mean calcium intake in milligrams per day
(standard deviation) by country, for males (M) and females (F)
(Novakovic et al., 2012). For those countries where the mean
intake was below the AR, there is clearly a risk of inadequacy:
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Figure 17 Mean calcium intake in milligrams per day (standard deviation) by country, for males (o) and females (). Countries are grouped according to
region: Central and Eastern Europe, Mediterranean countries, Western Europe and Scandinavian countries. Red line corresponds to AR for adult males and females
according to Nordic nutrient recommendations. (Color figure available online.)
in CEE, four out of eight countries had a mean intake of cal-
cium below the AR among males, and in three countries among
females.
With respect to evaluation of biomarkers for adequate mi-
cronutrient status, the EURRECA BPGs were followed (Activ-
ity 3). Cutoff values to indicate a risk of inadequacy in micronu-
trient status were defined on the basis of a literature review and
were mainly based on values proposed by the World Health Or-
ganization and other authorities. Figure 18 shows an example
of evaluation of iodine status for children and adolescents in
Europe: data from CEE indicate to mild iodine deficiency in
some countries (Novakovic et al., 2012).
The former approaches to evaluate micronutrient inadequacy
have intrinsic limitations. To enable comparison of the data
that stem from studies with different dietary methodologies,
the BPGs required that a single 24-hour recall or food records
should either be replicated for at least three days, or if less
than three days then adjusted for intra-individual variability,
or a validated FFQ (Activity 3). For micronutrients found in a
limited number of foods, using a short-term reference period
will probably miss information on frequency of intake, whereas
an FFQ will overestimate the intake of certain food groups
such as vegetables (Roman Vinas et al., 2011). These reporting
Figure 18 Median urinary iodine concentration in micrograms per liter per
day by country, in children and adolescents in Europe (10). ∗The optimal range
for median urinary iodine concentration: 100–199 μg/L. ∗∗Source of data:
WHO Vitamin and Mineral Nutrition Information System, except for studies
from Republic of Srpska and Serbia. (Color figure available online.)
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errors will affect the validity of the prevalence of nutrient intake
inadequacy when applying the cut-point method.
For the cross-country comparison, even though when coun-
tries had applied the same methodology for estimation of preva-
lence of inadequacy such as the cut-point method, diversity in
country specific DRVs (e.g., AR) can induce a substantial vari-
ation in estimating the prevalence of inadequacy.
Assessing Health Status Reflecting the Nutritional Status
Biomarkers for measuring nutrient status identified by EU-
RRECA are to be used for epidemiological analysis and can be
obtained from blood or urine. The list of biomarkers used in
EURRECA for evaluation of inadequacy in status was a result
of the literature review of the key publications issued by the
World Health Organization (WHO), the Institute of Medicine
and other authorities, as well as consulting micronutrient ex-
perts. More details on other biomarkers and the methodology of
BPGs can be found under Activity 3.
Reported levels of priority micronutrients (folate, vitamin
B12, zinc, iron, and iodine) were compared to reference values
proposed in Activity 3, the latter being based on key references
mostly published by the World Health Organization in cooper-
ation with other institutions (Activity 3). The levels below the
cutoff or below the optimal range point to a risk for inadequacy,
i.e., depending on the marker used, indicated that the dietary
intake was insufficient over the medium or long term.
These biomarkers can be used either in analysis of epidemi-
ological data or to be applied in field work. Some of them are
used those to indicate a health risk. For example, the most com-
mon cause of anemia is iron deficiency and the blood levels
of hemoglobin concentrations can be used to detect long-term
inadequate intake of iron. From the public health perspective
if the prevalence of anemia is at 4.9% or less, it is categorized
as acceptable proportion of inadequacy (Gorstein et al., 2007).
Another example is iodine: median level of urinary iodine con-
centration reflects iodine nutrition and it is used to detect mild
to severe iodine deficiency.
Identifying Vulnerable Groups
In Activity 1, population (sub) groups that are vulnerable be-
cause of higher requirements, accounted for in deriving DRVs
have been addressed. Here, we focus on vulnerability because
of high risk of low intake rather than increased physiological
needs. Low income and immigrant groups tend to have less op-
timal nutritional status because of a lower intake (James et al.,
1997; Church et al., 2006; Darmon and Drewnowski, 2008).
Identification of such groups may be relevant to the formula-
tion of micronutrient policies. Therefore, EURRECA collected
European-wide data on micronutrient intake and status in order
to identify such vulnerable population groups for a selected set
of micronutrients. To do so, an initial step was to have clear
definitions, i.e., search terms to be used for identification and
analysis of the studies from scientific electronic databases.
To define low income groups, key documents were screened
on poverty, socio-economic status/position, and diet: system-
atic reviews available in open access database (PubMed), The
WHO and collaborating bodies’ publications (DETERMINE
Project Working document No. 1, www.health-inequalities.eu;
http://www.who.int/en), EC/Eurostat statistical information
(www.ec.europa.eu), and data from gray literature (Brandolini,
2010). Based on these data, search terms for low-income groups
were defined: low income, indigenous population, social class,
poverty and socio-economic factors.
Search terms for immigrants involved commonly used de-
scriptors as proposed in PubMed database: emigration and im-
migration, migration, foreigner, resettlement. With respect to
definition of host country, European Union was limited to those
comprising the former EU-15 till 1st May 2004. To collect the
data on intake in low income and/or immigrants, a comprehen-
sive review was conducted that included a structured Medline
search, related references screening, and key expert consulta-
tions. Study inclusion criterion followed general EURRECA
guideline on dietary intake and study characteristics (Activities
1 and 3).
Immigrant and low-income/low-SES groups. Evidence sug-
gests that immigrant populations constitute a vulnerable group
for inadequate nutrient intake, of which the most marginal-
ized and isolated groups, such as the Roma/Gypsy populations,
present higher risk (Ngo et al., 2013). They often try to main-
tain their traditional food pattern and the food chains in their
new societies do often do not provide the opportunity to do so.
On top of that, the language and financial means may inhibit
socialization putting them on the lower socio-economic strata
of the recipient country. Poor socio-economic status and life
style factors, including diet might contribute to their nutritional
vulnerability.
People from low-income households typically have less nu-
tritionally adequate diets, especially those who live for long
periods of time on limited incomes. In addition, among other fac-
tors, lower literacy, numerical and language skills, physical dis-
abilities, and mental health problems are more common in low-
income groups, as well as low motivation, and as such, constitute
obstacles when identifying and assessing this population’s food
and nutrient intakes (Hoey et al., 2013). The above-mentioned
evidence indicates the need to identify different dietary assess-
ment methods that are appropriate for low-income groups.
Table 5 shows the definitions and the proportion of low in-
come and immigrants reported by Eurostat, the statistical office
of the European Union, on foreign citizens in the EU27 Member
States, EFTA, and Candidate countries.
Determinants of Micronutrient Inadequacy
Dietary inadequacy can be observed in populations because
of limitations of the measurements instruments, that affecting
either the systematic or random errors (see above); in prin-
ciple, such uncertainties should be bypassed by well-applied
inclusion criteria (when existing data are used) or sufficiently
standardized surveillance methodology (for future pan-
European nutrition surveillance). For immigrants and low-
income/low-socio-economic status (SES) groups, additional
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Table 5 Low social class and immigrant: definitions and proportion in EU27 Member states
Population groups vulnerable to micronutrient inadequacy
Low social class:
According to Eurostat definition, population in or at risk of poverty comprises all persons with disposable income, adjusted for family size, i.e., equivalized
income that is below 60% of the median national value in each year. Within the European Union (EU-27 member countries), there are 16% (80,199 thousands
persons), which are in or at risk of poverty. It ranges from 9% in Czech Republic to 22% in Romania.
Immigrants:
The total number of nonnationals (people who are not citizens of their country of residence) living on the territory of an EU Member State on 1 January 2010
was 32.5 million persons, representing 6.5% of the EU-27 population. However, more than one-third (a total of 12.3 million persons) of all nonnationals living
in the EU-27 on 1 January 2010 were citizens of another EU Member State.
(source: www.ec.europa.eu)
considerations apply. Evaluating dietary intake of immigrant
populations requires special attention to:
• Sampling and recruiting, instruments used, method of admin-
istration, food composition database, acculturation.
• Consumption in those eating from a shared serving dish/pot,
understanding of food terms and concepts, scarce informa-
tion on ethnic dishes and recipes, culture-specific foods and
portion sizes.
• Language issues: the use of forward and back-translation is
a widely used method in cross-cultural research, and when
combined with additional bilingual and monolingual post-
translation testing, it is considered as the most complete in-
strument translation process (Ngo et al., 2013).
Similarly, when assessing the dietary intake of low-
income/low-SES groups, the following points require specific
attention:
• Poor motivation of the low-income populations.
• Variations in the level of language and numeric skills across
the whole sample could induce difficulty in completing
dietary records unless assistance is provided by either
interviewers or other household members.
Four multiple-pass 24-hour recalls were shown to be the
most appropriate method for a study of diet and nutrition in
low-income households (Vucic et al., 2009).
Current evidence suggests that apart from income, there are
other socio-economic and cultural factors that influence mi-
cronutrient intake and/or status: education, occupation, employ-
ment, urbanization, marital status, and race/ethnicity.
Therefore, EURRECA included education and occupation as
two proxy key determinants of micronutrient intake and eval-
uated their association with differences in micronutrient intake
and/or status. Methodology comprised a search in Medline and
Embase to collect original studies that followed general EU-
RRECA guideline on dietary intake and study characteristics
(Activities 1 and 3).
For the evaluation of micronutrient adequacy in low-SES
groups, there are several aspects to consider when analyzing
available data: (i) existing evidence on micronutrient intake
and/or status across different SES levels in Europe is scarce,
especially for children and for all life stages in CEE; (ii) avail-
able publications differ in their categorization of groups for
indicator of interest (e.g., for education studies have stratified
subjects within 2–4 groups, for occupation 2–3 groups, for in-
come 2–4 groups); (iii) studies applied different dietary intake
instruments, etc. Figure 19 shows example result from this pub-
lication: mean intake of vitamin C in lowest and highest SES
group in adults/elderly and children by different socio-economic
indicator, and in comparison to AR (Novakovic et al., in
press).
To overcome these methodological constraints and pro-
duce the results that are based on harmonized and compara-
ble data, EURRECA has included additional work on eval-
uation of data from two European projects, i.e., HELENA
(www.helenastudy.com) and EPIC (www.epic.iarc.fr). Work on
assessment of micronutrient intake in adolescents (HELENA)
and adults and elderly (EPIC) in association with SES indicators
is ongoing and the results from these publications will be made
available for supporting nutritional policy in Europe.
Using Dietary Reference Values in Policy Making:
Identifying Policy Options (Activity 8)
This activity describes the complex processes through which
public health nutrition policy development is linked to micronu-
trient recommendations.
The drive toward evidence-based policy has been typified
by (1) a tendency to treat cost effectiveness and feasibility as
key criteria for policy selection, as exemplified by a rise of
health economics and impact assessments as evidence for pol-
icy; (2) a proliferation of frameworks and decision-making tools,
usually linear in character, developed in order to increase evi-
dence pull and utilization through anticipatory problem-solving,
planning and rational choice and often focused on developing
institutional forms that would act as bridges between research
and policy communities (e.g., Scientific Advisory Bodies; Lavis
et al., 2009; Oxman et al., 2009).
The need to expand the range of evidence that influences
the preferred policy option has become apparent following a
EURRECA case study based on folate recommendations (Tim-
otijevic et al., 2011a). It was shown that the link between DRVs,
as the scientific evidence underpinning decisions about nutrition
policies, and final policy action is not always made explicit and
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Figure 19 Mean intake of vitamin C (with their 95% confidence intervals where available) in lowest and highest SES group in Europe in males (M), females (F),
and in both genders (MF), and in comparison to AR. Abbreviations for countries: ES: Spain, FI: Finland, IE: Ireland, NL: The Netherlands, SCT: Scotland, UK:
The United Kingdom, BE: Belgium, TR: Turkey. Abbreviations for SES indicators: educ- education, occ- occupation, inc- income (Novakovic et al., in press).
(Color figure available online.)
that the SAC’s recommendation of mandatory food fortification
with folic acid in order to achieve recommended intake is vari-
ably applied in policy across Europe (Timotijevic et al., 2011a).
Based on these observations, EURRECA has developed steps
for decision-making that link DRVs with the final policy action,
depicted in Fig. 20. These steps correspond to some extent to
the depiction of the linear model of RAF (MacKerras, 2012),
though is more detailed about the range of considerations that are
typically considered. It is developed with an aim of depicting the
thinking requirements for linking DRVs and policy action. The
choice of an appropriate public health nutrition policy option
(or a combination thereof) is premised upon policy makers’
considerations of a range of evidence. At the heart of the policy
process is defining the policy goal and identifying appropriate
policy action.
Identify Policy Goals (e.g., Health Outcome)
A public health nutrition policy goal can be framed as achiev-
ing a desirable or decreasing the risks of undesirable nutrition-
related health outcomes. Key to identifying the policy goal is
clarifying the strength, relevance, and degree of uncertainty
Figure 20 EURRECA’s steps for decision-making. (Color figure available online.)
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around the evidence linking nutrient intake to nutrient status as
well as nutrient intake/status to a health outcome (Dhonukshe-
Rutten et al., 2010b). This work is typically conducted by SABs
resulting in a set of DRVs. These DRVs can provide reference
points for adequate and optimal intakes for a population or
sub-population, which can be combined with other sets of infor-
mation (e.g., monitoring data from national nutritional surveys,
advice from key stakeholders, over exposure data) and used (by
the SAB, government or another body) to set nutrient/dietary
recommendations and goals.
Although nutrient intake is ultimately a nutritional measure,
it is achieved through several food-related behaviors that may
include food choice, food storage, preparation, and food occa-
sions (when and how it is eaten). Social and behavioral science
provides useful insights into the hugely complex dynamic of
food choice (Jensen et al., 2012). First, clarity about the con-
texts that define nutrient intake, which include the sources of
the targeted nutrient, the targeted population, and the avail-
ability of foods, is a necessary starting point in considering
nutrient-relevant behaviors (and the range of policy options for
behavior change). It is also important to be clear about the kind
of behavioral changes required to achieve a nutrient-relevant
change—whether the nutrient intake needs to be increased or
decreased—and to understand that the link between food and
nutrient intake is complex since food choices are interrelated.
The challenge is even greater when considering the intake of
several nutrients. EURRECA have argued that moving beyond
simple models of behavior change to consider a range of behav-
ioral mechanisms underpinning behavior changes is an impor-
tant step in unpicking multiple influences on dietary behavior
(Jensen et al., 2012).
Public health nutrition policy options relevant to micronu-
trient recommendations can broadly be divided into those that
require voluntary behavior change, those that incentivise or pun-
ish through economic means (awards/taxes), those that enforce
a particular behavior or choice (e.g., regulation through man-
dating fortification), and those that rely on collaborations (e.g.,
private–public partnerships) and self-regulation (e.g., voluntary
codes of conduct; Timotijevic et al., 2010a). Considerations of
the key objectives of the existing policy, their timeline (both his-
torically and in the context of further policy development and
application), cost and who is involved in both the development
and delivery of the policy are some of the key parameters of
policy options selection (Kingdon, 2003). In addition, the key
values for consideration of policy options—equity, efficiency,
security, and liberty—will be guiding principles of policy mak-
ing. Evidence derived from stakeholder participations is also
sought to establish the dominant values for policy making. Ta-
ble 6 below summarizes some of the common policy options
and “catalysts of change” (the specific policy actions and inter-
ventions) in public health nutrition policy. In relation to public
health nutrition policy social voluntary options (usually target-
ing general diet), and to a lesser extent regulatory policy options
(usually targeting specific nutrients) are preferred policy options
(see Table 7).
There is a wider context to considerations that shape decision-
making. Ethical considerations are often invoked in delibera-
tions of stakeholders about public health nutrition policy. Public
participatory approaches or ethical reviews/consultations often
engage in balancing the right to the autonomy of the individual
in relation to food choice and consumption, with other princi-
ples (e.g., equity, social justice). The framing of the problem by
the significant opinion leaders such as the media, think tanks, or
major NGOs is taken into account. Broader beliefs, values, and
practices are also a part of the wider context. Other important
aspects of the evidence from the wider context include inter-
national (nonbinding) guidelines and recommendations, global
trends that are not directly related to public health nutrition (e.g.,
financial crisis) as well as technical capacities and infrastructure
for the delivery of policy options.
Policy action is a product of iterative considerations of evi-
dence within and across each of these steps. Final action will be
selected from a number of options (see Table 6).
Explicit and Transparent Process
EURRECA evaluated the step model of public health nu-
trition policy making (Fig. 20) for its usefulness in capturing
the actual processes of micronutrient-relevant policy decisions
through:
1. A workshop with key stakeholders with a view of refin-
ing the Steps of public health nutrition decision-making and
scooping out the supporting materials and guidelines for the
framework.
2. Case studies (N = 18) based on triangulated evidence from
interviews, desk research, and the workshop to map the exist-
ing nutrition policy decision-making onto the Steps of public
health nutrition decision-making.
The ideal of a rational-linear model of public health nutrition
policy making (Fig. 20), with its emphasis upon orderly consid-
eration of different types of evidence does not exist in practice.
These findings are not new, it has been long acknowledged
that the processes through which public policy is formed are
exceedingly complex (Kingdon, 2003). In recognition of this,
EURRECA has subsequently developed an alternative depic-
tion of the process (Fig. 21). This Public Health Nutrition Policy
Framework describes what considerations can influence the way
in which nutrition policy goal—a desired health outcome—is
linked to policy action. Its main premise is that (a) contexts
that form a backdrop of public health nutrition policy develop-
ment vary and therefore the orderly stepwise approach is un-
tenable and can hide the real influences upon policy decisions;
(b) the same type of evidence can be used to answer different
policy-relevant questions and therefore it should not be tied to
a specific step; (c) questions relevant to each step can be ad-
dressed using a combination of evidence. The three sources of
evidence are broadly defined as: Science, which includes both
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Table 6 Examples of nutrient related policy options (draws on definitions outlined in Ledbury et al., 2006)
Policy type Policy instrument for implementation Examples
Social voluntary Publications Multiple countries: food-based dietary guideline messages and food guides
Campaigns Czech Republic: 6th March iodine day
Labeling Multiple countries: back of pack nutritional information
Advisory service Multiple countries: training and advice provided to health professionals to
disseminate to the public
Representation service An expert is appointed to act on behalf of a person or business, e.g.,
Ombudsman
Economic Taxation Multiple countries: tax rate differences between healthy and unhealthy foods
Charges Government charges for services that are consumed∗
Subsides and vouchers UK: healthy start program—vouchers to swap for healthy foods/vitamin
supplements
Tax credits The government reduces the cost of an activity∗
Benefits and grants Finland: free school meals
Award auctioning of franchises and licenses Systems under which the right to produce a good/service is sold
Government loans, loan guarantees and
insurance
Government provides loans and/or a subsidy (e.g., through guarantees or
insurance)∗
Regulation and legislation Price and market structure regulation Denmark: fat tax
Production and consumption regulation Denmark: mandatory table and bread salt iodization; Poland: mandatory
infant formula fortification
Standard setting regulation UK: nutrient profiles for “traffic-light” nutrition labeling
Prescriptions and prohibition legislation France and UK: banning of school soft drink dispensers
Rights and representation legislation Rules that provide agents with rights and/or representation, e.g., food security
human rights
Self-regulation Voluntary agreement Spain: voluntary fortification of low fat milk and milk products with vitamin D
Codes of practice UK: Health Food Code of Good Practice (Food and Drink Industry)
Co-regulation UK: OFCOM (communications regulator) rules prohibiting high fat, salt, and
sugar food advertisement
Intervention short of legislation Goal setting EU platform for action on diet, physical activity, and health includes
reformulation
Infrastructure provision Multiple countries: urban development for health, e.g., urban farming
Note: ∗Not currently directly related to nutrition.
Figure 21 Public Health Nutrition Policy Framework. (Color figure available online.)
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Table 7 Reported policies implemented relevant to micronutrients in the 35 countries surveyed in 2007 (n countries, if ≥ 9)
General health Monitoring and Specific health
Micronutrient education FBDG evaluation education Fortification Supplementation Labeling Vol. action Task force
Vitamin A 14 12 9 10 9
Vitamin D 13 13 9 10 14
Vitamin E 12 11
Vitamin C 13 13 9
Thiamin 12 10
Riboflavin 11 10
Niacin 11 9
Vitamin B6 11 10
Folate 14 13 13 13
Vitamin B12 11 11
Sodium 16 15 9 11 11 15
Potassium 11 10
Calcium 14 13 9 10
Magnesium 10 10
Iron 15 12 9 10 10
Zinc 10 9
Copper 10 9
Phosphorus 10 9
Selenium 10 9
Iodine 18 15 11 9 21 9
Notes: FBDG = food-based dietary guidelines, Monitoring and evaluation = monitoring and evaluation of nutritional intake/status, Vol. action = inducing
voluntary action in industry, Task force = setting up a task force, Thirty-five countries surveyed: Albania; Austria; Belgium; Bosnia and Herzegovina, Federation
of Bosnia and Herzegovina1; Bosnia and Herzegovina, Republika Srpska1; Bulgaria; Croatia; Czech Republic; Denmark; Estonia; Finland; France; Germany;
Greece; Hungary; Iceland; Ireland; Italy; Latvia; Lithuania; Montenegro; Netherlands; Norway; Poland; Portugal; Romania; Russian Federation; Serbia; Slovakia;
Slovenia; Spain; Sweden; Switzerland; The former Yugoslav Republic of Macedonia; United Kingdom. 1Bosnia and Herzegovina are politically decentralized
with two governing entities: the Federation of Bosnia and Herzegovina and Republika Srpska.
Table adapted from de Wit et al. (2008).
natural (e.g., nutrition/bio-medical, epidemiological) and social
sciences (e.g., psychology, sociology); Institutions and Policy
(which includes, e.g., evidence about regulatory frameworks,
data on existing policy, governance networks); and Wider Con-
text (which for instance includes international guidelines, wider
ideology, ethics). Unlike the linear model of RAF (MacKer-
ras, 2012), the new representation simply classifies evidence
into logical types and leaves it to the decision-maker to decide
at what point and for what critical question they will source
different evidence. The Public Health Nutrition Policy Frame-
work (Fig. 21) aims to support greater transparency through
making explicit the sources of evidence in the complex process
of decision-making from policy goal to policy action, without
constraining the process to a linear format.
Using Dietary Reference Values in Policy Making:
Evaluating Policy Implementation (Activity 9)
Policy implementation and evaluation has been included here
to acknowledge the role of micronutrient requirements in the
wider public health nutrition context (research, policy, and prac-
tice). The work of EURRECA centered upon the activities pre-
viously presented. However, a small number of EURRECA re-
search findings were deemed relevant to policy implementation
and evaluation. These have been detailed below to illustrate how
data from this activity could be used to inform the selection of
effective policy options, as well as feedback information on
the need to review a policy or the micronutrient requirements
themselves.
Included below are descriptions of currently implemented
policies and evaluation measures, as well as perceived bar-
riers to policy implementation. For comprehensive data and
guidelines on nutrition policy implementation and evaluation in
Europe, please see other European Commission funded research
projects, United Nations organizations, or European Commis-
sion departments that have been recently active in this area,
e.g., The EATWELL project, the Directorate-General for Health
and Consumers European—DG SANCO, UNICEF, and WHO
(Oxman et al., 2006; Branca et al., 2009; Tru¨bswasser and
Branca, 2009; European Commission, 2010; ; Traill et al., 2010;
Capacci et al., 2012).
Current Policies in Europe
In 2007, EURRECA conducted a questionnaire survey with
key informants representing 35 European countries/regions
(see Table 7; de Wit et al., 2008). Each informant was asked
to indicate the policies implemented in their country relevant
to 20 predefined micronutrients using both open free format
and closed multiple choice option questions. Results suggested
that across a range of micronutrients, the most frequently
implemented policies were directed at the general diet rather
than specific micronutrients. These took the form of social
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and voluntary policies, such as food-based dietary guidelines
and general health education. Nevertheless, almost a third
of those surveyed also implemented policies targeted at one
or more of the following nutrients, namely, calcium, folate,
iodine, iron, sodium, vitamin A, and vitamin D. These policy
options included regulation and legislation, self-regulation,
and intervention short of legislation, for example, volun-
tary/mandatory fortification, supplementation, and labeling
programs (de Wit et al., 2008; Dhonukshe-Rutten et al., 2010a).
The policies implemented may differ between nutrients and
countries/regions for many of the reasons previously discussed
in Activities 1–8. For example, a policy relevant to iodine was
implemented in the majority of countries where 21 out of 35
countries conducted voluntary/mandatory fortification (e.g.,
salt iodization). It is likely this was due to the long standing
coordinated scientific opinion and international action from
WHO, UNICEF, and the nongovernmental organization of the
ICCIDD to implement universal salt iodization policies and
eradicate iodine deficiency disorders (Hetzel, 2005).
Policy Evaluation Measures
The questionnaire results in Table 7 identified nutrition mon-
itoring and evaluation of nutrient inadequacy in a number of
countries, particularly regarding iodine. These data from regu-
lar national or international monitoring surveys can act as policy
evaluation measures and provide change data on disease inci-
dence, health status, nutrient status, or dietary intake data pre-
and post-policy implementation to evaluate the impact of a pol-
icy. However, the EURRECA questionnaire data suggested that
these measures were not always put in place: there were no
nutrition monitoring or evaluation programs implemented for
any micronutrient in over half of the countries surveyed (see
Table 7).
An absence of policy evaluation measures or available eval-
uation data was also seen in further work by EURRECA. A sys-
tematic narrative literature review on food-based dietary guide-
lines (FBDG) found that although they were actively promoted
as a viable public health nutrition policy, there was little eval-
uation of FBDG effectiveness in terms of whether the general
public used the guidelines (Brown et al., 2011). Twenty-eight
studies were reviewed, which employed a variety of designs
and methods to judge the awareness, understanding, or use of
FBDG by consumers (qualitative interviews, focus groups, field
tests; quantitative questionnaire surveys and mixed methods ex-
periments and questionnaire surveys). Some of these were far
removed from a targeted health outcome or behavior, such as
the distribution of dietary education leaflets, posters, or flyers
(indicative of policy implementation rather than policy impact).
This work concluded that there was a degree of consumer aware-
ness and understanding regarding FBDG, but there was little
evidence to suggest consumer use of FBDG. However, more
importantly the quality and quantity of the studies available for
review was questioned and a paucity of available evaluation data
highlighted.
Barriers to Policy Implementation
A series of qualitative studies using questionnaires, in-depth
desk research, interviews or case studies (combination of ei-
ther/or questionnaire, in-depth desk research, and interview
data), were conducted by EURRECA between 2007 and 2011
(for further study details, please see the referenced publica-
tions). This work identified a number of possible barriers to
policy implementation and evaluation.
One study conducted 57 qualitative interviews with key in-
formants, predominantly representing scientific advisory bod-
ies and national governments, in 10 European countries: the
Czech Republic, Denmark, England, Germany, Greece, Italy,
the Netherlands, Norway, Poland, and Spain. Results suggested
that budget or economic constraints were a major barrier to
policy implementation. Furthermore, co-operation with and be-
tween organizations or institutions at a national level (e.g.,
government departments and all stakeholders—food industry
producers, manufacturers, retailers and caterers, research cen-
ters, health professionals, consumer groups, media, etc.) was
viewed as crucial to the successful implementation of any pol-
icy. This was in terms of accessing a broad range of knowl-
edge throughout the micronutrient requirement setting process
to ensure the policy implementation was sufficiently planned
as well as in terms of sharing resources, limiting conflict with
existing policies, and ensuring shared advocacy and support
for a policy (Jeruszka-Bielak et al., in preparation). However,
an additional EURRECA study (Timotijevic et al., 2010a) sug-
gested that the degree of stakeholders’ involvement prior to pol-
icy implementation and evaluation differed between countries
(the Czech Republic, Denmark, Germany, Hungary, Norway,
Spain, and the United Kingdom). This appeared to be influ-
enced by the historical, social, political context of the country
(e.g., previous food crises such as variant Creutzfeldt-Jakob dis-
ease (vCJD/nvCJD) the human prion disease caused by bovine
spongiform encephalopathy (BSE) in the UK led to formalized
stakeholder involvement throughout nutrition decision-making
processes).
CONCLUSIONS
A process for deriving and using micronutrient requirements
comprising nine activities grouped in four stages (i) defining the
problem, (ii) monitoring and evaluating, (iii) deriving DRVs,
and (iv) using DRVs in policy making has been presented. The
framework is meant to be comprehensive and includes an ex-
haustive list of activities that should if at all possible be used for
deriving DRVs and for providing the evidence base for policy
making (Table 8). The framework should not to be regarded as a
prescriptive description of a linear process. The circular nature
of the diagram indicates that it is a continuous and interactive
process in which all the stages are interlinked and have the poten-
tial to feed into each other. The central position of the “monitor-
ing and evaluation” stage communicates that dietary assessment
methodology and nutrition surveillance data are crucial to both
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Table 8 Overview of the EURRECA stages, activities and topics dealt with in each activity
Stage Activities Activity topics
Defining the problem Identifying the nutrition-related health problem (1) • Health outcomes
• Population groups
• Micronutrients
Defining the process (2) • Scientific Advisory Bodies
• Risk assessment and risk management
• Communicating findings to policy decision-makers
Monitoring and evaluating Establishing appropriate methods (3) • Assessment of dietary micronutrient intake
• Assessment of micronutrient status
Nutrient intake and status of population groups (7) • Assessing dietary intake and nutritional status
• Assessing health status reflecting the nutritional status
• Identifying vulnerable groups
• Determinants of micronutrient inadequacy
Deriving dietary reference values Collating sources of evidence (4) • Systematic data collection
• Factorial approach and bioavailability
• Dose–response approach
• Inter-individual variability
Appraisal of the evidence (5) • Study design: observational studies and RCTs
• Evaluation of heterogeneity
• Overall quality of the evidence
Integrating the evidence (6) • Quantification
• Expert consultation
• Factorial and bioavailability approach
• Dose–response model
• Scaling of ARs to other population groups
• Biological modeling for multiple micronutrients
Using dietary reference values in
policy making
Identifying policy options (8) • Identify policy goals
• Evaluate evidence
• Select appropriate policy action
• Explicit and transparent process
Evaluating policy implementation (9) • Current policies in Europe
• Policy evaluation measures
• Barriers to policy implementation
the definition of the problem (i), as well as to deriving reference
values (iii), and to proposing and evaluating policies (iv).
The first activity defines the nutrition-related health problem
in terms of (i) relevant health outcomes, (ii) specific population
groups, and (iii) the micronutrient of concern. This results in a
prioritization of the micronutrients, which is resulting from the
availability of new scientific evidence, public health relevance,
and heterogeneity of current reference values. In Activity 2, the
process by which DRVs are derived and applied is established
and usually involves bringing together an SAB to provide na-
tional and international credibility and expertise relevant to the
problem to be addressed. The SAB has to acknowledge that, due
to the pressure for scientific consensus, the difficulty of dealing
with scientific uncertainty in policy making contexts, unanimity
in communicating findings, and the inherently political nature
of SAB (as a bridge between science and policy) are particular
challenges in efforts to increase transparency of scientific advice
to policy makers relevant to micronutrient DRVs.
As mentioned in Activity 3, monitoring the intake and status
of certain micronutrients and related health endpoints requires
the use of best practice methodologies, definitions, and termi-
nologies. In fact, the “Monitoring and evaluating” stage is rele-
vant to all stages in the diagram. The information derived from
monitoring the intake, status, and health situation in European
countries or populations provides input to the priority setting
(stage “Defining the problem”) and refers to inadequacies and
public health problems. Moreover, evaluation measures provide
the basis for the policy options and implementation as well.
This includes inadequacies based on monitoring data. Activity
7 “Nutrient intake and status of population groups” in particular
focuses on evaluation relevant to “Using dietary reference val-
ues in policy making” and then closes the loop to “Defining the
problem.”
The stage “Deriving dietary reference values” consist of three
sequential activities, i.e., Activities 4, 5, and 6. A variety of
sources of evidence are used to derive dietary micronutrient
requirements. The availability of data from different types of
study influences whether the “factorial” or “dose–response” ap-
proach is adopted in the derivation process. Activity 4 “Sources
of evidence” describes a harmonized and standardized approach
for the identification and collation of robust data, which is indis-
pensable for the elimination of current disparity in the evidence
base for micronutrient recommendations. The strength of this
approach is that data identification, collation, and ultimately
analysis can be achieved in a transparent manner. The process
can be tailored with relevance to specific population groups
and micronutrients and for data to be used in both the facto-
rial and dose–response approach. Activity 5 “Appraisal of the
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evidence” involves interpreting the data by means of quanti-
tative or qualitative analysis, assessing the quality of the data,
and including certain elements of judgment, which will result in
a qualitative scientific conclusion. This conclusion will inform
decision-makers about which data could be used for the defini-
tion of micronutrient requirements. Activity 6 “Integrating the
evidence” involves the quantification and integration of both
factorial and dose–response approaches into ARs including the
derivation of the variation in requirements. Eventually, refer-
ence values for micronutrient intake for specified proportions of
the population (resembling the definition of AR and PRI) can
be derived from bivariate or trivariate models once thresholds
on the health or status variable are set.
Finally, as described in Activities 8 and 9 (stage “Using di-
etary reference values in policy making”), policy decisions re-
garding the implementation of nutrient recommendations need
to be made and include the need for an understanding of food
related behavior and other relevant evidence needed for develop-
ing public health nutrition policy. The framework for consider-
ing evidence in public health nutrition policy development that
was developed within EURRECA can be used for as a checklist
for the types of evidence that routinely enter decision-making.
It is important to note that the different activities can be
conducted by different bodies. The extent to which each stage
will be dealt with comprehensively will depend on the time,
resources (including expertise available) and information avail-
able in the country or region. It may be the case that some
of the activities need not be carried out in full in a particular
country or region if it is felt that these have already been ade-
quately dealt with on a previous occasion, e.g., decisions to go
with previously established information or the adoption of de-
cisions from other bodies. Where organizations choose to draw
on activities carried out elsewhere, the framework can act as a
checklist to ensure all important matters have been addressed.
The framework can serve as a structured guide for safeguarding
that all issues essential for deriving requirements have at least
been considered. Limits on resources, available time and avail-
able information will shape the scope of work a given body can
take; decisions will need to be taken as what can be regarded as
the most relevant and urgent activities.
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ABBREVIATIONS
A-1-ACT = Alpha-1-antichymotrypsin
ACE = Angiotensin-converting enzyme
AHRQ = Agency for Healthcare Research and
Quality
AI = Average intake
ANR = Average nutrient requirement
ApoE = Apolipoprotein E
AR = Average requirement
b-car = Beta-carotene
BMD = Bone mineral density
BPGs = Best practice guidelines
CASP = Critical appraisal skills programme;
CC = Correlation coefficients
CD2, CD4, CD19 = Cluster of differentiation 2, 4, and 19
CEE = Central and Eastern Europe
CHD = Coronary heart disease
CRP = C-reactive protein
Cu = Copper
CV = Coefficient of variation
CVD = Cardiovascular disease
DACH = German-speaking countries (Germany,
Austria, Switzerland, etc.)
DFE = Dietary folate equivalent
DR = Dietary records
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DRI = Dietary reference intake
DRV = Dietary reference value
EAR = Estimated average requirement
EBP = Evidence-based policy
EC = European Commission
EFSA = European Food Safety Authority
ENA = Early Nutrition Academy
ENHR = European Nutrition Health Report
ENO = European Nutrigenomics Organisation
EU = European Union
EU27 = The European Union (EU) is an economic
and political union or confederation of 27
member states located primarily in Eu-
rope.
EURRECA = EURopean micronutrient RECommenda-
tions Aligned Network of Excellence
FAO = Food and Agriculture Organisation
FBDG = Food-based dietary guidelines
FCDB = Food composition database
Fe = Iron
FFQ = Food frequency questionnaire
FSA = Food Standards Agency UK
GDS = Geriatric depression scale
GPx = Glutathione peroxidase
GST = Glutathione S transferase
GSTM1 = Glutathione S-transferase Mu 1 gene
GSTT1 = Glutathione S-transferase theta 1 gene
HBS = Household budget survey
HIV = Human immunodeficiency virus
i.m. = Intramuscular
ICCIDD = International Council for the Control of
Iodine Deficiency Disorders
ID = Iron deficiency
IDA = Iron deficiency anemia
IDD = Iodine deficiency disorders
IDE = Iron deficiency erythropoiesis
IL = Interleukin
IL-1 = Interleukin-1
ILSI = International Life Sciences Institute
IOM = North American Institute of Medicine
I-S-H = Intake–status–health
IU = International unit
LBW = Low birth weight
LRNI = Lower reference nutrient intake
LTI = Lower threshold intake
Mg = Magnesium
MMSE = Mini-mental state examination
MTHFR = Methylenetetrahydrofolate reductase
MT1A = Metallothionein 1A gene
NHANES = National Health and Nutrition Examina-
tion Survey
NO = Nitric oxide
NoE = Network of Excellence
NORDEN = Nordic Council of Ministers
NRSB = Nutrient recommendation setting body
NTD = Neural tube defect
NuGO = Nutrigenomics Organisation
NuGOwiki = European Nutrigenomics Organisation
webpages link
PGE2 = Prostaglandin E2
PGF2a = Prostaglandin F2a
PRI = Population reference intake
PSS = Perceived stress scale
PTH = Parathyroid hormone
RAF = Risk assessment framework
RCF = Red cell folate
RCT = Randomized controlled trial
RDA = Recommended dietary allowance
RNI = Reference nutrient intake
SAB = Scientific advisory body
SAC = Scientific Advisory Committee (or coun-
cil)
SACN = UK Scientific Advisory Committee on
Nutrition
SBP2 = Selenocysteine insertion sequence
Se = Selenium
SEBR = Systematic evidence-based review
SEEN = Spanish Society for Endocrinology and
Nutrition
SelH, SelI, SelK = Selenoproteins H, I, and K
SEP15 = 15 kDa selenoprotein gene
SEPP1 = Selenoprotein P gene
SES = Socio-economic status
SF = Serum ferritin
SNP = Single nucleotide polymorphism
TNFα = Tumor necrosis factor alpha
TNFαR2 = Tumor necrosis factor alpha receptor 2
TrxR1-3 = Thioredoxin reductases 1-3
TSH = Thyroid stimulating hormone
UIE = Urinary iodine excretion
UL = Tolerable upper intake level
UNICEF = United Nations Children’s Fund
USI = Universal salt iodization
UVB = Ultraviolet blue
VCAM = Vascular cellular adhesion molecule
VMNIS = Vitamin and Mineral Nutrition Informa-
tion Service
WBC = White blood cell
WCRF/AICR = World Cancer Research Fund/American
Institute for Cancer Research
WHO = World Health Organisation
WMD = Weighted mean difference
Zn = Zinc
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Appendix 3 Table 5 relationship between published works 1-5 and thesis (highlighted in yellow) 
Thesis: The process of setting micronutrient recommendations 
Publication 5 Dhonukshe-Rutten, 2013. 
EURRECA framework describing the process 
for setting micronutrient requirements.  
Brown, 2011a; 2011b; 2013; 
2015 contributed to activities 2, 
8 & 9 in Dhonukshe-Rutten, 
2013 Four stages Nine activities 
 Effective communication of risk is a prerequisite to a 
transparent risk analysis process and can facilitate 
stakeholder (lay and expert) involvement and the 
handling of uncertainty during the process of risk 
analysis. This is in addition to the traditional role of 
risk communication related to disseminating the 
outputs of risk assessment and risk management 
activities.  
 Identified challenges to communicating risk: 
1. Inconsistent terminology 
2. Managing lay involvement  
3. Clarifying the purpose of recommendations 
during problem formulation and evaluating 
recommendation implementation 
4. Articulating values, assumptions, judgements in 
the light of uncertain, unknown, variable 
evidence 
 Explicit awareness of the challenges to 
communicating risk will aid debate on the pre-
eminent micronutrient recommendation setting 
process and support international initiatives for 
transparent scientific and regulatory process. This 
will ultimately aid the evolution of micronutrient risk 
analysis to ensure it is fit for purpose: a valid and 
credible tool to promote and protect public health. 
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appropriate methods 
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ORIGINAL ARTICLE
From micronutrient recommendations to policy:
consumer and stakeholder involvement
L Timotijevic1, MM Raats1, J Barnett1, K Brown1, R Shepherd1, L Fernandez2, L Do¨mo¨lki3,
J Ruprich4, A-M Sonne5, M Hermoso6, B Koletzko6, L Frost-Andersen7 and A Timmer8
1University of Surrey, Guildford, UK; 2European Food Information Council, Brussels, Belgium; 3National Association for Consumer
Protection in Hungary, Budapest, Hungary; 4National Institute of Public Health, Brno, Czech Republic; 5University of Aarhus,
Aarhus, Denmark; 6Ludwig-Maximilians-University of Munich, Munich, Germany; 7University of Oslo, Oslo, Norway and
8UNICEF Headquarters, New York, NY, USA
Background/Objectives: To achieve the nutritional goals stipulated by micronutrient recommendations, greater attention must
be paid to the behavioural routes to such nutritional outcomes. Coopting stakeholders and consumers into decisions regarding
micronutrient recommendations is an important step towards achieving a greater link between micronutrient recommendations
and behaviour. This study aims to examine the rationale and processes associated with consumer and stakeholder involvement
in setting micronutrient recommendations across Europe.
Subjects/Methods: Using the contacts established through the Eurreca network of excellence (commissioned by the European
Commission), the research involved in-depth desk research of key documents and communication channels linked to the
process of setting micronutrient recommendations across seven countries: the United Kingdom, Norway, Denmark, Germany,
Spain, the Czech Republic and Hungary.
Results: Stakeholder engagement is recognized by most countries as an important aspect of the process of setting micronutrient
recommendations and their translation into policy, although there is notable variation in the extent to which this has been
achieved across the seven countries and its effect on final decisions. Stakeholders were not involved at the outset of the process
(‘framing’ of the problem) in any of the countries, and there was no evidence of consumer involvement and open public fora.
Conclusions: Some of the key explanatory factors for diversity in the degree of involvement include historical sociopolitical
context; the extent to which food and nutrition are key policy agenda; and the relative power of stakeholders in influencing food
and nutrition policy.
European Journal of Clinical Nutrition (2010) 64, S31–S37; doi:10.1038/ejcn.2010.58
Keywords: nutrient recommendations; stakeholder engagement; consumer behaviour; public participation; nutrition reference
values; nutrition policy
Introduction
Micronutrient recommendations function as a blueprint
for the development of public health nutrition policy
(Pijls et al., 2009). Although a product of scientific judgment,
micronutrient recommendations are a tool for which the
ultimate value will be decided by their relevance to those
who will use them and stand to benefit from them, including
policy makers, stakeholders (for example, industry, small and
medium enterprises, consumer groups) and the consumer.
Given their policy application and use, consumer and
stakeholder involvement in the development of micronu-
trient recommendations may be necessary for a number of
reasons. Their involvement may substantively contribute to
the outcome of the decision-making process, affecting the
quality of decisions by widening and scrutinizing frame-
works for debate, and broadening the range of knowledge
used to inform decision making (Irwin and Michael, 2003).
Their involvement is also instrumentally important
to increase the legitimacy and credibility of decisions
and maintain public trust (House of Lords, 2000). In the
context of greater emphasis on public involvement in the
decision-making process at all levels of national and
European governance (European Commission, 2001, 2006),
consumer and stakeholder engagement in the process of
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setting micronutrient recommendations is also necessary to
confirm the importance of open and transparent governance
of science and policy (Fiorino, 1989; Stirling, 2008).
It is now widely recognized that significant shifts in
dietary habits in line with recommendations will necessitate
a sustained multisector and joint working of a range of
stakeholders and government departments (Foresight, 2007).
The need to draw diverse perspectives and values into the
process of framing and setting the terms of reference when
developing recommendations and policies is deemed to be a
prerequisite in the efforts to identify optimal and most
effective policies to a healthier diet (European Commission,
2001, 2006). The political nature of the process of setting
recommendations and planning nutrition policy (Thuraisin-
gam et al., 2009), coupled with the policy emphasis on
democratization of science—the need to open up scientific
decision making to public scrutiny (European Commission,
2000; Wardman and Lofstedt, 2009)—calls for a better
understanding of when and how the involvement of various
stakeholders in the process of setting nutrient recommenda-
tions is best achieved. The aim of this paper is to examine
and evaluate the current rationale and processes associated
with stakeholder involvement in setting micronutrient
recommendations across Europe.
Evidence of stakeholder involvement in the process of setting
micronutrient recommendations and developing policy
applications
Stakeholders are socially organized groups who have a strong
interest in the outcome of the process of setting micronu-
trient recommendations, as they will invest resources or be
willing to accept some responsibility for maintaining the
viability of nutrient recommendations (Ashwell et al., 2008;
Renn, 2008). They can be identified along the whole food
chain, and can vary in their values, concerns and level
of technical expertise and resources that they bring into the
process of setting recommendations, development of policy
and policy application.
Despite European governments’ and policy makers’
increasing recognition of the crucial role of stakeholder
involvement in all aspects of decision making (for example,
European Commission, 2001, 2002, 2006), there is limited
evidence that stakeholder input is either not sought or only
sought at the later stages of nutrition policy development.
Tru¨bswasser and Branca (2009) suggest that multisector
collaboration is a preferred approach to developing nutrition
policy, but provide no detail as to how this is achieved. In
relation to nutrient recommendations, it is similarly unclear
at what stages of decision making the collaboration and
involvement of stakeholders is sought. The lack of publicly
available information and the lack of transparency on how
different factors contribute to the development of nutrition
policies suggested to Lachat et al. (2005) that stakeholder
mobilization was largely restricted to the implementation
phase and that a top–down approach to decision making, in
which stakeholder input is sought at the latter stages of
decision making, was the norm.
Evidence also points to the fact that, in cases in which
consultation processes are in place, they are not effective, as
the stakeholder’s contribution fails to affect final policy
decisions. Thuraisingam et al. (2009) analysed the views of
consultees to a draft document associated with the develop-
ment of the 2006 nutrient reference standards for Australia
and New Zealand. The authors pointed to the need to
include stakeholder views in the framing stages of the
decision-making process, such that the conceptual and
applied issues emergent from stakeholder submissions could
frame the terms of reference of the working group. This
paper seeks to increase the currently limited European
evidence on whether, when and how stakeholder involve-
ment is sought in the process of setting micronutrient
recommendations and policy applications.
Method
Cross-European case studies were conducted to obtain an
overview of stakeholder involvement in the workings of the
scientific advisory bodies that set micronutrient recommen-
dations in seven countries selected (Norway, Denmark, the
United Kingdom, Hungary, the Czech Republic (CR), Spain
and Germany), exemplifying a range of profiles with respect
to three criteria: public health tradition, the institutional
architecture of the country and the extent of participatory
democracy (Table 1).
Table 1 Criteria for the selection of countries for case study
Nordic
countries
Czech Republic
and Hungary
DACH Western Europe (United Kingdom,
the Netherlands, France, Ireland)
Southern Europe
(Greece, Italy, Spain)
Institutions Decentralized,
diversified
Intermediately
centralized,
undiversified
Decentralized (Germany and
Switzerland) and intermediately
centralized diversified
Decentralized (the United
Kingdom) and intermediately
centralized
Decentralized and
intermediately
decentralized
(Greece)
Public health
nutrition tradition
Long Emerging Long Medium Short
Participatory
democracy
Extensive Limited Extensive Extensive Medium
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The main objectives of the comparative desk research
were to
 understand the process from nutrition science to policy
and the determinants of variation in this process across
European countries;
 identify the way in which scientific, policy and consumer
issues are addressed throughout this process.
In each country, key policy document searches and
reviews addressed
(a) the degree of transparency of the decision making process
and of openness to public scrutiny;
(b) contextual characteristics: the institutional, administrative
and political context (for example, how food and policy
are conceptualized; the names of key stakeholders in
influencing nutrition policy, how public and stakeholder
input is sought in the development of nutrient policy);
(c) the generic process of setting micronutrient recommendations
(for example, who is in charge, triggers for the develop-
ment of recommendations, who is invited to take part,
what is the type of scientific data considered; the degree
of scientific certainty/controversy); and
(d) the process from nutrition science to policy application (for
sodium, folic acid, vitamin D and iodine), including
whether there were any public consultation exercises to
aid final policy decisions and how stakeholders were
positioned with respect to the nature of scientific
evidence and policy applications.
All available documents were used, including academic
and grey literature, to address the issues of interest. An
assessment was made of the degree to which literature and
documentation on the workings of the institutions respon-
sible for the development of micronutrient recommenda-
tions, public and stakeholder involvement and nutrition
policy processes is publicly available. This provided another
layer of data that signalled the degree to which participatory
democracy has evolved and the level of transparency and
openness in the processes of decision making from nutrition
science to policy.
Results
Stakeholder and consumer involvement in setting micronutrient
recommendations
Consultations and stakeholder involvement are a common
practice in the process of setting nutrient recommendations
in Norway, the United Kingdom and Denmark. Efforts
to open up the decision-making process in this domain in
Spain, the CR and Hungary, although encouraged, are not
consistently pursued, nor are they transparent. In Germany,
broader stakeholder involvement is only sought in the latter
stages of the implementation of policies and nutritional
recommendations, but not in relation to the development of
reference values.
United Kingdom. In the United Kingdom, the Scientific
Advisory Committee for Nutrition (SACN) has a remit to
engage with stakeholders and does so through consultation
processes during which stakeholders are invited to comment
on working documents under specific terms of reference. All
the processes that SACN engages in are open to public
scrutiny. The working documents, as well as stakeholder
submissions, are publicly available and it is possible to track
the way in which these submissions have been dealt with
in SACN’s subsequent decisions. Submissions come from a
range of sources, including consumer organizations, the
private corporate sector, members of academic and profes-
sional bodies, other international advisory bodies and
agencies and, sometimes, from individual members of the
public. Although stakeholder involvement is evident in
some cases as early as collecting evidence to be considered
in compiling micronutrient recommendations (for instance,
SACN, 2003a, b, c), this is notably carried out by invitation,
limiting stakeholder input to a number of well-established
and large organizations. Stakeholder involvement is typically
sought at the latter stages of the process through a formal
consultation, when the stakeholders are invited to submit
their comments to the draft report produced by an advisory
working group. Sometimes, specific stakeholders are expli-
citly invited from a very early stage to articulate their
opinion or bring to the group’s attention any work that they
think the group may not be aware of. Although the
consultation process is open and the working groups of
SACN are obliged to provide responses to the stakeholder
submissions, it is not clear how and why submissions are
considered and comments adopted and incorporated into
final documents. The rationale for the way in which
stakeholder input is managed is notably missing.
Norway and Denmark. There is evidence of involvement of a
wider expert and nonexpert community in the Nordic
region. There are two stages of stakeholder involvement,
the first being more informal than the latter. Having
constructed a working document, the committee sends it
to a broad range of stakeholders who are invited to comment
on it. This includes private sector, consumer organizations,
nutritional experts, academics and agencies. After this first
round of external consultations, the document may be
revised and is sent out to the participants of the Nordic
Nutritional Conference. At this conference, a plenary
discussion is organized in which all participants have an
opportunity to ask questions about the draft, lodge objec-
tions and put forward suggestions. This consensus-seeking
process involving many stakeholders is believed to be one of
the factors explaining the successful implementation of the
common Nordic Nutritional Recommendations. Neverthe-
less, it is notable that the process of seeking input from
stakeholders is evident at the latter stages of their develop-
ment. Furthermore, there is lack of clarity about the way in
which stakeholder input has been used to inform policies, as
the rationale for adopting (or not) certain policy options is
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not transparent. For instance, to date in Norway, despite the
existence of the Nordic Nutritional Recommendations, there
is no mandatory declaration of salt content, nor norms for
salt levels in foods. Similarly, in Denmark, despite the
discrepancy between daily recommended intake and actual
intake and the recommendations for population-wide re-
duction in sodium intake, no action has been taken by the
Danish authorities towards encouraging the industry or the
population to decrease the use of sodium.
Germany. Cross-institutional partnerships are common in
setting micronutrient recommendations and policy in
Germany. Indeed, the ‘Reference values for nutrient intake’
document (DGE, O¨GE, SGE, 2000) is the result of a close
collaboration between the German, Austrian and Swiss
nutrition societies/associations. Stakeholder input for the
development of reference values is limited, however, to
members of federal institutions, academic organizations and
specific working groups who contributed under the lead
of the working group ‘Reference values for nutrient intake’.
The contributors are invited to participate and there is no
evidence of a wider stakeholder consultation process taking
place at the early stages of developing reference values.
The wider involvement of stakeholders, such as regional
governments and other governmental institutions (for
example, offices for health promotion, regional offices for
consumer protection), professional associations, academic
institutions and working groups (for example, profesional
medical societies), industry (for example, industrial federa-
tions), nongovernmental organizations (for example, con-
sumer protection organizations), individuals and other
interest groups (for example, health insurances), often takes
place at a later stage, in the implementation of established
nutrition-related policies. For example, in the last few years,
a number of activities to strengthen and coordinate preven-
tion have been undertaken at the federal level involving and
promoting the participation of a broad set of stakeholders.
The national action plan ‘In form’, fostered by cooperation
between the ministries of health and consumer protection,
aims at promoting healthy eating and exercise in the
German population. The ‘In-form’ website shows that
regional and local authorities, scientists, industry and several
societal groups (non-governamental organizations, associa-
tions, unions and individuals) have been involved in the
development of ideas and action measures to be taken, and
that this has been carried out through reports, expert
discussions and workshops. These partnerships are being
further used during the implementation and further devel-
opment of the action plan. However, there is no information
on how this involvement has been managed from an early
stage in the planning of the action plans, which initiatives
were accepted or rejected and how decisions were taken.
Spain. There is some evidence of stakeholder involvement
in Spain but mainly at the latter stages of nutrition policy
development in the planning and implementation of
nutrition-related policy strategies. The NAOS (‘Nutrition,
physical activity and the prevention of obesity’) strategy was
created in response to the need for a national nutrition
policy that could promote regional action plans (Neira and
de Onis, 2006). This is a multisector approach to the problem
of obesity in Spanish children, involving stakeholders in
the planning and implementation phase of the actions.
A platform of more than 80 organizations was organized to
compile knowledge and expertise on the subject and revise it
to determine the necessary and most effective preventative
actions. Public administration (different ministries, autono-
mous communities), universities, professional colleges,
scientific societies, foundations, independent experts, con-
sumer associations and the food and beverage industry
were among the organizations invited to contribute to the
platform. They were divided into different working groups
with specific goals. Since its implementation, three conven-
tions (2007, 2008 and 2009) have been organized with the
different sectors involved in the development of the strategy
with the aim to share experiences and discuss future actions.
On two occasions, NAOS awards have been given to the best
initiatives in the different intervention areas.
Although the NAOS strategy, together with nutritional
recommendations and a FBDG NAOS pyramid, is publicly
available from the Spanish Authority for Food Safety and
Nutrition (AESAN) website, it is not clear from the existing
documents (a) how the organizations/stakeholders were
selected and approached; (b) which specific organizations/
stakeholders took part in the process; (c) the balance of
power and the relative weight given to each stakeholder
input in the development of the strategy; and (d) the exact
procedure for making decisions (is it consensus seeking or
adversarial; were differences accounted for and how?). Many
other issues are not clarified, including the way in which
evidence is evaluated and used in the development of NAOS
strategy.
However, involvement of stakeholders in the context of
setting micronutrient recommendations in Spain is less
explicit, partly because the process is fragmented and lacks
dedicated national-level government sanctioning. More
articulated and explicitly communicated was the process of
consensus seeking in the preparation of Spanish population
food-based dietary guidelines, carried out at a conference in
Bilbao, in which a number of industry and consumer
organizations were invited to comment on the expert panel’s
draft with the aim of developing a consensus on the overall
structure of dietary guidelines.
The CR and Hungary. There is little written evidence that a
wider stakeholder involvement is actively sought in Eastern
Europe. In the past, the setting of recommendations was
a government responsibility and communication with
other stakeholders was limited. Over the past 10 years,
following the push from the European Union to adapt the
country food production and consumption standards and
procedures, there is an increased focus on food governance.
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It is deemed desirable that stakeholders representing various
interests take part in formulating nutrition and food
recommendations. These would include mainly professional
medical societies, medical, technological and agricultural
universities and specialized research workplaces, societies
and bodies (for example, Scientific Committee for Foods, the
Food Research Institute Prague, the Czech Academy of
Agricultural Sciences), as well as the nonprofit sector
(for example, Society for Nutrition) and the industry
(Food Chamber of the CR, Union of Trade and Tourism,
representatives from international food companies and so
on). Indeed, during the sociopolitical transition since 1989,
non-governamental organizations and food industry became
increasingly active in food-related public health decision
making. However, their input is rarely formalized and
therefore lacks transparency. Some of the reasons for this
include the dominant and highly centralized governmental
structures and state institutes, limited scientific knowledge
available to non-governamental organizations and the food
corporate sector, an increasingly financial focus of the new
private food corporate sector, lack of standardized and
formalized procedures for stakeholder input and the influ-
ence of the international food companies that use own
country nutrient recommendations in developing products
for CR. There are also decreasing research activities in the
field of nutrition due to diminishing financial support from
newly privatized food industry and government.
In an attempt to address this and other issues with regard
to nutrition, and in response to pressures from the European
Union, in 2002, the National Scientific Committee for Food
(SCF) was established. This body’s evidence-based work is
transparent and independent (SCF, 2002) and the body has
a remit to communicate with stakeholders in this area
(for example, producers, consumers and academy). The
Czech SCF was invited to evaluate newly suggested Czech
nutritional recommendations prepared by an independent
group of experts (stakeholders involved) working for the
Ministry of Health in 2004 (SCF, 2005). The SCF did not
recommend accepting these new national recommendations
because of the fact that setting of values was not explained
transparently. Greater cooperation and alignment with the
European Union recommendations was deemed necessary.
Simultaneously, however, other organizations pushed to-
wards a more regional cooperation (for example, within
central Europe—with DACH countries) and these two
models of international collaboration in the process of
setting micronutrient recommendations are still a subject
of political debate. Involvement of stakeholders is partly
premised upon resolving the issue of which rationale for
international cooperation is to be adopted, and achieving
standardization of processes of setting micronutrient recom-
mendations.
In Hungary, although the decision-making process on
setting nutrient reference values was open to experts from
different institutions in the area of food and nutrition (for
example, nutrition institution, food research institutions,
universities, doctors and independent nutrition experts),
there was no public consultation nor was there an opportu-
nity for stakeholder input into the draft document.
Discussion
It is clear that, after both the European Union and the
national level policy imperatives to open up its decision
making to wider sections of society, stakeholder engagement
is recognized by most countries as being an important aspect
of the process of setting micronutrient recommendations
and their translation into policy. Most countries have either
engaged or plan to engage interested groups in decisions
regarding micronutrient recommendations. However, there
are also notable differences in the degree to which this has
been achieved.
Within the United Kingdom, Norway and Denmark, the
countries characterized by advanced participatory demo-
cracy, early engagement of sections of society with the
process of setting micronutrient recommendations is evi-
dent. Stakeholder involvement in Spain is encouraged at the
implementation stage, whereas in Germany, an early stage of
setting micronutrient recommendations is characterized by
cross-institutional collaboration between professional
bodies, whereas wider participation is only possible later in
the process. Within CR and Hungary, stakeholder and public
involvement, although encouraged (partly under interna-
tional pressures), is not yet established, whereas the decision-
making process is still limited to expert groups and
individuals.
It seems that such discrepancy is closely related to
the country-specific historical sociopolitical context char-
acterized by appropriate leadership in transforming defunct
governance structures. For instance, within the United
Kingdom, the previous food crises (for example, bovine
spongiform encephalopathy salmonella) have led to the
process of stakeholder involvement being clearly embedded
into the decision-making structures, formalized and made
transparent, thus addressing public concerns about openness
and transparency of nutrition policy governance.
Furthermore, the emphasis on food and nutrition as key
public policy domains also seems to be an important
explanatory factor for the observed discrepancy between
countries in the degree to which stakeholder input into the
setting of micronutrient recommendations is sought. Thus,
in Spain, the food and nutrition policy is weak and decisions
regarding micronutrient recommendations are fragmented;
in CR, the food and nutrition policy is in its infancy, whereas
in Nordic countries and the United Kingdom, food and
nutrition represent key policy and election agendas.
To some extent, the strength and power of stakeholders
themselves within the context of food and nutrition policy
making is also responsible for the observed discrepancy. In
Germany, for instance, the significant role of professional
groups (nutritionists and dieticians) has led to their taking
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control of the process of setting micronutrient recommenda-
tions quite separately from the government. Within the CR,
the weak consumer organizations and the traditional
biomedical approach to nutritional issues, coupled with
the post 1989 upheavals leading to liberalization of economy
(and the formation of new private food businesses), have
functioned as an obstacle to establishing and sustaining
stakeholder involvement.
Even in countries in which engagement is clearly for-
malized (for example, the United Kingdom and Nordic
countries), the stakeholders involved are usually selected by
government, and there is a notable lack of clarity with regard
to the rationale for their selection. Furthermore, their early
input is limited to commenting on the draft documents,
rather than framing the terms of reference of the working
groups. Although most stakeholder consultations are
conducted as a consensus-seeking exercise, there is little
information about the procedures in place to manage diverse
stakeholder inputs. Little is known with regard to how
different stakeholder input is weighed for its influence and
what mechanisms are in place to ensure that stakeholder
comments are reflected in the decisions. Finally, the example
from the Nordic countries shows that there is a lack of
transparency with regard to how and whether the final
decisions of the working groups end up in policy.
There is no open public involvement in decision making
in any of the countries. With the notable exception of the
United Kingdom, which invites one consumer representative
into the SACN meetings, a wider public forum for discussion
on micronutrient recommendations is absent. It is important
to hypothesize about the reasons for this: it might be because
of the perceived lack of interest of the public in this domain,
because of the perceived lack of expertise of the public in
the area of nutrition or because of practical constraints.
In addition, although considered a value in itself (Stirling,
2008), public involvement ought to be meaningful to be
effective (Barnett, 2007), as otherwise it can lead to
disengagement, participation fatigue and resentment. A
delicate balance is to be struck between the public’s
expectations of the existing systems and processes (including
scientific advisory bodies) to provide evidence-based policy
solutions and the public’s desire to shape those decisions
that might require careful balancing of multiple values and
interests. Setting micronutrient recommendations may not
be considered (by the public) as a sufficiently contested issue
to warrant public engagement, as micronutrient recommen-
dations are by definition set for health. Possibly, micronu-
trient recommendations are too removed from people’s
conceptualizations of food-related health and well-being;
this might reduce the likelihood of the public being willing
or able to make a meaningful contribution to the processes
of setting micronutrient recommendations. However, the
uncertainties within nutrition science that inform the reco-
mmendations, the vested interests linked with the policy
outcomes of the recommendations, as well as the growing
public scrutiny of the choices and recommendations of
experts, their independence and accountability for these
choices (Jasanoff, 2005), may function as a push factor for
public engagement. It is important to address when the
public ought to be engaged through future research, as it
will lead to better understanding of the optimal ways of
conducting open and transparent processes of setting
micronutrient recommendations. Questions to address here
include whether and how the public wish to be involved in
these decisions; at what point in the process they wish to do
so; which sections of the public might most usefully
contribute; with what effect and for what issues.
Study limitations
This study has been conducted in the context of limited
information being publicly available to examine in depth
the processes of setting micronutrient recommendations and
stakeholder involvement in these decisions. The desk
research conducted here therefore represents a somewhat
limited data source. However, the analytical framework
adopted took into account the shortcoming, as an additional
information about the state of stakeholder involvement,
helping draw conclusions regarding the level of transparency
and the degree to which governance structures engage
in open communication about these issues. Indeed, much
of what has been discussed in this paper has been drawn
from inferences about the manner in which information is
presented and made available to the public.
Conclusions
Despite the limitations, this paper represents the first careful
look at the extent to which consumer and stakeholder
engagement is established in the process of setting micro-
nutrient recommendations across Europe. The findings
suggest that to harmonize the process of setting recommen-
dations, care should be taken while accounting for the cross-
country differences in how this process is conceptualized not
only by those responsible for the decisions but also by the
wider sections of society. If stakeholder input is to be made a
requirement of the process, the diverse stakeholder policy
involvement experiences across different countries needs be
taken into account. Stakeholders may not be easily identifi-
able in all countries—for instance, consumer organizations
in countries in transition may be both less visible and less
experienced in influencing decisions. Similarly, the corpo-
rate food sector in some countries is still at the early stages of
establishing itself as a key factor, often competing with
much more powerful international corporate organizations
(this of course puts local industry at a disadvantage and
poses practical problems of who should be considered
‘national’ stakeholders). If satisfactory engagement is to be
achieved, there needs to be a clear delineation between the
imperative for greater stakeholder involvement and an
emphasis on policy decisions based on ‘sound science’.
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It is important to recognize that the requirement for
greater institutional and procedural harmonization of nu-
trient recommendation settings across Europe is at odds
with the simultaneous call for an increased stakeholder and
consumer involvement in this process, as the latter requires
increased sensitivity to local specificities (in terms of the
specific national sociopolitical and historical context),
whereas the former aims towards standardization. This is
perhaps one of the key challenges for the rhetoric of
increased stakeholder and consumer engagement.
The recognition that European governments need to rely
on citizens to take responsibility for their own behaviour
in order to avert some impending crises, including obesity
and malnutrition, necessitates a better understanding of the
optimal ways of enhancing consumer behaviour in line with
these goals. Coopting consumers and stakeholders into
decisions regarding how to frame the questions posed to
scientific advisory boards, and how to translate recommen-
dations into viable policy options, might be one of the
avenues towards a more effective nutrition policy. Whether
this is best achieved through stakeholder representatives or
whether open public fora should be pursued needs to be
addressed through future research.
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Abstract
Objective: To examine the workings of the nutrition-related scientific advisory
bodies in Europe, paying particular attention to the internal and external contexts
within which they operate.
Design: Desk research based on two data collection strategies: a questionnaire
completed by key informants in the field of micronutrient recommendations and
a case study that focused on mandatory folic acid (FA) fortification.
Setting: Questionnaire-based data were collected across thirty-five European
countries. The FA fortification case study was conducted in the UK, Norway,
Denmark, Germany, Spain, Czech Republic and Hungary.
Results: Varied bodies are responsible for setting micronutrient recommendations,
each with different statutory and legal models of operation. Transparency is highest
where there are standing scientific advisory committees (SAC). Where the standing
SAC is created, the range of expertise and the terms of reference for the SAC are
determined by the government. Where there is no dedicated SAC, the impetus for the
development of micronutrient recommendations and the associated policies comes
from interested specialists in the area. This is typically linked with an ad hoc selection
of a problem area to consider, lack of openness and transparency in the decisions and
over-reliance on international recommendations.
Conclusions: Even when there is consensus about the science behind micronutrient
recommendations, there is a range of other influences that will affect decisions about
the policy approaches to nutrition-related public health. This indicates the need to
document the evidence that is drawn upon in the decisions about nutrition policy
related to micronutrient intake.
Keywords
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Scientific advisory bodies
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Evidence
Food regulation
Currently, most countries in Europe establish their own
nutrient recommendations, and there is large heterogeneity
in the recommendations within Europe(1–3). The European
Food Safety Authority (EFSA) is in the process of reviewing
and updating the last report on recommended nutrient and
energy intakes for the European Union (EU) population
published in 1993, prepared by the Scientific Committee
on Food(4). Variability is partly due to the use of different
approaches (e.g. health outcomes and methods used when
data are missing for sub-populations), changes over time
in the approach to establishing recommendations and/or
data used(3) and the uncertain nature of many scientific
elements(5). The background information provided in the
recommendation reports lacks transparency as it is not
possible to disentangle the relative contribution of different
aspects of evidence. Because of this lack of transparency it is
*Corresponding author: Email l.timotijevic@surrey.ac.uk r The Authors 2010
often difficult to track why there is heterogeneity in micro-
nutrient recommendations. This lack of transparency then
leads to perceived inconsistency, perceived lack of objec-
tivity, complexity in presentation, lack of clarity, difficulty
in implementation, decreased chances of reliability and it
hides research gaps(6,7).
Variability may also be due to the variable influence of
international organisations such as the WHO, FAO or EFSA.
Although the WHO and FAO are mandated by Member
States to develop policy and programme guidance on
health, food and agriculture-related matters, including
nutrition recommendations, such guidance is freely
accepted by countries. The existing significant scientific
activity at the national level (e.g. Nordic countries –
Denmark, Finland, Iceland, Norway and Sweden, UK,
DACH countries – Germany, Austria and Switzerland) as
well as the historical links that exist between some
national scientific communities can explain the variability
in the acceptance of the international micronutrient
recommendations.
Scientific advisory bodies (SAB) are groups through
which expert advice enters the political process and can
establish institutions, short-term commissions, ad hoc and
standing committees and an informal network of experts(8).
Their key role is to feed technical recommendations into the
policy development process. Evidence suggests that SAB
play a crucial role in advising government on development
and implementation of nutrition policies: WHO has noted
the possible link between the existence of SAB and the
degree to which nutrition policies are developed and
implemented(9). There is, however, little research that seeks
to explain why this might be the case. The way in which
nutrition-related SAB operate in Europe, and how they
input into public health nutrition policy related to micro-
nutrient recommendations, is the focus of the current paper.
The changing policy context
Scientific expertise often underlies evidence-based policy
making, as it is used to make decisions more rational,
justifiable and effective. It may also facilitate greater public
acceptance, and is thus a valuable tool in policy makers’
efforts to manage accountability and justify value-based
decisions(9–11). Recent emphasis on evidence-based policy,
the proliferation of governance bodies whose job is to
monitor the evidence base (e.g. EFSA) and ‘knowledge
management systems’ signal a shift in policy making
towards greater reliance on scientific expertise(12).
Although SAB play a crucial role in informing and
providing a rationale for policy decisions, the recent
trajectory of their involvement in government decision
making has been characterised by a shift in their role and
relationship with policy decision makers, from a closed,
instrumental approach to policy (i.e. science-driven) to
the emphasis on openness (i.e. admission into policy
considerations of different forms of evidence, including
scientific) and transparency (i.e. more clarity about
the way in which decisions have been achieved(13–15)).
Following a series of high-profile failures of scientific
advisors and government officials to protect public
interest in assessing and managing health and environ-
mental risks (e.g. BSE), the recognition that uncertainty is
inherent to scientific judgement and that subjective and
objective elements of expert decision making are difficult
to disentangle, there are now public and policy pressures
for the democratisation of expertise(13,16,17). Various policy
documents(12,18–20) have indicated a need for greater
transparency in the workings of SAB.
In addition to transparency in the decision-making pro-
cesses of SAB, there is also a call for an increased openness
to the inclusion of stakeholder perspectives. Within the EU,
there has been a move towards pragmatic management
of multiple views and perspectives and co-production of
policy decisions, so that they take into account the views
of the various stakeholders(18,21), while science itself is
expected to be increasingly utilitarian in the way research
questions are framed and solutions sought, with the
expectations of it being informed by and responding to the
views of lay citizens and society at large(9,22). As part of the
call for the democratisation of expertise, recent academic
focus has been on the examination of the workings of
expert advisory bodies(9,15,23–25). The main streams of
empirical work around SAB are:
> knowledge gathering/formation and expert deci-
sions(9,24–26); and
> knowledge transfer – the way in which expert and
policy worlds meet and influence each other(27,28).
Knowledge gathering and formation
The way in which expertise is defined and SAB are
structured determine how a problem is framed, which in
turn influences the decisions around the inclusion or
exclusion of particular perspectives and the way in which
facts are selected and interpreted and conclusions are
drawn(10,23,29,30). The nature and source of expertise may
also be significant factors in whether scientific advice is
taken up in the policy-making process(23). Traditionally,
SAB-related expertise has been defined in terms of
an individual expert’s (i) qualifications, knowledge and
experience in their chosen field; (ii) ‘eminence’ or
‘authority’ as a trusted source of science in communica-
tion with wider society; and/or (iii) their institutional
affiliation(24,30,31).
With the crisis of confidence in science, academic
attention has turned towards the nature of decision
making in SAB, including the way in which experts within
SAB deal with scientific uncertainties, scientific con-
troversies and pressures for consensus(15,32) and the
variety of influences on expert advice(12). From a socio-
logical perspective it is recognised that scientific decision
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making is deeply intertwined with the context in which it
operates(23,32). The notion of co-production of knowl-
edge, which is concerned with the way in which science
and society shape each other, has been put forward as a
useful framework for the study of decision making in
SAB(33), leading to calls for various forms of knowledge
(e.g. technical, lay) being granted equality in the for-
mulation and deliberation around scientific issues(34).
Some of the issues discussed include how to achieve
engagement with the public(34,35), the notions of ‘opening
up’ of expert considerations and the questioning of the
boundaries between lay and expert perspectives(36).
However, many authors have recognised the inherent
tension between different forms of knowledge within
SAB and an unequal balance of power being assigned to
representatives of lay and technical knowledge on these
committees(37).
Applying these ideas to the evaluation of the existing
SAB, another line of research has examined the stages of
decision making and demonstrated how different types
of knowledge and expertise input can inform decisions
at each stage(38–40). Typical stages include risk assess-
ment, risk management and risk communication(12,38).
Decision making, however, is largely confined to experts
and professional risk managers, with little input from
other interested parties, including citizens(12). In recog-
nition of this, there have been attempts to develop a
tool to guide policy makers and scientists in making
decisions about when scientific decision making should
be opened up and when other stakeholders should be
involved(41,42).
Knowledge transfer
Much literature examines how SAB communicate with
policy decision makers(15,23,39,43) and takes into account
both the internal context in which decisions are made and
the external context that shapes this(39,43). The internal
context, which can be changed and controlled from
within the SAB and by their commissioners, includes the
way in which expertise is defined, how representative
SAB are, the degree of openness to stakeholder input
in framing, analysing and formulating solutions to an
issue, and transparency of the way in which decisions are
made. External context amounts to the environment in
which a decision is applied and cannot be easily altered
or controlled. Crucially, SAB are expected to maintain
independence from the bodies they advise, although in
practice, this remains a challenge(22). Given the unique
position of SAB as intermediaries between science and
policy, they have been a fertile ground for the study of
the boundary between politics and science, its negotia-
tion and the degree to which the two permeate each
other(9,44). Whether scientific advice is salient, credible
or legitimate is considered an important determinant of
influence(45). However, these criteria of influence as well
as SAB decision-making processes and outcomes will be
determined by the external context in which SAB operate,
and include ideological, socio-political, economic and
legal issues(43).
The present paper aims to examine the workings of
nutrition-related SAB in the process of setting recom-
mendations for folic acid (FA), through a comparative
analysis of the process of setting micronutrient recom-
mendations across Europe, paying particular attention
to the internal and external contexts within which the
SAB operate.
Methods
Questionnaire
Questionnaires were completed by key informants in
thirty-five European countries/regions. The main objectives
across countries were:
> to collate all the existing current micronutrient recom-
mendations and describe the process of deriving
nutrition recommendations and their use in nutrition
policies; and
> for each micronutrient, to identify the policies adopted
as a result of recommendations.
Data were collected on: ‘structure of the committee’
(e.g. type of expertise, selection criteria); ‘process of
scientific decision making’ (for each micronutrient: nature
of scientific evidence considered, type of recommenda-
tions, health endpoints, population groups, vulnerable
groups, how recommendations have informed the devel-
opment of food-based dietary guidelines (FBDG)); and
‘the way in which science resonates with policy’ (i.e. policy
options recommended by SAB setting Nutrient Reference
Values (NRV) and policy applications, i.e. actual policies
adopted by governing bodies responsible for these).
Case study
An in-depth case study was conducted in seven countries
varying in length of public health nutrition tradition, level
of centralisation and diversity of institutions involved
in the governance of nutrition, and extent of participatory
democracy: Czech Republic, Denmark, England, Germany,
Hungary, Norway and Spain. The main objectives were:
> to understand the process from science to policy, and
the determinants of variations in this process across
nations/regions, policy applications and micronutri-
ents, with a specific focus on FA; and
> to identify the way in which scientific, policy and
consumer issues interact throughout this process.
Information was obtained on: (i) the degree of trans-
parency of decision making and its openness to public
scrutiny; (ii) contextual characteristics, i.e. the institu-
tional, administrative and political context (e.g. how food
and policy were/are conceptualised, the names of key
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stakeholders); (iii) the generic process of setting up
micronutrient recommendations (e.g. who is in charge,
triggers for the development of recommendations, who
is invited to take part, what is the type of scientific
data considered, the degree of scientific certainty/con-
troversy); and (iv) the process from science to policy
application for FA. An assessment was made about the
public availability of literature and documentation on
the workings of the institutions responsible for the
development of micronutrient recommendations, public
and stakeholder involvement and nutrition policy pro-
cesses, indicating the degree to which participatory
democracy has evolved and the level of transparency and
openness in the processes of science and policy in each
of the countries in question.
Results
Institutional capacity
The questionnaire data indicate that in approximately
half of the countries (eighteen out of thirty-five), the
final responsibility for setting micronutrient recommen-
dations rests with government departments (Table 1).
Recommendations are supported by one or a combina-
tion of scientific bodies – scientific advisory committees
(often called ‘advisory councils’) or SAC (ten countries),
public health institutes (fifteen countries), nutrition
societies (five countries). The EU’s micronutrient recom-
mendations were set by EFSA and supported by SAC and
the WHO/FAO recommendations by a European expert
consultation.
Where SAC exist, there are either standing committees
providing continual advice to government, or they are
formed on an ad hoc basis. Standing SAC often form sub-
committees or working groups to deal with specific issues of
importance, mainly at the request of the government, such as
the need to develop recommendations for specific micro-
nutrients (e.g. iodine) or population groups (e.g. infants).
In some countries, the decisions about recommenda-
tions and nutritional matters rest with established research
centres, and sometimes with nutrition societies. Each of
the three types of SAB – SAC (e.g. the UK, Nordic coun-
tries), public health institutes (e.g. Spain, Czech Republic,
Hungary) and nutritional societies (e.g. DACH) – are
entities that substantially differ in their statutory responsi-
bilities and operate within diverse regulatory frameworks
(e.g. funding sources). Members of the SAC are appointed
by authorities (usually government departments) on the
basis of their individual expertise, eminence or affiliation
with an eminent institution, although potential members
often have to apply to be considered for SAC. Nutrition
societies are membership organisations whereby inclusion
is based on self-selection and satisfaction of membership
criteria, whereas research centres/institutes, like universities,
are employers.
A range of criteria was mentioned within the ques-
tionnaire as the basis of the selection of members of
various committees and societies (Table 1). Almost all
countries, as well as the EU and WHO/FAO, mentioned
individual expertise as an important criterion for the
selection of persons involved in setting micronutrient
recommendations, whereas institutional authority (fifteen
countries), representation of a sector (e.g. industry, acade-
mia, consumer – nine countries) and forms of knowledge
(six countries) were other – albeit overlapping – common
criteria. Most countries based their selection of persons
involved in setting micronutrient recommendations on
one (typically individual expertise) or two criteria (e.g.
individual expertise plus institutional authority).
The type of expertise that is selected on SAC is similar
across Europe. Most countries mention at least three
of the following fields of expertise: nutrition, (public)
health, medicine, biochemistry, food technology, epi-
demiology, food hygiene and toxicology. In several
countries (e.g. UK) lay or consumer representatives are
included in the SAC or the working groups. The ques-
tionnaire data do not indicate that there are variations
across countries in the propensity to recommend a policy
option, based on the type of SAB responsible. However, it
could be expected that policy recommendations (options
for policy) made by each of the respective SAB (i.e. SAC,
institutes and nutrition societies) would ‘resonate’ to
varying degrees with the government, stakeholders and the
public. The rationale for this is partly based on inferences
about the independence of SAB, their eminence/credibility,
their legitimacy (based on representativeness, selection
criteria) and salience(9,45). The differences might be parti-
cularly notable in the way in which recommendations for
the enforcement-type policy instruments (e.g. mandatory
fortification, legislation on micronutrient composition in
food products and labelling) are taken up by the respective
authorities. This will be explored in the case study.
A case study of mandatory folic acid fortification
Knowledge of the origins of the recommendations is
important as they indicate what possible frameworks of
decision making are operational within the SAB (from
framing of the problem to the possible solutions). Thus,
although the UK’s Scientific Advisory Committee for
Nutrition (SACN), the German Nutrition Society (DGE) in
DACH countries and the Nordic Nutrition Recommenda-
tions (NNR; the Nordic countries’ National Nutrition
Council (NNC), now the Nordic Directorate of Health
(NDH)) conduct their own systematic reviews of all the
available data (in the problem area specified by their
terms of reference, such as a specific micronutrient or the
nutrition for a particular population group), identifying
possible areas of uncertainties, the weaknesses of science
and actively engaging in problem delineation, this does
not seem to be the case in Czech Republic and Hungary.
Hungarian recommendations are adopted from the US,
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Table 1 The type and nature of the body responsible for setting micronutrient recommendations
Involvement in setting recommendations
Country/
organisation/region Body responsible Type of body Responsible since Persons involved Selection criteria Field of expertise
Albania Ministry of Health, supported by the
University Hospital, Agrofood
Department of Agricultural
University of Tirana and FAO local
office
Governmental,
scientific
No data available Three Individual expertise, institutional
authority
Nutrition, public health,
biochemistry, food technology
Belgium National Health Council (Hoge
Gezondheidsraad)
Governmental,
working group
1997 (first
publication)
Eight Individual expertise No data available
Federation of
Bosnia and
Herzegovina
Not defined Most probably
nutrition society or
medical academic
group
No data available No data available Individual expertise Medical doctors, specialised in
hygiene
Republika Srpska Ministry of Health and Social Welfare,
supported by the Public Health
Institute and health centres
Public Health Institute:
independent
scientific advisory
body
2003 Five Individual expertise, institutional
authority
Nutrition, public health,
biochemistry, medicine,
toxicology, epidemiology, food
technology
Bulgaria Ministry of Health, supported by the
National Centre of Public Health
Protection
Governmental 1980 Eight Individual expertise, different
forms of knowledge
Nutrition, public health,
biochemistry, medicine,
toxicology, epidemiology
Croatia Ministry of Health and Social
Welfare
Governmental No data available Eleven Individual expertise, institutional
authority, specific sector,
different forms of knowledge
Nutrition, public health,
biochemistry, medicine,
toxicology, epidemiology
Czech Republic Ministry of Health, Department of
Public Health, supported by the
Scientific Committee for Food –
iodine
Governmental,
working group for
iodine
1995 Eight (self-selected) Range of stakeholders included,
based on individual expertise
and sector
Nutrition, toxicology, chemistry,
risk assessment
DACH countries German Nutrition Society, Austrian
Nutrition Society, Swiss Society
for Nutrition Research and Swiss
Nutrition Association
Nutrition society 1992 (previous
publication)
Six (plus forty-one
contributors)
selected by the
nutrition society
Individual expertise
(experimental and scientific)
Nutrition, food, biochemistry
Estonia Ministry of Social Affairs, supported
by National Institute for Health
Development
Governmental,
scientific
No data available No data available Individual expertise
(scientific), institutional
authority
Nutrition, public health,
biochemistry, medicine,
epidemiology, food
technology
France French Food Safety Agency (Afssa),
former National Centre for Studies
and Recommendations on Nutrition
and Diet (CNERNA)
Independent body 1999 200 Individual expertise, different
forms of knowledge (from
national community)
Nutrition, public health,
biochemistry, medicine,
epidemiology
Greece Ministry of Health and Social Welfare,
supported by Hellenic National
Nutrition Policy Committee
Governmental,
committee
2002 No data available No data available No data available
Hungary Ministry of Health, supported by the
National Institute of Food Safety
and Nutrition
Governmental,
working group
No data available Twenty-five Individual expertise Nutrition, medicine
Ireland Food Safety Authority of Ireland Working group of
independent and
scientific body
1996 Four Individual expertise Clinical medicine, nutrition
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Table 1 Continued
Involvement in setting recommendations
Country/
organisation/region Body responsible Type of body Responsible since Persons involved Selection criteria Field of expertise
Italy Italian Society of Human Nutrition
(SINU), supported by the National
Research Institute on Food and
Nutrition (INRAN)
Nutrition society
(scientific with links
to governmental
bodies)
1977 Four working groups,
each with eight to
ten members
Individual expertise, institutional
authority, specific sector
Nutrition, public health,
biochemistry, medicine,
epidemiology, food
technology
Latvia Ministry of Health, supported by the
Latvian Food Centre and Nutrition
Council
Governmental,
probably individual
experts or working
group
No data available No data available Individual expertise, institutional
authority, specific sector
Nutrition, public health,
biochemistry, medicine, food
technology
Lithuania Ministry of Health, supported by
Food and Nutrition Scientific
Council, National Nutrition Centre
and Medical Faculty of Vilnius
University
Governmental,
scientific
2003 Four Individual expertise,
specific sector
Nutrition, public health,
biochemistry, medicine,
epidemiology, food
technology
Montenegro No body responsible for setting
recommendations
N/A N/A N/A N/A N/A
Netherlands Ministry of Health, supported by
The National Health Council
(TNHC)
Governmental, TNHC
is an independent
scientific advisory
body
1992 Thirty-eight Individual expertise
(independent experts)
Nutrition, public health,
biochemistry, medicine,
epidemiology
Nordic countries Nordic Committee of Senior Officials
on Food Issues, EK-Livs.,
supported by the Working Group on
Diet and Nutrition (NKE)
Project group
nominated by NKE
2000 Thirty (selected by
government)
Individual expertise
(scientific), institutional
authorities
Nutrition, public health,
medicine, toxicology,
epidemiology (Iceland:
nutrition and health)
Poland Ministry of Health, supported by the
National Food and Nutrition
Institute, Warsaw
Governmental 1963 Five Individual expertise
(experience), institutional
authority (long-term
employment), specific sector
Nutrition, biochemistry, medicine
Portugal No data available No data available No data available No data available No data available No data available
Romania Ministry of Health, supported by the
Institute of Public Health Bucharest
(IPH)
Governmental,
National
Committee of
Nutrition
(in 2008)
No data available Twenty Individual expertise, institutional
authority (IPH)
Nutrition, food hygene, public
health, medicine
Russian
Federation
Ministry of Health, supported by the
Institute of Nutrition at the Russian
Academy of Medical Sciences
Governmental,
scientific
1982 (previous
publication)
Three Individual expertise (scientific),
institutional authorities
Nutrition, biochemistry,
medicine, toxicology,
epidemiology, food
technology
Serbia Ministry of Labour and Social Policy Governmental, expert
group
1993 Four to five Individual expertise Nutrition, public health, hygiene,
medical ecology, medicine
Slovakia Ministry of Health Governmental No data available Two Individual expertise, institutional
authority, specific sector,
different forms of knowledge
Nutrition, public health,
medicine, toxicology,
epidemiology, food
technology
Slovenia Ministry of Health, department related
to Public Health
Governmental No data available Two Individual expertise, institutional
authority, specific sector,
different forms of knowledge
Nutrition, public health,
medicine, food technology
Spain Madrid University and Spanish
Society of Community Nutrition
(SENC)
Nutrition society,
expert group
No data available Three Individual expertise, institutional
authority
Nutrition
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Table 1 Continued
Involvement in setting recommendations
Country/
organisation/region Body responsible Type of body Responsible since Persons involved Selection criteria Field of expertise
The former YR
Macedonia
Ministry of Health, supported by
Republic Institute of Health
Protection (in 2001: Macedonian
Association of Physicians)
Working group
(2001)
No data available Five (2001) Individual expertise, institutional
authority, specific sector,
different forms of knowledge
Nutrition, public health,
biochemistry, medicine,
toxicology, epidemiology, food
technology
UK Department of Health and Food
Standards Agency, supported by
the Scientific Advisory Committee
on Nutrition (SACN) (previously
called Committee on Medical
Aspects of Food and Nutrition
Policy (COMA))
Governmental,
SACN is an
advisory
committee of
independent
experts
1991 (COMA 1990) Thirteen, including
two lay
representatives
(plus ten
observers).
Members must
apply and are
appointed by the
government
Individual expertise, specific
sector, institutional authorities
(COMA (appointed by
ministers), the Health
Education Authority and the
Medical Research Council,
Chief Medical Officers of
England, Scotland, Wales and
Northern Ireland,
representatives of the Ministry
of Agriculture, Fisheries and
Food and the Department of
Health)
Nutrition, public health,
biochemistry, medicine
EC* European Food Safety Authority,
Scientific Committee for Food
Working group No data available Nineteen Individual expertise, no data
available on other criteria
Various
WHO/FAO* WHO and FAO (United Nations) Expert Consultation 1973 No data available No data available No data available
EC, European Commission; N/A, not applicable.
DACH countries: Germany, Austria and Switzerland.
Nordic countries: Denmark, Finland, Iceland, Norway and Sweden.
All data are based on questionnaire primarily, scientific reports on recommendations secondarily and country-specific key informants in the third place.
*Data from the scientific reports only.
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EU and DACH recommendations, and some adjustments
made with reference to the Hungarian population surveys.
The committee was not engaged in problem framing,
delineation of the criteria for systematic reviews (the
type of evidence to be used) and the lengthy process of
adjudging the areas of uncertainties on which recom-
mendations are made. In Czech Republic, the few
recommendations that exist are also based on international
recommendations such as DACH.
Understanding how the process of setting recommen-
dations and their translation into policies varies across types
of SAB will help identify some determinants of variation in
the final micronutrient-relevant policy approaches across
countries. We will provide assessments of transparency of
this process and describe problem formulation, evidence
gathering, micronutrient recommendations achieved and
policy options that are recommended, as well as how these
are finally translated into policy across the seven countries
in relation to FA, chosen for its salience with regard to
fortification as a policy option. Options for mandatory,
partly mandatory and voluntary FA fortification attract
considerable debate and require considerations of both a
political and a scientific nature.
Transparency of the scientific process
The UK, Norwegian, Danish and DACH SAB endeavour
to provide the public with information on some aspects
of their workings. The main sources of information are
dedicated websites, which host information on reports,
meeting minutes, the make-up of the committee and the
working groups (names and affiliations), how the com-
mittee is organised, stakeholder consultation summaries
and, in the UK, a document clarifying the decision-making
process for evaluating scientific evidence and recom-
mending nutrient reference values(46).
The main source of information about the NNR is the
official publication of the Nordic Council of Ministers
2004(47). It lists the selection criteria for the project group,
the general approach for the establishment of a recom-
mended daily intake for certain nutrients and the meth-
odological considerations for the evaluation of the
available evidence. The evolution of nutrition-based
policies in Norway is visible through policy documents
(some of them published on official government web-
sites) and the list of stakeholders involved in the process.
The main source for information about micronutrient
recommendations in Germany is the official website of
the DGE. Information about the composition and affilia-
tions of the working group and of other contributors is
provided, as well as press releases related to the pub-
lication of the document. Summary tables are provided
and the document(48) is available for downloading in the
English language.
In the Czech Republic and Hungary, as well as Spain,
there is little documentation on the official criteria and
process that are used to establish these recommendations.
In each of these countries the fragmented institutional
context for the management of food and nutrition public
health issues and the low priority ascribed to nutritional
matters might explain this lack of transparency.
Fortification policies
The case of Norway illustrates NNC’s shift from public
campaign-based education to a recommendation of
mandatory fortification in the space of ,10 years, and
a reluctance of the governing bodies to follow through
the scientific advice. On two occasions, in 1996 and in
1997, the NNC was tasked with evaluating the needs
for FA intake: in 1996, the terms of reference were the
evaluation of the FA intake status for the general popu-
lation, and in 1997, the evidence of the FA intake of
women of childbearing age was examined. Committee
members included researchers in the area of FA and diet,
the Food Authorities, the Norwegian Medicines Agency,
the Norwegian Board of Health Supervision and the
NNC. The 1996 committee concluded that there was not
enough evidence to change the recommendation for the
general population and that the advice of the FBDG to
increase fruit, vegetable, potato and dark bread intake
was sufficient. The 1997 committee recommended an
increase in FA intake to 0?4 mg and a recommended daily
supplement and FBDG, although fortification of foods
with FA was not considered a suitable option to increase
intake (since the general population could be at risk of
having too high an intake). A subsequent report pro-
duced in 2004 by a working group appointed by the
NNC – Norwegian Directorate of Health – recommended
that mandatory fortification should be considered due to
the unsatisfactory results of the current periconceptional
FA recommendations; but, as yet, there is no mandatory
fortification policy in Norway(49).
A similar case is reported in Denmark. A report on FA(50)
and neural tube defects (NTD) was prepared in 1997 by the
National Food Agency in Denmark based on the work of a
group of experts within the area. Enrichment as a policy
option was discussed, but not recommended. Following the
Danish Dietary Survey as well as the creation of a working
group of experts for FA in 2003, the committee recom-
mended to the Danish Veterinary and Food Administration
policy makers a combined approach of both mandatory
fortification and supplementation. Fortification levels were
recommended to be low (0?1–0?2mg) so as to minimise risk
to other population groups. To date, policy makers have
not introduced compulsory fortification in Denmark and,
instead, as a result of foreign experience, supplementation
was upheld as the only viable policy option.
To date, there is no FA food fortification policy in
Germany; however, it is currently being considered.
Recommendations for the prevention of NTD by FA
supplementation were given for the first time in 1994 as
common recommendations by five German societies (DGE,
German Society of Gynaecology and Obstetrics, German
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Society of Human Genetics, German Society of Paediatrics
and Society of Neuropaediatrics), who recommended for-
tifying selected staple foods, such as bread. The fortification
debate continued after the 1998 German National Health
Interview and Examination Survey(51). Two SAB worked in
parallel on the issue of FA. The final recommendations
included three possible policies for FA-fortified foods:
mandatory fortification of wheat and rye flour all over the
country; voluntary fortification of wheat and rye flour; or
voluntary fortification of table and cooking salt. The DGE
subsequently established an FA working group, which
published a position paper in 2006(52) in which mandatory
fortification of baking flours with FA was favoured.
The UK national food fortification with FA is currently
being considered by Health Ministers. National FA for-
tification was recommended in a Committee on Medical
Aspects of Food Policy (COMA) report in 2000(53); yet in
2002, the FSA decided against recommending mandatory
fortification to the UK health ministers. This was largely
due to stakeholder concerns over health risks in the
elderly population and consumer concerns over lack of
product choice. In 2007, following a review of evidence
since the COMA report, the FSA received a draft report
from SACN, which recommended mandatory FA food
fortification (of bread and flour) in order to decrease
the incidence of NTD-affected pregnancies in the UK.
Recommendations also included control over industry
voluntary FA fortification and the necessity of clear advice
on the use of FA supplements(54). The SACN-updated
review of FA fortification allowed stakeholders the
opportunity to again discuss mandatory fortification.
Following the consultation, some of the difficulties with
adopting fortification were identified; however, the FSA
adopted mandatory fortification of bread and flour in
2007(55) and presented the option to Health Ministers
(who have the ultimate decision about fortification) in
early 2009(56). In order to inform the ministers’ final
decision on mandatory fortification, in October 2007 the
Chief Medical Officer (CMO) of England, on behalf of all
the UK CMO, asked SACN to further consider two studies
that suggested that FA may increase the risk of colorectal
cancer(57,58). In 2009, SACN concluded that the new evi-
dence does not provide a substantial basis to change its
previous recommendation; it was only amended to clarify
the advice on supplement use. The CMO is expected to
advise UK Health Ministers of SACN’s recommendation
shortly, and Health Ministers will then decide whether to
approve mandatory FA fortification in the UK. The timing
for this decision is not known.
In Spain, the recommended intake for FA was set by the
Spanish Society of Community Nutrition (2005)(59) and
included FBDG and supplementation as policy options.
Industry has engaged in voluntary fortification of foods
although currently there is no coherent effort to estimate
the bioavailability of FA in food products, as well as
population intake of FA.
In Czech Republic, nutrition recommendations issued
in 1989 have been updated with the general nutrition
recommendations of the Society for Nutrition of 2004 and
recommendations of the Ministry of Health (MZ CR) of
2005; but these do not provide recommendations for total
FA intake. Numeric recommendations for FA are defined in
regulation(60), which deals with the requirements for food
supplements and on foodstuffs fortified with food supple-
ments. At present a proposal for recommended dietary
allowances, which also includes numeric recommendations
for FA, is being prepared. This proposal is based on inter-
national publications (The Safety of Vitamins and Minerals
(2002) and Vitamin and Mineral Supplements (2004) by the
European Responsible Nutrition Alliance) and the opinion
of the Scientific Committee on Food, which proposes
adopting the current EU nutrition recommendations(61). It is
not clearly defined who in the Czech Republic should
be involved in establishing FA recommendations. It is
thought that the initiator should be the Ministry of Health
together with scientific societies and the professionals in
the area of nutrition so that both state-controlled and
non-governmental organisations are represented.
In Hungary, reference values have existed since 2006,
based on international recommendations and adjusted for
the Hungarian population, following a Hungarian Nutri-
tional Survey in 2003–2004. Currently, in Hungary, there
is no mandatory FA food fortification. An FA team was
created to discuss the survey results; however, no agree-
ment was reached, and mandatory policy is not expected
to come into force in the near future. Voluntary fortification
is allowed under government policy and legislation, but
there is no available database showing details of the foods
that are fortified. Voluntary FA bread fortification existed in
Hungary, but has since disappeared due to a lack of official
support and insufficient health education(62,63). No public
stakeholder consultation exercises were set up to aid final
decisions on fortification. Consumer issues were con-
sidered through the adoption of voluntary fortification,
which maintains that consumer choice and nutrition
policies are partly visible through policy document press
releases and periodical and website publications. How-
ever, micronutrient policies are exclusively discussed by
scientists, medical doctors and dietitians.
Discussion and conclusions
The above analysis indicates that across Europe a variety
of bodies are responsible for setting micronutrient
recommendations, each with different statutory and legal
models of operation. Where there are standing SAC, e.g.
UK and the Nordic countries, the processes of decision
making are publicly reported, and the results of at least
some interactions with policy makers and stakeholders
are published in the form of consultation reports, meeting
minutes and final decisions. Lack of transparent and
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open decision making is characteristic of those countries
where there are no dedicated publicly funded and
government-supported bodies dealing with nutritional
issues. In the countries where there are no standing SAC
or dedicated and recognised professional bodies, pro-
cesses for selecting who is involved in setting recom-
mendations, for determining which issues to focus on and
how the science links with public health actions are either
non-existent or non-transparent. Spain and Czech Republic
are examples of countries where the links between science
and regulatory realities are largely unspecified.
In the countries where a standing SAC is created, the
selection of experts is carried out by the government;
once selected, these committees appear to have a degree
of autonomy in choosing the members who will sit on
specific working groups or sub-committees. Nevertheless,
the process is driven by self-selection, whereby pro-
spective members of standing and working committees
must apply to be considered. In the countries without
standing committees, experts are drawn from the centres
of excellence or institutes with authority and a long
history of scientific work in the relevant area (as in the
case of Spain, Czech Republic and Hungary), or through
membership of professional organisations (e.g. DACH).
The case of DACH is indicative of the important role that a
strong professional corpus can play in providing vision
and strategy, as well as active shaping of the public health
agenda. In contrast to the UK/Nordic model, in the German
case there is no clear separation between risk assessment
and risk management/communication. DGE has a role both
in setting NRV and in translating these into FBDG and
developing communication strategies of nutritional guide-
lines. This may be a consequence of a specific public health
and risk management context within which recommenda-
tions have evolved. Arguably, the situation in the UK has
been shaped by public disquiet about the role science plays
in policy decision making. The consequent separation of
risk assessment from risk management has not been evident
in Germany.
Where there is no dedicated SAB (Spain, Czech Republic,
Hungary), the impetus for the development of micro-
nutrient recommendations and the associated policies
comes from interested specialists in the area. Typically, in
these cases, we observe an ad hoc selection of problem
areas to consider (e.g. which micronutrients or which
population groups) based on specific institutional or indi-
vidual interests and expertise, the lack of a coherent
approach to science informing possible decisions, over-
reliance on international scientific and political influences
and policies that are neither informed by science nor a
result of a transparent consultation process. When there is a
dedicated SAB for nutrition, government sets its terms of
reference. These are often to evaluate the current micro-
nutrient status in the whole population or a population
group, evaluate the existing evidence leading to setting
country- and population-specific NRV and to re-evaluate
previous recommendations. However, as indicated in the
analysis, their terms of reference can sometimes include
a more political remit such as providing government
with an assessment of feasibility of a particular policy
option (although the final decision always rests with the
government).
Mandatory fortification of food with FA is recommended
by four (UK, Norway, Denmark, Germany) out of seven
SAB studied here; however, in most cases it is rejected by
governing bodies as either not feasible or too sensitive to
pursue. Despite our speculation that the decision made
within the dedicated SAC will ‘resonate’ with government
bodies and be more likely to be adopted and translated into
policy, we can see that this is not the case, especially in the
case of mandatory fortification. The case of fortification,
which necessitates considerations of wider socio-political
context, illustrates the scope of political considerations
performed by some SAC. The case study showed that the
science behind the recommendations of mandatory FA
fortification is far from conclusive – a frequently voiced
concern among scientists and SAC is that excessive expo-
sure to FA may be associated with a number of health risks,
whereas ethical considerations play a part in evaluating
these risks. Recent expectations to engage with stake-
holders in the process of decision making (e.g. through
consultations) put a further onus on these bodies to engage
in a political process. Scientific uncertainties coupled with
the political context in which the SAC operate indicate
that the decision for mandating FA fortification is in fact
subjected to multiple, often subtle influences.
Extrapolating from the case of FA we suggest that the
process of setting micronutrient recommendations is
political as well as scientific, and call for greater trans-
parency in the workings of these bodies, in particular of
the sources and salience of different types of evidence.
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The objective of this study was to relate behaviour change mechanisms to nutritionally relevant behav-
iour and demonstrate how the different mechanisms can affect attempts to change these behaviours.
Folate was used as an example to illuminate the possibilities and challenges in inducing behaviour
change. The behaviours affecting folate intake were recognised and categorised. Behaviour change mech-
anisms from ‘‘rational model of man’’, behavioural economics, health psychology and social psychology
were identiﬁed and aligned against folate-related behaviours. The folate example demonstrated the com-
plexity of mechanisms inﬂuencing possible behavioural changes, even though this only targets the intake
of a single micronutrient. When considering possible options to promote folate intake, the feasibility of
producing the desired outcome should be related to the mechanisms of required changes in behaviour
and the possible alternatives that require no or only minor changes in behaviour. Dissecting the theories
provides new approaches to food-related behaviour that will aid the development of batteries of policy
options when targeting nutritional problems.
 2012 Elsevier Ltd. All rights reserved.Introduction
Nutritional factors contribute to the risk of many non-communi-
cable diseases aswell as to being overweight (WHO report, 2011). In
addition to overconsumption of food and suboptimalmacronutrient
composition of the diet, deﬁciency of speciﬁc micronutrients can
create negative health outcomes, such as anaemia or hypothyroid-
ism. Conversely, optimal intake ofmicronutrients is believed to pro-
mote health and well-being, even if the effects may not be directly
perceivable by individuals. Recommendations on micronutrient
intake aim at providing a reference point for adequate or optimal
intake and reaching this intake can be regarded as a desirable goal
within a population or sub-population. Setting these reference val-
ues is a complicated task, but even if these values are taken as given,
identifying the determinants of intake is also difﬁcult. People eatll rights reserved.
been carried out within the
hich is ﬁnancially supported
peciﬁc Research, Technology
and Management of Living
, contract no. 036196. This
views or its future policy infood, not nutrients, and making the link between nutrient intake
and food-related behaviour requires two processes going in oppo-
site directions; these processes, however, are not symmetric. The
desired changes in nutrient intake have to be translated into neces-
sary changes in food intake, but to translate changes in food intake
back to nutrient intake requires understanding of the mechanisms
of food-related behaviours that are mostly governed by factors
independent of their nutritionals consequences (Steptoe, Pollard,
& Wardle, 1995). In this paper the latter process will be unravelled.
From a nutritional point of view, the same micronutrient intake
can be reached in different ways and the total composition of the
diet (including supplements) determines how well individuals
within the population reach the recommended intake. If dietary
surveys suggest that current intake is a possible cause of negative
health outcomes, policy makers need to consider different options
that could improve the situation. One such option is the possibility
of inducing changes in individuals’ food-related behaviours (either
as a single strategy or as one part of a broader suite of measures
such as for instance fortiﬁcation initiatives). Changing behaviour
requires that the relevant food behaviours are identiﬁed and their
determinants understood.
Folate was chosen as the target micronutrient for this paper,
because folate intake is currently widely discussed and offers a
useful arena for demonstrating the complexity of behaviours that
can be related to increasing the intake of a single micronutrient.
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pregnancy to reduce the risk of foetal neural tube defects, such
as spina biﬁda (Locksmith & Duff, 1998). Current UK recommenda-
tions, for example, advise adults to consume a varied balanced diet
in order to maintain adequate folate levels, whereas women of
child bearing age are advised to take a daily folic acid supplement
of 0.4 mg from the time they stop using contraception to the 12th
week of pregnancy (Food Standards Agency, 2003).
Traditionally, desired behaviour changes are induced by aiming
at individuals’ voluntary behaviour changes via education or social
marketing campaigns, with much less emphasis on the environ-
mental prerequisites that may promote desired behaviour changes
(Hoek & Jones, 2011; Michie, van Stralen, & West, 2011). Related to
folate intake, there are recent studies on testing the effectiveness
of campaign messages (Lindsey et al., 2009), of radio and television
spots in promoting supplements for women (Warnick et al., 2004),
or promoting intake of folate among vulnerable consumer groups
in Florida both by education and by providing folic acid supple-
mentation (Thomas, Hauser, Rodriguez, & Quinn, 2010). Indeed,
there is evidence that food fortiﬁcation may be a more effective
way to prevent folate deﬁciency and its negative health outcomes
(Solomons, 2007).
The objective of this paper is to relate behaviour change mech-
anisms to nutritionally relevant behaviour by using folate intake as
an example to demonstrate how the different mechanisms can af-
fect attempts to change these behaviours. First, eating behaviour in
relation to micronutrient intake is explored in order to recognise
the possible behavioural changes that have an impact on folate in-
take. Second, appropriate mechanisms of behaviour change are
identiﬁed and extracted from different theories and models and
then aligned against the possible impacts on folate intake to illumi-
nate the possibilities and challenges in inducing behaviour change.
Finally, the applicability of these behaviour change mechanisms in
changing micronutrient intake through voluntary behaviour
change is discussed.
Micronutrient intake and food-related behaviour
Although appearing deceptively simple, food-related behaviours
are complicated actions governed by a mix of cultural conventions,
social interaction, individual perceptions and physiological inﬂu-
ences (Blake, Bisogni, Sobal, Devine, & Jastran, 2007; Rozin, 2007).
Sobal and colleagues (1998) divide the food and nutrition system
into three subsystems: producer, consumer and nutrition, pointing
out the separate, but closely interlinked, systems of food acquisition
and intake. Overall, micronutrient intake is a nutritional measure,
but several steps are required in order to reach a certain intake.
Having become aware of the need to increase the intake, the poten-
tial sources of the targeted micronutrient must be recognised and
then it must be assessed whether and how the intake of these foods
can be in- or decreased in the diet (Fig. 1). Furthermore, the link be-
tween food and nutrient intake is complex asmany food choices are
interrelated and not chosen in isolation from each other (Sjöberg,
Hallberg, Höglund, & Hulthen, 2003). One food added to the diet
may replace another, or the omission/addition of a food often eaten
in combination with another food would subsequently mean omit-
ting or adding the other one as well. Thus, the net inﬂuence of a
seemingly straightforward recommendation to add a single food
in a diet may result in lower or higher intake change than antici-
pated. Changing the intake of one micronutrient is challenging,
but in reality the intake of several micronutrients must be consid-
ered to make sure that changes linked to one micronutrient are
not counterproductive in relation to other micronutrients.
The process of eating behaviour leading the micronutrient
intake is presented in Fig. 1. Foods available in the choice situation
determine an individual’s access to particular micronutrients. Thepreparation required before the food is edible may, however, also
inﬂuence the micronutrient content. For instance, storage and
preparation methods may decrease the amount of micronutrients
in foods (Fillion & Henry, 1998; Severi, Bedogni, Manzieri, Poli, &
Battistini, 1997). Eating occasions vary from unstructured to struc-
tured: e.g. for snacking there are few rules about what should be
eaten and when, whereas meals tend to follow predeﬁned conven-
tions and rules related to combining foods and scheduling meals
(Blake et al., 2007; Mäkelä, 2001). Some suggested changes in
choices may ﬁt into existing practices whereas others require
major modiﬁcations in the composition of the meal. Exchanging
one type of vegetable for another may be easier than adding a veg-
etable as a second side dish to the meal, because the latter strategy
may require omitting another option from the meal or putting
extra effort into preparing an additional component to the meal.
Table 1 lists examples of behaviour changes that have an impact
on folate intake.
Eating behaviour is further complicated by individuals eating
varying amounts of the purchased and prepared food resulting in
an uneven distribution of micronutrient intake among household
members. Furthermore, some of the food bought is not consumed
and the waste can vary across products. It is estimated that in the
UK up to 6.8 million tonnes of the food bought for household con-
sumption ends up as waste, particularly vegetables, fruit, and
bread (WRAP, 2009).
One way of bypassing the complexity of eating behaviour is to
opt for micronutrient-containing supplements. Yet, paradoxically,
the use of supplements seems to be more common among those
whose dietary habits can be categorised as healthy (Dwyer et al.,
2001). Thus, though seemingly an easier route to provide micronu-
trients to consumers, current practice suggests that those more in
need of supplements may be unaware of their need, or of the pos-
sibility of supplementing their diet in this way, or they may lack
the motivation to do so.
In summary, when considering possible policy options, the fea-
sibility of obtaining the desired outcome should also be considered
in relation to the mechanisms of the required changes in behav-
iour. To have an impact on micronutrient intake, not only should
food choice behaviours that contribute to the accessibility of good
sources of micronutrients at home and food services be targeted,
but also the determinants of intake and food-related practices in
households. Although supplements may offer an alternative, sim-
pler route to complement dietary micronutrient intake, the possi-
ble barriers to this approach should also be considered.
The present paper explores how to achieve an increase in the in-
take of folate, especially among women of fertile age, by voluntary
changes of behaviour rather than by changing the food supply (e.g.
fortiﬁcation). After awareness has been raised, the required
changes include a wide range of separate actions in purchases
(choice behaviour), eating patterns, storage conditions used and
cooking methods (Table 1). Because individuals vary in their eating
patterns, the changes required and the need for supplements will
also vary across individuals. Changes in different behaviours differ
in their efﬁcacy to increase folate intake and the impact of the
changes needs to be assessed against the feasibility of the behav-
iour change.Behaviour change mechanisms
Inducing changes in food-related behaviour can be based on a
range of models and theories that contain a limited number of
behaviour change mechanisms, some of which may be overlap-
ping. Previous studies have identiﬁed and categorised a number
of behaviour change mechanisms (e.g. Fishbein et al., 2001; Michie
et al., 2005). In the present paper the major approaches used are
Fig. 1. Process of eating behaviour contributing to the micronutrient intake.
Table 1
Examples of behaviour changes related to changes in folate intake.
Choices – availability for the individual
 Purchasing/choosing foods that are naturally good sources of folates (e.g. green vegetables, dried beans, liver and whole grain products)
 Purchasing/choosing products fortiﬁed with folic acid
 Purchasing supplements containing folic acid (in the form of pills, capsules or herbal preparations)
Meal patterns and eating habits – intake
 Switching from reﬁned grain products to whole grain products
 Increasing use of whole grain products as snacks
 Including green vegetables and dried beans in meals
 Adoption of new storage conditions, recipes and cooking methods that conserve the folate content
 Switching to fortiﬁed products
 Taking supplements regularly
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nomics, health psychology, and social psychology. Behaviour
change mechanisms are extracted from these (see Table 2). The lit-
erature on factors inﬂuencing human behaviour is enormous (Maio
et al., 2007). From this vast volume of work, the aim has been to
identify the mechanisms which are the most relevant in a food
context and which can be targeted to induce changes at the wider
population level. As such, the list of mechanisms is not exhaustive
and may lack some obvious ones. For instance, behaviour change
mechanisms that are used in individual counselling have been
omitted (Spahn et al., 2010), e.g. those from Cognitive Behavioural
Theory (Beck, 1976), because, due to its cost, counselling rarely is
an option when aiming at changes at the wider population level.
Themechanisms listed in Table 2 includemost of those identiﬁed
in the context of promoting HIV preventive behaviour by Fishbein
and colleagues (2001), who suggested that intentions, environmen-
tal constraints and skills are necessary and sufﬁcient prerequisites
for the performance of any behaviour, whereas the other ﬁve
mechanisms in their list (anticipated outcomes/attitude, norms,
self-standards, emotion, and self-efﬁcacy) can be viewed as moder-
ators of the strength and direction of the intention. In the present
paper their list has been supplemented by considering mechanisms
related to habits (Verplanken & Wood, 2006; Wood & Neal, 2009),
stage theories (Prochaska & DiClemente, 1983; Schwarzer, 2008)
and goal setting (Gollwitzer, 1999;Gollwitzer&Brändstatter, 1997).
As illustrated in Fig. 2, behavioural outcomes can be the result
of conscious processes and intentions (Sections 1–3), or of habits
(Section 4) that bypass these processes and lead directly to behav-
iour (Triandis, 1977; Verplanken & Wood, 2006). The conscious
processing path starts with awareness, information processingand belief formation. Awareness can increase information seeking,
but several cognitive mechanisms may interfere with people’s
information processing and thus ability to make strictly reasoned
decisions. According to most socio-psychological models, adopted
beliefs serve as input to conscious processing of pros and cons, so-
cial norms and self-efﬁcacy, which may result in an intention to
change food-related behaviour. Socio-psychological models have
been criticised for not addressing how to maintain good intentions
(Schwarzer, 2008), which may help explain the ‘‘intention-behav-
iour gap’’ that has been observed again and again (Schwarzer,
2008; Sheeran, 2002). Stages of change models and goal-setting
theories explicitly acknowledge the need for planning and behav-
iour maintenance in the post-intentional phases to facilitate
long-lasting behaviour change (Section 3 in Table 2). Repetition
of intentional behaviour may eventually lead to food-related habits
that are automatically triggered responses to environmental cues.
The last section of Table 2 concerns mechanisms relating to how
habits are formed and broken down. Below, each of the mecha-
nisms identiﬁed in relation to the folate example will be discussed.
Awareness of folate and information processing
Being aware of a problem or recognising a need to change is a
starting point for seeking solutions and making volitional changes
in one’s behaviour. Awareness of folate recommendations and how
to comply with them may be raised by providing information.
Beliefs are acquired and changed through a learning process.
Learning may take place through active information seeking and/
or passive information acquisition. Economic theory acknowledges
that people may not be fully aware of the consequences of their
Table 2
Mechanisms of behaviour change.
Behaviour change mechanisms facilitating/
mitigating change
Major theories/models
where the behaviour
change mechanism is used
1. Mechanisms affecting belief formation
Cognitive mechanisms E.g. Behavioural economics,
Social psychology
Attentions bias
Optimistic bias
Hyperbolic discounting
Cognitive dissonance
Loss aversion/Framing
Heuristics
2. Mechanisms of intention formation
Decisional balance
Pros and cons/cost-beneﬁt/outcome
expectancies
Rational model of man’’,
SCTa, HBMb, PMTc, TTMd,
HAPAe
Attitudes TRAf, TPBg, TIBh
Motivational factors E.g. HBMb
Social inﬂuences
Subjective norms, injunctive norms TRAf, TPBg, TIBh
Model learning, descriptive norms SLTi, SCTa
Control mechanisms
(Action) self-efﬁcacy SCTa, PMTc, TTMd, HAPAe
Perceived behavioural control TPBg
3. Adopting and maintaining behaviour
Coping and recovery self-efﬁcacy HAPAe
Planning and goal setting
Implementation intentions E.g. Gollwitzer (1999)
Action and coping planning HAPAe
4. Habits and routines
Accumulated experience with behaviour TIBh
Strength of habit E.g. Verplanken and Wood
(2006)
Change in contextual factors,
e.g. environmental cues
E.g. Verplanken and Wood
(2006)
Life-transition stages/imposed changes E.g. Chapman and Ogden
(2009)
a SCT = Social Cognitive Theory
b HBM = Health Belief Model
c PMT = Protection Motivation Theory
d TTM = Trans-Theoretical Model of change
e HAPA = Health Action Process Approach
f TRA = Theory of Reasoned Action
g TPB = Theory of Planned Behaviour
h TIB = Theory of Interpersonal Behaviour
i SLT = Social Learning Theory
2. Mechanisms of 
intention formation
1. Mechanisms of 
belief formation
3. Adopting and 
maintaining 
behaviour
4. Habits and 
routines
Fig. 2. Illustration of the relationship between behaviour change mechanisms.
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and process additional information (if provided to them at no cost),
which subsequently may affect their beliefs. Stage models, like the
Precaution Adoption Process Model (Weinstein & Sandman, 1992)
and the Trans-Theoretical Model of change (Prochaska & DiClem-
ente, 1983; Prochaska & Velicer, 1997), recognise the need to pro-
vide information about the possible health risks to shift people
from being unaware (or under-aware) of an issue to being aware.
Information is necessary but not sufﬁcient to increase aware-
ness among the target population. Due to attention bias people tendto favour messages they ﬁnd personally relevant and in order for
information to have an impact, women of fertile age should both
be aware of the problem and recognise themselves as belonging
to the target group. Awareness of the increased need for folate be-
fore and during early stages of pregnancy may result in different
motivational states depending on whether one is planning to get
pregnant or not. For women planning pregnancy, searching for
information may be an active part of preparation. Women trying
or planning to get pregnant are more likely to actively seek and
process information about prenatal health. Accordingly, this group
of women may not only be well aware of the folate issue and foods
that are naturally good sources of folate, but also highly motivated
to look after their own health and that of their unborn child.
According to the Health Belief Model (Rosenstock, 1974), motiva-
tion is an important factor in health-promoting behaviours and
therefore this group is likely to be more responsive to information
about folate and more attentive to possible routes to reach the rec-
ommended intake. Even when women plan pregnancy, they may
not consider themselves as belonging to the target group because
they may perceive their folate intake to be higher than the intake
of women on average, or that their risk of neural tube defects in
their newborns is lower than for mothers in general. Research re-
fers to this cognitive mechanism as optimistic bias (Weinstein,
1984) and the consequence may be that these women disregard re-
lated health risk messages.
One of the challenges in inducing behaviour change, in particu-
lar among women not actively planning pregnancy, is hyperbolic
discounting. This relates to the fact that people tend to balance
the information about long-term beneﬁts against short-term re-
wards and this calculation results in a discount rate (Shapiro,
2005). Hence, as seemingly the risks are remote, these women
may perceive the long-term beneﬁts of maintaining an adequate
folate intake as less rewarding when balanced against the immedi-
ate beneﬁts of not preventing the folate deﬁcit (e.g. saving money
and less required effort).
Cognitive dissonance occurs when individuals hold beliefs that
are inconsistent, or when individuals’ actions and beliefs are
inconsistent (Festinger, 1957). Individuals experiencing cognitive
dissonance are assumed to take steps to reduce it, either (a) by
changing beliefs or actions to achieve consistency, or (b) by adopt-
ing new beliefs that overpower the dissonant belief (conﬁrmatory
bias) (O’Keefe, 1990). To mitigate discounting, Aronson’s hypocrisy
inducing technique (1999) may be used to promote choosing foods
high in folate. Futuremothersmay be confrontedwith the assertion
that they are likely to want the best for their unborn child, which
requires changes in their practices. A possible discrepancy should
result in an uncomfortable state, perhaps even feelings of shame,
which may induce these women to actually seek information about
the good sources of folates to avoid the cognitive dissonance asso-
ciated with their actions on the one hand and their self-image as a
caring parent on the other.
Choosing and purchasing foods naturally good sources of folate
Choosing foods naturally high in folates can be divided into rel-
atively clearly deﬁned behaviours (Table 1), but different factors
may promote or hinder these behaviours as they are related to
foods that have different roles in our eating behaviour. The feasibil-
ity of behaviour change can be assessed by using the Theory of
Planned Behavior (TPB) (Ajzen, 1991) as a framework and studying
the role of attitudes, subjective norms and perceived behavioural con-
trol in predicting the likelihood of women’s intentions to purchase
folate-rich foods.
According tomostmodels of behaviour, it is assumed that people
decidewhich foods to purchase by balancing costs and beneﬁts. Thus,
ifwomenperceive a net beneﬁt from increasing their folate intake, it
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foods. This weighing of pros and cons of a change in behaviour can
be termed as the decisional balance, or attitude towards the behav-
iour.Attitudes are a function of beliefs about the consequences of the
behaviour weighted by an evaluation of each outcome. However, as
described in the previous section, the cognitive mechanisms affect-
ing belief formation will play a role in assessing the possible out-
comes of behaviours. Strong positive beliefs paired with strong
negative beliefs reﬂect a degree of attitudinal ambivalence. In rela-
tion to food choice, studies have demonstrated that people with
higher ambivalence in their beliefs show less consistency between
attitudes and behaviour (Conner, Povey, Sparks, James, & Shepherd,
2003; Conner et al., 2002). If people believe that it is important to
ensure sufﬁcient folate intake by buying whole-grain products,
but at the same time they are averse to the palatability of whole-
grain products thus doubting whether the household will actually
eat them, it is difﬁcult to predict the behavioural outcome.
Some outcome expectancies may be strongly linked to affective
and emotional responses. Future mothers’ perceived risk of foetal
neural tube defects in their new-borns may be associated with fear.
Affective responses and emotions can be regarded as independent
factors inﬂuencing behaviour as in Theory of Interpersonal Behav-
ior (TIB) (Triandis, 1977),or considered as the affective beliefs be-
hind attitudes resulting in considerable overlap between attitude
and emotion (Fishbein et al., 2001).When anticipating positive
and negative self-sanctions, such as feelings of fear, delight, anxi-
ety and repulsion, they can be viewed as outcome expectancies
having an impact on decisional balance.
Subjective norms act as a guide to how people think that others
expect them to behave and may therefore facilitate or mitigate in-
creased folate intake. People tend to comply to some degree with
what those who are important to them want them to do (Ajzen
& Fishbein, 1980). In addition to subjective norms, injunctive norms
refer to an individual’s appraisal of the overall social support for
certain behaviours within a culture (Cialdini, Kallgren, & Reno,
1991). Injunctive norms may promote choosing foods high in folate
if it is perceived to be what is expected of a young woman and the
right thing to do in one’s social and cultural environment. How-
ever, injunctive norms may also act as barriers to behaviour
change: if the norm does not support the purchase of folate-rich
foods, for instance the apparently higher social status of reﬁned
grain products may act as an injunctive norm.
Another social inﬂuence is based on vicarious learning. Accord-
ing to Social Learning Theory (Bandura, 1977a), people tend to base
their behaviour on ‘‘model learning’’, which is closely related to
descriptive norms, i.e. perceptions of what most other people do,
or what they believe is commonly done. In campaigns promoting
folate intake, famous people, or people who are similar to the
target group (and therefore easy to identify with), can be used as
role models for increasing folate intake.
The last mechanism derived from TPB is perceived behavioural
control, which is predicted partly by beliefs about one’s capability
to perform behaviour and partly by beliefs about environmental
constraints, such as resource availability. Thus, the environment
must provide an opportunity, or be free of constraints, for realising
the desirable behaviours. In relation to this, some women may per-
ceive the availability and price level of folate-rich foods as insur-
mountable barriers to purchasing such foods, which again may
result in low perceived behavioural control.
Perceived behavioural control is closely related to the concept
of self-efﬁcacy, which is the central element of Social Cognitive The-
ory (Bandura, 1997c). Self-efﬁcacy refers to the conﬁdence in one’s
capability to perform a desired behaviour in different situations
(Bandura, 1977b, 1997c). People with higher self-efﬁcacy are more
motivated to change, will put more effort into their attempts to
change, and will have a better chance of succeeding. Althoughperception of one’s capabilities may not always reﬂect a realistic
representation of the actual capability, it can nevertheless act as
a motivator for change. Due to its dynamic nature, self-efﬁcacy
evolves over time as success adds to a sense of self-efﬁcacy,
whereas failure in changing behaviour can reinforce the perception
of low self-efﬁcacy. Hence, two women who have the same knowl-
edge of natural sources of folate may differ in their capability to
use this information in their purchase behaviour.
When making changes in food choices, the elaborate weighing
of pros and cons does not always take place, because it requires ef-
fort. Prospect theory (Kahneman & Tversky, 1979) describes how
people are averse to risk of loss and thus reluctant to depart from
status quo. For instance, omitting foods associated with hedonic
pleasure from the shopping list to make room for green vegetables
and dried beans may be perceived as a loss. The decisions made by
individuals may depend on how the choices available are pre-
sented to them. Framing the choices in terms of loss instead of gain
can alter the decisions made, as can presenting the items in a dif-
ferent order. If the aim is to promote increased intake of folate, the
outcome may be framed either as reducing the risk of foetal neural
tube defects or as promoting the health of future offspring thereby
being a caring mother. Bounded rationality (Simon, 1982) takes the
complexity of everyday decisions (e.g. choice overload and clutter)
into account stating that people use cognitive short cuts, heuristics
to reduce the effort as a response to the cost of obtaining and pro-
cessing full information. As a consequence, simple heuristics may
be promoted in order to alter beliefs about barriers to choosing
the right foods, e.g. ‘‘the greener, the better’’.
Meal patterns and eating habits
A precondition for increasing intake of folate is purchasing
foods that are naturally good folate sources. Availability in the
household is, however, no guarantee that these food items will
actually be consumed in sufﬁcient quantities by individuals in
need of increasing their folate intake. A number of barriers related
to meal patterns and habits may emerge.
One could assume that unstructured eating occasions offer eas-
ier options to promote folate intake because they are less rule-
bound than meals. It may be relatively easy to include products
rich in folate (e.g. whole-grain products) as snacks. Yet foods
bought and consumed on the spot may be strongly inﬂuenced by
subjective norms that are related to other people’s presence and
expectations in that situation as described earlier in the section
on food choices. Whole-grain snacks would ﬁt nicely after sports
for instance, but the norms of one’s surroundings may inhibit eat-
ing of whole-grain snacks and thus function as a barrier to increas-
ing one’s folate intake.
In addition to continuum models like TPB assuming that the
same factors inﬂuence behaviour regardless of the type of behav-
iour, Prochaska andDiClemente (1983) introduced amodel that dis-
tinguishes different stages in the change process based on their
experience with smokers quitting their habit. The Health Action
Process Approach(HAPA) (Lippke, Ziegelmann, & Schwarzer, 2004;
Schwarzer, 2008) combines the stage and continuum models and
suggests that a change in behaviour is more likely to happen if
intentions are transformed into detailed instructions on how to per-
form the desired action. In the case of folate, this means planning
shopping lists and meals that contain folate-rich components. The
post-intentional phase in HAPA incorporates action planning (when,
where andhow to act (Gollwitzer& Sheeran, 2006)) and coping plan-
ning (the generation of alternative behaviours to overcome antici-
pated barriers (Schwarzer, 2008; Sniehotta, Scholz, & Schwarzer,
2005) as mediators of intentions and behaviours. Several authors
have found evidence for phase-speciﬁc self-efﬁcacy beliefs (Bandura,
1997c; Luszczynska& Schwarzer, 2003; Schwarzer & Renner, 2000),
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changes, but are challenged in maintaining the behaviour or taking
correcting actions when failing to go through with the actions
planned. As such, planning such coping may aid the formation of
strong beliefs about how to deal with barriers arising while adopt-
ing or maintaining a new behaviour (coping self-efﬁcacy), or getting
back on track after a potential setback (recovery self-efﬁcacy). In the
case of unstructured eating occasions with friends, one may antici-
pate and plan how to cope with reactions from friends as well as
how to avoid a setback due to temptations while, for instance,
snacking together in the sports cafeteria. Action planning may also
be required in order to turn good intentions into consuming the
‘right’ foods, e.g. by planningwhere andwhen to purchase andwhen
to bring a whole-grain snack.
Folates, however, mostly appear in foods that are part of struc-
tured eating occasions. Conventions for constructing meals provide
a speciﬁc room for green vegetables and dried beans on the plate.
Firstly, vegetables must be an integral part of a meal; otherwise the
behaviour change requires the household to re-assess their habit-
ual meal concept. Secondly, if certain vegetables are included, they
may need to be exchanged for ones providing folates, which may
require self-efﬁcacy in preparing and storing the leafy vegetables.
It is estimated that in the UK up to 50% of green vegetables bought
for household consumption actually goes to waste (WRAP, 2009).
In families, other household members’ negative attitudes may act
as an insurmountable barrier against including leafy vegetables
in the meal. This may require coping planning in order to increase
beliefs that support coping self-efﬁcacy, e.g. deliberately deciding
to ignore others’ opinions.
Planning in HAPA is related to implementation intentions (Gollw-
itzer, 1999; Gollwitzer & Brändstatter, 1997) that form cognitive
links between situational circumstances or opportunities and the
goal behaviour. Goals do not induce actions directly, but they
may lead to highly speciﬁc plans, which in turn induce actions
through mental simulation of success scenarios (Gollwitzer,
1999). Thus, promoting the use of meal plans and cooking skills
that provide foods sufﬁciently high in folates may be one way of
promoting action and coping self-efﬁcacy thus transforming the
good intention into a long-lasting behavioural change.
If habits are very strong, good intentions may fall short and even
implementation intentions may not be sufﬁciently powerful to
change behaviour (Verplanken & Faess, 1999). According to Trian-
dis’ (1977) Theory of Interpersonal Behavior, accumulated experi-
ence with a behaviour results in increased inﬂuence from habit
and decreased inﬂuence of intention. Habitual behaviour becomes
detached from the original motivating factors. Thus, changing those
factors (e.g. attitudes and intentions) will not necessarily change
the habit as their power to inﬂuence the behaviour has diminished.
Verplanken and Wood (2006) argue that habits may develop as
environment-response associations that gradually become stronger
in memory with repeated experience. Consequently, habitual re-
sponses may be triggered automatically by environmental cues
(Ouelette & Wood, 1998; Wood & Neal, 2009), e.g. meals are re-
peated at the same time in the same pattern without giving any
thought to the content. If the family’s habitual meal concept leaves
no place for green vegetables and dried beans, promoting increased
folate intake may fall short if not tailored to the habit strength.
Thus, such strong habits cannot be changed by inﬂuencingwomen’s
decisional balance (e.g. through informational campaigns). Rather
they require changes in the environmental cues, e.g. lower prices
due to subsidisation of folate-rich food products, active promotions
by food suppliers in speciﬁc use contexts, or addressing social
norms supporting habits (McKinlay, 1975, 1993).
Wood and colleagues (2005) have observed that established rou-
tines can be broken and new ones formed at certain life-transition
stages. Verplanken andWood (2006) suggest that health promotionactivities should take advantage of this. Accordingly, health inter-
ventions targeted at certain life-transition stages, where people
need to adapt to changes in their environment, may stand a better
chance of changing habitual behaviours. For instance, families
may be more responsive to changing habits, which otherwise miti-
gate (voluntarily) increasing folate intake, at life-transition stages,
such as when planning a pregnancy (Wood, Tam, & Guerrero Witt,
2005). Health professionals and family planning clinics might be
effective in imposing behaviour changes in these transition situa-
tions. Chapman and Ogden (2009) address a passive path to behav-
iour change, in which diet changes happen to people without them
initiating the change, although they are aware of it. Imposed changes
due to changing life circumstances fall into this category. If a work-
place canteen, for example, decides to add more green vegetables
andwhole-grain products to themenu offered to its employees, this
may impose an increase in folate intake.Purchasing and regular use of supplements
It may not always be feasible or practical to increase folate in-
take through one’s diet, because the quantity of, for instance, green
vegetables one needs to eat is simply too large or too difﬁcult to
integrate into one’s meal patterns. An alternative to changing food
choices and eating patterns is to take folic acid as a supplement.
This requires less of an effort than altering one’s eating patterns,
but taking a supplement regularly still means that an individual
needs to establish a new routine. Thinking how and when to take
the supplement can be described as implementation intention plan-
ning (Gollwitzer, 1999). For instance, eating a supplement every
morning before breakfast links the behaviour to environmental
cues and establishes a habitual new routine. However, implemen-
tation intentions are more useful when forming new habits than
countering existing strong habits automatically cued by contexts
(Verplanken & Faess, 1999).
There are also pros and cons to consider when opting for a folic
acid supplement. When focusing on folates in the diet, one is likely
to get other beneﬁcial compounds as well from the good sources of
folates. Supplements guarantee the sufﬁcient intake if taken accord-
ing to recommendations, but on the other hand they may be costly
and perceived as taking the easy option, which may not correspond
to the subjective or injunctive norms that other people in one’s
community regard as responsible eating behaviour. In addition,
among young girls not actively planning pregnancy, taking a folic
acid supplement may be prevented by the suggestion that taking
the supplement signals acceptance of sexual activity. Supplements
also tend to be adopted more often by those who are health con-
scious, whereas the basic mechanisms of optimistic bias, discounting
the beneﬁts may decrease the willingness of the less health con-
scious to adopt folic acid supplements as part of eating behaviour.Discussion and implications
Linking nutrient intake with behaviour change mechanisms
The objective of this paper is to explore the role of behaviour
change mechanisms in inducing changes in micronutrient intake
through volitional behaviour change. There are a number of behav-
iour change models that have been applied in promoting and
explaining changes in food choices and eating behaviour. In this
paper the different behaviour change mechanisms have been ex-
tracted from these models and aligned against inducing possible
changes in folate intake. The novelty of this paper is the attempt
to link nutrient intake with behaviour change by systematically
describing the mediating food-related behaviours that are required
to achieve the desired outcomes in nutrient intake. People do not
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reasons for these choices are rarely articulated in nutritional terms
(Steptoe et al., 1995). Rather than trying to make a causal analysis,
or even to give an exhaustive view of all factors inﬂuencing folate
intake, this paper has attempted to reveal the challenges and pos-
sibilities of inducing behaviour changes in relation to folate intake.
Naturally this approach must be applied in a speciﬁc culture and to
dietary patterns within that culture but it is also important to use
this approach to consider whether promoting the behaviour
change is a feasible way of affecting nutrient intake.
This paper demonstrates that different models of behaviour
change from a range of behavioural sciences contain similar com-
ponents. Most of these models have been developed in other do-
mains than food and their direct applicability in explaining food
choices or eating behaviour has been limited. Food choices and eat-
ing behaviour differ from many other behaviours in two crucial
ways: Firstly, they contain a number of small decisions that each
have very little relevance, but cumulatively they add up to behav-
iour that has a big inﬂuence on health outcome. Secondly, these
consumption behaviours are necessary and characterised by
involving choices among alternatives and by extent rather than
dichotomous decisions either to do or not to do something. Inter-
vention studies in the food domain emphasise the need to use
atheoretical model when planning interventions (e.g. Ammerman,
Lindquist, Lohr, & Hersey, 2002; Glanz & Bishop, 2010; Prättälä,
Roos, Hulshof, & Sihto, 2002), but based on this paper we would ar-
gue that it is important to recognise and select the most relevant
behaviour change mechanisms in relation to the desired changes
in target behaviours, regardless of the origin of these mechanisms.
Forcing the complexity of food-related behaviour into models that
are developed in other ﬁelds of behavioural science may result in
artiﬁcial actions that bear no relevance on the food domain, or
alternatively omit some important factors. Dissecting the theories
in order to identify the most relevant mechanisms of change
provides a new approach to inﬂuencing food-related behaviours.
The approach can be used to develop new combinations of policy
options to target nutritional problems more efﬁciently, including
those related to micronutrients.
Mechanisms affecting behaviour
The cognitive mechanisms that inﬂuence people’s information
processing and belief formation propose a number of explanations
why the traditional approach of providing information to people
has not always been successful in changing behaviour. In their be-
lief formation people tend to actively process information in a way
that does not threaten their existing beliefs or practices and thus
have an impact on decisional balance. Although seen as factors that
interfere with reasoned behaviour, these mechanisms have a func-
tional role in information adoption. Embracing new beliefs openly
without these mechanisms would impose constant re-evaluation
of the decisional balance thereby requiring much effort to maintain
a cognitive balance. As keeping the balance may require behaviour
change, the change would become easier, but at the same time the
behaviour would be less stable. Although providers of information
or health promoters are aware of these mechanisms, their impact
is not always recognised as constraining or facilitating targeted be-
lief and behaviour changes. This article has tried to demonstrate
how the information may be interpreted based on these mecha-
nisms and why some messages are harder to convey than others.
Beliefs behind factors (e.g. attitudes, norms, self-efﬁcacy) inﬂu-
encing intention formation must be taken into account when for-
mulating messages. Cognitive dissonance can act as a barrier
against getting the information through, but it can also be used as
a tool to promote behaviour change when actively presented as a
problem that needs solving. Using emotional and affectivemessagesin changing beliefs behind attitudes may provide one way forward,
although in food behaviour the perceived risk and possible negative
outcomes have not inﬂuenced reported intentions to change behav-
iour in any strongway (e.g. Henson, Cranﬁeld, &Herath, 2010; Vass-
allo et al., 2009). Similarly social inﬂuences and norms can act as
barriers or facilitators of behaviour change, but it is important to
be able to link the desired changes in nutrient intake with those
behaviours that are required in relation to food choices and eating.
Social factors are likely to be more important in relation to meals
and other structured eating occasions as these are typically enjoyed
repeatedly in similar social contexts at home and at work, whereas
unstructured eating occasions can vary in their social context from
eating alone to sharing with friends or public eating. To effectively
change unstructured eating occasions, the social context must be
recognised as a factor that inﬂuences the behaviour change.
In changing food related behaviours little emphasis has been put
on behaviour maintenance. Many interventions aim at changing
behaviour and applying goal setting and implementation intentions,
but there is less understanding of how changed behaviour can be
maintained and how to support its maintenance. In part this may
bedue to the complexityof food-relatedbehaviours,wheredifferen-
tiating between behaviour change and behaviour maintenance can
be difﬁcult. Taking supplements or not taking supplements can
moreeasily be aligned to clearly distinguishable stages. For instance,
in eating leafy vegetables as part of themeal, themaintenance canbe
deﬁned as every meal, every other meal, or as three times per week.
Food choices and eating behaviour are largely habitual behav-
iours with repetitive low involvement choices that require very lit-
tle active decision-making. From a nutritional point of view this
creates an additional challenge. Hence, when translating nutrient
intake into possible behavioural changes contributing to the in-
take, one needs to assess how such behaviours are embedded in
daily routines. People tend to be unaware of decisions they make
in relation to habitual behaviours. Breaking automatically cued
behaviour patterns therefore requires actions that either make
people more aware of their behaviours or disrupt the habitual pat-
terns by environmental changes. Environmental changes may in-
clude monetary subsidies or affecting the availability of relevant
foods in order to promote more deliberate decision-making. Often,
inducing change in nutrient intake may be easier by accommodat-
ing current behaviour patterns and by changing the availability of
the nutrient in products that people already eat, e.g. by folic acid
fortiﬁcation. In the case of folate, many countries have found this
to be a more efﬁcient way to reach sufﬁcient levels of the nutrient.
However, in other countries fortiﬁcation is seen as problematic be-
cause it forces individuals to take the nutrient rather than provid-
ing them with an opportunity to make an informed choice.
Limitations of the study
The approach taken in this study has some limitations. Instead
of trying to take a comprehensive approach to the complexity of
food choices and eating behaviour this article has tried to unravel
the puzzle of linking nutrient intake and behaviour change by
using one nutrient as an example. However, using one nutrient
as a starting point shows the complexity of the relationship be-
tween nutrition and behaviour in the food domain. Trying to inte-
grate the required changes in behaviour in relation to increasing
the intake of several micronutrients (e.g. iron, calcium, vitamin
D) would be even more challenging. Sometimes there may also
be a need to reduce the intake of a micronutrient, as is the case
of sodium in many countries.
Similarly the choice of behaviour change mechanisms can be
criticised as being arbitrary to some extent. However, instead of
trying to cover all possible mechanisms, this article has focused
on the ones that are applicable in relation to food-related
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how these mechanisms could work in the case of folate. Therefore
this paper is not meant as a solution to induce behaviour change in
relation to folate intake, but merely to demonstrate which factors
must be considered in any speciﬁc condition where there is a dis-
crepancy between desired and actual intake of a micronutrient and
how narrowing this discrepancy can be translated into desired
changes in behaviour.
In doing a general overview of choice and eating behaviour, the
cultural aspects have been demonstrated by examples of possible
inﬂuence. To thoroughly study the social inﬂuences one would
need to do this in a culture-speciﬁc manner.Conclusions
When considering the policy options that are most effective in
producing desired outcomes in micronutrient intake, decision-
makers should consider whether the outcome can be best reached
by trying to inﬂuence the behaviour of the target population, or by
promoting changes in the environment, e.g. food supply, or per-
haps by combining these options. Inducing changes in food-related
behaviours in the target group requires understanding of the inter-
play between individual, social, cultural, and food-related inﬂu-
ences on choices and eating, e.g. how habitual the behaviours are
and whether social norms can be used to support desired changes
(Verplanken & Wood, 2006). Policy options that require no or only
limited changes (e.g. fortiﬁcation) may be considered as possible
alternatives to campaigns that target individuals and their eating
patterns. The folate example demonstrates the complexity of pos-
sible behavioural changes when targeting a single micronutrient
and having a relatively narrowly deﬁned main target group. The
jigsaw of behaviour change and possible desired and undesired
outcomes becomes much more complicated when multiple micro-
nutrients enter the equation.References
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A key step toward developing appropriate evidence-based public health nutrition policies is determining exactly how that
evidence should be collected and assessed. Despite this the extent to which different evidence bases influence policy selection
is rarely explored. This article presents an epistemological framework which offers a range of considerations affecting
this process generally and with particular implications for both micronutrient requirements and the role of behavior in
the policy-making process. Qualitative case study data covering 6 European countries/regions (Czech Republic, Italy, the
Netherlands, Nordic countries, Poland, and Spain), and three micronutrients (folate, iodine, and vitamin D), have been
presented to illustrate the relevance of the Framework.
Keywords Public health, evidence based, policy making, nutrition, EURRECA
INTRODUCTION
As the role played by nutrition in the rising prevalence of non-
communicable diseases becomes increasingly evident (World
Health Organization, 2011) so does the corresponding need for
more rigorously evidence-based public health policy (EBP) to
counter it (European Commission, 2001; World Health Orga-
nization, 2004). The establishment of systems to collate and
assess such evidence is therefore a key objective for policy
makers.
Currently, the scientific evidence base for nutrition policy
is provided by the same advisory bodies (e.g., European Food
Address correspondence to Lada Timotijevic, Food Consumer Be-
haviour and Health Research Centre, Department of Psychology, Univer-
sity of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom. E-mail:
l.timotijevic@surrey.ac.uk
Safety Authority, EFSA; Food Standards Agency UK, FSA UK;
The National Health Council in the Netherlands, HCN) tasked
with developing micronutrient Dietary Reference Values (DRV)
and monitoring diet adequacy (Matthys et al., 2011). Micronu-
trient DRVs, therefore, provide the template for public health
nutrition policy development, informing policy options as both a
tool for product development and a guide for professional prac-
tice [e.g., dietetics (EFSA Panel on Dietetic Products, 2010;
King and Garza, 2007)].
Nevertheless the actual processes by which DRV-based ev-
idence influences the development and application of public
health nutrition policy remains poorly understood. Elucidat-
ing this relationship will require a better understanding of the
full range of considerations that can influence policy makers
as they attempt to balance scientific evidence with information
from myriad other perspectives (Parsons, 2002). To this end, the
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EURRECA Network of Excellence is developing a framework
to help map out these different types of influence.
EVIDENCE-BASED POLICY MAKING
The growing desire for EBP has generated an on-going de-
bate about exactly what constitutes evidence given the increas-
ing recognition of the extent to which other influences such as
prejudices, values, tacit understandings, and competing world
views all factor into the process of translating evidence into
policies (Brownson, Chriqui, and Stamatakis 1576–83; Nutley;
Owens 294–401;Oxman et al. S1).
Even if one accepts Lomas et al’s definition that “evidence
concerns facts (actual and asserted) intended for use in support
of a conclusion,” translating these facts into policy and practice
still requires not just the selection and interpretation of evidence
but also decisions about which conclusions to draw from it and
how to communicate those conclusions to others (Oxman et al.,
2009).
The drive toward EBP assumes a model of policy-making
guided by instrumental rationality, in which cost-effectiveness
criteria underpin decisions. This assumption has led to the emer-
gence of frameworks that represent evidence-based decision
making as a linear translation of science into policy, and the
corresponding development of tools intended to increase use
of evidence through anticipatory problem solving (e.g., sce-
nario testing), planning, and rational choice making (Lasswell,
1951). Such approaches have been criticized for not recognizing
the role of context, practices, and norms, as well as personal bias
due to academic, professional, or commercial interests (Norris
et al., 2012).
The context-specific nature of policy making perhaps par-
tially explains the aforementioned lack of clarity concerning
the exact role evidence plays in this process. The persistence
of this uncertainty despite a concerted global effort to put ev-
idence at the heart of nutrition policy (Brownson et al., 2009;
World Health Organization, 2011) is no more apparent than
with micronutrient DRVs. Some attempts have been made to
develop frameworks specifically intended for translating mi-
cronutrient DRVs into nutrition policy. For instance, MacKerras
(MacKerras, 2012) reviews the Risk Analysis Framework
approach to development of food dietary guidelines, though this
approach, like many others, has an implicit linearity. The valid-
ity in practice of such linear models (of translation of science
into policy) has often come in for criticism (Dhonukshe-Rutten
et al., 2010). Dhonukshe-Rutten et al. (Dhonukshe-Rutten et al.,
2010) have argued that elucidating the true role played by DRVs
in the decisions of policy makers requires a framework capable
of teasing out the various factors that interact with science-based
recommendations in guiding policy formation.
This article will present such a framework, one specifically
designed to make explicit decision-making processes by identi-
fying the key domains of evidence and knowledge policy makers
draw upon. The framework is based on several studies and was
developed through a series of meetings and workshops in which
its utility was assessed by relevant stakeholders.
DEVELOPMENT OF THE FRAMEWORK
The framework discussed in this article emerged from an
iterative examination of a substantial body of comparative and
multidimensional research.
An initial version of the framework was proposed early on
in the research process and drew largely on reviews of exist-
ing literature and theoretical concepts. The model was then
repeatedly revised and reevaluated via meetings of the mul-
tidisciplinary project team, several stakeholder workshops (in-
cluding representatives from national and international nutrition
advisory bodies, charities and consumer representatives, public
health policy makers, industry, academics, and practitioners)
and through case studies specifically designed to test and fur-
ther develop the framework (Table 1). The constant presence
of competing perspectives made the process of developing the
framework challenging to say the least. Because one of the
important aspects of this process was clarification of what the
framework was and what it was not it was decided to define the
framework in the following way:
(1) It is epistemological, concerned with the “thinking process”
underpinning the selection of policy options. It is not a pre-
scriptive decision-making tool, but an abstracted description
Table 1 Data sets that constitute case studies used to evaluate the Framework
Study 1: quantitative Study 4: qualitative
and qualitative online Study 2: qualitative interviews
questionnaire interviews (Brown et al., Study 3: qualitative (Brown et al., In-depth desk
(Dhonukshe-Rutten et al. 2010) 2012) interviews in preparation) research
Czech Republic Fo, I, D Dietary guidelines Fo, I, D Fo, I, D
Italy Fo, I, D Fo, I, D Fo, I, D
Netherlands Fo, I, D Fo, I, D Fo, D Fo, I, D
Nordic countries (Denmark, Finland,
Iceland, Norway, Sweden)
Fo, I, D Fo, I, D (Denmark only) Fo, D Fo, I, D
Poland Fo, I, D Fo, I, D Fo, D Fo, I, D
Spain Fo, I, D Dietary guidelines Fo, I, D Fo, D Fo, I, D
Abbreviations: Fo, folate; I, iodine; D, vitamin D.
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of the process. Thus, its purpose is not to prescribe the “best
way of making decisions” but to make this process more
transparent.
(2) It is nonlinear—it does not dictate a specific ordering of
the elements of the framework, and recognizes iterative,
sometimes circular process of decision making. Each ele-
ment of the frameworks is in some way connected and can
impact upon the others. Implicit in the framework is the
assumption that the starting point for considering nutrition
policy options and the way in which evidence is weighed
and prioritized will vary with each problem.
(3) It is inevitably an abstraction of the process, not an exhaus-
tive list of all the factors and possible linkages between the
different factors. Its choices of emphasis are substantiated
by the analysis of the case studies below, but the complex
nature of the problem is such that it can never capture the
full complexity of the process.
CASE STUDY DATA
A series of 18 retrospective case studies were created to
reveal the role played by micronutrient recommendations in
the public health nutrition policy-making process of 6 coun-
tries or regions [Czech Republic, CZ; Italy, IT; the Netherlands,
NL; Nordic countries (Denmark, DK; Finland, FI; Iceland, IS;
Norway, NO; and Sweden, SE); Poland, PL; and Spain, ES].
The 3 micronutrients—folate, iodine, and vitamin D—were se-
lected from the 10 priority micronutrients identified by previ-
ous research within the EURRECA network (Cavelaars et al.,
2010). The countries and micronutrients were chosen to pro-
vide case studies offering policy decision-making contexts that
varied widely in terms of health outcomes, geography, political,
historical, and socio-cultural factors.
Each case study was created from data collated during
EURRECA.
Quantitative online questionnaire survey conducted in
2007:
(1) Study 1 surveyed micronutrient DRV relevant key infor-
mants from universities, public health institutes and govern-
mental organizations representing various countries/regions
(CZ, DK, ES, FI, IS, IT, NL, NO, PO, and SE). Open- and
closed-ended questions identified the organizations respon-
sible for developing micronutrient DRVs and nutrition poli-
cies and elicited the current micronutrient policies for each
country/region (Table 2) (Dhonukshe-Rutten et al. 2010).
All 35 questionnaires sent out were completed and scien-
tific background reports on micronutrient recommendations
were collated for 11 European countries.
Qualitative interview studies conducted from 2008–
2011:
(2) Study 2 interviewed micronutrient DRV stakeholders about
their beliefs regarding consumers and dietary guidelines
[CZ, ES (Brown et al. 872-74; Brown)]. In total, 77 in-
terviews were conducted. The 21 CR participants were re-
cruited within the context of a workshop. Response rates
ranged from 75% (ES) to 95% (CR).
(3) Study 3 explored the policy-making process by interviewing
57 participants who had been involved in areas of national
policy development relevant to the DRVs for folate, iodine
or vitamin D [CZ, DK, ES, IT, NL, and PO. Response rates
Table 2 Achieving micronutrient DRVs: changes in individual behavior
Increase micronutrient intake Decrease micronutrient intake
Targeted nutrient Several nutrients Targeted nutrient Several nutrients
Add Foods or
supplements
Buy/choose new
foods/supplements that are
good sources of targeted
nutrient
Buy/choose
foods/multisupplements that
are micronutrient rich, e.g.,
fruit and vegetables, lentils,
whole grain products
Omit Foods or
supplements
Stop buying/choosing
foods/supplements that are
good sources of targeted
nutrient
Stop buying
foods/multisupplements that
are micronutrient rich, e.g.,
fruit and vegetables, lentils,
whole grain products
Switch Shopping purchases Change within/between
product categories to
foods/supplements that are a
better source of target
nutrient
Change within/between
product categories to
foods/multisupplements are
more micronutrient rich,
e.g., fruit and vegetables,
lentils, whole grain products
Change within/between
product categories to
foods/supplements that are a
worse source of target
nutrient
Change within/between
product categories to
foods/multisupplements that
less micronutrient rich, e.g.,
sweetened confectionery
Portion size Increase the portion size of foods that are micronutrient rich Decrease the portion size of foods that are micronutrient rich
Composition of
meal
Change the components of a meal to increase the proportion of
micronutrient rich foods
Change the components of a meal to decrease the proportion of
micronutrient rich foods
Frequency/dietary
pattern
Change dietary patterns to include more opportunity for
micronutrient rich foods (e.g., add breakfast)
Change dietary patterns to avoid the opportunity for
micronutrient rich foods (e.g., skip breakfast)
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Figure 1 Public Health Nutrition Policy-making Framework. (color figure available online.)
ranged from 38% to 100% (ES and IT with 38% and CZ,
DK, NL, PO with 86–100%).
(4) Study 4 interviewed 21 key informants about the process
of developing of DRVs for folate and vitamin D [ES, NL,
Nordic Countries, and PL (Brown, 2012)]. The response
rate ranged from 67% (NL) to 100% (PL).
(5) In-depth desk research of policy documents relevant to
the 3 micronutrients within each country (reports, meet-
ing minutes, press releases, journal articles, consultation
documents/responses from the government, scientific ad-
visory body (SAB)/expert committee, academic, profes-
sional, industry, charity, and nongovernmental organiza-
tions (NGOs).
Content Analysis of the 18 case studies was conducted using
NVivo software (QSR International Pyt Ltd. Version 9, 2010).
Case study data identifying the evidence bases and other influen-
tial factors in the DRV development process were categorized
using an iteratively developed coding scheme. The top-level
coding comprised 3 codes which were not mutually exclusive:
“Science,” “Policy and Institutions,” and “Wider context” (rep-
resented in the final framework Figure 1). Four of the case
studies were coded by 2 researchers each to check inter-rater
reliability, which was found to be within acceptable ranges ac-
cording to Cohen’s kappa coefficient, (agreement ranged from
85.8% to 94.73% and kappa values from 0.55 to 0.78 for each
category). Any areas of disagreement were resolved through
discussion and the remaining twelve case studies then coded by
a single researcher.
The proposed framework (Figure 1, Public Health Nutrition
Policy-making Framework) classifies the various types of con-
sideration that influence public health nutrition policy using the
following broad categories:
• science (as an institution and process) and scientific commu-
nity;
• the policy-making process and its institutions/actors;
• wider contextual elements.
The link with micronutrient DRVs is key since DRVs are
a product of scientific decision making for the purpose of
policy making, product development, and other applied en-
deavors, but are developed with policy making as a guiding
principle.
Central to the Framework is a description of the decision-
making process which translates the policy goal, most often a
measure of health outcome, into the final policy decision. This
decision-making process may draw on considerations from any
one of the 3 categories. Furthermore, each consideration may
exert a different degree of influence over the decision-making
process.
The following text outlines the Public Health Nutrition
Policy-making Framework and describes its main character-
istics using qualitative case study data to illustrate the relevance
of the Framework.
The remainder of this article presents the various components
of the Public Health Nutrition Policy-making Framework with
illustrative case study data. Double quotation marks and italics
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have been used to identify the use of direct interview quotes and
single quotation marks to denote the use of case study text.
DESIRED HEALTH OUTCOME AND POLICY ACTION
Nutrition policy makers are tasked with choosing policy op-
tions that will maximize the likelihood of the relevant popula-
tion achieving a desired health outcome. The ultimate goal of
micronutrient DRVs (and any policy action based on them) is
achieving such an outcome as defined in terms of either opti-
mal health or the prevention of nutrient deficiency. The choice
of health outcome is typically informed by scientific evidence
based on intake amounts, health and nutrient status, bioavail-
ability data, and study of the links between nutrient intake and
health outcomes. Such choices are typically prompted by the
on-going monitoring of the healthiness of the population and
are usually considered in the context of broader health policy.
The following quotes highlight a range of health outcomes
cited in the case studies as bases for nutrition policy, some
directly linked to DRVs and others based on broader obesity
policies.
“We did not only think about the bone health but we took into account
the role of vitamin D in the prophylaxis of obesity and coronary heart
disease and that’s why we prepared the dietary guidelines for adults”
[Study 3, NGO representative, PL, vitamin D].
However, the case studies indicate that science and popula-
tion monitoring are not the only factors influencing the choice
of health outcome. Political realities (e.g., lobbying and cam-
paigning, ideological orientation, economic, and budgetary con-
straints) and aspects of the wider context (e.g., international
pressures, ethical considerations, technological, and economic
trends) can influence which micronutrient-related health out-
come becomes a policy goal.
“So first, we looked at the Dutch nutrient reference values and the
scientific evidence for new developments. Second, we looked at intake
and status data [ . . . ] and after this we also looked at current policy and
current legislation, hence, on European level, and we looked at foreign
policies, just to complete the picture” [Study 3, SAB, NL, vitamin D].
This process of evidence gathering varies in the degree to
which it is formalized across Europe. Whilst western European
and Nordic countries have clear protocols for collation of evi-
dence, this is less notable in Italy and Poland.
“Public health nutrition policy based on dietary reference values is
[ . . . ] informal . . . based mainly on available evidence, on the evaluation
of evidence by experts, dialogue with stakeholders, consumers, citizens,
target groups of population; identification of the policy instrument for
the implementation of the decision, evaluation of barrier, and continuous
adjustment of aims. But, it is something very flexible and very informal”
[Study 2, Independent expert, IT, folate].
Every policy action (a concrete action to achieve a policy
goal) hinges on the choice of policy option. Policy options rele-
vant to micronutrient DRVs can target a specific micronutrient
(e.g., recommend supplementation with folic acid) or the whole
diet (e.g., Food-based Dietary Guidelines, FBDG) and often
vary in how much they rely on individuals actually changing
their food-related behaviors. For example, some policy options
can achieve health outcomes without behavior change simply
by altering the composition of food. Such policy options usu-
ally require strong evidence of the link between intake of a
single nutrient with the health outcome and that the population-
level risks and benefits of food composition changes are clearly
understood. Moreover, the policy option must have general so-
cietal acceptance (Kim, 2007; United Nations System Standing
Committee on Nutrition, 2007). This is illustrated in the extracts
below.
‘There are very few policy actions regarding micronutrients in Spain.
Iodine is the most documented example, with a long history of mea-
sures as legislative policy instrument. Efforts are nowadays in obesity,
with little room for other integrated strategies, despite of the opinion of
scientific societies and public health experts’ [Case study, ES, iodine].
“There has to be a significant part of the population that has the problem
before one should control it through the diet. If there is a smaller part
of the population that has a need and [ . . . ] on top of that risk that
some people will be harmed then you shouldn’t do it through the diet.
In this case [regarding folate], one has to try to encourage the use of
supplements” [Study three, DK, folate].
On the other hand, behavioral approaches are often seen as
the only option as they rely on consumers’ voluntary accep-
tance of messages to change diet and does not require under-
taking a complex legislative process to implement it. The basis
of national nutrition and health policy is to make healthy di-
etary patterns more accessible to consumers, or “to make the
healthy choice the easy choice” [Desk research, Ministry of
Health Welfare and Sport and Ministry of Agriculture Nature
and Food safety, 2008, NL, iodine]. The effectiveness of such
approaches, however, is not always measured (Brown et al.,
2011).
SCIENCE
Nutrition policy is typically informed by evidence from the
natural and social sciences. Links between markers of nutri-
ent status/intake and health status/outcome, for example, can
be evaluated for their strength, relevance, and degree of associ-
ated uncertainty (Scientific Advisory Committee on Nutrition,
2011). Producing micronutrient DRVs from such work typically
involves a series of systematic reviews and meta-analyses con-
ducted within SABs, which are then communicated to policy
makers who will develop an appropriate policy action (please
see publications in this issue detailing systematic review and
meta-analysis case study examples for vitamin B12, folate, io-
dine, iron, selenium, and zinc).
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“Micronutrient recommendations, in particular, for iodine, derive fun-
damentally from WHO epidemiological surveys and it was scientifically
proven that, through a programme of iodine supplementation, there were
beneficial effects . . . that is the scientific evidence of the benefits of the
health care programme has for sure influenced our politicians in choos-
ing to approve the law” [Study 3, individual expert, IT].
With an increased focus upon prevention of chronic diseases
(as opposed to nutrient deficiencies), achieving wellbeing and
optimal health (World Health Organization, 2003), and food-
based dietary targets, there is now a recognized need for use
of evidence based on social science paradigms and approaches
such as dietary attitudes or behavior evidence. Motivations ef-
fecting dietary choice which compete with and may supersede
health motivations, such as geographical, cultural, economic,
and psycho-social factors, as well as taste preferences (Pollard
et al., 1998) are recognized in literature as important in design-
ing public health nutrition policy. This applies equally to both
food based-approaches targeting changes in dietary pattern, and
nutrient-based approaches such as fortification. In each case,
consumer acceptance (partly determined by their attitudes, be-
liefs and habits) is a necessary precondition for any success-
ful policy option. Therefore, the need to identify the consumer
factors influencing nutrient intake that are linked to a desired
health outcome emerges strongly from our case studies, just as
the importance of looking beyond nutrient intake is articulated
by many interviewees.
“When we were thinking about the promotion of diet and of some foods,
we haven’t forgotten food culture, which is an Italian thing, and the
habits, the productions, our agriculture [ . . . ] you can’t overturn a food
habit when promoting health, it is something that has to be introduced
in that culture” [Study 3, SAB, IT].
“So if you look at older population groups in Scandinavia they actually
have a higher level of vitamin D than in Southern Europe. This is due
to tradition in Denmark to take a vitamin supplement every day and
although we have lower amount of sun hours—when the sun is finally
out we love to sunbath whereas in southern parts of Europe they stay
in the shade. So this behavior also needs to be taken into account when
discussing whether or not to introduce mandatory fortification” [Study
3, DK, vitamin D].
Nevertheless, nutrition surveys are frequently the only evi-
dence of food and dietary behaviors available. This is a prob-
lem because nutrient intake as a measure says little about the
complex food-related behavior that underpins it and which can
include food choice (buying certain foods), food storage, prepa-
ration, and food occasions (when and how it is eaten) (Jensen
et al., 2012).
‘The dietary survey is used widely by the Veterinary and Food Ad-
ministration, by other scientific institutions, policy makers, and other
stakeholders. Without the dietary survey, it would not be possible to
carry out targeted dietary campaigns, enrichments programs, as well
as nutritional and toxicological evaluation of new food products. The
nutritional surveys, performed by the National Food Institute, give the
answer to the current micronutrient status in the Danish population and
this can be compared to the answer book’ [Desk research, NNA 2004,
DK].
Based on these observations, the current Framework calls
for the development of a more nuanced way of representing and
thinking about nutrient-related behavior. Table 2 represents the
typology of behaviors relevant to nutrient intake as developed by
EURRECA, reflecting the breadth and complexity of possible
behavioral changes based on using nutrient intakes as a target
for behavior.
Whilst some of the behaviors in the above table can overlap
it is nonetheless essential to keep the “choice/buying behaviors”
and the “eating behaviors” separate given that “choice behav-
iors” precede the availability of an option at home (or at the
table), whereas “eating behaviors” encompass choosing how
much to eat and the cultural conventions of how we construct
our meals.
There are also other nutrient-related behaviors that do not di-
rectly impact on nutrient intake. For instance, information about
specific nutrients can increase motivation to eat more healthily,
fostering a greater awareness of nutrition and an increased abil-
ity to make the right dietary changes. Such behaviors are more
prerequisites for behavior change (in this case, by acquiring
sufficient knowledge to make better choices) than food choice
or eating behaviors in themselves, and as such are valid targets
for policy actions, even though they only impact nutrient intake
indirectly through choice and eating behaviors.
In addition to considerations about the kind of behavioral
changes that are required one must also consider the behav-
ioral mechanisms underpinning these changes. There is now
growing recognition that most successful behavior change ap-
proaches share substantial commonalities (Beutler 997–1007;
Michie, van Stralen, and West 42;Thaler and Sunstein) both
in terms of focusing on the capability, opportunity, or motiva-
tion to change and in that many of these discrete theoretical
models actually function via broadly comparable mechanisms.
This allows interventions to be based on empirically validated
mechanisms (Jensen et al., 2012).
Extending this reasoning to food choice, it becomes clear that
nutrient-related health outcomes can be effected by myriad be-
havioral mechanisms including habit, cognitive dissonance, atti-
tudes, self-efficacy, emotions, identity, and social norms (Jensen
et al., 2012). This is consistent with the failure of information
campaigns which fail to acknowledge the roles played by heuris-
tics and cognitive distortions (Kahneman and Tversky, 2012)
and assume that individuals are motivated to seek information in
order to achieve an optimal outcome (Fishbein and Ajzen, 1975).
POLICY AND INSTITUTIONS
Strong scientific evidence and a clear rationale for the ben-
efits and risks of micronutrient intake do not by themselves
guarantee that a policy will be adopted. Such decisions will
be made in the context of both the wide array of policy op-
tions available (Table 3) and the institutional and regulatory
frameworks within which they exist. In general, voluntary be-
havior change is often the preferred policy option (Jensen et al.,
2012), with voluntary food fortification, supplementation and
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legislation for food composition, and labeling being popular
choices where micronutrient DRVs are concerned.
The kinds of evidence considered for each type of policy
will vary in how implicit or explicit they are and in their relative
weightings. The factors affecting a decision to adopt DRV-based
policy options are wide ranging and include the feasibility and
effectiveness of existing policies, regulatory and institutional
frameworks, interactions with stakeholders and vested interest
groups, and ultimately the likely economic consequences of the
policy in action. These are ultimately an issue of politics in its
broadest sense, defined as “activity through which people make,
preserve and amend the general rules under which they live”
(Heywood, 2007). “Politics” is an extremely wide concept and
can relate to: the art of government; public affairs; compromise
and consensus; and power and the distribution of resources. This
is the reason we have avoided using the term “politics” explicitly
in our text. Instead, we specify the elements of decision making
that can be subsumed under the concept of politics.
The following table summarizes policy options adopted
within Europe for the micronutrients folate, iodine, and vita-
min D.
In general, legislative options are only considered if all other
options are deemed unsuitable (Lawrence, 2005), and indeed,
only a few EU countries EU have opted for mandatory fortifi-
cation. Voluntary fortification is more widely considered (see
Table 3) but in countries such as Sweden or Norway even this
rarely deemed acceptable.
The hard line taken against fortification by some member
states is potentially problematic as any bans on importing for-
tified foods risk contravening EU regulations on liberal trade,
which only permit such prohibitions when justified by a clearly
demonstrated risk assessment rather than simply on the basis of
nutrition policy (Fletcher et al., 2004). This can have the effect of
allowing economic concerns, such as the need to compete on the
European market, to override public health considerations and
become the dominant influence on whether food fortification
policy is adopted or not.
“One of the biggest limitations is the role of the European legislation on
voluntary fortification. That is actually the main limitation of the entire
advisory process” [Study 3, SAB, NL].
“[ . . . ] costs were taken into account, as well as exportation options, be-
cause not all countries accept foods with an obligatorily added nutrient”
[Study 3, SAB, PL, folate].
While voluntary social policy options such as FBDGs are
much more widely accepted their actual ability to raise aware-
ness, increase understanding, and change diets remains un-
proven (Brown et al., 2011). Indeed, evaluations that do include
an assessment of actual behavior change are a source of evidence
with potentially huge relevance for cost effectiveness, and yet
one that is often overlooked.
“It is quite unique that we have such a strong monitoring program for
iodine. There are many countries that have fortification with iodine but
they do not have monitoring. This has only been possible because we
have a strong scientific group that stand behind it and is very interested
in following this through. Despite this, it is a battle every year to get
money set aside to be able to continue this monitoring” [Study 3, SAB
representative, DK].
The cost implications of a policy option, for the targeted
consumer as well as for related stakeholders and the govern-
ment itself, are also routinely considered. The affordability of
a fortified product, for example, is an important determinant of
its likely effectiveness as a policy option because even small
variations in food prices can effect purchasing decisions (Allen,
2006). Similarly, the costs of establishing the regulatory frame-
work and an appropriate infrastructure necessary for product
development and manufacture are often balanced against the
costs of micronutrient malnutrition to public health.
The case studies confirm, then, that evidence of public health
needs, though often hailed as the primary motive for adoption
or rejection of food fortification policies, frequently plays a
secondary role. Economic and financial considerations, and the
need for short-term impact, can easily undermine any decision
to adopt (or not) a food fortification policy.
“In the old days, the decision to fortify food products was based on
a health outcome motive but about 10 years ago, there was a shift of
paradigm, so today it is just as much based on a market share motive”
[Study 3, Government official, NO].
“In the Nordic countries, we haven’t wanted health claims and stuff
like that. We just wanted to inform people on how to choose a healthy
diet. The philosophy was that if people follow the food-based dietary
guidelines then they will get the micronutrients they need. But given the
new EU regulation, we will probably also have health claims in Denmark
which will mean more fortified food products” [Study 2, DK, folate].
Vested interests are another important context influencing
policy decisions and one that presents its own complex chal-
lenges. For instance, the same legislation for changing the com-
position of foods can present both an opportunity for some
stakeholders and a threat to others.
On the one hand, industry is often quick to respond to calls
for food fortification which might lead to new marketing oppor-
tunities, especially given the growing emphasis upon optimal
nutrition, and often cite “Consumer choice” as an argument for
voluntary fortification. On the other, many groups express con-
cern about excessive manipulation of products and favor educa-
tion about natural foods as the optimal policy option. Consumer
groups, in particular, tend to be naturally skeptical, seeing volun-
tary fortification as purely a vehicle for market expansion rather
than beneficial for public health. This can even lead to calls for
regulated, mandatory fortification in preference to harder-to-
control voluntary options (Tedstone et al. 23–29). The opposite
is true when it comes to salt, however, where efforts to reduce
levels in foods are opposed by the salt industry and by retailers
but supported by consumer groups (Timotijevic, 2012).
In the following extracts, interviewees discuss how they ac-
commodate consumer preferences and the extent to which stake-
holder interests play a role in policy development.
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“[ . . . ] we took into account what is the perception of the consumer
when he sees that product is fortified with folate. Consumers do not
know what the folate is and it seems to them to be a food preservative.
For example, this was a constraint in the campaign led by one of the
chain stores, when it gave the information that its bread was fortified
with folate” [Study 3, SAB, CZ, folate].
“A policy official puzzles with [vested] interests. Every time it’s looking
again. [ . . . ] what interests are there? What interest weights heaviest?
And what do you prioritize?” [Study 3, government official, NL, vitamin
D].
Stakeholder consensus is a related issue which has bearing
not just on the decision-making process itself but on gauging
the effectiveness of policies already implemented. Legislation
can sometimes circumvent the lack of consensus, but a more
popular approach amongst interviewees was achieving the pol-
icy goal through a mixture of private/public partnerships and
voluntary self-regulation, as in the case of food fortification
(Ramakrishnan and Yip, 2002). Interviewees saw bringing to-
gether key private sector players such as producers and retailers
with public sector groups such as health agencies, research com-
munities, and legislators as the recipe for building the solid base
of support required for a successful policy. Most interviewees
emphasized the importance of involving the broadest possible
range of sectors and stakeholders in the policy making process,
ensuring that all their motivations and concerns are addressed
(Griffiths, 2002).
‘Placing more emphasis in existing nutritional consumer information on
overall dietary patterns, rather than merely focusing on specific products.
The Netherlands Nutrition Centre, NGOs (including foundations and
patients’ associations), industry groups, and educational institutions all
play an important role in this effort’ [Desk research, Ministry of Health
Welfare and Sport and Ministry of Agriculture Nature and Food safety,
2008, NL, vitamin D].
However, the range of policy options available for consider-
ation in the first place often depends on more nebulous factors
such as the underlying level of commitment to public health
goals and pervading beliefs about the role of the state in achiev-
ing a healthy population. For example, the perceived reluctance
to adopt legislative approaches is often described in terms of
respect for “consumer choice” and freedom from state interfer-
ence (Mayor, 2011). The extract below illustrates this point.
“[ . . . ] It sounds very strange, but also nutrition policy has a “political
color.” We now have a minister who prefers no paternalism; hence,
people have to make their choices themselves. [ . . . ] you do not only
look at, okay, what is industry doing, but particularly also to who are
the House of Representatives [the lower house/second chamber] and
what direction/flow do they want regarding public health” [Study 3,
SAB, NL, vitamin D].
The breadth of policy options available can also be influ-
enced by the pervading attitude toward public health nutrition,
which may be considered a less important area than mainstream
healthcare and, therefore, receive less funding. Such attitudes
tend also to be reflected in the degree to which policies are sup-
ported by the institutions tasked with EBP development. The
existence of a dedicated SAB and an aligned Public Health
Ministry, for example, tend to coincide with more explicit pub-
lic health nutrition policy (Trubswasser and Branca, 2009) and
better implementation and monitoring programmes. As the fol-
lowing extract demonstrates, the remits and responsibilities of
different departments and the interactions between them can
also influence institutional policy option preferences.
‘The Ministry of Health, Welfare, and Sport worked in conjunction with
the Ministry of Agriculture, Nature, and Food Quality to create this pol-
icy document. After all, making it easier for consumers to make healthier
food choices is a priority for both the Ministry of Health, Welfare, and
Sport (making the healthy choice the easy choice) and the Ministry of
Agriculture, Nature, and Food Quality (to promote knowledge of where
food comes from). The Ministry of Health, Welfare, and Sport is partic-
ularly skilled in the areas of prevention, the relationship between dietary
choices and (chronic) diseases, and the association between prevention
and care. The Ministry of Agriculture, Nature, and Food Quality, on the
other hand, has expert knowledge on the production and supply chain as
well as the broader context of food. In addition, both ministries promote
research, innovation, and self-regulation within the business commu-
nity’ [Desk research, Ministry of Health Welfare and Sport and Ministry
of Agriculture Nature and Food safety, 2008, NL].
WIDER CONTEXT
As well as being influenced by their immediate political con-
text, policy option decisions were also seen to be affected by the
wider social, legal, political, and economic environment. Such
considerations include international influences, technological
infrastructure, broader economic trends, ethical considerations,
and events in the wider world.
Whilst scientific evidence provides an essential grounding
for public health policy making, decisions about whether a mi-
cronutrient policy is ultimately adopted are often just as depen-
dent on international influences, such as the success or failure of
similar policies in other countries (Allen, 2006). In addition, in-
ternational micronutrient recommendations can sometimes ex-
ert even more influence over the public health nutrition agenda
than domestic DRVs.
‘Many countries have set and updated their recommendations for many
years, so action was perceived as necessary in Spain too’ [Case study,
ES].
Ethical considerations such as the right to food, the right to
privacy, and the right to autonomy also factored into policy deci-
sions and are commonly invoked by stakeholders as arguments
for or against fortification or food composition changes. For
example, worries that mandatory fortification threatens the in-
dividual’s right to the autonomy promoted the UK FSA to com-
mission a report on ethical ramifications of different approaches
to fortifying foods (Fuller-Deets and Dingwall, 2007; United
Nations System Standing Committee on Nutrition, 2007). This
right to autonomy must be balanced with other key ethical
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considerations, most notably the value of equity and social jus-
tice, as it is argued that despite years of supplementation and
voluntary fortification micronutrient malnutrition still has a clear
socio-economic gradient which could be overcome through
mandatory fortification.
‘The Health Council of the Netherlands is aware of the ethical and so-
cietal implications of scientific developments, but does not focus on the
implementation of concrete policies. Despite the great importance of sci-
entific knowledge and information about uncertainties in this knowledge,
in taking policy actions political, economic, or social considerations al-
ways play a role. The consideration required for policy decisions is the
role of government and parliament’ [Desk research, Gezondheidsraad,
2011, NL].
The availability of technical skills and resources must also be
considered when making policy decisions, especially those in-
volving changes in food composition. Considerations here will
range from whether the technological capacity exists to, for
example, install and maintain new machinery, to the scientific
feasibility of tasks such as developing appropriate micronutri-
ents as supplements). Policy makers also have to assess whether
the infrastructure necessary for successfully implementation ac-
tually exists.
‘Official recommendations for vitamin D could not be determined pre-
cisely because there is a lack of the specialized science capacities in
the CZ and foreign materials are often contradictory. Therefore, the
chosen way is unofficial recommendation at the moment, for example,
recommendation prepared by the Society for Nutrition’ [Case study, CZ,
vitamin D].
Broader economic trends and global events also impact on
policy decisions. For example, in many of the future EU coun-
tries the end of World War II prompted a wave of progressive
interventionist public health policies, such as universal iodiza-
tion of salt. Events such as wars and global economic trends
often lead to changes in health policy orientation, for example,
away from a paternalistic approach and toward a model driven
by consumer choice and market forces.
IMPLICATION AND SOME CONCLUSIONS
Clearly, the range of considerations effecting micronutrient
DRV policy decisions is extremely wide and our understanding
of the process needs to acknowledge this. Both the framework
developed by the EURECCA network and its associated case
studies suggest that regardless of the quality of scientific evi-
dence available, the likelihood of a policy option being adopted
and successfully put into practice is to largely determined by
the institutions involved and their wider political context.
Any attempt to put evidence at the heart of policy making,
therefore, needs to acknowledge gaps in scientific knowledge
regarding the certainty of relationships between micronutrients
and markers of health, as well as a lack of research into the
behavioral factors underpinning an individual’s diet. Equally,
though, it must recognize the central role played by context
in deciding which considerations to engage with and how to
reconcile them to create a coherent public health nutrition policy.
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FBDG = Food-based dietary guidelines
FI = Finland
FSA UK = Food Standards Agency UK
HCN = Health Council of the Netherlands
IDD = Iodine deficiency disorder
IS = Iceland
IT = Italy
NGO = Nongovernmental organization
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SEEN = Spanish society of endocrinology and nutrition
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 O
f S
ur
rey
] a
t 0
7:2
9 1
1 S
ep
tem
be
r 2
01
5 
1134 L. TIMOTIJEVIC ET AL.
UK = United Kingdom of Great Britain and Northern
Ireland
USA = United States of America
USI = Universal salt iodization
WHO = World Health Organization
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Scientiﬁc advisory committees (SACs) are seen as “boundary organisations” working at the interface
between science, policy and society. Although their narrowly deﬁned remit of risk assessment is
anchored in notions of rationality, objectivity, and reason, in reality, their sources for developing rec-
ommendations are not limited to scientiﬁc evidence. There is a growing expectation to involve non-
scientiﬁc sources of information in the formation of knowledge, including the expectation of stake-
holder consultation in forming recommendations. Such a move towards “democratisation” of scientiﬁc
processes of decision-making within SACs has been described and often studied as “post-normal science”
(PNS) (Funtowicz & Ravetz, 1993). In the current paper we examine the application of PNS in practice
through a study of stakeholder consultations within the workings of the UK Scientiﬁc Advisory Com-
mittee for Nutrition (SACN). We use the theoretical insights from PNS-related studies to structure the
analysis and examine the way in which PNS tenets resonate with the practices of SACN. We have selected
a particular case of the SACN UK recommendations for salt as it is characterized by scientiﬁc controversy,
uncertainty, vested interests and value conﬂict. We apply the tenets of PNS through documentary
analysis of the SACN Salt Subgroup (SSG) consultation documents published in 2002/2003: the minutes
of the 5 SACN SSG’s meetings which included summary of the SACN SSG’s stakeholder consultation and
the SSG’s responses to the consultation. The analysis suggests that the SACN consultation can be
construed as a process of managing sources of risk to its organisation. Thus, rather than being an evi-
dence of post-normal scientiﬁc practice, engagement became a mechanism for conﬁrming the speciﬁc
framing of science that is resonant with technocratic models of science holding authority over the facts.
The implications for PNS theory are discussed.
 2013 Elsevier Ltd. All rights reserved.Introduction
Post Normal Science (PNS) is a theoretical framework developed
by Funtowicz and Ravetz (1993) to denote a newway of production
of science that is required in the context of high scientiﬁc uncer-
tainty and high stake (interest), when the problems are multifac-
eted and decisions are urgent. Within this context, scientiﬁc
process, traditionally conﬁned to scientiﬁc peer community, is seen
to beneﬁt from engagement with an extended peer community
that includes many perspectives and values. Arguably, scientiﬁc
advisory committees (SAC) are the sitewithinwhich PNS practice is
most visible (Lorenzoni, Jones, & Turnpenny, 2007) due to their: þ44 1483682913.
Timotijevic), julie.barnett@
rown), m.raats@surrey.ac.uk
All rights reserved.boundary position between science and policy (Guston, 2001). We
report on a case study of the Scientiﬁc Advisory Committee for
Nutrition in its efforts to engage awider network of stakeholders in
the processes of setting recommendations for salt. Uniquely, the
case study examines the actual consultation outputs throughout
the recommendations setting process. We apply the analytical
framework developed by Turnpenny, Lorenzoni, and Jones (2009)
to capture the elements of practice within SACs that can be
described as “post-normal science”, and critically evaluate the
application of the concept. The current article reﬂects on the extent
to which PNS is a helpful lens through which the processes of
engagement within SACs are explained and theorised.
The remainder of this introduction unfolds as follows: we will
ﬁrst give an overview of PNS theoretical framework and the aligned
notion of democratisation of science, then review the policy origins
of the calls for democratisation of science with a particular refer-
ence to the workings of SACs. We will then describe the case of
L. Timotijevic et al. / Social Science & Medicine 85 (2013) 79e8680SACN reviewing both the policy context and the institutional
characteristics of the SACN.
Post-normal science and democratisation of science
PNS is a step change in our understanding of the practices of
science, diverging from Kuhn’s (1962) framing of “normal” science.
“Normal” science is characterised by a high degree of scientiﬁc
consensus about the scientiﬁc approaches, until such time that the
on-going critical reﬂections of scientists reach a point of “paradigm
shift”. In contrast to this, the new, “post-normal” approach to sci-
entiﬁc practice reﬂects the emergence of complex, multifaceted
and multidisciplinary nature of problems (deﬁned as “wicked”
problems), which in turn call for the inclusion of multiple per-
spectives and values. Broadening of the scientiﬁc practice from the
traditional (scientiﬁc) peer community to the extended community
of peers is seen as necessary for a number of reasons. It is believed
that it enables scrutiny of assumptions and questions (Nowotny,
2003), that it ensures that ethical dimensions of social problems
are not overlooked through scientiﬁc evidence production, and that
it leads to trust in the decisions of the regulator (Government Ofﬁce
for Science, 2009; Government Ofﬁce for Science, 2007a,2007b;
Parliament Ofﬁce of Science and Technology, 2001; Wynne, 2006).
According to PNS framework, the “extended peer community”
(Rosa, 1998) as the community of individuals who should be
included into scientiﬁc deliberation either because they are
affected by the issue or can provide perspectives that broaden and
extend the framing of the problem, make quality judgements of the
scientiﬁc process based on considerations of values as well as sci-
entiﬁc facts (Turnpenny, Jones, & Lorenzoni, 2011).
The concepts of PNS and the extended peer community have
been in wide use for the past couple of decades, both as a theo-
retical framework to explain and guide the relationship between
science, policy and broader society, and as a method developed to
identify the contexts e issues, stakes and uncertainties e that call
for the extended peer community in scientiﬁc practice (Turnpenny
et al., 2009). The studies employing PNS as a framework have used
it to identify the “wicked” problems e issues characterised by un-
certainty, value inconsistency, urgency and heterogeneity of visions
and epistemologies e that call for the adoption of post-normal
scientiﬁc practice (e.g. Saloranta, 2001); and to explain the pro-
cesses of science in practice in the light of PNS (e.g. Petersen, Cath,
Hage, Kunseler, & van der Sluijs, 2011; Turnpenny Lorenzoni, &
Jones, 2009). Among the more enduring debates about PNS is the
extent to which it represents a normative framework for scientiﬁc
practice and its links to policy, or rather, is a theoretical model, a
description or a heuristic (Farrell, 2011) that offers an explanatory
framework for this interaction as it happens in practice. The
growing critique of PNS framework questions some of its unex-
amined assumptions that ascribe a normative role to the extended
peer community as “quality control” (Wesselink & Hoppe, 2011).
More recent examination of the processes of the EPC through
alternative theoretical angles such as risk colonisation (Rothstein,
2006; Rothstein, Huber, & Gaskell, 2006), showed how applica-
tion of the concept can be played out in practice with unintended
consequences that are at variance with the values of inclusivity,
information completeness and heterogeneity. In a similar vein,
Walls, Rowe, and Frewer (2010) have demonstrated how the
pressures for openness and engagement can lead to selective
transparency by making obvious only those elements of scientiﬁc
decisions characterised by consensus and uniformity. It is argued
that the current procedure for linking democratic control and risk
assessment as the two modalities of decision-making within a SAC
can lead to institutional deﬁciency and diminished legitimacy
(Bijker, Bal, & Hendriks, 2009; Ferretti, 2007). This raises an issue ofthe applicability of PNS aims in practice, their compatibility with
the traditional governance approaches, and their relationship with
aligned concepts of better governance such as accountability and
transparency. This is particularly relevant to the workings of sci-
entiﬁc advisory committees. The way in which PNS aims are re-
ﬂected in policy discourse related to the workings of scientiﬁc
advisory bodies will be examined below.
Policy rationales for the extended peer community in the
operations of SACs
Scientiﬁc advisory committees are seen as “boundary organisa-
tions” working at the interface between science, policy and society
(Guston, 2001), which makes them clear contenders for the post-
normal scientiﬁc practice. Historically, however, they have been
taskedwith risk assessment, that is the technical decision-making of
expertswhoengage insystematic, analytical, andlargelyprobabilistic
thinking to characterise hazard, model its distribution, and estimate
its risk (Renn,1998). Thepast 10e15yearshavewitnessed agreatdeal
of regulation of this process through clear guidelines of when and
how SACs are convened, the mechanisms through which their de-
cisionsaremadeandconveyed(asexempliﬁed inCodesofPractice for
Scientiﬁc Advisory Committees (Chilvers & Burgess, 2008; Liberatore
& Funtowicz, 2003; Ofﬁce of Science and Technology, 2001; Scientiﬁc
Advisory Committee on Nutrition, 2002).
The principles of scientiﬁc universalism and independence
enshrined in deﬁnitions of risk assessment have been under
increasing scrutiny. Various documents such as the House of Lords
report (House of Lords, 2000) and Code of Practice for Scientiﬁc
Advisory Committees 2001 (Ofﬁce of Science and Technology, 2001)
in the UK, and Science in Society Action Plan (European Commission,
2001), and Communication on Collection and Use of Expertise
(European Commission, 2002) in the EU emphasised the require-
ment of SACs to seek external input on their decisions, broaden the
basis on which they are made, increase transparency, and ensure
active acceptance by those who will be implementing them.
Consequently, the framing of SACs’ role and practices as
embodied in policy documents contains a dichotomy of the
competing and simultaneous emphasis upon the technocratic ba-
ses of policy (“normal science”) and the ethos of stakeholder
engagement (or extended peer community). For example, along-
side the EC Science and Society Action Plan (European Commission,
2001), which calls for democratisation of expertise, is the
enshrining of the key principle of scientiﬁc independence from
external constraints (in the Part II of the Draft Treaty Establishing a
Constitution in Europe, 2003, Article II:13 (European Commission,
2003). An interesting and thus far unexamined question of both
practical and conceptual importance therefore is whether and how
the twin pressures (implicit within policy documents) of engage-
ment and scientiﬁc independence can co-exist within the workings
of SACs. The examination of this tension in the current paper will
focus on the operational aspects of the Scientiﬁc ADvisory Com-
mittee for Nutrition (SACN) and the strategies used to manage the
consultation procedures.
Aim of the paper
The aim of the current paper is to examine the application of
PNS in practice through a study of the Scientiﬁc Advisory Com-
mittee for Nutrition (SACN). We use the theoretical insights from
PNS-related studies to structure the analysis and examine the way
in which PNS aims resonate with the practices of the boundary
organization such as SACN. We have selected a particular case of
SACN recommendations for salt, the scientiﬁc area that is charac-
terized by controversy, uncertainty, vested interests and conﬂict,
L. Timotijevic et al. / Social Science & Medicine 85 (2013) 79e86 81and can therefore be described as a “wicked problem”. We apply
the frame of PNS through documentary analysis.
The case of SACN UK and the analytical framework
The Scientiﬁc Advisory Committee for Nutrition (SACN) UK
SACN provides a potentially interesting case since its formation
and the replacement of its predecessor, the Committee of Medical
Aspects of Food and Nutrition Policy (COMA) was explicitly driven
by the expressed need for clear separation between risk assessment
and risk management, as this institutional reform aimed to remove
policy considerations from the remit of the scientiﬁc committee.
Like COMA before, SACN (UK) brings together independent experts
who provide advice to the government department primarily
responsible for nutrition policye until recently, the Food Standards
Agency and now the Department of Healthe as well as other gov-
ernment agencies and departments. Its remit includes matters
concerning nutrient content of individual foods, advice on diet, and
the nutritional status of people in the UK. The Committee members
are appointed as independent scientiﬁc experts on the basis of their
speciﬁc skills and knowledge (mostly in nutrition and biomedical
sciences, but also in social sciences) and typically hold a Chair in
academic institutions. There are also two laymembers representing
consumers. SACN is supported by a secretariat provided by the
relevant department in charge, who are selected for their scientiﬁc
expertise. This ensures that they can provide comprehensive
background information to SACN members when brieﬁng them
about the Terms of Reference and throughout the decision-making
process of the Committee.
There are clear guidelines for the conduct of the members (Code
of Conduct for Scientiﬁc Advisory Committees 2001; revised in 2007
and then 2011) as well as a document that speciﬁes the decision-
making processes in assessing risk (SACN Framework for Evaluation
of Evidence, 2002; revised in 2012). SACN can co-opt experts to form
working groups (‘standing groups’) who meet on an ad hoc basis to
discuss speciﬁc issues. SACN subgroups include non-SACN mem-
bers. The appointment process is less rigorous (as it often does not
follow an open call and application process) and members are
selected for their topic expertise. The subgroups are disbanded
once the work is completed.
SACN communicates through reports based on risk assessments
and position statements. They also sometimes engage in consul-
tation exercises with an aim of identifying relevant evidence to take
into consideration or as a way of getting feedback on draft reports
in preparation for a ﬁnal report. These consultations are usually
written communiqués that invite comments from relevant stake-
holder groups; it is at the discretion of SACN whether to engage
with these comments.
SACN publishes minutes of its meetings on its website (http://
www.sacn.gov.uk) and designates consultation summaries as
open access. It is these documents from the meetings of SACN
Subgroup for Salt and the consultation summaries (see Table 1 for
details) that will form the basis of our research.
Analytical framework
To address whether and to what extent the practice of post-
normal science is evident in the workings of SACN, we have identi-
ﬁed themes to develop a coding system, which was guided on the
one hand by the existing literature, and on the other, through
inductive analysis of the data. We found the analytical framework
summarized and applied by Turnpenny et al. (2009) particularly
useful and resonant with the thematic codes that were emerging
inductively. Turnpenny et al. (2009) adapted the key concepts of PNSand developed a new framework for analysis to suit the needs of
their case studies, along the following themes: 1) Participation 2)
Issue framing; 2) Evidence; and 4) Inﬂuence of knowledge. We
applied this frame in our analysis of the available documents, which
included the consultation summary. We also reﬁned it since the
inductive analysis suggested an extension of this frame to include
decision-making outcomes. The following key questions linked with
the analytical frame helped guide the current processes of analysis:
 Issue Framing: What constitutes a scientiﬁc and political back-
drop against which the issue is framed? How is the problem
deﬁned bya) the commissioner; b) the SACNSalt Subgroup (SSG)
 Participation: How is the SSG composed and overseen? Who
constitutes the extended peer community? What was the
mode of engagement?
 Issue framing by the extended peer community: How is the
framing of the problem by the SSG perceived by the extended
peer community? Is there evidence of the conﬂict in values/
interests?
 Evidence: Are there disputes about the nature, quality, selec-
tion and interpretation of evidence? Is this underpinned by
value preferences?
 Decision-making outcome: Is there clarity about how the de-
cision/recommendation has been reached? Is this disputed and
why?
 Inﬂuence of knowledge: How were the comments of the
extended peer community incorporated into the ﬁnal report?
Whose comments were addressed, and how?
All publicly available documents related to the workings of the
SSG were identiﬁed, which included 5 reports on the minutes of
meetings of the SSG (the ﬁnal one of which included the Subgroup’s
response to consultation), a table summarising submitters’ com-
ments, the draft report, and the ﬁnal Salt and Health reports (see
Table 1 for the list and summary of the documents).Analysis
Issue Framing by the commissioner and the SACN SSG
“Three decades of controversy over the putative beneﬁts of salt
reduction show how the demands of good science clash with
the pressures of public health policy.” (Taubes, 1998: 898).
Salt recommendations setting by the SACN UK was set against
the backdrop of a long running, acerbic dispute in nutrition and
medicine over the putative risks and beneﬁts of the nutrient. When
the SACN SSG was established to review the evidence on salt, the
salt controversy had been in its full swing, fuelled by a number of
scientiﬁc uncertainties, value conﬂicts and vested interests. The key
aspect of the debate is whether a drop of blood pressure by 1 or
2 mm of mercury due to reduction in salt is a sufﬁcient basis for a
prolonged, expensive public health campaign. It is argued that at
the individual level, its effect upon hypertension is considerably
smaller than that of drugs, and at the population level, though
signiﬁcant for the hypertensive, the effect of salt reduction is in fact
insigniﬁcant for the majority of the population with normal blood
pressure (Swales, 1988, 2000). The existence of the controversy is
often attributed to the powerful interests and lobby groups of food
processing industry, who are seen as the principal culprit of the
current intake of salt, most of which is through processed food
(Godlee, 1996; McGregor, 1997).
Against such a backdrop in 1994, the UK scientiﬁc advisory body
for Nutrition e COMA, the forerunner of the SACN UK, recom-
mended a ‘reduction in the average intake of sodium by reducing
Table 1
SACN SSG posted documents.
The document title Date of issue Summary of the document
1st Meeting of SSG SACN/SaltSub SACN/
SaltSub/02/min01
25 January 2002 Members asked to express conﬂict of interest. The purpose of the group is clariﬁed. The oral
summary of the submissions of evidence by interested parties (e.g. Salt Manufacturers
Association; Consensus Action on Salt and Health; Food and Drink Federation) is discussed.
The draft framework of risk assessment (dated 24/01/02) is considered and judged a useful
checklist when considering and evaluating the evidence.
2nd Meeting of SSG SACN/SaltSub SACN/
SaltSub/02/min02
18 April 2002 Framing of the problem to be addressed in terms of: 1) sodium as an essential nutrient; need to
identify the physiological range of sodium required to maintain homeostasis and the associated
individual variations; 2) relative importance of chloride ion; 3) salt sensitivity; 4) morbidity and
mortality outcomes; 5) age-related changes in the above areas. The relevant evidence is sought
to address these areas.
3rd Meeting of SSGSACN/SaltSub/02/min03 21 May 2002 The SACN Secretariat proposes a structure for the draft report. The Subgroup proceeds to
evaluate the collated evidence as per the problem frame deﬁned at the previous meeting.
The Members agree that, “on the basis of the evidence assessed to date, the 1994 COMA
recommendation for a reduction in population average intake, to 100 mmol (2.4g) of
sodium (6g salt) per day, represented a pragmatic target, which was greater than the
minimal requirement but represented an achievable objective for the population” (p. 3) The
Subgroup needs to ascertain the adverse effects on certain sections of the population and
to this end further review evidence.
SACN Salt and Health Draft Report No
longer available
Circulated by the
Secretariat
The Subgroup ﬁnds no evidence to suggest that a reduction in salt to 6g/day for the adult
population recommended by COMA in 1994 would be a risk to health as the evidence to
support it is now stronger.
4th Meeting of SSGSACN/SaltSub/02/min04 11 September
2002
Discussion of the draft statement on salt. Agreement about the way to characterise the studies
reviewed; agreement that there is no evidence that the reduction of salt intake to 6g/day
(as per COMA report) would be a risk to health and the evidence is now stronger than in 1994.
Need for greater understanding of habitual intakes. Reduction to be achieved by changing content
of food and drinks and dietary recommendations. Interested parties will be alerted to the draft and
be given 1 month to comment on the draft.
5th Meeting of SSG SACN/SaltSub/05/min01 7 February 2003 Comments on the draft statement about salt received (after an extended consultation of 3 months)
and the Members agreed to go through the report section by section in order to incorporate agreed
changes in the light of comments received. The responses are analysed in the main body of the
Analysis of the paper.
SACN SSG Summary of Responses Received
to Request for Comments on Salt and
Health Draft Report SACN/SaltSub/03/
02/07/02/03
7th Feb 2003 Responses summarised by the Secretariat of SACN. (We analyse them in our paper)
SACN Final Salt and Heath Report TSO,
Norwich
15th May 2003 COMA recommendations upheld. There is now “larger” body of evidence to link salt consumption
and hypertension. A public health approach to reduction in salt intake is required.
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recommendation of COMA did not ﬁnd its way into policy however,
due to a considerable amount of controversy this triggered within
interested parties (particularly the corporate sector) who disputed
the government recommendations. In September 2001, the Food
Standards Agency and the Chief Medical Ofﬁcer for Wales reques-
ted that the newly established SACN review the evidence and up-
date the previous recommendations made by COMA, in the light of
any new evidence, taking into account the submissions that had
been received from interested parties. In addition, the SACN was
asked to consider whether the evidence for children should be
reviewed in order to quantify a recommended amount for the
general population of children (Scientiﬁc Advisory Committee on
Nutrition, 2003b). To this end SACN set up the SSG which
embarked on a series of meetings to evaluate evidence using the
framework of risk assessment developed by SACN in 2002. They in
turn launched a consultationwhichwas conducted in the context of
the growing unease of the salt industry about the mounting sci-
entiﬁc evidence that salt increases blood pressure, and the recog-
nition that most dietary salt (65e85%) is sourced from processed
foods. Indeed, food manufacturers had actively sought to engage
with government’s policy on salt with an aim of minimizing the
potentially negative effect upon industry (Godlee, 1996). In recog-
nition of this, the SSG included three independent experts with
academic backgrounds in human nutrition and epidemiology and a
representative of industry. There were six observers from the
Department of Health and the Food Standards Agency.
The SSG’s proceedings began with collation of responses from
interested parties. Responses were received from 11 organisations,all but two of whom were private corporate organisations and their
representatives. The nature of these submissions by the interested
parties was twofold: to contribute to the development of the frame
for sourcing and interpreting evidence and to suggest new evidence
for consideration, published since the last salt recommendations by
COMA. Many submissions requested careful considerations of risks
of salt reduction, of reliability of measurements, the range of health
outcomes, the nature of studies (how able are they to capture
“habitual” intake). As a result of this exercise, the SSG drafted
statements which provided an important frame for the further
sourcing and interpretation of evidence in terms of: 1) importance of
sodium and understanding physiological requirements for sodium;
2) relative importance of chloride ion; 3) need to understand salt
sensitivity; 4) need to clarify morbidity and mortality outcomes.
Participation
Following a series of the SSG’s meetings, a draft report was
placed on the SACN website in September 2002 for consultation
(please see Table 1 for the summary of the Draft Report conclu-
sions). After a 3 month consultation period, stakeholder sub-
missions to the draft report on Salt and Health were collated, and
the SSG issued a response on 7 February 2003. The ﬁnal Salt and
Health report was published on 15 May 2003 (Scientiﬁc Advisory
Committee on Nutrition, 2003b).
In total 28 responses to the draft report were received, and the
extended peer community included 10 corporate sector organisa-
tions, 8 NGOs, 7 professional or academic institutions, and 3 indi-
vidual submitters (Text box 1).
Text box 1. The Extended Peer Community
The extended peer community included the following or-
ganisations: 1. British Dietetic Association (BDA); 2. British
Frozen Food Federation (BFFF); 3. British Nutrition Foun-
dation (BNF); 4. British Retail Consortium (BRC); 5.
Cochrane Heart Group (CHG); 6. Consensus Action on Salt
and Health (CASH); 7. Co-operative Group (Co-op); 8. Food
Commission (FC); 9. Food & Drink Federation (FDF); 10.
Hooper L, Bartlett C, Davey Smith G, Ebrahim S; 11. Inside
Story; 12. Institute of Food Science & Technology (UK)
(IFST); 13. Intercollegiate Group on Nutrition (IGN); 14.
LoSalt; 15. Macnair A; 16. McGee E; 17. Meat & Livestock
Commission (MLC); 18. Medical Research Council, Human
Nutrition Research (MRC HNR); 19. National Heart Forum
(NHF); 20. National Osteoporosis Society (NOS); 21. Nutri-
tion Society (NS); 22. Sainsbury’s; 23. Salt Institute (SI); 24.
Salt Manufacturers’ Association (SMA); 25. Scottish Con-
sumer Council (SCC); 26. Socialist Health Association
(SHA); 27. Snacks, Nuts & CrispsManufacturers Association
(SNACMA); 28. Stroke Association (SA).
L. Timotijevic et al. / Social Science & Medicine 85 (2013) 79e86 83Of the total number of respondents, 15 were in agreement with
the conclusions, 2 agreed with parts of the report, 4 respondents
raised points but did not comment on the conclusions, and 7 did
not agree with its conclusions. Organisations that were not sup-
portive of the draft report were six corporate organisations and one
individual. Table 2 indicates that the most commentary came from
the corporate sector or its membership organisations. Those who
were in agreement with the main body of the report and its con-
clusions were mostly members of academic, professional, and non-
governmental organisations (NGOs).
The extended peer community’s comments about the framing of the
issue
A considerable number of comments related to theway inwhich
the SSG conducted the review. One of the key issues that emerged
from submitters’ comments concerned the way the SSG framed the
problem. Many questioned the health end-points taken into
consideration, for instance a speciﬁc medical indicator of health
such as blood pressure or a health outcome such as cardiovascular
disease or mortality. Some stakeholders felt that the problem under
consideration was framed in terms of risk of excessive intake,
whilst it was felt that broadening this to include the risk of sodium
deﬁciency would lead to substantively different conclusions. Many
submitters requested broadening the scope of the review to includeTable 2
Key themes identiﬁed in the analysis of consultation documents.
Key themes Extended peer community (N ¼ 28)
Corporate NGO Academi
Framing
Problem framing 11 1 1
Transparency 15 2 1
Range of expertise 1
Evidence
Type and breadth of evidence 16 6 7
Quality of evidence 1 1
Interpretation 19 2 4
Decision
Final recommendations 15 7 8
Implementation 15 12 1
Conclusions 9 4the role of other factors in hypertension. Others commented on the
way in which certain concepts were deﬁned and how this inﬂu-
enced the sourcing of evidence. For instance, comments were
received about the lack of clarity about the choice of age bands for
children, as well as the reasoning behind the decision not to
separate recommendations for men and women. The majority of
comments around the framing of the problem were submitted by
those representing the corporate sector.
A large number of comments addressed a perceived lack of
transparency in the rationales for setting the boundaries of the
problem frame. The respondents appeared to be unclear about the
inclusion/exclusion criteria for the studies selected. Therewere also
more general accusations of bias, lack of accuracy in interpreting
the data and lack of clarity and consistency in reporting.
One submitter questioned the legitimacy of the subgroup,
querying the appropriateness of the current range of expertise
selected to address the issue as framed by the Subgroup’s terms of
reference.
The extended peer community’s comments about the evidence
A wide range of comments related to the way evidence was
gathered, selected, and interpreted. There was considerable
disagreement about the degree to which the list of the studies
selected for inclusion was exhaustive: whilst some respondents felt
that the breadth of studies fromwhich evidence was drawnwas too
wide (e.g., animal studies), others felt it was partial (e.g., individual
trials included, but few systematic reviews). It was also felt that the
selectionof the studies favoured short-termphysiological effects over
the long-term impact of salt consumption on health. Some responses
requested the broadening of the range of studies to include consid-
eration of other factors inﬂuencing hypertension, rather than just salt
consumption. A related point addressed the quality of evidence and
commentedon the inclusionof outdatedstudies in the review. Finally,
a host of submissions centred on the Subgroup’s interpretation of the
evidence presented and how the conclusions were drawn. Some
submitters commented on the lack of an explicit account of what
approach was used to evaluate evidence. It was felt that too much
weightwas given to some studies, that the choice of terms to describe
the new evidence (since the last COMA report) should be charac-
terised as ‘more numerous’ rather than ‘stronger’, and that the po-
tential dangers of sodium restriction had been ignored.
The extended peer community’s comments about the SSG’s decision
The ﬁnal recommendations for daily intake of sodium and how
these were to be implemented attracted a range of respondents’Comments addressed by SACN SSG
c/professional Individual
Partially addressed
Addressed fully
Not addressed
2 Partially addressed
Partially addressed
2 Partially addressed
2 Addressed fully
1 Not addressed
Addressed fully
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to warrant the ﬁnal conclusions reached by the SSG.
The extent of stakeholder disagreement was further apparent in
the diverse assessments of whether the Subgroup’s recommenda-
tions of 6 g of salt per day was above or below the levels suggested
by the reviewed evidence. For instance, an NGO queried why,
despite the body of scientiﬁc evidence suggesting that 4 g of salt per
day should be the recommended dose, the current recommenda-
tion of 6 g of salt a day was endorsed. On the other hand, a
corporate sector submission characterised the target levels set for
children as unrealistically low and unachievable, suggesting it
could potentially deter consumption of foods of nutritional
importance for children such as cheese and milk. One comment
raised the expectation that the ﬁnal recommendation must be in
line with the internationally accepted values for salt, quoting the
WHO’s recommended 5 g of salt a day. A separate, though related
point was the way in which the population group of interest was
deﬁned and conclusions generalised to the whole adult population.
The challenges of translating the recommendations into policy,
and the viability of possible implementation strategies were key
concerns for many submitters. In particular, how the recommen-
dation would be legislated around food labelling, whether imple-
mentation necessitated considerations of issues of food safety (e.g.,
the use of salt as a preservative), and what speciﬁc measures would
be taken to achieve the target (e.g., how to marry up advice
regarding processed food and discretionary consumer use of salt)
were questions posed by a number of respondents. Some sub-
mitters felt that this was an opportunity to query the research
commissioning process and the direction of further research.
How inﬂuential was the extended peer community?
The SSG produced a ‘response to the stakeholder submissions’
document on 7 February 2003, during the 5th Meeting of the
Subgroup noting possible modiﬁcations of the document in light of
the stakeholder comments. They agreed with some of the com-
ments around the issues of transparency and clarity of presenta-
tion, and for themost part, the SSG accepted criticism and agreed to
amend the draft document to achieve greater clarity. Thus, for
instance, the SSG agreed to provide a clear rationale for the eval-
uation of evidence and a rationale for why the report advocated a
population-based approach. They also agreed to make editing
changes to the document, including reiterating certain issues (e.g.,
future research) in the Conclusion section and amending wording
in the text (e.g., from ‘stronger evidence’ to ‘larger body of evi-
dence’). The concern raised around the legitimacy of the SSG in
relation to the range of expertise within the SSG was rejected,
though this decision was not elaborated.
The issue that generated the most controversy and debate
related to the selection criteria for the inclusion/exclusion of evi-
dence for consideration. The committee chose selectively which
comments pertinent to the selection and breadth of evidence to
accept. Thus, for instance, the committee agreed to extend the re-
view by widening the range of longer-term and meta-analytic
studies included in the review as well as more recent dietary
exposure surveys. The criticism suggesting that the SSG’s report
gave disproportionate consideration to the animal studies was
rejected, and justiﬁed as largely being pre-determined by the terms
of reference and the framing of the problem. Indeed, one of the key
arguments justifying the selection criteria centred on what was
thought to be restrictive terms of reference (or problem framing)
for the workings of the SSG. However, our reading of the SSG’s
responses suggests that the Subgroup in fact had some autonomy in
how the problem was framed. Thus, in response to the request for
an inclusion of other factors affecting hypertension in conjunctionwith salt (in order to provide a balanced review of the role of salt in
health), the SSG emphasised some factors (e.g. physical activity and
lifestyle), to the exclusion of others (e.g., genes). The basis for such
prioritisation was not always made explicit.
The ﬁnal recommendation that sodium intakewas not to exceed
6 g was reﬂective of the SSG’s judgements about the possibilities of
achieving behaviour change in line with the recommendations, in
the context of the large behavioural shifts required to move from
the current 9 g of average intake to the requirements of no more
than 4 g. Although this decision was based on pragmatic consid-
erations, the whole section of submitter comments focussing upon
implementation of recommendations was rejected as being beyond
the SSG’s scope of providing recommendations based on risk
assessment.
Before the revised report could be agreed on, the SSG sought the
advice of another SACN subgroup, the Subgroup on Maternal and
Child Nutrition (SMCN). A more specialist opinionwas needed from
experts on the adequacy of ﬁndings in children and infants. On 15
May 2003, and after much deliberation SACN published the ﬁnal
Salt and Health report.Discussion and conclusions
PNS theory posits that the management of controversial policy
issues that draws upon often uncertain scientiﬁc evidence must
recognise the value of engaging multiple perspectives not only in
the policy process, but also in the scientiﬁc processes informing it.
It has long been argued that scientiﬁc advisory committees, which
exist on the boundary between scientiﬁc and political realm, are
the clear contender for the post-normal scientiﬁc practice (e.g.
Farrell, 2011; Lorenzoni, 2007; van de Kerkhof and Leroy, 2000).
However, the analytical focus thus far has been upon the way in
which PNS is realised in the interaction between a SAC and a po-
litical body, whilst the extended peer community is studied as an
emergent (rather than an intended) process. In the current paper
we set out to examine PNS practice and the intended engagement
with the extended peer communitywithin the conﬁnes of the SACN
SSG scientiﬁc decision-making.We have argued at the outset of this
paper that the simultaneous expectation of independence of sci-
entiﬁc advisors, and consultation with the extended peer com-
munity, will provide a particularly informative context to reﬂect on
the value of PNS as a theoretical framework. The analysis of
consultation summary documents represented a unique prism
through which to study the processes of scientiﬁc decision-making.
Whilst we recognise the inherent processes of re-presentation of
stakeholder views by those with responsibility for their use in
science policy, the analysis of these documents provided useful
insights into the ways in which the SACN SSG operated behind the
scenes (‘back stage’) (Hilgartner, 2000).
There are several points of discussion that emerge from the
results. The current results conﬁrm the value of PNS as a framework
to describe the workings of the SSG since both the comments of
submitters and the SSG’s responses fell outside the strict conﬁnes of
risk assessment and addressed considerations stemming from the
broader policy and political perspectives. However, the SSG’s rela-
tive autonomy in determining the framing of the issue ensured that
they achieved a consistent scientiﬁc authority, more akin to the
processes within “normal” science. In addition, whilst ostensibly
consulting, the SSG continued to exercise authority in how stake-
holder comments were addressed, referring strategically to scien-
tiﬁc rationale or policy/political realities. Thus scientiﬁc autonomy
was successfully safeguarded in the face of alternative readings of
the problem under scrutiny. We will discuss each of these points
with reference to PNS.
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that the submitters’ reﬂections on the draft report were made in
the context of the overall nutrition policy development process
rather than its narrowly deﬁned remit of risk assessment. One
explanation is that submitters attributed to the SSG amore political
role than formally ascribed, possibly as a reﬂection of its “bound-
ary” position (Guston, 2001). In the context of salt, the stakeholders
saw the risk assessment aspect of decision-making inseparable
from risk management. The current analysis suggests that such
perception was not unwarranted: whilst the SSG maintained, at
least formally, that their role was ﬁrmly within the risk assessment
stage of decision-making, in practice, some of the decisions (e.g.,
recommendations) were based on pragmatic considerations of
what was achievable and were only partially informed by the
assessed scientiﬁc evidence. This provides some evidence for the
validity of PNS framing of SACs activity since the risk management
and communication elements of the issue are inextricably linked
with the science/risk assessment as they provide context and
bound science to political realities.
And yet, many of the submitters’ comments were rejected as
‘risk management/communication’ issues and deemed to be
outside of the SSG’s remit. Literature has established that, in the
effort to downplay the elements of judgement in the process of risk
assessment, expert advisors “actively work to enact objectivity,
separating themselves sharply from ‘vested interests’ that might seek
to inﬂuence their advice”, thus downplaying diverse views
(Hilgartner, 2000, pp. 14e15; Martin, 2008). The SSG endorsement
of the value of the extended peer community is at variance with
their simultaneous efforts to distance themselves from the social
and political realities. The conﬁning of scientiﬁc advice to risk
assessment as separate from the context of its application, which is
explicit in the policy documents guiding the workings of the SACN,
poses an additional pressure to exemplify objectivity, which in
reality can lead to restrictive transparency (Walls et al., 2010). There
is some evidence of this in our data e enacted in our case through
strategic and partial addressing of the submitters’ comments.
The analysis also demonstrated that the expert committee
exercised a degree of autonomy in determining the scope of the
review process through the decisions made about the inclusion and
exclusion of evidence and the way in which certain concepts were
deﬁned. Considering the number of submissions reﬂecting on these
issues, the framing of the problem appears to be an area where
some debate and disagreement is evident. Even when the terms of
reference for the expert committee are provided in no ambiguous
terms (as was the case above), there appears to be area of ambiguity
that will invite scrutiny and interest of the extended peer com-
munity e a clear evidence for the need for post-normal scientiﬁc
practice. In anticipation of the controversy, the SSG engaged the
extended peer community explicitly both through consultation
processes and by including an industry representative as a Com-
mittee Member (apparently to shape problem framing in line with
the broader sets of values and interests). Despite adopting what is
ostensibly PNS practice, however, the SSG appeared to be set on
distancing itself from the demonstrable pressures of different in-
terest groups through the repeated reference to the “objectivity” of
risk assessment. This is particularly poignant in the light of the
submissions analysed here which came mainly from the organi-
sations with narrow specialisms (linked with nutrition andmedical
conditions associated with over consumption of salt), or vested
interests (corporate sector, NGOs active in the area of nutrition).
Very few submissions came from individual members of the public,
and none were submitted from representatives of the target pop-
ulation as deﬁned by the terms of reference (e.g., children). Thus,
the submissions were far from representative of the broad cross-
section of perspectives and views. This raises a practical questionrelevant to boundary organisations such as the SACN SSG about
how the aims of PNS are to be achieved in the context of the
simultaneous policy imperative of scientiﬁc independence from the
vested interests.
What we have witnessed through this analysis is therefore a
curious contradiction between the engagement of a SAB with the
extended peer community on one hand, and the simultaneous
distancing from the consequences of such engagement through re-
assertion of scientiﬁc authority. Viewed in such light, the engage-
ment with stakeholders on behalf of the SACN can be construed as a
political act e to gain credibility and acceptance through PNS
practice, whilst maintaining legitimacy as an independent body by
deﬂecting the inﬂuence of controversial values and vested interests
upon the decision outcomes.
We can ﬁnd theoretical resonance of this ﬁnding with the
recently proposed concept of risk colonisation (Rothstein, 2004;
Rothstein, 2006; Rothstein et al., 2006). The concept has been put
forward to explain the way in which an increased emphasis upon
risk assessment in regulation has acted to amplify institutional
risks (risks to the institution’s legitimacy, credibility and account-
ability) thus threatening institutions’ organisation and practices.
The emphasis upon “good governance” that requires an organisa-
tion’s greater transparency and openness, consultation as well as
constant accounting for their practices (to thewider audienceswith
often conﬂicting judgement criteria) has given rise to the practice
of managing “institutional risks”. This creates a dual role for gov-
erning organisations: to govern societal risks whilst simultaneously
managing their own institutional risks. As the current analysis
demonstrates, the SACN consultation process is as much a process
of engaging in optimal risk assessment, as a way of managing
sources of risk to its organisation. Thus, rather than being evidence
of post-normal scientiﬁc practice, the engagement became a
mechanism for conﬁrming the speciﬁc scientiﬁc practice that is
resonant with technocratic models of science as “holding authority
over the facts”.
Examined in the context of a case study of the SSG consultation
we can see the value of PNS as a normative framework though less
support for its role as a theoretical model in explaining newmodes
of science practice. This may be partly due to the speciﬁc nature of
our case of micronutrient recommendations which, though un-
certain, complex, and often controversial and disputed, is never-
theless characterised by a degree of consensus about its
overarching aime to help achieve healthy population (Dhonukshe-
Rutten et al., 2010). Scientists within scientiﬁc advisory committees
for nutrition may see their role as the “guardians of public health”,
their values aligned with those of the public and in conﬂict with
food industry, and hence their science as a “quest for truth” rather
than “quality control”. The evaluation of the extent to which the
adoption of PNS aims in practice by SACs is the function of the
nature of and interactions between the value networks clustered
around an issue might provide useful insights into the applicability
and limitations of PNS.
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INTRODUCTION
Public health nutrition policy is aimed at achieving desir-
able public health nutrition outcome(s) through a statement 
of  values, beliefs and  intentions towards shaping the  food 
and nutrition system [Lawrence, 2007].
The global evolution of nutrition policies started twenty 
years ago with the  “World Declaration and Plan of Action 
* Corresponding Author: Tel.: +48 22 5937119; Fax: +48 22 5937117;
E-mail: marta_jeruszka_bielak@sggw.pl
for Nutrition” [FAO/WHO, 1992]. After that, two European 
Action Plans were developed [WHO, 2001; WHO, 2008] to 
further encourage Member States to integrate actions, bridge 
different government sectors, involve public and private actors 
and consider their own national policies in order to improve 
health, nutrition, food safety and  food security. Moreover, 
many other documents and  council resolutions in  the  Eu-
ropean Union were endorsed, which are focused mostly on 
the diet and physical activity as two of the main risk factors 
for non-communicable diseases [EC, 2007; EC, 2005].
Stakeholders’ Views on Factors Infl uencing Nutrition Policy: 
a Qualitative Study Across Ten European Countries
Marta Jeruszka-Bielak1,*, Ewa Sicińska1, Liesbeth de Wit2, Jiří Ruprich3, Irena Řehůřková3, Kerry A. Brown2, 
Lada Timotijevic2, Anne-Mette Sonne4, Pernille Haugaard4, Antonella Guzzon5, Noé Brito Garcia6, 
Eleni Alevritou7, Maria Hermoso8, Yuliya Sarmant8, Liisa Lähteenmäki4, Wojciech Roszkowski1, Monique M. Raats2
1Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences – SGGW (WULS-SGGW), 
159c Nowoursynowska str., 02–776 Warsaw, Poland
2Food Consumer Behaviour and Health Research Centre, Department of Psychology, University of Surrey, Guildford, UK
3Department for Food Safety Analyses, National Institute of Public Health, Praha, Czech Republic
4MAPP, School of Business, University of Aarhus, Aarhus, Denmark
5Hylobates Consulting SRL, Italy
6Faculty of Health Sciences, Department of Clinical Sciences, University of Las Palmas de Gran Canaria, Las Palmas, 
Gran Canaria, Spain
7EKPIZO, Athens, Greece
8Division of Metabolic Diseases and Nutritional Medicine, University of Munich, Munich, Germany
Key words: public health, nutrition, micronutrients, policy actors, qualitative study, factors
The objective was to identify the main factors infl uencing micronutrient policies in the opinion of policy actors in ten European countries. Study 
was carried out during Jan-Nov 2010 in European countries: the Czech Republic, Denmark, England, Germany, Greece, Italy, the Netherlands, Nor-
way, Poland and Spain. Semi-structured qualitative interviews were conducted with representatives of stakeholders involved in the vitamin D, folate 
and iodine policy making process. Fifty eight key informants representing mainly scientifi c advisory bodies (n=24) and governmental organisations 
(n=19) participated in the study. The remaining interviewees represented non-governmental organisations (n=6), industry (n=4) or were indepen-
dent academic or health professional experts (n=5). Data were analysed by theoretical interpretative thematic analysis. Insights from interviewees on 
the development of micronutrient policies were grouped using the Public Health Nutrition Policy-making model. The main factors infl uencing the mi-
cronutrient policies were: systematic monitoring of nutrition and health, causal relationships between consumers’ diet-related behaviours and health 
outcomes, scientifi c recommendations from national bodies (Science area); scientifi c recommendations from international authorities and experiences 
of other countries, EU legislation, cultural factors (Wider context) and political environment, national capacity to deal with the problem, national leg-
islation, economics, stakeholder engagement, relationships between stakeholders (Policy and institutions area). The spectrum and weight of the factors 
infl uencing nutritional policy depends on nutrient, country and degree of its “advanced status” within nutrition policy, political environment, culture 
and socio-economic conditions as well as the point of view (who is expressing the opinion).
ABBREVIATIONS
CZ – Czech Republic; DE – Germany; DK – Denmark; EL – Greece; EN – England; ES – Spain; GOV – governmental organization; IND EXP – 
independent academic or health professional expert; IT – Italy; NGO – non-governmental organization; NL – Netherlands; NO – Norway; PL – Poland; 
SAB – scientifi c advisory body/expert committee.
0 Factors Influencing Nutrition Policy
Throughout last few decades some theories and models 
have been provided to explain how nutrition policy is made 
and  to help the  policy-makers to elaborate and  implement 
nutrition policies successfully [Lawrence, 2007; Lang, 2006; 
Margetts, 2004]. The  shift from a  rational policy-making 
model toward more pronounced role of  stakeholders/ac-
tors and their political interests was an important milestone 
in health policy development [Brugha & Varvasovszky, 2000]. 
Recently observed encouragement for evidence-based policy 
making is also aimed at increasing its transparency, accept-
ability and accomplishment. But the subjectivity of evidence 
evaluation and  context may infl uence the  fi nal decision 
causing that the same evidence (“fact”) may result in action 
in one context and inaction in another one. The constituents 
of the context again vary in different environments, some may 
be precisely identifi ed and  controlled while others may not 
[Dobrov et al., 2004]. 
The purpose of  this study was to identify the main fac-
tors infl uencing micronutrient nutrition policy in the opinion 
of policy actors in ten European countries varying in their po-
litical, cultural and socio-economic environment.
METHODS
Semi-structured qualitative interviews with 58 representa-
tives of stakeholders involved in the vitamin D, folate and io-
dine policy making process were conducted in ten European 
countries, representing different regional and  socio-cultural 
backgrounds, namely: the  Czech Republic, Denmark, Eng-
land, Germany, Greece, Italy, the Netherlands, Norway, Po-
land and  Spain. The  interviewees represented government, 
scientifi c advisory bodies or expert committees, non-govern-
ment organizations, industry or were independent academic or 
health professional experts. They were selected based on their 
involvement in different areas of national policy development 
on vitamin D, folate and iodine, such as policy advice, coordi-
nation, decision making, and implementation. Those three mi-
cronutrients were chosen from the ten priority micronutrients 
identifi ed within EURRECA network [Cavelaars et al., 2010]. 
Researchers in  the  ten countries conducted interviews 
in their local language, either in person or on the telephone, 
and  recorded them with prior obtained consent and  tran-
scribed verbatim. Interviews contained open questions on 
the participant’s role in policy decisions, the process of policy 
making, factors involved in policy development, constraints 
in policy making, and evaluation of policy instruments. Par-
ticipants were also asked to refl ect on two draft models that 
could support policy making. Data were collected during Jan-
-Nov 2010 and then were analysed by theoretical interpreta-
tive thematic analysis [Braun & Clarke, 2006; Joffe & Yardley, 
2004; Boyatzis, 1998] in  two stages. The fi rst stage was to 
prepare individual summary (in English) of  identifi ed com-
mon as well as distinctive themes in each country. In the sec-
ond stage, summaries from all ten countries were analysed 
to distinguish the  prominent factors infl uencing national 
policies on vitamin D, folate and iodine from the perspective 
of the stakeholders. The fi nal results were discussed with all 
researchers from ten countries to ensure that participant’s 
views were interpreted and refl ected accurately. Data present-
ed herein are part of  the data set represented in Timotijevic 
et al. (case study #3) [Timotijevic et al., 2013]. 
The main study fi ndings – factors infl uencing nutrition 
policy in stakeholders’ opinions – have been presented below 
(and in Figure 1) using the three types of evidence categories 
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FIGURE 1. Main factors infl uencing nutrition policy.
M. Jeruszka-Bielak et al. 0
(Science, Wider context, Policy and  Institutions) identifi ed 
in a Public Health Nutrition Policy-making Framework, de-
veloped by Timotijevic et al.[2013]. 
RESULTS
Description of the interview sample
Most key-informants were representatives of scientifi c ad-
visory bodies/expert committees (24 out of 58) or government 
offi cials (n=19), mainly from health ministries (Table  1). 
In addition, representatives of relevant non-governmental or-
ganizations (n=6) and  industry (n=4) were interviewed as 
well as individual experts (n=5). Three (EN and IT) to eleven 
(CZ) interviews were conducted in  each country depend-
ing on a  country’s policy development context or response 
of key informants approached. The response rates were high 
in  the Czech Republic, Norway, Poland, Greece, the Neth-
erlands and  Denmark (100–80%), while in  Italy, Germany, 
Spain and England were much lower (37–30%).
SCIENCE
Systematic monitoring of  nutrition, nutritional 
and  health status of  population and  especially the  risk 
groups, was indicated by  interviewees as a crucial factor in-
fl uencing the nutrition policy. The actual, regularly collected 
data on nutrient intake and status as well as the prevalence 
of nutrient-related diseases were seen as essential to defi ne 
and  prioritize the  population needs and  to start the whole 
process of  improving their health status. As the  interview-
ees underlined, such monitoring was satisfactory in  most 
of  the countries (especially in NL, DK and NO). However, 
it was believed to be insuffi cient specifi cally in relation to rep-
resentative populations for folate and vitamin D in EL, PL 
and CZ and iodine in the UK. A defi ciency of such data was 
considered to be an important reason for political inaction 
in those countries (Table 2, #1).
According to informants, identifi cation of  the  problem 
scale, e.g. who is  affected, the  whole population or only 
the specifi c subgroups, their characterisation e.g. age, socio-
economic status, culture/religion also infl uences the fi nal deci-
sions in nutrition policy, especially the choice of policy instru-
ment. Food fortifi cation (obligatory) was proposed in many 
countries as the way of  overcoming the  nutrient defi ciency 
when the whole or a signifi cant part of population is affected, 
while the use of dietary supplements was recommended for 
the  individuals (Table  2, #2). Generally, children, elderly, 
and people of low socio-economic status were mentioned as 
the most vulnerable groups in all countries. Immigrants were 
perceived as the risk groups especially for vitamin D defi cien-
cy in Scandinavian countries. 
Evidence on health outcome
Diffi culties with problem characterisation in terms of am-
biguous health consequences of  inadequate nutrition were 
mentioned by  the  majority of  key informants as the  main 
reason for inaction. Lack of clear evidence was mainly stated 
for folate (in NO, CZ, EN, ES, DE, NL, PL) and  vitamin 
D in  the context of  its roles other than in bone metabolism 
(in CZ, DK, EN, ES, DE) (Table 2, #3, 4). In the case of fo-
late, the main reason for not undertaking an obligatory food 
fortifi cation, according to interviewees’ opinion, was the con-
tradiction, i.e. neural tube defect protection in new-borns on 
one hand and increased colon cancer risk in elderly on the oth-
er hand with elevated folate intake. On the contrary, for iodine 
the evidence was considered suffi cient to develop policy in al-
most all countries, except England (Table 2, #5). Generally, 
in each country at least one informant stated that nutrition 
policies are targeted on improving overall diet (e.g.  increase 
the fruit and vegetables consumption, decrease saturated fats, 
salt and  sugar consumption), instead of  improving specifi c 
micronutrient intake/status, as the prophylaxis of many diet-
related diseases, like obesity or heart diseases. 
TABLE 1. Interviewee sample and response rates.
Country
Participant group
Total Response 
rates (%)
Scientifi c 
advisory 
body / Expert 
committee
Independent 
expert
Governmental 
organisation
Non-governmental 
organisation Industry
Czech Republic 3 1 4 2 1 11 11/11 (100)
Denmark 2 2 4 4/5 (80)
England 21 1 3 3/10 (30)
Germany 42 4 4/13 (31)
Greece 23 3 1 6 6/7 (86)
Italy 2 1 3 3/8 (38)
Netherlands 2 1 24 1 6 6/7 (86)
Norway 3 1 2 6 6/6 (100)
Poland 5 1 1 1 1 9 9/10 (90)
Spain 1 1 4 6 6/175 (35)
Total 24 5 19 6 4 58
Both participants also represented a SAB; 2 Two participants represented a SAB (obligatory function) and two represented an expert committee (volun-
tary function); 3 Both participants represented also a NGO and their own experience; 4 Both participants represented also a SAB; 5 One interview with 
an industry representative was excluded from the analysis (and this table) because it was considered irrelevant for the purpose of the study.
0 Factors Influencing Nutrition Policy
Many interviewees indicated that also the  evidence on 
consumer’s attitude and behaviour of different age and so-
cio-economic subgroups should be  gathered and  evaluated. 
Lack of such information may cause implementing unsuccess-
ful policy option(s) (Table 2, #6). Consumers’ negative atti-
tude to the fortifi ed products was perceived as the main reason 
for not introducing too many of such foods in the market, es-
pecially in NO, DK and IT (Table 2, #7). Changing consum-
ers’ behaviour throughout education programs, campaigns, 
etc. was emphasised as one of  the  favourable policy instru-
ments in most of the countries, which is in line with the politi-
cal environment (liberalism) occurring in the country (Table 2, 
#8). In a few countries, especially PL and CZ, key informants 
raised the question of not suffi cient and scientifi c-based edu-
cation of consumers who are mostly educated by media (TV, 
internet, magazines) (Table 2, #9, 10). 
Scientifi c recommendations from national bodies
According to interviews, conclusions and  fi nal advic-
es of  national SABs (the  risk assessment) should inform 
the  government about the  nutrient-related health problems 
that need to be solved. Additionally, the message coming from 
SAB should be explicit and based on scientifi c evidence. Well 
established and systematic process of informing the govern-
ment by SAB was indicated in NL, DK, NO. On the contrary, 
non-harmonised recommendations from various scientifi c 
institutions impede the  communication between scientists 
and government and often cause inaction in nutrition policy. 
Interviewed SAB representatives from Czech Republic, Po-
land, Greece and Spain called for better organisation within 
scientifi c bodies to improve the effectiveness of nutrition pol-
icy (e.g. for vitamin D and folate and generally) and to avoid 
misleading communication for the  policy makers and  for 
the  consumers. SAB representatives proposed to establish 
one independent institution in those countries, which would 
be  multidisciplinary and  would prepare one clear and  un-
equivocal opinion. According to Czech informants, a model 
for iodine operating in this country i.e. Intersectoral Commit-
tee for Solving the  Iodine Defi cit which gathers representa-
tives from different public and private organizations, should 
be followed for vitamin D and folate policies (Table 2, #11). 
WIDER CONTEXT
Scientifi c recommendations from international au-
thorities and other countries experiences, EU legislation 
and  culture are additional factors that infl uence nutrition 
policy as key informants indicated. International organisa-
tions, like WHO, FAO, EFSA, ICCIDD, UNICEF and their 
initiatives were noticed as very important drivers for nutrition 
policies at national levels, which was observed especially for 
TABLE 2. Illustrating quotes in Science area.
Number 
of quote The quote
Author of the quote 
(stakeholder 
and country)
Systematic monitoring of nutrition, nutritional and health status
1. “The problem we are faced with is the lack of organized and systematic recording of data which will clearly show the needs [for vitamin D].” GOV EL
2.
“There has to be a signifi cant part of the population that has the problem before one should control it through the diet. 
If there is a smaller part of the population that has a need and, on top of that risk that some people will be harmed, 
then you shouldn’t do it through the diet. In this case one has to try to encourage the use of supplements.” 
GOV DK
Evidence on health outcome
3.
“when we were doing folic acid, folate, reduce NTDs, that’s easy, that’s understandable 
as a health outcome. Improve folate status, nobody understands that. How do you do (...) 
how so you get a minister’s head around what improving folate status means?”
GOV EN
4.
“There is a general agreement that the Danes get too little vitamin D during winter time, 
but there is not agreement on how dangerous that is for the majority of the population. So 
we are not there yet where we introduce mandatory fortifi cation with vitamin D.” 
GOV DK
5. “(…) iodine defi ciency induces completely defi ned, defi nite, and coherent disorders which are clinically described and people understand and apprehend them. There are objective tests of the saturation.” GOV CZ
Evidence on consumer’s attitude and behaviour
6.
“(…)We also analyzed the sources of folate in a daily diet; it appeared that people who do not eat 
bread consume lower amount of this vitamin than other people, which means that for this specifi c 
population fortifying bread would be of no use since those people do not eat bread whatsoever.” 
SAB PL
7.
“(…) However, by that time the industry believed that the consumer attitudes towards fortifi ed food 
products had changed to the more negative and were afraid to loose market shares and was not 
longer prone to fortify all milk. So now only one type of milk comes with added vitamin D.” 
SAB NO
8. “(…) if we did not take into account the consumer perception and behaviour, we would fail. It would not work, if we did not consider the consumer perception.” SAB DE
9. “(...) there are needed skilled resources accredited by some authority, which would make up the information clear (...).” SAB CZ
10.
‘The Chief of Polish Society of Paediatrics asked the National Health Fund (NFZ=Gov) for 
establishing the special dietician procedures. But they answered that there is no need for this 
as everyone is enough educated and this is conducted by television and radio…” 
IND EXP PL
Scientifi c recommendations from national bodies
11. “(...) the establishment of an independent institution that would use the knowledge from different spheres of science and offer them to the political sphere and to the public for use” GOV CZ
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iodine (CZ, IT, PL) and folate (IT) (Table 3, #1). There was 
a call for such initiatives also for vitamin D and folate (CZ). 
In Greece, the need for harmonisation with WHO/EFSA rec-
ommendations and EU legislation was seen as the fundamen-
tal motive for action in nutrition policy (Table 3, #2).
Lessons from other countries, their experiences with 
the  effectiveness of  different nutrition policy options (for 
iodine) or the  decisions undertaken by  other governments 
(e.g. for folate) also infl uenced the action/inaction at the na-
tional level in stakeholders’ opinions (Table 3, #3).
On the other hand, EU law was perceived rather as a kind 
of  constraint in nutrition policy, especially in NL, NO, DK 
and  EN, and  was underlined by  different stakeholders but 
mostly by government representatives (Table 3, #4). In Spain 
and Greece, on the contrary, recommendations and  regula-
tions from EU were rather appreciated to establish policies at 
the national level (Table 3, #5).
Cultural factors
When the  nutrition policy options and  instruments are 
discussed, the  culture/religious aspects of  particular popu-
lation/country or region cannot be neglected as mentioned 
by  the  representatives from all countries. They infl uence 
the  diet, eating habits, lifestyle of  inhabitants of  different 
countries or regions, e.g. Mediterranean one (Table 3, #6). 
POLICY AND INSTITUTIONS
Based on interviewees opinions, factors infl uencing 
the  general approach in  nutrition policy and  particularly 
the  choice of  policy option(s) and  instrument(s) that can 
be placed in  this area are: economic factors (costs, budgets 
– at the national level), political environment (e.g. type of gov-
erning, political changes), national capacity to deal with 
the  topic (e.g. the  infrastructure and  organisation, timing), 
national legislation, engagement of stakeholders in decision-
-making and relationship between stakeholders.
Economic factors, e.g. lack of money/limited budgets, 
high costs of  particular policy instruments, expressed also 
in  costs to benefi ts relation, were noticed as powerful con-
straints in  nutrition policy in  all countries. Insuffi cient re-
sources were the  main reason for insuffi cient monitoring 
and up-dating the micronutrient intake or status data in vari-
ous populations (Table 4, #1, 2). Limited resources on nu-
trition policies were connected with governmental offi cials’ 
opinions that they were less signifi cant/urgent than other 
public health problems (Table 4, #3).
Political environment, especially the type of governing 
occurring in the country was perceived as a meaningful com-
ponent in nutrition policy. Liberalism was mentioned to shape 
the general character of nutrition policy, mainly in the context 
of policy instruments preferences (especially the educational 
programmes/campaigns and  voluntary food fortifi cation) 
and  it was indicated in most of  the  countries, like in north 
(NL, DK, NO and EN), central (CZ) and south (ES) of Eu-
rope (Table 4, #4, 5). 
This liberal attitude of  government was expressed as 
a positive factor, nevertheless in  the Czech Republic it was 
also seen as a kind of barrier in the nutrition policy (Table 4, 
#6).
Political changes in  terms of  changing the  ruling party/
ies as well as the time of elections when some decisions can 
be  suspended or just opposite – can be  accelerated to win 
the votes, also infl uence the nutrition policymaking as gov-
ernment representatives from NL, EN and  EL mentioned 
(Table 4, #7). Greek interviewees pointed that no procedure 
in nutrition policy was settled that operates non-stop, inde-
pendently of political changes and it rather depends on actual 
political leadership. Besides, the lack of political will was indi-
TABLE 3. Illustrating quotes in Wider context area.
Number 
of quote The quote
Author of the quote 
(stakeholder 
and country)
Scientifi c recommendations from international authorities and other countries experiences
1. “...micronutrients recommendations, in particular for iodine, derive fundamentally from WHO epidemiological surveys and it was scientifi cally proven that, through a programme of iodine supplementation there were benefi cial effects (…).” SAB IT
2. “Any recommendations for micronutrients intake are based on WHO-EFSA relevant recommendations and EC’s requirements for harmonization of legislation.” GOV EL
3.
“(...) we looked at the experiences from other countries. We put a lot of emphasis on what 
goes on in Europe and in particular the other Nordic countries and here the situation 
is similar – one has evaluated the possibility of fortifi cation but no country has ended up 
implementing it. So in that way we have been a part of the European reticence.” 
SAB NO
EU legislation factors
4. “You would very much like to apply national oriented nutrition policy, but you are just bound, bound by European legislation.” GOV NL
5.
“... it is desirable a more European policy, based on global knowledge (...) that gives advice to the countries in order to 
prioritise the interventions. (...) The EU should steer this process by establishing guidelines [regarding micronutrients 
recommendations] (...). Because besides, if we are talking about recommended intakes and fortifi ed foods for public 
health improvement, common policies should be established for the sake of ‚free circulation for community goods’.” 
IND EXP ES
Cultural factors
6.
“…our proposal, based on laboratory analysis of certain Greek traditional foods which proved to be very 
rich in some micronutrients, is: If a healthy adult follows a balanced diet in the frame of Mediterranean 
diet there is no need to eat enriched foods or take food supplements, because this diet can ensure not only 
the recommended daily intake of the three specifi c micronutrients but totally all of the necessary nutrients.” 
SAB EL
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TABLE 4. Illustrating quotes in Policy and institutions area.
Number 
of quote The quote
Author of the quote 
(stakeholder 
and country)
Economic factors
1. “(...) the situation is not improving but getting worse – the monitoring fi nancial resources are getting smaller  which is linked to the economic crisis and pressure to decrease the national costs.” SAB CZ
2.
“I think that the most important factor in our country is the economic issue. Conducting 
good nutritional research, actualization of nutrition recommendations, or others 
is connected with expenses, and for these too little money is allocated.” 
SAB PL
3. “But there are potential - it’s the potential for confl ict. I mean, I think that em....as a nutritionist, I just have to accept that actually there are bigger things for public health.” GOV EN
Political environment
4.
“The fi rst principle is to ensure that people just stay, as long as possible, as healthy 
as possible. And that they particularly do it themselves…. That is the governments 
withdrawing themselves, what you actually see pretty much everywhere.” 
GOV NL
5.
“(...) generally speaking, the Mediterranean countries have been more permissive regarding nutrition policies. 
It has been based on voluntarism rather than legislation and prohibition (...). It is a matter of character, 
we don’t like to oblige or prohibit. Also our shorter regulatory experience plays a role I guess.” 
IND EXP ES
6. “(...) we have no rights to order people how and what to eat (...) it is not possible to restrict the freedom of human decisions (...) the excessive liberalism – this is the problem in the Czech Republic.” GOV CZ
7.
“(...)It sounds very strange, but also nutrition policy has a ‘political colour’. We now have a minister 
who prefers no paternalism; hence, people have to make their choices themselves. Because actually 
we are, let’s say, that’s part of the translation into policy, that you also look at politics; that you do not 
only look at, okay, what is industry doing, but particularly also to who are the House of Representatives 
[the lower house/second chamber] and what direction/fl ow do they want regarding public health.”
GOV NL
8. “…however, whether its [SAB]recommendations will be adopted and implemented or not, it is a matter of political will…” NGO EL
9.
“...that’s why we’ve got the separation of risk assessment from...from risk management, 
i.e. the science from the policymaking, is so that this...so that you so the science 
totally without the political context, totally without the money context.” 
GOV EN
10. “In Norway we have adapted the EFSA model were you have an independent risk assessment committee independent of both commercial and political interests.” IND EXP NO
National capacity to deal with the topic
11.
“To develop Health-Behaviour-Policy framework is quite problematic; because there are not enough 
people who would be devoted to this and prepare something from this is not easy. The number 
of nutrition experts is decreasing rather than increasing, so there is no one to do it” 
NGO CZ
National legislation
12. “(…) In Poland it is an obligatory process, salt iodization. (…) Iodine defi ciencies are observed in all age groups, so the best way is to use a commonly consumed food product. (…)” SAB PL
Engagement of stakeholders within nutrition problem
13.
“(…) we try to involve the local government into the nutrition policy as they may allocate some 
money into nutritional programs e.g. nutrition education at schools, and also we cooperate with 
the Ministry of Health, but in our opinion the Ministry of Health has other priorities.” 
SAB PL
14. “(…) maybe the little interest of politics on the issue, even if health care programmes mean savings in terms of money, …” SAB IT
15.
“Consumers play a marginal role in Norwegian nutritional policy. From complicated historical 
reasons I think, where consumer politics were oriented towards protecting but not involving consumers. 
Consumers therefore do not have a strong and clear voice in nutritional policy making. (…) It is not 
that one do not take consumer issues into consideration – there is a strong tradition in Norway for 
conducting nutritional policy - it is just that it is a very nutritional science driven way of thinking.” 
IND EXP NO
Relationship between the stakeholders
16. “From the producers’ point of view, some things cannot be so easily achieved (…). There are some technological barriers, so it is good when they ask us, whether we are able to do this and that.” INDUSTRY PL
17.
“Stakeholders are involved at all levels. When new rules are negotiated in the EU in the food area we 
usually discuss them with a group of stakeholders – industry associations, consumer associations, patient 
associations (e.g. cancer society). There is also a formal hearing process on new rules and regulations. 
Stakeholders are given the chance to comment on both suggestions for new EU and national regulations.” 
GOV DK
18.
“Nutrition policy must safeguard different interests. To my mind top priority is the promotion of health 
and well-being of the population. At the same time the nutrition policy facilitates the task to advance 
the commercial interests. Employment in the agriculture and job industry should not be ignored either. And all 
these different interests are not always in harmony with each other. So there are some tension zones.” 
SAB DE
19.
“(...) There are things that can be changed in the policy and institutional context, at the national 
level, if a ‚declaration of interest’ were implemented for the stakeholders working in nutrition 
recommendations and public health. As it is already occurring at EFSA. (...) [if authorities] start 
asking for a declaration of interests at the meetings related to nutrients recommendations.” 
GOV ES
20.
“The role of general practitioners (...) And they are saying: ‘all this extra vitamin D [that the SAB advices] 
is nonsense, with this you medicalize society. We are not going to do this, and we do not adopt our advice, because 
it is insuffi ciently substantiated [with evidence]. And there you are in a confl ict between different lines of thought.”
SAB NL
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cated as one of the major obstacles in developing and imple-
menting nutrition policy (Table 4, #8).
Clear separation between risk management (e.g. balancing 
the risks and benefi ts, analysis of unintended consequences) 
which is in government hands and risk assessment – in SAB 
hands, was underlined by a  few interviewees from northern 
countries (EN, NO, DK, DE) representing both government 
and  SAB, as an important constituent improving nutrition 
policy throughout increasing objectivity (Table 4, #9, 10). 
National capacity to deal with the topic 
In a  few countries, like CZ and EL, interviewees under-
lined that the lack of action in nutrition policy could be due 
to insuffi cient human resources that would be able to initiate, 
prepare and  implement the policy (Table 4, #11). Also lack 
of clear task assignments (who is doing what) and devoted 
coordinator(s) was perceived as a barrier, especially in Greece. 
Those problems escalate in the context of time defi ciency. 
National legislation
In a  few countries it was mentioned that national legis-
lation was an important factor (and  in some cases the only 
instrument) in micronutrient policy (Table 4, #12). According 
to informants, it was mostly applied for food re-formulation 
(e.g. obligatory fortifi cation of table salt with iodine; marga-
rine with vitamin D) and was perceived as a positive option, 
just opposite to the impact of EU legislation (“our own” deci-
sion vs. “we are forced”). 
Engagement of stakeholders within nutrition problem
Substantial commitment of the different groups as well as 
individuals to nutrition policy, especially from government in-
stitutions were indicated as crucial determinant of its accom-
plishment. Key informants expressed that governments were 
quite interested and  involved in nutrition policy in northern 
countries (EN, NO, DK, NL, DE), while in Central-Eastern 
(CZ, PL) as well as in Southern Europe (IT, ES, EL), this en-
gagement could have been greater (Table 4, #13, 14). In Den-
mark, the commitment of the whole group of scientists in io-
dine policy was indicated as the main reason for its success. 
Individual (scientists, physicians) rather than the authorities’ 
initiatives were indicated as a trigger for nutrition policy de-
velopment in EL, IT, ES and PL. 
As some interviewees stated, also the engagement of con-
sumer and  industry groups, their desire to take part in  e.g. 
consultations, shape the process of policy making, especially 
the  choice of  fi nal option(s). Strong consumers’ interest 
in nutrition policy was indicated in DK, while in others e.g. 
NO, ES, CZ, IT, was suggested to be rather minimal (Table 4, 
#15). Engagement of industry, although derived from fi nan-
cial motives, was appreciated in some countries (e.g. PL, CZ, 
EL) as it  gave resources and  enabled to conduct nutrition 
studies.
Relationship between the stakeholders
In all ten countries, good cooperation among all actors 
involved in nutrition policy was underlined as a crucial deter-
minant of its success (Table 4, #16). According to interview-
ees representing different stakeholders, cooperation among 
governmental institutions, SAB, industry and  NGOs was 
practised in NL, NO, DK and EN, whereas in  some coun-
tries cooperation was less obvious and  could be  improved 
(CZ, PL), or was suggested to be completely missing (EL) 
(Table 4, #17). Consultation with industry was perceived as 
necessary if the chosen option is to change the micronutrient 
intake through the diet. The food producers should commu-
nicate if planned innovation is feasible and has an impact on 
the fi nal price of the product. 
On the  other hand, confl icts of  interests, lobbing were 
noticed as important constraints in nutrition policy making. 
Some kinds of ongoing lobbing, mostly from the economic 
organisations and  industry, were indicated by  informants 
from DE, EN, ES and PL (Table 4, #18). As key informants 
from ES and EL suggested, the cure for such situation may 
be following EFSA practices and applying “Declaration of In-
terest” to make the process more transparent and  to ensure 
the independence of different stakeholders’ opinions (Table 4, 
# 19).
A  few interviewees stated that some problems may oc-
cur when the  implementers e.g. physicians, do not agree 
with the  recommended policy option, which also indicates 
the need to include those groups into the decision making 
process (Table 4, #20).
Summarising, there can be found some similarities among 
all countries and the patterns of differences between countries 
in perceiving factors infl uencing the micronutrient policy. 
In all ten countries interviewees underlined that economic 
factors, (lack of) evidence of  health outcome, engagement 
of all actors within nutrition policy and a good cooperation 
between them, experiences of other countries are important 
determinants for development of nutrition policy.
In  Western Europe, the  countries are more advanced 
in  the  development of  nutrition policy as they have longer 
policy history per se and  thus the history and  tradition was 
a meaningful factor. Representatives from the Netherlands, 
Denmark, Norway and  England stated that the  European 
legislation is  the main constraint for the nutrition policy at 
national level and that the clear separation between risk as-
sessment and risk management is a crucial factor of its suc-
cess. Besides, in  the Netherlands and England, the political 
change was mentioned as an important factor in  nutrition 
policy development. 
In Poland and Czech Republic, there were indicated similar 
barriers, like insuffi cient monitoring of nutrition, nutritional 
and health status of different populations, insuffi cient human 
resources, thus the  key informants appreciated the  exterior 
sources of  recommendations, especially from international 
authorities (WHO, FAO, EFSA, etc.). Also in both countries 
the  engagement of  food producers that fi nancially support 
the nutritional surveys was perceived as important for micro-
nutrient policy. In Greece, analogous elements were pointed 
out, but additionally administrative barriers (fragmentation 
of  responsibilities, lack of  coordination among several au-
thorities), extensive bureaucracy and lack of political will were 
crucial for inaction in nutrition policy. In contrary to western 
countries, in Greece EU legislation was perceived positively as 
it imposes the need for law harmonisation and thus triggers 
the action. 
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DISCUSSION
Micronutrient nutrition policy depends on a  combina-
tion of many factors, operates on many levels and  includes 
many actors. High-quality, purpose-specifi c surveys [Mar-
getts, 2004], preferably systematic reviews of  randomised 
experiments [Nutley, 2002] are an important information 
source for making nutrition policy that allows the  defi ni-
tion of  nutritional goals for policymakers. The  nutritional 
problem should be  clearly linked with the  health outcome 
and  should be  integrated into the overall health and other 
relevant policies of the government [Margetts, 2004] but as 
our study revealed it is not so obvious for many micronutri-
ents and constitutes an important obstacle for taking any ac-
tion. Our key informants underlined that the task of problem 
characterisation (risk assessment) lays within SAB and usu-
ally is made by government request. The way in which SAB 
are appointed, how their work is organised, and how prob-
lems are framed and  solved, shapes their fi nal conclusions 
[Timotijevic et al., 2011]. This in turn will infl uence the pol-
icy-makers’ decisions who may take up the scientifi c advice 
or give less weight to it compared to other factors [Dhonuk-
she-Rutten, 2013; Timotijevic et al., 2011]. Besides, not only 
what, but also in what way is submitted to authorities, infl u-
ences the process. The review of interview studies with pol-
icy-makers showed that personal contact between research-
ers and policy-makers was the most commonly mentioned 
facilitator while the  absence of  such personal contact was 
the most often recognised barrier to the use of research evi-
dence in policy-making [Innvær, 2002]. Special training pro-
grammes for scientists in order to increase their communica-
tion and advocacy skills [Lawrence, 2007; Choi et al., 2009] 
or invitation into the process “knowledge brokers” [Choi et 
al., 2009] who will be a bridge between scientists and policy-
makers may further help to introduce the scientifi c evidence 
into the process and to accomplish the policy goals.
The  results of  our study indicate that clear separation 
between risk assessment and risk management, according to 
EFSA model, is an important factor in improving the process. 
Our study and others [Timotijevic et al., 2011] indicated that 
such an approach is in place mostly in the Northern Europe 
where advanced policy development is achieved [Trübswasser 
& Branca, 2009]. Such division is not always clear and a “grey 
area” may exist between them as at some point the evidence 
should be evaluated in a broader context, i.e. what is achiev-
able in particular realities. According to the qualitative study 
on EFSA performance [Assessment…, 2004], the  covering 
of “grey area” should be the priority for science and scientifi c 
panels to minimize the politics in the management process. 
As the key informants pointed out in  the present study, 
when preparing the  risk management politicians consider, 
beside scientifi c-based evidence, many other factors mostly 
connected with the limited budgets, political conditions, tim-
ing and organizational capacity as well as existing regula-
tions. Analysis of policy documents from 46 Member States 
of  WHO European Region revealed that obstacles in  im-
plementing nutrition policies were mainly limited fi nancial 
resources, lack of  coordination, lack of  political support 
and lack of expertise as well as insuffi cient legislation and lack 
of scientifi c support because of lack of information from sur-
veys [Trübswasser & Branca, 2009]. It  is worth underlying 
that our study based on interviews with key informants con-
fi rms those results coming out of desk research. Another real-
ity in nutrition policy is that it is usually a part of preventive 
services which in most countries receive a small proportion 
of the overall health budget [Margetts, 2004]. That is at least 
partially connected with the  timing as the benefi ts of  such 
policies might be  seen in  the  long-term and  the politicians 
need the successes for their political expedience in close fu-
ture [Margetts, 2001]. 
Our interviewees stressed that changes in political situa-
tion and in ministries hampered the collaboration and the de-
velopment of nutrition policy. Those reasons as well as the lack 
of  coordination and  lack of  clearly defi ned responsibilities 
were reported to contribute to the lack of inter-sectorial col-
laboration in fi ve out of 46 WHO European region countries 
[Trübswasser&Branca, 2009]. Political instability or high 
turnover of policy-making staff was also one of the reported 
barriers to the use of research evidence in policy-making [In-
nvær et al., 2002].
Not only good cooperation among governmental sectors, 
but also with other groups of  interests, especially scientists, 
industry, consumers, etc. is required for nutrition policy suc-
cess. Our results from this qualitative study confi rm data 
from desk research [Timotijevic et al., 2010] that such part-
nership is  still not applied in  some European countries al-
though it has been recommended by international authorities 
like WHO from the very beginning of nutrition policy develop-
ment [FAO/WHO, 1992]. Again, it is more commonly prac-
ticed in  the countries with longer history of democracy, like 
Norway, Denmark, United Kingdom, the Netherlands than 
in central or south Europe.
As our study revealed, involvement within the nutrition is-
sues of groups or even individuals, especially governmental 
offi cials, scientists and consumers has a positive impact on 
the  process. Lawrence [2007] suggested that coordinating 
responsibility for public health nutrition policy should be lo-
cated at the central or cabinet level of government to increase 
the political will and accomplish a whole-government com-
mitment to the policy. When the political will is missed the in-
terest should be  generated based on the  national context, 
including potential “winners” and “losers” of recommended 
policy [Maetz & Balié, 2008].
Involvement of whole-government, community and other 
groups and sectors is recommended by WHO to implement 
successfully the  Action Plans [FAO/WHO, 1992; WHO, 
2008]. Active civil society is proposed to be a  third impor-
tant force, next to state and supply chain, in the relationship 
between food, the  law and public health (the  ‘triangular dy-
namic’ model) [Lang, 2006]. Improvement of  the  public 
involvement process can be achieved by accessible informa-
tion, accountability, inclusiveness and  openness and  vis-
ibility of  the  government infrastructure [McGregor, 2003]. 
Well educated and  informed consumers may be  crucial de-
terminants of policy outcomes [Boaz et al., 2008]. Involve-
ment of different stakeholders will also improve transparency 
of the process, which is nowadays perceived as a democratic 
right [Timotijevic et al., 2010; McGregor, 2003]. 
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According to our interviewees, food manufactures may 
have a dual infl uence on the nutrition policy. In some coun-
tries, where nutrition issues are underfi nanced by  state, 
the sponsoring of surveys by industry were well appreciated. 
On the other hand, lobbying from this group may push the nu-
trition policy into the wrong direction. Besides, they infl uence 
the nutrition policy by constant reformulation of their prod-
ucts to attract the  (new) consumers and  to gain the fi nan-
cial profi ts. The reformulation of products is a consequence 
of constant competition between food manufactures. These 
“new products” although catching consumers with health-
-related attributes are not always as healthy as the produc-
ers persuade them to be [Golan &Unnevehr, 2008]. Interna-
tional food companies administrate huge fi nancial resources 
they spend on marketing and advertising products regardless 
of their healthiness; this creates a tension zone and contradic-
tion with nutrition policies. 
The key informants in the present study emphasised that 
liberal politics, occurring in  many countries, is  not in  line 
with the state interference into the citizens lives, thus the role 
of consumers education and their conscious choices in a mat-
ter of nutrition and  lifestyle is  extremely important. In  such 
priorities, the knowledge how consumers behave, what, when 
and why they choose is crucial for successful implementation 
of nutrition policy [Ozimek et al., 2009]. Nevertheless, some 
protectionist principles should be  undertaken by  the  state, 
otherwise the dietary choices will increasingly be set by mar-
ketplace and the enormous forces and subtle lobbyist of large 
commercial players [Lang & Rayner, 2007]. Review of applied 
policies to promote healthy eating in Europe indicated that 
the  majority constituted the  interventions supporting more 
informed choice (82 policies out of the total 121), especially 
public information campaigns (38 policies) and nutrition edu-
cation for schoolchildren (31 policies) [Cappaci et al., 2012]. 
STRENGTHS AND WEAKNESSES OF THE STUDY
The present qualitative study bridges information achieved 
from other surveys in the area of nutrition public health but as 
the results are based on the perceptions of people they might 
not represent the  totality of policy making and would need 
the external validity in future research projects. 
Some limitations of this study are the low responding rates 
in a few countries, like England, German, Italy and Spain as 
well as low representatives of some stakeholders (independent 
experts, NGO and industry). 
CONCLUSION
The spectrum and weight of the factors infl uencing nutri-
tional policy depends on (micro)nutrient, country, especially 
its “advanced status” in policy generally, and public health 
nutrition policy particularly, political environment, culture 
and socio-economic conditions as well as the point of view 
(who is expressing the opinion). Lack of money, lack of clear 
evidence on health outcome, lack of  systematic monitoring 
of nutritional and health status as well as lack of political will 
were perceived as powerful constraints in nutrition policy. On 
the other hand, according to interviewees good cooperation 
among stakeholders and their engagement, especially offi cials 
within nutrition problems, clear separation between risk as-
sessment and risk management may improve nutrition policy. 
One should be aware that the presented results are based 
on people’s opinions, which always includes a  subjective 
bias. Nevertheless, authors believe that this work may help 
the policy-makers, as it is essential to have a sense of factors 
and forces that may infl uence nutrition policy.
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Appendix 4.7 Table 6 Contribution of thesis author to co-authored supporting publications 
Supporting publication 
KAB contribution 
Citation 
number  
 
RQ 
formation/ 
design 
Lit. 
review 
Data 
collection 
Study co-
ordination/ 
management 
Data 
analysis 
1
st
 draft 
author 
Draft/ revise 
intellectual 
content 
Published 
version 
approval 
1. Timotijevic L, Raats MM, Barnett J, Brown K et al. 
(2010). From micronutrient recommendations to policy: 
consumer and stakeholder involvement. EJCN, 64:S31-
S37 
     LT   9 
2. Timotijevic L, Barnett J, Brown K et al. (2011). The 
process of setting micronutrient recommendations: a 
cross-European comparison of nutrition-related scientific 
advisory bodies. PHN, 14(4):716-728 
     LT   8 
3. Jensen BB, Lähteenmäki L, Grunert KG, Brown KA 
et al. (2012). Changing micronutrient intake through 
(voluntary) behaviour change. The case of folate. 
Appetite, 58(3):1014-1022 
     BBJ   6 
4. Timotijevic L, Brown KA et al. (2013a). EURRECA - 
A Framework for Considering Evidence in Public Health 
Nutrition Policy Development. CRFSN, 53(10):1124-
1134 
     LT   4 
5. Timotijevic L, Barnett J, Brown K et al. (2013b). 
Scientific decision-making and stakeholder 
consultations: the case of salt recommendations. SSM, 
85:79-86. 
     LT   0 
6. Jeruszka-Bielak M, Sicińska E, de Wit L, Ruprich J, 
Řehůřková I, Brown KA et al. (2015). Stakeholders’ 
views on factors influencing nutrition policy: a 
qualitative study across 10 European countries. Pol J 
Food Nutr Sci 65(4):0-0 
   UK  
 
UK 
MJ-B   0 
RQ: research question; KAB: Kerry Ann Brown; : small; : medium; : large 
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Appendix 5 A note on EURRECA  
EURRECA was a large and complex network of excellence consisting of 34 partners across 17 
countries. It was designed to establish a framework for setting micronutrient recommendations that 
could align the process of setting micronutrient recommendations across Europe by supporting the 
European Food Safety Authority (EFSA), as well as individual nutrition societies or bodies 
responsible for setting micronutrient recommendations in individual countries or regions. Figure 4 
visually represents EURRECA showing a separation of activities into research activities (RA1: best 
practice tools for dietary intake and status methods; RA2: micronutrient and health data; RA3: 
estimating micronutrient average requirements; RA4: micronutrient recommendation case studies) 
and integrating activities (IA1: consumer understanding and stakeholder involvement; IA2: tools; 
IA3: individuality; IA4: SME opportunities). Each of these activities could be viewed as similar, in 
size and scope, to a project of their own, thus the work undertaken was vast and the integration of 
findings challenging. As a Research Fellow the thesis author worked in integrating activity 1, which 
interacted with each research activity. IA1 was led by the University of Surrey and involved up to 10 
partners. The thesis author joined EURRECA in its second year (2008), as maternity cover for Lada 
Timotijevic, and continued until project completion (2012). Monique Raats and Lada Timotijevic 
were part of the EURRECA grant writing team. The thesis author contributed to the data collection 
and reporting of the work led by Lada Timotijevic in 2007 (Timotijevic, 2010; Timotijevic, 2011). 
The thesis author subsequently designed and led three research studies within EURRECA from which 
this thesis is formed (Brown, 2011a; Brown, 2011b; Brown, 2013; Brown, 2015). In addition, the 
thesis author collaborated – in varying degrees – to the design, data collection, analysis, interpretation 
and reporting of further studies led by Birger Jensen and Lada Timotijevic (Jensen, 2012; Timotijevic, 
2013a) and Liesbet de Wit (Jeruszka-Bielak, 2015). Finally, Lada Timotijevic and the thesis author 
led the integration of the EURRECA Consumer and Stakeholder Integrating Activity findings 
(Timotijevic, 2013b; Dhonukshe-Rutten, 2013. 
 
 
 
 
 
 
 
 
Figure 4 Overview of EURRECA network of excellence (Ashwell 2008) 
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- Development of multi-disciplinary and international food and health research infrastructure 
Additional interest in supporting general practice to improve public health services to UK NHS patients.   
CURRENT EMPLOYMENT (see annex 1 for past employment) 
(Oct 2016-present) Research Fellow in public health, London School of Hygiene & Tropical Medicine  
Primary researcher on a Health Foundation funded project run in collaboration between the LSHTM and the 
Royal College of GPs. The project explores what is currently being done in general practice to improve 
services for patients and identifies the specific needs of frontline staff (GPs and practice managers) to support 
this work. This is a mixed methods study, including focus groups, interviews and two nationwide quantitative 
surveys. F will be used to provide targeted training for general practice staff.  
PROFESSIONAL MEMBERSHIP                                                                                                                                    
 European Nutrition Leadership Programme alumni 2011  
 Registered Associate Nutritionist. UKVRN since inception (UK Nutrition Society 2005-2011)  
QUALIFICATIONS  
 Pursuing a professional PhD via PhD published works. Accepted submission from the Uni. of Surrey 
research committee in 2015; viva completed; awaiting corrections review. PhD title: The process of 
setting micronutrient recommendations (see *annex 2 for relevant publications) 
 Masters of Science and Nutrition (London, UK) 
 Bachelors of Science (2:1 joint honours) Sports Science and Psychology (Birmingham, UK) 
TRAINING 
 Statistics for Nutrition research course, Nutrition Society, Uni. of Westminster, 2014 
 Research Ethics & Integrity and Introduction to the IRAS system, Uni. of Surrey ethics workshops, 2014 
 National Centre for Research Methods Autumn School on international and comparative research, 
Southampton, UK, 2013 
 EURRECA systematic review protocol two-day workshop, UEA, UK, 2009 
 EURRECA network communicating to different audiences training course, Rome, IT, 2009 
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23: 1-11 
 Dhonukshe-Rutten RAM, Bouwman J, Brown KA, Cavelaars AEJM, Collings R, Grammatikaki E, De 
Groot LCPGM, Gurinovic M, Harvey LJ, Hermoso M, Hurst R, Kremer B, Ngo J, Novakovic R, Raats 
MM, Rollin F, Serra-Majem L, Souverein OW, Timotijevic L, Van't Veer P (2013). EURRECA-Evidence-
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Critical Reviews in Food Science and Nutrition, 53 (10): 1124-1134 
 Brown KA, Timotijevic L, Barnett J, Shepherd R, Lahteenmaki L, Raats MM (2011b). A review of 
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 Brown KA, Ogden J, Vögele C, Gibson EL (2008). The role of parental control practices in explaining 
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REFEREES 
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ANNEX 1 PAST EMPLOYMENT                                                                                                                                     
(2015-Sep 2016) 0.4 Research Design Service South East (Surrey) NIHR Research Advisor, Uni. of 
Surrey, Guildford, UK  
Supported NHS clinicians with designing research and applying for NIHR or charity research funding. 
(2008-Sep 2016) Research Fellow, Uni. of Surrey, Guildford, UK  
Designed and led multi-disciplinary, multi-national teams in a variety of European research activities. 
Research experience includes a breadth of methodological designs, including qualitative, quantitative and 
mixed method protocols via experiment, questionnaire/survey, interview, workshop, case study and narrative 
literature review. Research projects included: 
 RICHFIELDS: Horizon 2020 Research Infrastructure on Consumer Health and Food Intake for EScience 
with Linked Data Sharing (Sep 2015-Sep 2016). Research Fellow on the methodology work package 
ensuring alignment in research question and work package delivery to fulfil ESFRI roadmap criteria. 
 EuroDISH: FP7 studying the need for food and health research infrastructures in Europe, contract number 
311788 (Sep 2012-Aug 2015). A co-ordination and supporting action assessing the needs for food and 
health research infrastructure.  
- Designed scoping research activity: status quo of European food and health research infrastructure 
- Design and organisation of four EuroDISH workshops (Jun 2013, May 2014, Feb 2015, May 2015) 
- Contributed to design of a food and health research infrastructure (ESFRI 2016 roadmap proposal).   
 CLYMBOL: FP7 role of health-related claims and symbols in consumer behaviour, contract number 
311963 (2012-Aug 2016). CLYMBOL, a research project running from 2012 to 2016 which aims to 
understand how health claims and symbols on food labels may affect purchase and consumption 
behaviour. www.clymbol.eu 
- Conducted qualitative interviews to establish the history of health claim use across Europe 
- Collaborated in the design and led the UK audit to explore the prevalence of health claims in Europe 
- Designed and led parallel, randomised trial on the effect of health claim exposure on consumption. 
Jul-Aug 2012 two-month bridging contract to complete EURRECA publications and prepare grant proposals 
 EURRECA (FP6 European micronutrient Recommendations Aligned, contract number 036196) (2008-
2012). EURRECA, a network of excellence to standardise micronutrient recommendation setting.  
- Designed and led qualitative interview and case study research activities: i) stakeholder beliefs about 
consumers and dietary guidelines; ii) the decision-making processes for implementing micronutrient 
relevant policies; iii) how uncertain evidence is handled in the development of folate and vitamin D 
DRVs 
- Designed a systematic literature review on evidence for consumer use of food-based dietary 
guidelines 
- Contributed to the design and organisation of three EURRECA workshops 
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Jul 2007 – May 2008 travelled around New Zealand 
(Jan-Jun 2007) Research Assistant, Auckland Uni., Auckland, NZ   
General research assistant for the Nursing Department. Completed statistical data analysis and drafted papers 
for peer reviewed journal publications. In addition, researched and prepared bid proposals and ethics 
submissions for Mental Health and Palliative care teams. 
(Oct-Dec 2006) Research Officer, Uni. of Surrey, Guildford, UK  
Continued working on the Joint Innovation Fund (JIF) project described below. Completed statistical analysis 
of questionnaire data, summary reports for individual participating schools and drafted research papers for 
publication. 
(Oct 2005-Sep 2006) Research Officer, Roehampton Uni., London, UK 
The primary researcher on a project called the role of the home environment in protecting child health and 
funded by Uni. of Surrey and Roehampton Joint Innovation Fund (JIF). A one-year project investigated home 
environment variables such as parental covert/overt dietary control and explored the role these variables 
might play in protecting children from becoming overweight and/or encouraging the adoption of healthy 
lifestyles. Consisted of quantitative questionnaire survey and experimental food choice/delayed gratification 
experiments with parents and their 4-6 year-old children.   
(Sep 2004-Sep 2005) Research Fellow, Uni. of Surrey, Guildford, UK   
Researcher on a project called Young People & Food - Adolescent’s Dietary Beliefs & Understandings, 
funded by: Safefood - food safety promotion board, Northern & the Republic of Ireland. A three phase 
project; which looked at the factors that may influence the efficacy of food risk and dietary communications 
directed at young people. Consisted of large scale (N=3,500) quantitative survey and two smaller quasi-
experimental surveys. Also carried out additional consultancy work on a series of surveys. This included the 
design of questionnaires, programming of scanners, scanning and preparing questionnaire databases for a 
number of food, environment and psychology projects including five waves of the longitudinal Northern 
Ireland army Attitude Survey (NIAS 13/14/15/16/17) 
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Sicinska E, Moore AN, Lawrence M, Raats MM (2015). Communication of scientific uncertainty: 
international case studies on the development of folate & vitamin D DRV. PHN, Sep 23: 1-11* 
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ANNEX 3 RESEARCH                                                                                                                                                     
Research income and awards 
Title of grant Total £ Source of grant Duration Dates 
RICHFIELDS: Research 
Infrastructure on Consumer Health 
and Food Intake using E-science 
with Linked Data Sharing  
[Co-investigator 2015-2016] 
Total €3M 
Surrey 
awarded 
€311K 
European Commission 
Horizon 2020 
3 years 
2015- 
2017 
CLYMBOL: Role of health-related 
claims and symbols in consumer 
behaviour [Researcher] 
Surrey 
awarded 
€233K 
European Commission 
Framework Programme 
7 KBBE 
4 years 
2012- 
2016 
EuroDISH: Study on the need for 
food and health research 
infrastructures in Europe 
[Researcher] 
Total 
€2.254M 
Surrey 
awarded 
€173K 
European Commission 
Framework Programme 
7 co-ordination and 
support action KBBE 
3 years 
2012- 
2015 
The role of the home environment 
in protecting child health project  
[Researcher] 
Total 
£29,530 
Uni. of Surrey and 
Roehampton Uni. Joint 
Innovation Fund 
1 year 
2005- 
2006 
Young people and Food – 
Adoelscent’s Dietary Beliefs and 
Understandings [Researcher] 
Surrey 
awarded 
£197,660 
Safefood – food safety 
promotion board for 
Northern and the 
Republic of Ireland 
2 years 
[researcher 
for final 
year] 
2003- 
2005 
 
ANNEX 4 TEACHING 
Supervision 
2015: Assisted dissertation supervision (with Kath Hart) of two final year undergraduates on the Uni. of 
Surrey BSc Nutrition and Dietetics, as well as one MSc student who was visiting from Monash Uni., 
Australia  
2016: Assisted dissertation supervision (with Kath Hart) of a student on the Uni. of Surrey MSc Human 
Nutrition 
Lecturing 
Food-based dietary guidelines guest lecture on the Public Health Nutrition module BMS3018, Nutrition and 
Dietetics undergraduate degree course (2008-2009, 2009-2010) 
 
